Systematic	Gene Symbol	Genbank	FC EGC/NOR	P-value	Description	Chromosomal Location	Alignments of probe sets to the genome	GO biological process	GO molecular function
205449_at	SHD1	NM_013299	8.66	1.17E-03	SAC3 domain containing 1	chr11q13.1	chr11:64565017-64568875 (+)
202859_x_at	IL8	NM_000584	8.46	1.36E-03	interleukin 8	chr4q13-q21	chr4:74825165-74828295 (+)	1525 ; angiogenesis ; traceable author statement ; 6928 ; cell motility ; traceable author statement ; 6935 ; chemotaxis ; traceable author statement ; 7050 ; cell cycle arrest ; inferred from direct assay ; 7186 ; G-protein coupled receptor protein signaling pathway ; traceable author statement ; 7242 ; intracellular signaling cascade ; traceable author statement ; 7267 ; cell-cell signaling ; Unknown ; 7600 ; sensory perception ; inferred from electronic annotation ; 8285 ; negative regulation of cell proliferation ; traceable author statement ; 19722 ; calcium-mediated signaling ; traceable author statement ; 30155 ; regulation of cell adhesion ; inferred from direct assay ; 30593 ; neutrophil chemotaxis ; inferred from genetic interaction ; 42119 ; neutrophil activation ; traceable author statement ; 45091 ; regulation of retroviral genome replication ; inferred from direct assay ; 50930 ; induction of positive chemotaxis ; inferred from genetic interaction ; 6935 ; chemotaxis ; inferred from electronic annotation ; 6954 ; inflammatory response ; inferred from electronic annotation ; 6955 ; immune response ; inferred from electronic annotation ; 6954 ; inflammatory response ; traceable author statement ; 7155 ; cell adhesion ; traceable author statement ; 7165 ; signal transduction ; traceable author statement	5153 ; interleukin-8 receptor binding ; inferred from physical interaction ; 5515 ; protein binding ; inferred from physical interaction ; 8009 ; chemokine activity ; traceable author statement ; 5125 ; cytokine activity ; inferred from electronic annotation ; 8009 ; chemokine activity ; inferred from electronic annotation ; 5153 ; interleukin-8 receptor binding ; traceable author statement
205278_at	GAD1	NM_000817	8.00	5.39E-03	glutamate decarboxylase 1 (brain, 67kDa)	chr2q31	chr2:171381317-171425895 (+)	6520 ; amino acid metabolism ; inferred from electronic annotation ; 6540 ; glutamate decarboxylation to succinate ; traceable author statement ; 7268 ; synaptic transmission ; traceable author statement ; 18352 ; protein-pyridoxal-5-phosphate linkage ; traceable author statement ; 42136 ; neurotransmitter biosynthesis ; inferred from electronic annotation ; 7268 ; synaptic transmission ; inferred from electronic annotation ; 6538 ; glutamate catabolism ; traceable author statement ; 6538 ; glutamate catabolism ; inferred from sequence or structural similarity ; 6540 ; glutamate decarboxylation to succinate ; inferred from sequence or structural similarity ; 7268 ; synaptic transmission ; inferred from sequence or structural similarity ; 18352 ; protein-pyridoxal-5-phosphate linkage ; inferred from sequence or structural similarity	4351 ; glutamate decarboxylase activity ; inferred from direct assay ; 5515 ; protein binding ; inferred from physical interaction ; 16829 ; lyase activity ; inferred from electronic annotation ; 4351 ; glutamate decarboxylase activity ; inferred from electronic annotation ; 16831 ; carboxy-lyase activity ; inferred from electronic annotation ; 4351 ; glutamate decarboxylase activity ; inferred from sequence or structural similarity ; 5515 ; protein binding ; inferred from sequence or structural similarity
209395_at	CHI3L1	M80927	6.96	7.38E-03	chitinase 3-like 1 (cartilage glycoprotein-39)	chr1q32.1	chr1:201414679-201422445 (-)	5975 ; carbohydrate metabolism ; inferred from electronic annotation ; 6032 ; chitin catabolism ; inferred from electronic annotation	4553 ; hydrolase activity, hydrolyzing O-glycosyl compounds ; inferred from electronic annotation ; 4568 ; chitinase activity ; inferred from electronic annotation ; 5201 ; extracellular matrix structural constituent ; traceable author statement ; 5529 ; sugar binding ; inferred from electronic annotation
226670_s_at	C20orf119	AL109839	6.77	1.78E-02	Similar to embryonic poly(A) binding protein	chr20	chr20:42972156-43001371 (+)
209016_s_at	KRT7	BC002700	6.57	4.22E-02	keratin 7	chr12q12-q13	chr12:50913304-50928976 (+)	7010 ; cytoskeleton organization and biogenesis ; non-traceable author statement	5198 ; structural molecule activity ; non-traceable author statement ; 5198 ; structural molecule activity ; inferred from electronic annotation
223229_at	HSPC150	AB032931	6.22	1.22E-03	ubiquitin-conjugating enzyme E2T (putative)	chr1q32.1	chr1:200567573-200571547 (-)	6512 ; ubiquitin cycle ; inferred from electronic annotation ; 6464 ; protein modification ; inferred from electronic annotation	4842 ; ubiquitin-protein ligase activity ; inferred from electronic annotation ; 8642 ; ubiquitin-like activating enzyme activity ; inferred from electronic annotation ; 16874 ; ligase activity ; inferred from electronic annotation
209942_x_at	MAGEA3	BC000340	6.19	4.13E-02	melanoma antigen family A, 3	chrXq28	chrX:151617920-151621470 (+)
213150_at	HOXA10	BF792917	6.05	1.17E-03	homeo box A10	chr7p15-p14	chr7:27176748-27180716 (-)	6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7275 ; development ; traceable author statement ; 7283 ; spermatogenesis ; traceable author statement ; 6350 ; transcription ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation ; 45449 ; regulation of transcription ; inferred from electronic annotation	3700 ; transcription factor activity ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation
214974_x_at	CXCL5	AK026546	5.85	2.28E-03	chemokine (C-X-C motif) ligand 5	chr4q12-q13	chr4:75080223-75081969 (-)	6935 ; chemotaxis ; traceable author statement ; 6954 ; inflammatory response ; not recorded ; 7165 ; signal transduction ; traceable author statement ; 7267 ; cell-cell signaling ; traceable author statement ; 8284 ; positive regulation of cell proliferation ; traceable author statement ; 6955 ; immune response ; inferred from electronic annotation ; 6955 ; immune response ; not recorded	8009 ; chemokine activity ; traceable author statement ; 5125 ; cytokine activity ; inferred from electronic annotation ; 8009 ; chemokine activity ; inferred from electronic annotation
238956_at		AA502384	5.41	1.46E-02	Transcribed locus, strongly similar to XP_524032.1 PREDICTED: similar to ribosomal protein S15; rat insulinoma gene [Pan troglodytes]	chr19	chr19:1251721-1252427 (+)
213008_at	FLJ10719	BG403615	5.38	1.30E-03	hypothetical protein FLJ10719	chr15q25-q26	chr15:87637175-87661958 (+)
223381_at	CDCA1	AF326731	5.34	1.21E-03	cell division cycle associated 1	chr1q23.3	chr1:161558377-161592171 (+)	51301 ; cell division ; inferred from electronic annotation ; 7059 ; chromosome segregation ; non-traceable author statement
229777_at	MGC32871	AA863031	5.01	1.75E-02	transmembrane protein 12	chr10q26.2	chr10:129566099-129572050 (-)
222549_at	CLDN1	AF101051	4.96	1.17E-03	claudin 1	chr3q28-q29	chr3:191506187-191522909 (-)	7155 ; cell adhesion ; traceable author statement ; 16338 ; calcium-independent cell-cell adhesion ; inferred from sequence or structural similarity	5198 ; structural molecule activity ; inferred from electronic annotation ; 42802 ; protein self binding ; inferred from sequence or structural similarity ; 5515 ; protein binding ; inferred from sequence or structural similarity
203691_at	PI3	NM_002638	4.87	1.85E-03	peptidase inhibitor 3, skin-derived (SKALP) ; peptidase inhibitor 3, skin-derived (SKALP)	chr20q12-q13	chr20:43236857-43238582 (+)	7620 ; copulation ; inferred from electronic annotation	4867 ; serine-type endopeptidase inhibitor activity ; traceable author statement ; 5515 ; protein binding ; traceable author statement ; 4866 ; endopeptidase inhibitor activity ; inferred from electronic annotation ; 4867 ; serine-type endopeptidase inhibitor activity ; inferred from electronic annotation ; 4866 ; endopeptidase inhibitor activity ; traceable author statement
201291_s_at	TOP2A	AU159942	4.82	2.28E-03	topoisomerase (DNA) II alpha 170kDa	chr17q21-q22	chr17:35660692-35827676 (-)	6260 ; DNA replication ; non-traceable author statement ; 6265 ; DNA topological change ; inferred from electronic annotation ; 6281 ; DNA repair ; non-traceable author statement ; 48015 ; phosphoinositide-mediated signaling ; non-traceable author statement ; 6259 ; DNA metabolism ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3918 ; DNA topoisomerase (ATP-hydrolyzing) activity ; traceable author statement ; 5524 ; ATP binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 3916 ; DNA topoisomerase activity ; inferred from electronic annotation ; 3918 ; DNA topoisomerase (ATP-hydrolyzing) activity ; inferred from electronic annotation ; 16853 ; isomerase activity ; inferred from electronic annotation ; 3677 ; DNA binding ; traceable author statement ; 3916 ; DNA topoisomerase activity ; traceable author statement
235911_at	LOC440995	AI885815	4.78	1.11E-02	hypothetical gene supported by BC034933; BC068085	chr3q28-q29	chr3:198213007-198213465 (-)
209792_s_at	KLK10	BC002710	4.76	4.65E-03	kallikrein 10	chr19q13.3-q13.4	chr19:56209408-56215094 (-)	6508 ; proteolysis ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation ; 45786 ; negative regulation of progression through cell cycle ; inferred from electronic annotation	4252 ; serine-type endopeptidase activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 8236 ; serine-type peptidase activity ; traceable author statement
209847_at	CDH17	U07969	4.65	2.76E-02	cadherin 17, LI cadherin (liver-intestine)	chr8q22.1	chr8:95208898-95289946 (-)	6810 ; transport ; non-traceable author statement ; 7155 ; cell adhesion ; traceable author statement ; 7156 ; homophilic cell adhesion ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation ; 7155 ; cell adhesion ; inferred from electronic annotation	5215 ; transporter activity ; traceable author statement ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
212942_s_at	KIAA1199	AB033025	4.63	6.24E-03	KIAA1199	chr15q24	chr15:78968946-79031154 (+)	7605 ; sensory perception of sound ; inferred from electronic annotation
235178_x_at	ESCO2	AL120674	4.62	5.13E-03	establishment of cohesion 1 homolog 2 (S. cerevisiae)	chr8p21.1	chr8:27717133-27718720 (+)	7049 ; cell cycle ; inferred from electronic annotation	8415 ; acyltransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
212141_at	MCM4	AA604621	4.58	2.51E-03	MCM4 minichromosome maintenance deficient 4 (S. cerevisiae)	chr8q11.2	chr8:49036051-49053631 (+)	6260 ; DNA replication ; non-traceable author statement ; 6270 ; DNA replication initiation ; inferred from electronic annotation ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6260 ; DNA replication ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; non-traceable author statement ; 8094 ; DNA-dependent ATPase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation
222155_s_at	GPR172A	AK021918	4.41	4.55E-02	G protein-coupled receptor 172A	chr8q24.3	chr8:145553032-145555738 (+)		4872 ; receptor activity ; inferred from electronic annotation
223642_at	ZIC2	AF193855	4.40	1.32E-02	Zic family member 2 (odd-paired homolog, Drosophila)	chr13q32	chr13:99432319-99437019 (+)	6813 ; potassium ion transport ; inferred from electronic annotation ; 7399 ; nervous system development ; inferred from electronic annotation ; 7420 ; brain development ; traceable author statement ; 30154 ; cell differentiation ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation	3677 ; DNA binding ; inferred from electronic annotation ; 5249 ; voltage-gated potassium channel activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation
202790_at	CLDN7	NM_001307	4.40	7.01E-03	claudin 7	chr17p13	chr17:7104179-7107236 (-)	16338 ; calcium-independent cell-cell adhesion ; inferred from sequence or structural similarity	5198 ; structural molecule activity ; inferred from electronic annotation ; 42802 ; protein self binding ; inferred from sequence or structural similarity ; 5515 ; protein binding ; inferred from sequence or structural similarity
222608_s_at	ANLN	AK023208	4.38	6.12E-04	anillin, actin binding protein (scraps homolog, Drosophila)	chr7p15-p14	chr7:36396005-36459925 (+)	910 ; cytokinesis ; inferred from direct assay ; 921 ; septin ring assembly ; traceable author statement ; 7096 ; regulation of exit from mitosis ; traceable author statement	3779 ; actin binding ; inferred from direct assay ; 3779 ; actin binding ; traceable author statement
227174_at	FLJ38736	Z98443	4.36	1.90E-02	WD repeat domain 72	chr15q21.3	chr15:51594651-51596763 (-)
205980_s_at	ARHGAP8; PRR5; PP610; BPGAP1; FLJ20185	NM_015366	4.32	1.04E-03	Rho GTPase activating protein 8 ; PRR5-ARHGAP8 fusion	chr22q13.31	chr22:43560997-43637256 (+)
218542_at	C10orf3	NM_018131	4.27	1.04E-03	chromosome 10 open reading frame 3	chr10q23.33	chr10:95249894-95278837 (+)
219918_s_at	ASPM	NM_018123	4.27	3.02E-03	asp (abnormal spindle)-like, microcephaly associated (Drosophila)	chr1q31	chr1:195320014-195338389 (-)	7049 ; cell cycle ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation ; 51301 ; cell division ; inferred from electronic annotation	5516 ; calmodulin binding ; inferred from electronic annotation
222760_at	FLJ14299	BG290193	4.16	1.37E-02	zinc finger protein 703	chr8p12	chr8:37672458-37676697 (+)		3676 ; nucleic acid binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
221577_x_at	GDF15	AF003934	4.08	1.87E-03	growth differentiation factor 15	chr19p13.1-13.2	chr19:18357997-18360745 (+)	7165 ; signal transduction ; traceable author statement ; 7179 ; transforming growth factor beta receptor signaling pathway ; traceable author statement ; 7267 ; cell-cell signaling ; traceable author statement	5125 ; cytokine activity ; traceable author statement ; 8083 ; growth factor activity ; inferred from electronic annotation ; 5125 ; cytokine activity ; inferred from electronic annotation
226661_at	CDCA2	T90295	4.07	1.72E-03	cell division cycle associated 2	chr8p21.2	chr8:25416808-25421307 (+)
204259_at	MMP7	NM_002423	4.06	4.05E-03	matrix metallopeptidase 7 (matrilysin, uterine)	chr11q21-q22	chr11:101896448-101906688 (-)	270 ; peptidoglycan metabolism ; inferred from electronic annotation ; 6508 ; proteolysis ; traceable author statement ; 30574 ; collagen catabolism ; inferred from electronic annotation ; 6508 ; proteolysis ; inferred from electronic annotation	4235 ; matrilysin activity ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 4222 ; metalloendopeptidase activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8237 ; metallopeptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4222 ; metalloendopeptidase activity ; traceable author statement
201970_s_at	NASP	NM_002482	4.01	7.79E-03	nuclear autoantigenic sperm protein (histone-binding)	chr1p34.1	chr1:45822321-45856503 (+)	6323 ; DNA packaging ; traceable author statement ; 7283 ; spermatogenesis ; traceable author statement	5488 ; binding ; inferred from electronic annotation
226980_at	DEPDC1B	AK001166	4.00	1.04E-03	DEP domain containing 1B	chr5q12.1	chr5:59928497-59976383 (-)	7242 ; intracellular signaling cascade ; inferred from electronic annotation
232291_at	C13orf25	AA256157	3.96	2.45E-02	chromosome 13 open reading frame 25	chr13q31.3	chr13:90802089-90804832 (+)
223509_at	CLDN2	AF177340	3.96	1.56E-02	claudin 2	chrXq22.3-23	chrX:106030049-106059459 (+)	16338 ; calcium-independent cell-cell adhesion ; inferred from sequence or structural similarity	5198 ; structural molecule activity ; inferred from electronic annotation ; 42802 ; protein self binding ; inferred from sequence or structural similarity ; 5515 ; protein binding ; inferred from sequence or structural similarity
205345_at	BARD1	NM_000465	3.92	8.90E-03	BRCA1 associated RING domain 1	chr2q34-q35	chr2:215301521-215382611 (-)	1894 ; tissue homeostasis ; traceable author statement ; 6974 ; response to DNA damage stimulus ; non-traceable author statement ; 7050 ; cell cycle arrest ; non-traceable author statement ; 16567 ; protein ubiquitination ; non-traceable author statement ; 31441 ; negative regulation of mRNA 3-end processing ; non-traceable author statement ; 42325 ; regulation of phosphorylation ; inferred from mutant phenotype ; 43065 ; positive regulation of apoptosis ; inferred from mutant phenotype ; 43066 ; negative regulation of apoptosis ; inferred from mutant phenotype ; 45732 ; positive regulation of protein catabolism ; non-traceable author statement ; 46826 ; negative regulation of protein export from nucleus ; inferred from direct assay ; 16567 ; protein ubiquitination ; inferred from electronic annotation	4842 ; ubiquitin-protein ligase activity ; non-traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 19900 ; kinase binding ; non-traceable author statement ; 42803 ; protein homodimerization activity ; inferred from physical interaction ; 46872 ; metal ion binding ; inferred from electronic annotation ; 46982 ; protein heterodimerization activity ; inferred from physical interaction ; 3723 ; RNA binding ; inferred from direct assay ; 4842 ; ubiquitin-protein ligase activity ; inferred from electronic annotation
228729_at	CCNB1	N90191	3.92	5.58E-03	cyclin B1	chr5q12	chr5:68509082-68509828 (+)	74 ; regulation of progression through cell cycle ; inferred from electronic annotation ; 86 ; G2/M transition of mitotic cell cycle ; non-traceable author statement ; 7067 ; mitosis ; inferred from electronic annotation ; 51301 ; cell division ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation	5515 ; protein binding ; inferred from physical interaction
206023_at	NMU	NM_006681	3.91	3.00E-02	neuromedin U	chr4q12	chr4:56156154-56197222 (-)	6940 ; regulation of smooth muscle contraction ; traceable author statement ; 7165 ; signal transduction ; traceable author statement ; 7218 ; neuropeptide signaling pathway ; inferred from electronic annotation ; 7586 ; digestion ; traceable author statement ; 6940 ; regulation of smooth muscle contraction ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; traceable author statement	5102 ; receptor binding ; traceable author statement
204170_s_at	CKS2	NM_001827	3.85	1.04E-03	CDC28 protein kinase regulatory subunit 2	chr9q22	chr9:91115932-91121437 (+)	79 ; regulation of cyclin dependent protein kinase activity ; traceable author statement ; 7049 ; cell cycle ; non-traceable author statement ; 7051 ; spindle organization and biogenesis ; non-traceable author statement ; 8283 ; cell proliferation ; traceable author statement ; 48015 ; phosphoinositide-mediated signaling ; non-traceable author statement ; 51301 ; cell division ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation	16538 ; cyclin-dependent protein kinase regulator activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation
210052_s_at	TPX2	AF098158	3.83	1.71E-03	TPX2, microtubule-associated, homolog (Xenopus laevis)	chr20q11.2	chr20:29790791-29852956 (+)	7067 ; mitosis ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement	5524 ; ATP binding ; traceable author statement ; 5525 ; GTP binding ; traceable author statement
204855_at	SERPINB5	NM_002639	3.83	3.56E-02	serpin peptidase inhibitor, clade B (ovalbumin), member 5	chr18q21.3	chr18:59295198-59323297 (+)	6928 ; cell motility ; traceable author statement	4867 ; serine-type endopeptidase inhibitor activity ; inferred from electronic annotation ; 4867 ; serine-type endopeptidase inhibitor activity ; not recorded
201292_at	TOP2A	AL561834	3.82	2.26E-03	topoisomerase (DNA) II alpha 170kDa	chr17q21-q22	chr17:35660692-35827676 (-)	6260 ; DNA replication ; non-traceable author statement ; 6265 ; DNA topological change ; inferred from electronic annotation ; 6281 ; DNA repair ; non-traceable author statement ; 48015 ; phosphoinositide-mediated signaling ; non-traceable author statement ; 6259 ; DNA metabolism ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3918 ; DNA topoisomerase (ATP-hydrolyzing) activity ; traceable author statement ; 5524 ; ATP binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 3916 ; DNA topoisomerase activity ; inferred from electronic annotation ; 3918 ; DNA topoisomerase (ATP-hydrolyzing) activity ; inferred from electronic annotation ; 16853 ; isomerase activity ; inferred from electronic annotation ; 3677 ; DNA binding ; traceable author statement ; 3916 ; DNA topoisomerase activity ; traceable author statement
202095_s_at	BIRC5	NM_001168	3.82	6.81E-03	baculoviral IAP repeat-containing 5 (survivin)	chr17q25	chr17:73721943-73732372 (+)	86 ; G2/M transition of mitotic cell cycle ; inferred from direct assay ; 6915 ; apoptosis ; inferred from electronic annotation ; 6916 ; anti-apoptosis ; inferred from direct assay ; 6916 ; anti-apoptosis ; inferred from electronic annotation ; 7166 ; cell surface receptor linked signal transduction ; non-traceable author statement	4869 ; cysteine protease inhibitor activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 8017 ; microtubule binding ; inferred from direct assay ; 8270 ; zinc ion binding ; non-traceable author statement ; 43027 ; caspase inhibitor activity ; inferred from mutant phenotype ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4866 ; endopeptidase inhibitor activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 30414 ; protease inhibitor activity ; non-traceable author statement ; 4872 ; receptor activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 4872 ; receptor activity ; non-traceable author statement
232165_at	EPPK1	AL137725	3.77	2.15E-02	epiplakin 1	chr9	chr8:145011487-145012764 (-)		5198 ; structural molecule activity ; non-traceable author statement ; 5198 ; structural molecule activity ; inferred from electronic annotation
228955_at		AL041761	3.73	7.03E-03	Homo sapiens, clone IMAGE:4753714, mRNA	chr1	chr1:53480631-53481305 (-)
213147_at	HOXA10	AI375919	3.69	2.07E-03	homeo box A10	chr7p15-p14	chr7:27176748-27180716 (-)	6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7275 ; development ; traceable author statement ; 7283 ; spermatogenesis ; traceable author statement ; 6350 ; transcription ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation ; 45449 ; regulation of transcription ; inferred from electronic annotation	3700 ; transcription factor activity ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation
236113_at		H40020	3.68	9.73E-03	Transcribed locus, moderately similar to XP_510104.1 PREDICTED: similar to hypothetical protein FLJ25224 [Pan troglodytes]	chr11	chr11:69792948-69793331 (-)
204641_at	NEK2	NM_002497	3.67	1.05E-03	NIMA (never in mitosis gene a)-related kinase 2	chr1q32.2-q41	chr14:19166878-19168938 (+)	6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 7088 ; regulation of mitosis ; traceable author statement ; 7126 ; meiosis ; inferred from electronic annotation ; 51301 ; cell division ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation ; 74 ; regulation of progression through cell cycle ; traceable author statement ; 7067 ; mitosis ; traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 287 ; magnesium ion binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; traceable author statement ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
203213_at	CDC2	AL524035	3.66	4.68E-03	Cell division cycle 2, G1 to S and G2 to M	chr10q21.1	chr10:62208241-62224668 (+)	6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation ; 7089 ; traversing start control point of mitotic cell cycle ; not recorded ; 51301 ; cell division ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation ; 74 ; regulation of progression through cell cycle ; non-traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 4693 ; cyclin-dependent protein kinase activity ; not recorded ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; non-traceable author statement
203954_x_at	CLDN3	NM_001306	3.66	4.13E-02	claudin 3	chr7q11.23	chr7:72821265-72822502 (-)	16338 ; calcium-independent cell-cell adhesion ; inferred from sequence or structural similarity	4888 ; transmembrane receptor activity ; traceable author statement ; 5198 ; structural molecule activity ; inferred from electronic annotation ; 42802 ; protein self binding ; inferred from sequence or structural similarity ; 5515 ; protein binding ; inferred from sequence or structural similarity
223883_s_at	STK31	AF332194	3.64	7.38E-03	serine/threonine kinase 31	chr7p15.3	chr7:23716469-23838553 (+)	6468 ; protein amino acid phosphorylation ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation
214651_s_at	HOXA9	U41813	3.64	4.48E-02	homeo box A9	chr7p15-p14	chr7:27168744-27175794 (-)	6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7275 ; development ; traceable author statement ; 6350 ; transcription ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation ; 45449 ; regulation of transcription ; inferred from electronic annotation	3700 ; transcription factor activity ; inferred from electronic annotation ; 16563 ; transcriptional activator activity ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation
235985_at	PITPNB	AI821477	3.60	2.33E-02	Phosphatidylinositol transfer protein, beta	chr22q12.1	chr22:26635197-26635799 (-)	6629 ; lipid metabolism ; non-traceable author statement ; 6810 ; transport ; inferred from electronic annotation	8289 ; lipid binding ; inferred from electronic annotation ; 8526 ; phosphatidylinositol transporter activity ; not recorded
229215_at	ASCL2	AI393930	3.60	1.99E-02	achaete-scute complex-like 2 (Drosophila)	chr11p15.5	chr11:2246303-2246889 (-)	6355 ; regulation of transcription, DNA-dependent ; non-traceable author statement ; 7417 ; central nervous system development ; non-traceable author statement ; 7422 ; peripheral nervous system development ; non-traceable author statement ; 30154 ; cell differentiation ; inferred from electronic annotation ; 45449 ; regulation of transcription ; inferred from electronic annotation	3700 ; transcription factor activity ; non-traceable author statement ; 30528 ; transcription regulator activity ; inferred from electronic annotation
226320_at	THOC4	AF047002	3.59	2.68E-02	THO complex 4	chr17q25.3	chr17_random:2405225-2408222 (-)	398 ; nuclear mRNA splicing, via spliceosome ; inferred from electronic annotation ; 6406 ; mRNA export from nucleus ; inferred from electronic annotation ; 6457 ; protein folding ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation ; 6397 ; mRNA processing ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3723 ; RNA binding ; inferred from electronic annotation ; 51082 ; unfolded protein binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 3676 ; nucleic acid binding ; inferred from electronic annotation
205043_at	CFTR	NM_000492	3.59	2.13E-02	cystic fibrosis transmembrane conductance regulator, ATP-binding cassette (sub-family C, member 7)	chr7q31.2	chr7:116907252-117095951 (+)	6811 ; ion transport ; inferred from electronic annotation ; 7585 ; respiratory gaseous exchange ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation ; 6810 ; transport ; traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 5216 ; ion channel activity ; inferred from electronic annotation ; 5224 ; ATP-binding and phosphorylation-dependent chloride channel activity ; traceable author statement ; 5260 ; channel-conductance-controlling ATPase activity ; non-traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; traceable author statement ; 16887 ; ATPase activity ; inferred from electronic annotation ; 30165 ; PDZ domain binding ; inferred from direct assay ; 5254 ; chloride channel activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 17111 ; nucleoside-triphosphatase activity ; inferred from electronic annotation ; 42626 ; ATPase activity, coupled to transmembrane movement of substances ; inferred from electronic annotation ; 5254 ; chloride channel activity ; traceable author statement
222037_at		AI859865	3.58	4.91E-03	MCM4 minichromosome maintenance deficient 4 (S. cerevisiae)	chr8q11.2	chr8:49052283-49053270 (+)	6260 ; DNA replication ; non-traceable author statement ; 6270 ; DNA replication initiation ; inferred from electronic annotation ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6260 ; DNA replication ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; non-traceable author statement ; 8094 ; DNA-dependent ATPase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation
212444_at		AA156240	3.58	4.09E-03	G protein-coupled receptor, family C, group 5, member A	chr12	chr12:12959250-13082801 (+)	7165 ; signal transduction ; traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation ; 7165 ; signal transduction ; inferred from electronic annotation	4872 ; receptor activity ; inferred from electronic annotation ; 8067 ; metabotropic glutamate, GABA-B-like receptor activity ; inferred from electronic annotation ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; traceable author statement
225261_x_at	TH1L	AJ238376	3.55	2.24E-02	TH1-like (Drosophila)	chr20q13	chr20:56996159-57003565 (+)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 16481 ; negative regulation of transcription ; inferred from electronic annotation	5515 ; protein binding ; inferred from physical interaction
239022_at	TFRC	AW090199	3.54	7.03E-03	Succinate dehydrogenase complex, subunit A, flavoprotein-like 2	chr3q29	chr3:196891034-196891563 (+)
212935_at	MCF2L	AB002360	3.53	1.75E-02	MCF.2 cell line derived transforming sequence-like	chr13q34	chr13:112670814-112800932 (+)	7242 ; intracellular signaling cascade ; inferred from electronic annotation	5085 ; guanyl-nucleotide exchange factor activity ; inferred from electronic annotation
229490_s_at	IQGAP3	AW271106	3.53	1.22E-03	IQ motif containing GTPase activating protein 3	chr1	chr1:154761848-154762170 (+)	7264 ; small GTPase mediated signal transduction ; inferred from electronic annotation ; 46580 ; negative regulation of Ras protein signal transduction ; inferred from electronic annotation	5099 ; Ras GTPase activator activity ; inferred from electronic annotation ; 5516 ; calmodulin binding ; inferred from electronic annotation
233007_at	XRCC5	AU147192	3.49	4.68E-03	X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining; Ku autoantigen, 80kDa)	chr2q35	chr2:216749726-216751055 (+)	6303 ; double-strand break repair via nonhomologous end-joining ; inferred from electronic annotation ; 6310 ; DNA recombination ; traceable author statement ; 6281 ; DNA repair ; inferred from electronic annotation ; 6310 ; DNA recombination ; inferred from electronic annotation ; 6974 ; response to DNA damage stimulus ; inferred from electronic annotation ; 6302 ; double-strand break repair ; traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 3690 ; double-stranded DNA binding ; traceable author statement ; 4003 ; ATP-dependent DNA helicase activity ; traceable author statement ; 4386 ; helicase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 4003 ; ATP-dependent DNA helicase activity ; inferred from electronic annotation
229139_at	JPH1	AI202201	3.49	1.97E-03	junctophilin 1	chr8q21	chr8:75309492-75309982 (-)
225827_at	EIF2C2	AI832074	3.47	6.98E-04	eukaryotic translation initiation factor 2C, 2	chr8q24	chr8:141610423-141664593 (-)	6412 ; protein biosynthesis ; non-traceable author statement ; 6412 ; protein biosynthesis ; inferred from electronic annotation	3743 ; translation initiation factor activity ; non-traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 3743 ; translation initiation factor activity ; inferred from electronic annotation
221501_x_at	LOC339047	AF229069	3.40	1.92E-02	hypothetical protein LOC339047	chr16p13.11	chr16:16351448-16351944 (+)
225834_at	FAM72A	AL135396	3.40	1.04E-03	family with sequence similarity 72, member A	chr1q32.1	chr1:120640549-120657204 (+)
214097_at	RPS21	AW024383	3.39	1.30E-02	ribosomal protein S21	chr20q13.3	chr20:60395499-60396971 (+)	6412 ; protein biosynthesis ; inferred from electronic annotation ; 30154 ; cell differentiation ; non-traceable author statement	3735 ; structural constituent of ribosome ; inferred from electronic annotation
203967_at	CDC6	U77949	3.37	4.05E-03	CDC6 cell division cycle 6 homolog (S. cerevisiae)	chr17q21.3	chr17:35697671-35712539 (+)	76 ; DNA replication checkpoint ; traceable author statement ; 79 ; regulation of cyclin dependent protein kinase activity ; traceable author statement ; 6260 ; DNA replication ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation ; 7089 ; traversing start control point of mitotic cell cycle ; traceable author statement ; 8156 ; negative regulation of DNA replication ; traceable author statement ; 8285 ; negative regulation of cell proliferation ; traceable author statement ; 51301 ; cell division ; inferred from electronic annotation	166 ; nucleotide binding ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation ; 17111 ; nucleoside-triphosphatase activity ; inferred from electronic annotation ; 166 ; nucleotide binding ; inferred from electronic annotation
212531_at	LCN2	NM_005564	3.37	4.72E-02	lipocalin 2 (oncogene 24p3)	chr9q34	chr9:129951569-129955552 (+)	6810 ; transport ; inferred from electronic annotation	5215 ; transporter activity ; inferred from electronic annotation ; 5488 ; binding ; inferred from electronic annotation
204033_at	TRIP13	NM_004237	3.32	1.04E-03	thyroid hormone receptor interactor 13	chr5p15.33	chr5:946068-971070 (+)	6366 ; transcription from RNA polymerase II promoter ; traceable author statement	3712 ; transcription cofactor activity ; traceable author statement ; 166 ; nucleotide binding ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 17111 ; nucleoside-triphosphatase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; non-traceable author statement
232164_s_at	EPPK1	AL137725	3.30	9.68E-03	epiplakin 1	chr8q24.3	chr8:145011487-145012764 (-)		5198 ; structural molecule activity ; non-traceable author statement ; 5198 ; structural molecule activity ; inferred from electronic annotation
219148_at	PBK	NM_018492	3.28	1.97E-03	PDZ binding kinase	chr8p21.2	chr8:27723331-27751219 (-)	6468 ; protein amino acid phosphorylation ; non-traceable author statement ; 7067 ; mitosis ; non-traceable author statement ; 6468 ; protein amino acid phosphorylation ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; traceable author statement ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; non-traceable author statement ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation
203108_at	GPCR5A	NM_003979	3.27	2.04E-03	G protein-coupled receptor, family C, group 5, member A	chr12p13-p12.3	chr12:12935619-12957855 (+)	7165 ; signal transduction ; traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation ; 7165 ; signal transduction ; inferred from electronic annotation	4872 ; receptor activity ; inferred from electronic annotation ; 8067 ; metabotropic glutamate, GABA-B-like receptor activity ; inferred from electronic annotation ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; traceable author statement
209396_s_at	CHI3L1	M80927	3.27	1.20E-02	chitinase 3-like 1 (cartilage glycoprotein-39)	chr1q32.1	chr1:201414679-201422445 (-)	5975 ; carbohydrate metabolism ; inferred from electronic annotation ; 6032 ; chitin catabolism ; inferred from electronic annotation	4553 ; hydrolase activity, hydrolyzing O-glycosyl compounds ; inferred from electronic annotation ; 4568 ; chitinase activity ; inferred from electronic annotation ; 5201 ; extracellular matrix structural constituent ; traceable author statement ; 5529 ; sugar binding ; inferred from electronic annotation
205107_s_at	EFNA4	NM_005227	3.24	3.65E-02	ephrin-A4	chr1q21-q22	chr1:153302896-153308638 (+)	7267 ; cell-cell signaling ; traceable author statement	5005 ; transmembrane-ephrin receptor activity ; traceable author statement
219555_s_at	BM039	NM_018455	3.24	8.79E-03	uncharacterized bone marrow protein BM039	chr16q23.2	chr16:79598064-79613979 (+)
206074_s_at	HMGA1	NM_002131	3.24	5.65E-03	high mobility group AT-hook 1	chr6p21	chr6:34312645-34321985 (+)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; traceable author statement ; 7001 ; chromosome organization and biogenesis (sensu Eukaryota) ; inferred from electronic annotation ; 7169 ; transmembrane receptor protein tyrosine kinase signaling pathway ; non-traceable author statement ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6869 ; lipid transport ; inferred from electronic annotation ; 42157 ; lipoprotein metabolism ; inferred from electronic annotation ; 45941 ; positive regulation of transcription ; inferred from mutant phenotype ; 6337 ; nucleosome disassembly ; traceable author statement ; 6345 ; loss of chromatin silencing ; traceable author statement ; 6461 ; protein complex assembly ; traceable author statement ; 6268 ; DNA unwinding during replication ; non-traceable author statement	3680 ; AT DNA binding ; traceable author statement ; 3677 ; DNA binding ; inferred from electronic annotation ; 3677 ; DNA binding ; traceable author statement ; 8289 ; lipid binding ; inferred from electronic annotation ; 3700 ; transcription factor activity ; inferred from mutant phenotype ; 30374 ; ligand-dependent nuclear receptor transcription coactivator activity ; inferred from mutant phenotype ; 8134 ; transcription factor binding ; inferred from physical interaction ; 42974 ; retinoic acid receptor binding ; inferred from physical interaction ; 42975 ; peroxisome proliferator activated receptor binding ; inferred from physical interaction ; 46965 ; retinoid X receptor binding ; inferred from physical interaction
235545_at	DEPDC1	AI810054	3.24	4.68E-03	DEP domain containing 1	chr1	chr1:68712424-68713230 (-)	7242 ; intracellular signaling cascade ; inferred from electronic annotation
222489_s_at	WRNIP1	AA621580	3.24	2.18E-02	Werner helicase interacting protein 1	chr6p25.2	chr6:2694428-2732130 (+)	731 ; DNA synthesis during DNA repair ; inferred from direct assay ; 30174 ; regulation of DNA replication initiation ; inferred from direct assay ; 6260 ; DNA replication ; inferred from electronic annotation ; 6281 ; DNA repair ; inferred from electronic annotation ; 6974 ; response to DNA damage stimulus ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5515 ; protein binding ; inferred from sequence or structural similarity ; 5524 ; ATP binding ; Unknown ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 16887 ; ATPase activity ; inferred from mutant phenotype ; 5524 ; ATP binding ; inferred from electronic annotation ; 17111 ; nucleoside-triphosphatase activity ; inferred from electronic annotation
208079_s_at	STK6	NM_003158	3.24	2.02E-03	serine/threonine kinase 6	chr20q13.2-q13.3	chr20:54377872-54396667 (-)	6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 6468 ; protein amino acid phosphorylation ; traceable author statement ; 7049 ; cell cycle ; non-traceable author statement ; 7051 ; spindle organization and biogenesis ; non-traceable author statement ; 7067 ; mitosis ; traceable author statement ; 48015 ; phosphoinositide-mediated signaling ; non-traceable author statement ; 31647 ; regulation of protein stability ; inferred from mutant phenotype ; 7049 ; cell cycle ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from direct assay ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; traceable author statement
227140_at	INHBA	AI343467	3.23	1.91E-02	Inhibin, beta A (activin A, activin AB alpha polypeptide)	chr7	chr7:41691236-41693304 (-)	1501 ; skeletal development ; traceable author statement ; 1541 ; ovarian follicle development ; non-traceable author statement ; 6917 ; induction of apoptosis ; inferred from direct assay ; 6952 ; defense response ; traceable author statement ; 7050 ; cell cycle arrest ; traceable author statement ; 7166 ; cell surface receptor linked signal transduction ; traceable author statement ; 7267 ; cell-cell signaling ; traceable author statement ; 7399 ; nervous system development ; non-traceable author statement ; 7498 ; mesoderm development ; inferred from sequence or structural similarity ; 9605 ; response to external stimulus ; traceable author statement ; 30154 ; cell differentiation ; traceable author statement ; 30218 ; erythrocyte differentiation ; non-traceable author statement ; 40007 ; growth ; inferred from electronic annotation ; 42326 ; negative regulation of phosphorylation ; traceable author statement ; 42541 ; hemoglobin biosynthesis ; inferred from direct assay ; 45077 ; negative regulation of interferon-gamma biosynthesis ; traceable author statement ; 45578 ; negative regulation of B cell differentiation ; traceable author statement ; 45650 ; negative regulation of macrophage differentiation ; traceable author statement ; 46881 ; positive regulation of follicle-stimulating hormone secretion ; traceable author statement ; 46882 ; negative regulation of follicle-stimulating hormone secretion ; non-traceable author statement ; 7165 ; signal transduction ; traceable author statement ; 45786 ; negative regulation of progression through cell cycle ; traceable author statement ; 1541 ; ovarian follicle development ; inferred from sequence or structural similarity ; 6917 ; induction of apoptosis ; inferred from sequence or structural similarity ; 6952 ; defense response ; inferred from sequence or structural similarity ; 7050 ; cell cycle arrest ; inferred from sequence or structural similarity ; 7166 ; cell surface receptor linked signal transduction ; inferred from sequence or structural similarity ; 7267 ; cell-cell signaling ; inferred from sequence or structural similarity ; 7399 ; nervous system development ; inferred from sequence or structural similarity ; 30154 ; cell differentiation ; inferred from sequence or structural similarity ; 30218 ; erythrocyte differentiation ; inferred from sequence or structural similarity ; 42326 ; negative regulation of phosphorylation ; inferred from sequence or structural similarity ; 42541 ; hemoglobin biosynthesis ; inferred from sequence or structural similarity ; 45077 ; negative regulation of interferon-gamma biosynthesis ; inferred from sequence or structural similarity ; 45578 ; negative regulation of B cell differentiation ; inferred from sequence or structural similarity ; 45650 ; negative regulation of macrophage differentiation ; inferred from sequence or structural similarity ; 45786 ; negative regulation of progression through cell cycle ; inferred from sequence or structural similarity ; 46881 ; positive regulation of follicle-stimulating hormone secretion ; inferred from sequence or structural similarity ; 46882 ; negative regulation of follicle-stimulating hormone secretion ; inferred from sequence or structural similarity	5125 ; cytokine activity ; traceable author statement ; 5160 ; transforming growth factor beta receptor binding ; not recorded ; 5179 ; hormone activity ; inferred from electronic annotation ; 5179 ; hormone activity ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 8083 ; growth factor activity ; inferred from electronic annotation ; 8083 ; growth factor activity ; traceable author statement ; 17106 ; activin inhibitor activity ; traceable author statement ; 5125 ; cytokine activity ; inferred from sequence or structural similarity ; 5179 ; hormone activity ; inferred from sequence or structural similarity ; 5515 ; protein binding ; inferred from sequence or structural similarity ; 8083 ; growth factor activity ; inferred from sequence or structural similarity ; 17106 ; activin inhibitor activity ; inferred from sequence or structural similarity
201015_s_at	JUP	NM_021991	3.22	2.19E-02	junction plakoglobin	chr17q21	chr17:37164389-37181643 (-)	7155 ; cell adhesion ; non-traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation	5198 ; structural molecule activity ; inferred from electronic annotation ; 8092 ; cytoskeletal protein binding ; traceable author statement ; 5488 ; binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
209040_s_at	PSMB8	U17496	3.19	3.53E-02	proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7)	chr6p21.3	chr6:32916602-32919779 (-)	6508 ; proteolysis ; not recorded ; 6511 ; ubiquitin-dependent protein catabolism ; inferred from electronic annotation ; 6955 ; immune response ; inferred from electronic annotation	4298 ; threonine endopeptidase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 4175 ; endopeptidase activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
220615_s_at	MLSTD1	NM_018099	3.17	1.56E-02	male sterility domain containing 1	chr12p11.22	chr12:29193498-29378272 (+)
236641_at	KIF14	AW183154	3.17	1.04E-03	kinesin family member 14	chr1pter-q31.3	chr1:198787252-198787868 (-)	7018 ; microtubule-based movement ; inferred from electronic annotation ; 6412 ; protein biosynthesis ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3777 ; microtubule motor activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 3774 ; motor activity ; inferred from electronic annotation ; 3735 ; structural constituent of ribosome ; inferred from electronic annotation
202580_x_at	FOXM1	NM_021953	3.16	1.38E-03	forkhead box M1	chr12p13	chr12:2837110-2853954 (-)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6366 ; transcription from RNA polymerase II promoter ; traceable author statement ; 6979 ; response to oxidative stress ; traceable author statement	3700 ; transcription factor activity ; traceable author statement ; 3702 ; RNA polymerase II transcription factor activity ; traceable author statement ; 3677 ; DNA binding ; inferred from electronic annotation ; 3700 ; transcription factor activity ; inferred from electronic annotation ; 3677 ; DNA binding ; traceable author statement
222740_at	ATAD2	AI925583	3.14	2.02E-04	ATPase family, AAA domain containing 2	chr8q24.13	chr8:124401730-124441079 (-)		166 ; nucleotide binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 17111 ; nucleoside-triphosphatase activity ; inferred from electronic annotation
230563_at	RASGEF1A	BF446578	3.13	3.41E-02	RasGEF domain family, member 1A	chr10q11.21	chr10:43009989-43010748 (-)	7242 ; intracellular signaling cascade ; inferred from electronic annotation ; 7264 ; small GTPase mediated signal transduction ; inferred from electronic annotation	5085 ; guanyl-nucleotide exchange factor activity ; inferred from electronic annotation
206445_s_at	HRMT1L2	NM_001536	3.12	4.30E-02	HMT1 hnRNP methyltransferase-like 2 (S. cerevisiae)	chr19q13.3	chr19:54872354-54883516 (+)	6479 ; protein amino acid methylation ; traceable author statement ; 6952 ; defense response ; not recorded ; 7166 ; cell surface receptor linked signal transduction ; traceable author statement	5515 ; protein binding ; inferred from physical interaction ; 8170 ; N-methyltransferase activity ; traceable author statement ; 8757 ; S-adenosylmethionine-dependent methyltransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 8168 ; methyltransferase activity ; inferred from electronic annotation ; 8168 ; methyltransferase activity ; traceable author statement
212203_x_at	IFITM3	BF338947	3.12	5.58E-03	interferon induced transmembrane protein 3 (1-8U)	chr11p15.5	chr11:309676-310900 (-)	6955 ; immune response ; traceable author statement ; 9607 ; response to biotic stimulus ; inferred from electronic annotation ; 6955 ; immune response ; inferred from electronic annotation
217875_s_at	TMEPAI	NM_020182	3.12	3.81E-02	transmembrane, prostate androgen induced RNA	chr20q13.31-q13.33	chr20:55660241-55719022 (-)	30521 ; androgen receptor signaling pathway ; non-traceable author statement
214898_x_at	MUC3B	AB038783	3.12	4.19E-02	mucin 3A, intestinal ; mucin 3B	chr7q22	chr7:100388685-100398339 (+)	30277 ; maintenance of gastrointestinal epithelium ; non-traceable author statement	30197 ; extracellular matrix constituent, lubricant activity ; non-traceable author statement ; 5201 ; extracellular matrix structural constituent ; non-traceable author statement
222962_s_at	MCM10	AB042719	3.11	1.04E-03	MCM10 minichromosome maintenance deficient 10 (S. cerevisiae)	chr10p13	chr10:13246132-13292317 (+)		5515 ; protein binding ; inferred from physical interaction
206102_at	KIAA0186	NM_021067	3.11	3.28E-03	DNA replication complex GINS protein PSF1	chr20p11.21	chr20:25336362-25375949 (+)	6260 ; DNA replication ; inferred from electronic annotation
220688_s_at	C1orf33	NM_016183	3.11	4.21E-03	chromosome 1 open reading frame 33	chr1p36.13	chr1:19450886-19458076 (+)	7046 ; ribosome biogenesis ; inferred from electronic annotation ; 42254 ; ribosome biogenesis and assembly ; inferred from electronic annotation
207165_at	HMMR	NM_012485	3.11	3.42E-03	hyaluronan-mediated motility receptor (RHAMM)	chr5q33.2-qter	chr5:162820240-162851523 (+)	6928 ; cell motility ; not recorded	5540 ; hyaluronic acid binding ; inferred from electronic annotation ; 5540 ; hyaluronic acid binding ; not recorded
203256_at	CDH3	NM_001793	3.11	7.03E-03	cadherin 3, type 1, P-cadherin (placental)	chr16q22.1	chr16:67236730-67290432 (+)	7155 ; cell adhesion ; traceable author statement ; 7156 ; homophilic cell adhesion ; inferred from electronic annotation ; 7600 ; sensory perception ; inferred from electronic annotation ; 7601 ; visual perception ; inferred from electronic annotation ; 7155 ; cell adhesion ; inferred from electronic annotation	5509 ; calcium ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
232510_s_at	DPP3	AW250952	3.10	9.69E-03	dipeptidylpeptidase 3	chr11q12-q13.1	chr11:66006236-66033700 (+)	6508 ; proteolysis ; traceable author statement ; 6508 ; proteolysis ; inferred from electronic annotation	4177 ; aminopeptidase activity ; inferred from electronic annotation ; 8237 ; metallopeptidase activity ; inferred from electronic annotation ; 17039 ; dipeptidyl-peptidase III activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 8239 ; dipeptidyl-peptidase activity ; traceable author statement
219787_s_at	ECT2	NM_018098	3.09	6.14E-03	epithelial cell transforming sequence 2 oncogene	chr3q26.1-q26.2	chr3:174003355-174021951 (+)	7242 ; intracellular signaling cascade ; inferred from electronic annotation ; 43123 ; positive regulation of I-kappaB kinase/NF-kappaB cascade ; inferred from mutant phenotype	4871 ; signal transducer activity ; inferred from mutant phenotype ; 5085 ; guanyl-nucleotide exchange factor activity ; inferred from electronic annotation
218663_at	HCAP-G	NM_022346	3.07	5.58E-03	chromosome condensation protein G	chr4p15.33	chr4:17421702-17454229 (+)	7049 ; cell cycle ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation ; 7076 ; mitotic chromosome condensation ; non-traceable author statement ; 51301 ; cell division ; inferred from electronic annotation ; 7076 ; mitotic chromosome condensation ; inferred from electronic annotation	5488 ; binding ; inferred from electronic annotation
202690_s_at	SNRPD1	BC001721	3.07	1.36E-02	small nuclear ribonucleoprotein D1 polypeptide 16kDa	chr18q11.2	chr18:17446266-17463193 (+)	398 ; nuclear mRNA splicing, via spliceosome ; inferred from electronic annotation ; 6397 ; mRNA processing ; inferred from electronic annotation	5515 ; protein binding ; inferred from physical interaction
228273_at	FLJ11029	BG165011	3.07	1.17E-03	Hypothetical protein FLJ11029	chr17	chr17:54636997-54640015 (+)
214710_s_at	CCNB1	BE407516	3.07	2.83E-03	cyclin B1	chr5q12	chr5:68498643-68509323 (+)	74 ; regulation of progression through cell cycle ; inferred from electronic annotation ; 86 ; G2/M transition of mitotic cell cycle ; non-traceable author statement ; 7067 ; mitosis ; inferred from electronic annotation ; 51301 ; cell division ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation	5515 ; protein binding ; inferred from physical interaction
206858_s_at	HOXC6	NM_004503	3.06	4.84E-02	homeo box C6	chr12q13.3	chr12:52708460-52710787 (+)	6357 ; regulation of transcription from RNA polymerase II promoter ; traceable author statement ; 7275 ; development ; traceable author statement ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation ; 45449 ; regulation of transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; non-traceable author statement ; 7275 ; development ; non-traceable author statement	3700 ; transcription factor activity ; inferred from electronic annotation ; 3714 ; transcription corepressor activity ; traceable author statement ; 3677 ; DNA binding ; inferred from electronic annotation ; 3700 ; transcription factor activity ; non-traceable author statement
202338_at	TK1	NM_003258	3.06	7.72E-03	thymidine kinase 1, soluble	chr17q23.2-q25.3	chr17:73681775-73694726 (-)	6139 ; nucleobase, nucleoside, nucleotide and nucleic acid metabolism ; traceable author statement ; 6260 ; DNA replication ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4797 ; thymidine kinase activity ; traceable author statement ; 5524 ; ATP binding ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4797 ; thymidine kinase activity ; inferred from electronic annotation
204825_at	MELK	NM_014791	3.05	3.02E-03	maternal embryonic leucine zipper kinase	chr9p13.2	chr9:36562872-36667678 (+)	6468 ; protein amino acid phosphorylation ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation
204146_at	RAD51AP1	BE966146	3.05	4.35E-03	RAD51 associated protein 1	chr12p13.2-p13.1	chr12:4518293-4539473 (+)	724 ; double-strand break repair via homologous recombination ; non-traceable author statement ; 6281 ; DNA repair ; non-traceable author statement ; 6281 ; DNA repair ; inferred from electronic annotation ; 6974 ; response to DNA damage stimulus ; inferred from electronic annotation	3690 ; double-stranded DNA binding ; inferred from direct assay ; 3697 ; single-stranded DNA binding ; inferred from direct assay ; 3723 ; RNA binding ; inferred from direct assay ; 5515 ; protein binding ; inferred from physical interaction ; 3677 ; DNA binding ; inferred from electronic annotation ; 3723 ; RNA binding ; inferred from electronic annotation
219531_at	Cep72	NM_018140	3.04	1.78E-02	centrosomal protein 72 kDa	chr5p15.33	chr5:665460-706664 (+)
204315_s_at	GTSE1	AI340239	3.04	1.30E-03	G-2 and S-phase expressed 1	chr22q13.2-q13.3	chr22:45071939-45106293 (+)	85 ; G2 phase of mitotic cell cycle ; non-traceable author statement ; 6977 ; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest ; non-traceable author statement ; 7017 ; microtubule-based process ; non-traceable author statement
204653_at	TFAP2A	BF343007	3.02	1.89E-02	transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)	chr6p24	chr6:10504905-10523471 (-)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6357 ; regulation of transcription from RNA polymerase II promoter ; traceable author statement ; 7165 ; signal transduction ; not recorded ; 7398 ; ectoderm development ; traceable author statement	3700 ; transcription factor activity ; inferred from electronic annotation ; 3705 ; RNA polymerase II transcription factor activity, enhancer binding ; not recorded ; 3713 ; transcription coactivator activity ; traceable author statement ; 3677 ; DNA binding ; inferred from electronic annotation ; 3700 ; transcription factor activity ; non-traceable author statement
205081_at	CRIP1	NM_001311	3.02	4.86E-02	cysteine-rich protein 1 (intestinal)	chr14q32.33	chr14:105024641-105026072 (+)	8283 ; cell proliferation ; traceable author statement ; 19735 ; antimicrobial humoral response (sensu Vertebrata) ; traceable author statement	8270 ; zinc ion binding ; traceable author statement ; 46872 ; metal ion binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
202870_s_at	CDC20	NM_001255	3.02	8.44E-03	CDC20 cell division cycle 20 homolog (S. cerevisiae)	chr1p34.1	chr1:43597214-43601458 (+)	74 ; regulation of progression through cell cycle ; traceable author statement ; 6511 ; ubiquitin-dependent protein catabolism ; traceable author statement ; 6512 ; ubiquitin cycle ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation ; 51301 ; cell division ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation ; 7049 ; cell cycle ; traceable author statement	5515 ; protein binding ; inferred from physical interaction
201841_s_at	HSPB1	NM_001540	3.02	4.48E-02	heat shock 27kDa protein 1	chr7q11.23	chr7:75769858-75771548 (+)	6446 ; regulation of translational initiation ; traceable author statement ; 6457 ; protein folding ; inferred from electronic annotation ; 6986 ; response to unfolded protein ; traceable author statement ; 6986 ; response to unfolded protein ; inferred from electronic annotation
207076_s_at	ASS	NM_000050	3.02	9.02E-03	argininosuccinate synthetase	chr9q34.1	chr12:33029972-33031502 (+)	50 ; urea cycle ; traceable author statement ; 6526 ; arginine biosynthesis ; inferred from electronic annotation ; 8652 ; amino acid biosynthesis ; inferred from electronic annotation ; 50 ; urea cycle ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4055 ; argininosuccinate synthase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation ; 16874 ; ligase activity ; inferred from electronic annotation
219000_s_at	DCC1	NM_024094	3.02	2.99E-04	defective in sister chromatid cohesion homolog 1 (S. cerevisiae)	chr8q24.12	chr8:120915397-120937330 (-)
206392_s_at	RARRES1	NM_002888	3.02	2.02E-02	retinoic acid receptor responder (tazarotene induced) 1	chr3q25.32-q25.33	chr3:159905135-159932925 (-)	8285 ; negative regulation of cell proliferation ; traceable author statement	4872 ; receptor activity ; inferred from electronic annotation
214100_x_at	WBSCR20B	AI284845	3.02	4.71E-02	Williams Beuren syndrome chromosome region 20C	chr7q11.23	chr7:74883590-74884006 (+)
209567_at	RRS1	BC001811	3.00	9.89E-03	RRS1 ribosome biogenesis regulator homolog (S. cerevisiae)	chr8q13.1	chr8:67503830-67505520 (+)	7046 ; ribosome biogenesis ; inferred from electronic annotation ; 42254 ; ribosome biogenesis and assembly ; inferred from electronic annotation
217109_at	MUC4	AJ242547	3.00	4.36E-02	mucin 4, tracheobronchial	chr3q29	chr3:196959310-197023157 (-)	7160 ; cell-matrix adhesion ; inferred from electronic annotation	5176 ; ErbB-2 class receptor binding ; traceable author statement ; 5201 ; extracellular matrix structural constituent ; non-traceable author statement ; 30197 ; extracellular matrix constituent, lubricant activity ; non-traceable author statement
207375_s_at	IL15RA	NM_002189	2.99	6.99E-03	interleukin 15 receptor, alpha	chr10p15-p14	chr10:6034339-6059543 (-)	7165 ; signal transduction ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement	4872 ; receptor activity ; inferred from electronic annotation ; 4907 ; interleukin receptor activity ; traceable author statement ; 4871 ; signal transducer activity ; traceable author statement
223500_at	CPLX1	BC002471	2.98	7.46E-03	complexin 1	chr4p16.3	chr4:768745-809945 (-)	6836 ; neurotransmitter transport ; inferred from electronic annotation ; 6887 ; exocytosis ; traceable author statement ; 7268 ; synaptic transmission ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation	19905 ; syntaxin binding ; inferred from electronic annotation
212022_s_at	MKI67	BF001806	2.97	1.97E-03	antigen identified by monoclonal antibody Ki-67	chr10q25-qter	chr10:129784916-129814639 (-)	74 ; regulation of progression through cell cycle ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement ; 7049 ; cell cycle ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation
232277_at	SLC28A3	AA643687	2.96	3.73E-02	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 3	chr9	chr9:86080586-86082920 (-)	6810 ; transport ; inferred from electronic annotation	5415 ; nucleoside:sodium symporter activity ; inferred from electronic annotation ; 1882 ; nucleoside binding ; inferred from electronic annotation
232238_at	ASPM	AK001380	2.96	2.28E-03	asp (abnormal spindle)-like, microcephaly associated (Drosophila)	chr1q31	chr1:195340482-195370953 (-)	7049 ; cell cycle ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation ; 51301 ; cell division ; inferred from electronic annotation	5516 ; calmodulin binding ; inferred from electronic annotation
222923_s_at	KCNE3	AF302494	2.94	2.95E-02	potassium voltage-gated channel, Isk-related family, member 3	chr11q13-q14	chr11:73844985-73850798 (-)	6811 ; ion transport ; inferred from electronic annotation ; 6813 ; potassium ion transport ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation	5249 ; voltage-gated potassium channel activity ; inferred from electronic annotation ; 30955 ; potassium ion binding ; inferred from electronic annotation ; 5216 ; ion channel activity ; inferred from electronic annotation ; 5244 ; voltage-gated ion channel activity ; inferred from electronic annotation
227923_at	SHANK3	BF439330	2.94	5.66E-03	SH3 and multiple ankyrin repeat domains 3	chr22q13.3	chr22:49505898-49518504 (+)
224646_x_at	H19	BF569051	2.93	2.05E-02	H19, imprinted maternally expressed untranslated mRNA	chr11p15.5	chr11:1972981-1975062 (-)
205071_x_at	XRCC4	AB017445	2.92	3.94E-02	X-ray repair complementing defective repair in Chinese hamster cells 4	chr5q13-q14	chr5:82409206-82684913 (+)	6281 ; DNA repair ; inferred from electronic annotation ; 6302 ; double-strand break repair ; traceable author statement ; 6310 ; DNA recombination ; inferred from electronic annotation ; 6310 ; DNA recombination ; traceable author statement ; 6974 ; response to DNA damage stimulus ; inferred from electronic annotation
210074_at	CTSL2	AF070448	2.92	3.77E-03	cathepsin L2	chr9q22.2	chr9:98834905-98840157 (-)	6508 ; proteolysis ; inferred from electronic annotation	4217 ; cathepsin L activity ; traceable author statement ; 4197 ; cysteine-type endopeptidase activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8234 ; cysteine-type peptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 8234 ; cysteine-type peptidase activity ; traceable author statement
235217_at	MLL5	AW148862	2.92	1.50E-02	Myeloid/lymphoid or mixed-lineage leukemia 5 (trithorax homolog, Drosophila)	chr7	chr7:104409425-104410928 (-)	6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	5515 ; protein binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
238617_at		AW207243	2.92	4.46E-02	CDNA FLJ38181 fis, clone FCBBF1000125	chr1	chr1:243938544-243939357 (+)
221521_s_at	Pfs2	BC003186	2.92	3.02E-03	DNA replication complex GINS protein PSF2	chr16q24.1	chr16:84268781-84280089 (-)	6260 ; DNA replication ; inferred from electronic annotation
226936_at	C6orf173	BG492359	2.91	5.34E-03	chromosome 6 open reading frame 173	chr6q22.32	chr6:126702943-126711447 (+)
239108_at	MLSTD1	H16791	2.91	2.30E-02	Male sterility domain containing 1	chr12p11.22	chr12:29379397-29379815 (+)
223349_s_at	BOK	BE614255	2.88	4.97E-02	BCL2-related ovarian killer	chr2q37.3	chr2:242146978-242162206 (+)	42981 ; regulation of apoptosis ; inferred from electronic annotation ; 6915 ; apoptosis ; inferred from direct assay ; 6915 ; apoptosis ; inferred from electronic annotation	46983 ; protein dimerization activity ; inferred from sequence or structural similarity
224753_at	CDCA5	BE614410	2.88	1.41E-02	cell division cycle associated 5	chr11q12.1	chr11:64601500-64608104 (-)	7049 ; cell cycle ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation ; 51301 ; cell division ; inferred from electronic annotation
205774_at	F12	NM_000505	2.87	9.02E-03	coagulation factor XII (Hageman factor)	chr5q33-qter	chr5:176761746-176769183 (-)	6508 ; proteolysis ; inferred from electronic annotation ; 7596 ; blood coagulation ; traceable author statement ; 42730 ; fibrinolysis ; inferred from electronic annotation ; 7596 ; blood coagulation ; inferred from electronic annotation	3805 ; coagulation factor XIa activity ; traceable author statement ; 3806 ; coagulation factor XIIa activity ; traceable author statement ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 3806 ; coagulation factor XIIa activity ; inferred from electronic annotation ; 4252 ; serine-type endopeptidase activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 8236 ; serine-type peptidase activity ; traceable author statement
204798_at	MYB	NM_005375	2.86	3.02E-03	v-myb myeloblastosis viral oncogene homolog (avian)	chr6q22-q23	chr6:135544250-135581998 (+)	6355 ; regulation of transcription, DNA-dependent ; non-traceable author statement ; 45449 ; regulation of transcription ; inferred from electronic annotation ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3677 ; DNA binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 16563 ; transcriptional activator activity ; non-traceable author statement
232278_s_at	DEPDC1	AJ278112	2.86	8.34E-03	DEP domain containing 1	chr1p31.2	chr9:107560205-107563641 (+)	7242 ; intracellular signaling cascade ; inferred from electronic annotation
203612_at	BYSL	NM_004053	2.86	1.57E-02	bystin-like	chr6p21.1	chr6:42003210-42008760 (+)	7155 ; cell adhesion ; traceable author statement ; 7565 ; pregnancy ; traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation	5515 ; protein binding ; inferred from electronic annotation
205891_at	ADORA2B	NM_000676	2.85	6.02E-03	adenosine A2b receptor	chr17p12-p11.2	chr17:15788955-15819783 (+)	187 ; activation of MAPK activity ; traceable author statement ; 6968 ; cellular defense response ; traceable author statement ; 7165 ; signal transduction ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; traceable author statement ; 7190 ; adenylate cyclase activation ; traceable author statement ; 7254 ; JNK cascade ; traceable author statement ; 7588 ; excretion ; traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation	1584 ; rhodopsin-like receptor activity ; inferred from electronic annotation ; 1612 ; A2B adenosine receptor activity, G-protein coupled ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 1609 ; adenosine receptor activity, G-protein coupled ; inferred from electronic annotation ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; inferred from electronic annotation
232417_x_at	ZDHHC11	AU150300	2.85	4.13E-02	zinc finger, DHHC-type containing 11	chr5p15.33	chr5:848720-895610 (-)		46872 ; metal ion binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 8415 ; acyltransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation
205828_at	MMP3	NM_002422	2.81	1.61E-02	matrix metallopeptidase 3 (stromelysin 1, progelatinase)	chr11q22.3	chr11:102211387-102219550 (-)	270 ; peptidoglycan metabolism ; inferred from electronic annotation ; 6508 ; proteolysis ; traceable author statement ; 30574 ; collagen catabolism ; inferred from electronic annotation ; 6508 ; proteolysis ; inferred from electronic annotation	4248 ; stromelysin 1 activity ; traceable author statement ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 4222 ; metalloendopeptidase activity ; inferred from electronic annotation ; 4248 ; stromelysin 1 activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8237 ; metallopeptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
218009_s_at	PRC1	NM_003981	2.81	1.17E-03	protein regulator of cytokinesis 1	chr15q26.1	chr15:89310278-89338729 (-)	22 ; mitotic spindle elongation ; traceable author statement ; 910 ; cytokinesis ; traceable author statement
222848_at	FKSG14	BC005400	2.80	6.94E-03	leucine zipper protein FKSG14	chr5p15.2-q12.3	chr5:64849349-64894741 (-)
202286_s_at	TACSTD2; M1S1; EGP-1; GA733; TROP2; GA733-1	J04152	2.80	8.00E-03	tumor-associated calcium signal transducer 2	chr1p32-p31	chr1:58813230-58816033 (-)	7166 ; cell surface receptor linked signal transduction ; traceable author statement ; 7600 ; sensory perception ; inferred from electronic annotation ; 7601 ; visual perception ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement ; 7601 ; visual perception ; inferred from electronic annotation	4872 ; receptor activity ; traceable author statement
205240_at	GPSM2	NM_013296	2.80	8.13E-03	G-protein signalling modulator 2 (AGS3-like, C. elegans)	chr1p13.3	chr1:109229523-109274214 (+)	7165 ; signal transduction ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; traceable author statement	5096 ; GTPase activator activity ; inferred from electronic annotation ; 5488 ; binding ; inferred from electronic annotation ; 42802 ; protein self binding ; inferred from physical interaction ; 5515 ; protein binding ; inferred from physical interaction
244665_at	ITGA6	AI056776	2.79	4.13E-02	Integrin, alpha 6	chr2q31.1	chr2:173014172-173014532 (+)	7044 ; cell-substrate junction assembly ; traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation ; 7160 ; cell-matrix adhesion ; inferred from electronic annotation ; 7229 ; integrin-mediated signaling pathway ; inferred from electronic annotation ; 7160 ; cell-matrix adhesion ; not recorded	4872 ; receptor activity ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
228401_at	ATAD2	AI656807	2.77	4.62E-04	ATPase family, AAA domain containing 2	chr8q24.13	chr8:124401270-124401894 (-)		166 ; nucleotide binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 17111 ; nucleoside-triphosphatase activity ; inferred from electronic annotation
202771_at	LOC348180	NM_014745	2.77	4.18E-02	family with sequence similarity 38, member A	chr16q24.3	chr16:87309255-87330160 (-)
217817_at	ARPC4	BE891920	2.77	4.13E-02	actin related protein 2/3 complex, subunit 4, 20kDa	chr3p25.3	chr3:9814341-9823785 (+)	30041 ; actin filament polymerization ; inferred from electronic annotation
243000_at	CDK6	AW194766	2.74	2.73E-02	cyclin-dependent kinase 6	chr7q21-q22	chr7:92078713-92079318 (-)	74 ; regulation of progression through cell cycle ; traceable author statement ; 80 ; G1 phase of mitotic cell cycle ; traceable author statement ; 6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 8283 ; cell proliferation ; traceable author statement ; 51301 ; cell division ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; traceable author statement
209709_s_at	HMMR	U29343	2.74	1.67E-03	hyaluronan-mediated motility receptor (RHAMM)	chr5q33.2-qter	chr5:162820238-162851265 (+)	6928 ; cell motility ; not recorded	5540 ; hyaluronic acid binding ; inferred from electronic annotation ; 5540 ; hyaluronic acid binding ; not recorded
201797_s_at	VARS2	NM_006295	2.73	3.10E-02	valyl-tRNA synthetase	chr6p21.3	chr6:31853277-31871489 (-)	6412 ; protein biosynthesis ; inferred from electronic annotation ; 6414 ; translational elongation ; non-traceable author statement ; 6438 ; valyl-tRNA aminoacylation ; inferred from electronic annotation ; 6418 ; tRNA aminoacylation for protein translation ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4832 ; valine-tRNA ligase activity ; inferred from direct assay ; 4832 ; valine-tRNA ligase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16874 ; ligase activity ; inferred from electronic annotation ; 4812 ; tRNA ligase activity ; inferred from electronic annotation
224461_s_at	AMID	BC006121	2.73	4.44E-02	apoptosis-inducing factor (AIF)-like mitochondrion-associated inducer of death ; apoptosis-inducing factor (AIF)-like mitochondrion-associated inducer of death	chr10q22.1	chr10:71543741-71553862 (-)	6917 ; induction of apoptosis ; inferred from mutant phenotype ; 6917 ; induction of apoptosis ; inferred from direct assay ; 30261 ; chromosome condensation ; inferred from direct assay ; 6118 ; electron transport ; inferred from electronic annotation ; 8152 ; metabolism ; inferred from electronic annotation ; 8637 ; apoptotic mitochondrial changes ; non-traceable author statement	4174 ; electron-transferring-flavoprotein dehydrogenase activity ; inferred from sequence or structural similarity ; 15036 ; disulfide oxidoreductase activity ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation
227894_at	LOC197336	AL043021	2.72	5.22E-03	similar to RIKEN cDNA 3230401M21 [Mus musculus]	chr16p13.3	chr16:656691-657831 (+)
223748_at	SLC4A11	AF336127	2.72	4.69E-03	solute carrier family 4, sodium bicarbonate transporter-like, member 11	chr20p12	chr20:3156063-3166373 (-)	6820 ; anion transport ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation ; 6811 ; ion transport ; inferred from electronic annotation	5452 ; inorganic anion exchanger activity ; inferred from electronic annotation ; 15380 ; anion exchanger activity ; inferred from electronic annotation
242560_at	FANCD2	AA579890	2.71	7.27E-03	Fanconi anemia, complementation group D2	chr3p26	chr3:10118333-10118614 (+)	6281 ; DNA repair ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation ; 6974 ; response to DNA damage stimulus ; inferred from electronic annotation	5515 ; protein binding ; inferred from physical interaction
220520_s_at	FLJ20130	NM_017681	2.71	3.53E-02	hypothetical protein FLJ20130	chrXq22.3	chrX:106253366-106336200 (-)		17056 ; structural constituent of nuclear pore ; inferred from electronic annotation
218796_at	C20orf42	NM_017671	2.70	1.75E-02	chromosome 20 open reading frame 42	chr20p12.3	chr20:6003711-6022819 (-)	7155 ; cell adhesion ; inferred from electronic annotation	5488 ; binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
206019_at		NM_014852	2.69	7.30E-03	RNA binding motif protein 19	chr12q24.13-q24.21	chr12:112738929-112888494 (-)		3723 ; RNA binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation
227342_s_at	MYEOV	AA621983	2.68	9.89E-03	myeloma overexpressed gene (in a subset of t(11;14) positive multiple myelomas)	chr11q13	chr11:68818199-68821496 (+)
235716_at	TRA2A	AW157450	2.67	2.06E-02	Transformer-2 alpha	chr7	chr7:23530851-23531536 (-)	398 ; nuclear mRNA splicing, via spliceosome ; inferred from direct assay ; 398 ; nuclear mRNA splicing, via spliceosome ; inferred from electronic annotation ; 6397 ; mRNA processing ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3723 ; RNA binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation
239350_at	MARVELD3	AI420156	2.67	1.18E-02	MARVEL domain containing 3	chr16q22.3	chr16:70225959-70226434 (+)
203082_at	BMS1L	NM_014753	2.67	1.97E-03	BMS1-like, ribosome assembly protein (yeast)	chr10q11.21	chr10:42599821-42646855 (+)	7046 ; ribosome biogenesis ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation
202188_at	NUP93	NM_014669	2.67	3.35E-02	nucleoporin 93kDa	chr16q13	chr16:55321572-55436177 (+)	6810 ; transport ; inferred from electronic annotation
211864_s_at	FER1L3	AF207990	2.66	5.54E-03	fer-1-like 3, myoferlin (C. elegans)	chr10q24	chr10:95056709-95231941 (-)	6936 ; muscle contraction ; traceable author statement ; 8015 ; circulation ; traceable author statement
209714_s_at	CDKN3	AF213033	2.66	2.79E-03	cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase)	chr14q22	chr14:53936360-53956576 (+)	79 ; regulation of cyclin dependent protein kinase activity ; traceable author statement ; 82 ; G1/S transition of mitotic cell cycle ; traceable author statement ; 6470 ; protein amino acid dephosphorylation ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation ; 7050 ; cell cycle arrest ; traceable author statement ; 8285 ; negative regulation of cell proliferation ; traceable author statement	4725 ; protein tyrosine phosphatase activity ; inferred from electronic annotation ; 8138 ; protein tyrosine/serine/threonine phosphatase activity ; traceable author statement ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 4721 ; phosphoprotein phosphatase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation
216237_s_at	MCM5	AA807529	2.66	2.24E-02	MCM5 minichromosome maintenance deficient 5, cell division cycle 46 (S. cerevisiae)	chr22q13.1	chr22:34149474-34150494 (+)	74 ; regulation of progression through cell cycle ; traceable author statement ; 6260 ; DNA replication ; traceable author statement ; 6270 ; DNA replication initiation ; inferred from electronic annotation ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6260 ; DNA replication ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation ; 8094 ; DNA-dependent ATPase activity ; inferred from electronic annotation
238263_at	LOC285965	AW590543	2.65	3.53E-02	hypothetical protein LOC285965	chr7	chr7:142822279-142823044 (+)
203362_s_at	MAD2L1	NM_002358	2.65	1.43E-02	MAD2 mitotic arrest deficient-like 1 (yeast)	chr4q27	chr14:60316360-60317733 (+)	7049 ; cell cycle ; inferred from electronic annotation ; 7067 ; mitosis ; traceable author statement ; 7093 ; mitotic checkpoint ; traceable author statement ; 51301 ; cell division ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation	5515 ; protein binding ; inferred from physical interaction
204092_s_at	STK6	NM_003600	2.65	6.14E-03	serine/threonine kinase 6	chr20q13.2-q13.3	chr20:54377851-54400656 (-)	6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 6468 ; protein amino acid phosphorylation ; traceable author statement ; 7049 ; cell cycle ; non-traceable author statement ; 7051 ; spindle organization and biogenesis ; non-traceable author statement ; 7067 ; mitosis ; traceable author statement ; 48015 ; phosphoinositide-mediated signaling ; non-traceable author statement ; 31647 ; regulation of protein stability ; inferred from mutant phenotype ; 7049 ; cell cycle ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from direct assay ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; traceable author statement ; 16301 ; kinase activity ; inferred from electronic annotation
209053_s_at	WHSC1	BE793789	2.65	7.42E-03	Wolf-Hirschhorn syndrome candidate 1	chr4p16.3	chr4:1865253-1953728 (+)	6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 16567 ; protein ubiquitination ; inferred from electronic annotation ; 9653 ; morphogenesis ; traceable author statement ; 6350 ; transcription ; inferred from electronic annotation	5515 ; protein binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 4842 ; ubiquitin-protein ligase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
239539_at	NEK3	AI291210	2.65	1.04E-03	NIMA (never in mitosis gene a)-related kinase 3	chr13q14.13	chr13:51617631-51618090 (-)	6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 6468 ; protein amino acid phosphorylation ; non-traceable author statement ; 7049 ; cell cycle ; non-traceable author statement ; 7067 ; mitosis ; non-traceable author statement ; 51301 ; cell division ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 287 ; magnesium ion binding ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; non-traceable author statement ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation ; 5524 ; ATP binding ; non-traceable author statement ; 16740 ; transferase activity ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
203802_x_at	NSUN5	NM_018044	2.65	4.71E-02	NOL1/NOP2/Sun domain family, member 5	chr7q11.23	chr7:74877570-74884001 (+)
233445_at	BUB1; BUB1A; BUB1L; hBUB1	AK022040	2.64	1.71E-03	BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast)	chr2q14	chr2:111138622-111144304 (-)	6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation ; 7094 ; mitotic spindle checkpoint ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement ; 51301 ; cell division ; inferred from electronic annotation ; 7093 ; mitotic checkpoint ; traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; traceable author statement
222843_at	FIGNL1	AK023411	2.64	3.62E-03	fidgetin-like 1	chr7p12.2	chr7:50479324-50485542 (-)		166 ; nucleotide binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 17111 ; nucleoside-triphosphatase activity ; inferred from electronic annotation
215034_s_at	TM4SF1	AI189753	2.64	7.35E-03	transmembrane 4 L six family member 1	chr3q21-q25	chr3:150570147-150572013 (-)
209171_at	ITPA	AF219116	2.64	2.86E-02	inosine triphosphatase (nucleoside triphosphate pyrophosphatase)	chr20p	chr20:3138093-3152501 (+)	9117 ; nucleotide metabolism ; inferred from electronic annotation	16787 ; hydrolase activity ; inferred from electronic annotation ; 47429 ; nucleoside-triphosphate diphosphatase activity ; inferred from electronic annotation
225676_s_at	DKFZP564O0463	BE409290	2.64	5.84E-05	WD repeats and SOF1 domain containing	chr8q22.3	chr8:104496773-104524854 (+)
243874_at	FLJ42393	AI079544	2.64	7.07E-03	FLJ42393 protein	chr3q28	chr3:189410094-189410614 (+)
219588_s_at	MTB	NM_017760	2.63	4.89E-03	leucine zipper protein 5	chr7q36.3	chr7:158116888-158175348 (-)		5488 ; binding ; inferred from electronic annotation
219215_s_at	SLC39A4	NM_017767	2.63	3.38E-02	solute carrier family 39 (zinc transporter), member 4	chr8q24.3	chr8:145608606-145612704 (-)	6810 ; transport ; inferred from electronic annotation ; 6829 ; zinc ion transport ; inferred from electronic annotation ; 30001 ; metal ion transport ; inferred from electronic annotation	8270 ; zinc ion binding ; inferred from electronic annotation ; 46873 ; metal ion transporter activity ; inferred from electronic annotation
204470_at	CXCL1	NM_001511	2.63	1.01E-02	chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)	chr4q21	chr4:74953972-74955817 (+)	6935 ; chemotaxis ; traceable author statement ; 6954 ; inflammatory response ; traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; traceable author statement ; 7242 ; intracellular signaling cascade ; traceable author statement ; 7399 ; nervous system development ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement ; 8285 ; negative regulation of cell proliferation ; traceable author statement ; 30036 ; actin cytoskeleton organization and biogenesis ; traceable author statement ; 6954 ; inflammatory response ; inferred from electronic annotation ; 6955 ; immune response ; inferred from electronic annotation ; 7165 ; signal transduction ; traceable author statement	8009 ; chemokine activity ; traceable author statement ; 8047 ; enzyme activator activity ; traceable author statement ; 8083 ; growth factor activity ; inferred from electronic annotation ; 5125 ; cytokine activity ; inferred from electronic annotation ; 8009 ; chemokine activity ; inferred from electronic annotation ; 5102 ; receptor binding ; traceable author statement
235266_at	ATAD2	AI139629	2.62	7.30E-03	ATPase family, AAA domain containing 2	chr8q24.13	chr8:124452554-124477861 (-)		166 ; nucleotide binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 17111 ; nucleoside-triphosphatase activity ; inferred from electronic annotation
203560_at	GGH	NM_003878	2.61	7.07E-03	gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)	chr8q12.3	chr8:64090194-64113940 (-)	6541 ; glutamine metabolism ; inferred from electronic annotation	8238 ; exopeptidase activity ; traceable author statement ; 8464 ; gamma-glutamyl hydrolase activity ; traceable author statement ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; inferred from electronic annotation ; 8464 ; gamma-glutamyl hydrolase activity ; inferred from electronic annotation
236027_at	C10orf78	N23587	2.60	1.36E-03	chromosome 10 open reading frame 78	chr10q25.1	chr10:105872710-105876131 (+)
203557_s_at	PCBD	NM_000281	2.60	1.61E-02	6-pyruvoyl-tetrahydropterin synthase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1)	chr10q22	chr10:72313423-72315693 (-)	6729 ; tetrahydrobiopterin biosynthesis ; inferred from electronic annotation	8124 ; 4-alpha-hydroxytetrahydrobiopterin dehydratase activity ; inferred from electronic annotation ; 16829 ; lyase activity ; inferred from electronic annotation
206364_at	KIF14	NM_014875	2.60	1.88E-03	kinesin family member 14	chr1pter-q31.3	chr1:198787929-198856485 (-)	7018 ; microtubule-based movement ; inferred from electronic annotation ; 6412 ; protein biosynthesis ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3777 ; microtubule motor activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 3774 ; motor activity ; inferred from electronic annotation ; 3735 ; structural constituent of ribosome ; inferred from electronic annotation
215444_s_at	TRIM31	X81006	2.60	3.65E-02	tripartite motif-containing 31	chr6p21.3	chr6:30178655-30181409 (-)	16567 ; protein ubiquitination ; inferred from electronic annotation	4842 ; ubiquitin-protein ligase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
200910_at	CCT3	NM_005998	2.59	1.17E-02	chaperonin containing TCP1, subunit 3 (gamma)	chr1q23	chr1:154545383-154572303 (-)	6457 ; protein folding ; inferred from electronic annotation ; 6457 ; protein folding ; traceable author statement ; 44267 ; cellular protein metabolism ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 51082 ; unfolded protein binding ; inferred from electronic annotation ; 51082 ; unfolded protein binding ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 5515 ; protein binding ; inferred from electronic annotation
235029_at	SLD5	H52284	2.58	4.68E-03	SLD5 homolog	chr8p11.21	chr8:41520540-41521952 (+)
227852_at	RP9	BF438270	2.58	3.62E-03	retinitis pigmentosa 9 (autosomal dominant)	chr7p14.3	chr7:33101273-33106698 (-)	7600 ; sensory perception ; inferred from electronic annotation ; 7601 ; visual perception ; inferred from electronic annotation ; 8380 ; RNA splicing ; traceable author statement	5515 ; protein binding ; inferred from physical interaction ; 46872 ; metal ion binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
227301_at	LOC441241 ; LOC441244	BE644816	2.57	1.50E-02	chaperonin containing TCP1, subunit 6A (zeta 1)-like ; chaperonin containing TCP1, subunit 6A-like	chr7q11.21	chr7:64862006-64866720 (+)	6457 ; protein folding ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 51082 ; unfolded protein binding ; inferred from electronic annotation
203755_at	BUB1B	NM_001211	2.56	5.08E-03	BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast)	chr15q15	chr15:38240671-38300613 (+)	6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 7049 ; cell cycle ; non-traceable author statement ; 7051 ; spindle organization and biogenesis ; non-traceable author statement ; 7067 ; mitosis ; traceable author statement ; 7093 ; mitotic checkpoint ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement ; 48015 ; phosphoinositide-mediated signaling ; non-traceable author statement ; 51301 ; cell division ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; traceable author statement
222714_s_at	LACTB2	BC000878	2.56	2.21E-03	lactamase, beta 2	chr8p22-q22.3	chr8:71712534-71743990 (-)
225578_at	LOC440145	AI885466	2.56	5.58E-03	similar to RIKEN cDNA 2410129H14	chr13q22.1	chr13:72180505-72199814 (-)
203764_at	DLG7	NM_014750	2.56	1.06E-02	discs, large homolog 7 (Drosophila)	chr14q22.3	chr14:54684600-54725528 (-)	7049 ; cell cycle ; inferred from electronic annotation ; 7267 ; cell-cell signaling ; inferred from electronic annotation ; 87 ; M phase of mitotic cell cycle ; inferred from direct assay ; 7079 ; mitotic chromosome movement towards spindle pole ; non-traceable author statement ; 8283 ; cell proliferation ; non-traceable author statement ; 45842 ; positive regulation of mitotic metaphase/anaphase transition ; non-traceable author statement ; 87 ; M phase of mitotic cell cycle ; inferred from sequence or structural similarity ; 7079 ; mitotic chromosome movement towards spindle pole ; inferred from sequence or structural similarity ; 8283 ; cell proliferation ; inferred from sequence or structural similarity ; 45842 ; positive regulation of mitotic metaphase/anaphase transition ; inferred from sequence or structural similarity	5515 ; protein binding ; inferred from physical interaction ; 4721 ; phosphoprotein phosphatase activity ; inferred from direct assay ; 4721 ; phosphoprotein phosphatase activity ; inferred from sequence or structural similarity
205266_at	LIF	NM_002309	2.56	4.86E-03	leukemia inhibitory factor (cholinergic differentiation factor)	chr22q12.2	chr22:28966440-28972748 (-)	6955 ; immune response ; inferred from electronic annotation ; 7166 ; cell surface receptor linked signal transduction ; not recorded ; 7267 ; cell-cell signaling ; not recorded ; 7275 ; development ; traceable author statement ; 8284 ; positive regulation of cell proliferation ; traceable author statement	5125 ; cytokine activity ; inferred from electronic annotation ; 5146 ; leukemia inhibitory factor receptor binding ; inferred from electronic annotation ; 5147 ; oncostatin-M receptor binding ; not recorded ; 8083 ; growth factor activity ; inferred from electronic annotation ; 5146 ; leukemia inhibitory factor receptor binding ; not recorded
238214_at	SLC26A7	AA639289	2.55	5.45E-03	Solute carrier family 26, member 7	chr8q21.3	chr8:92208562-92209005 (+)	6810 ; transport ; inferred from electronic annotation	5215 ; transporter activity ; inferred from electronic annotation
210150_s_at	LAMA5; KIAA1907	BC003355	2.55	1.61E-02	laminin, alpha 5	chr20q13.2-q13.3	chr20:60317512-60323330 (-)	30155 ; regulation of cell adhesion ; inferred from electronic annotation ; 30334 ; regulation of cell migration ; inferred from electronic annotation ; 45995 ; regulation of embryonic development ; inferred from electronic annotation ; 7155 ; cell adhesion ; inferred from electronic annotation ; 7229 ; integrin-mediated signaling pathway ; inferred from mutant phenotype ; 16477 ; cell migration ; inferred from direct assay ; 1525 ; angiogenesis ; non-traceable author statement ; 7010 ; cytoskeleton organization and biogenesis ; non-traceable author statement ; 8037 ; cell recognition ; non-traceable author statement ; 8283 ; cell proliferation ; non-traceable author statement ; 9790 ; embryonic development ; non-traceable author statement ; 30154 ; cell differentiation ; non-traceable author statement ; 45446 ; endothelial cell differentiation ; non-traceable author statement ; 48041 ; focal adhesion formation ; non-traceable author statement	5102 ; receptor binding ; inferred from electronic annotation ; 5198 ; structural molecule activity ; non-traceable author statement ; 5198 ; structural molecule activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation ; 5178 ; integrin binding ; inferred from direct assay ; 4872 ; receptor activity ; inferred from electronic annotation
204420_at	FOSL1	BG251266	2.55	5.34E-03	FOS-like antigen 1	chr11q13	chr11:65416183-65424461 (-)	6357 ; regulation of transcription from RNA polymerase II promoter ; traceable author statement ; 6935 ; chemotaxis ; traceable author statement ; 6968 ; cellular defense response ; traceable author statement ; 8284 ; positive regulation of cell proliferation ; traceable author statement ; 9615 ; response to virus ; traceable author statement ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6366 ; transcription from RNA polymerase II promoter ; traceable author statement	3700 ; transcription factor activity ; traceable author statement ; 3677 ; DNA binding ; inferred from electronic annotation
205286_at	TFAP2C	U85658	2.55	4.46E-02	transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)	chr20q13.2	chr20:54637841-54647740 (+)	6350 ; transcription ; inferred from electronic annotation ; 6357 ; regulation of transcription from RNA polymerase II promoter ; traceable author statement ; 7267 ; cell-cell signaling ; traceable author statement ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3700 ; transcription factor activity ; traceable author statement ; 3677 ; DNA binding ; inferred from electronic annotation ; 3700 ; transcription factor activity ; inferred from electronic annotation
218960_at		NM_016425	2.54	4.55E-02	transmembrane protease, serine 4	chr11q23.3	chr11:117453020-117494375 (+)	6508 ; proteolysis ; non-traceable author statement ; 6508 ; proteolysis ; inferred from electronic annotation	4252 ; serine-type endopeptidase activity ; non-traceable author statement ; 5044 ; scavenger receptor activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 4252 ; serine-type endopeptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
218687_s_at	MUC13	NM_017648	2.54	1.06E-02	mucin 13, epithelial transmembrane	chr3	chr3:126106986-126125114 (-)
201114_x_at	PSMA7	NM_002792	2.53	1.10E-02	proteasome (prosome, macropain) subunit, alpha type, 7	chr20q13.33	chr20:60145185-60151767 (-)	6511 ; ubiquitin-dependent protein catabolism ; inferred from electronic annotation	4298 ; threonine endopeptidase activity ; inferred from electronic annotation ; 4175 ; endopeptidase activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
201478_s_at	DKC1	U59151	2.53	1.30E-03	dyskeratosis congenita 1, dyskerin	chrXq28	chrX:153644353-153658611 (+)	74 ; regulation of progression through cell cycle ; traceable author statement ; 6364 ; rRNA processing ; traceable author statement ; 7004 ; telomerase-dependent telomere maintenance ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement ; 6364 ; rRNA processing ; inferred from electronic annotation ; 6396 ; RNA processing ; inferred from electronic annotation ; 7046 ; ribosome biogenesis ; inferred from electronic annotation ; 6396 ; RNA processing ; traceable author statement	3720 ; telomerase activity ; inferred from direct assay ; 3723 ; RNA binding ; traceable author statement ; 4730 ; pseudouridylate synthase activity ; inferred from electronic annotation ; 16853 ; isomerase activity ; inferred from electronic annotation ; 3723 ; RNA binding ; inferred from electronic annotation
204767_s_at	FEN1	BC000323	2.53	1.04E-03	flap structure-specific endonuclease 1	chr11q12	chr1:91566396-91568399 (+)	6260 ; DNA replication ; non-traceable author statement ; 6302 ; double-strand break repair ; traceable author statement ; 9650 ; UV protection ; traceable author statement ; 48015 ; phosphoinositide-mediated signaling ; non-traceable author statement ; 6281 ; DNA repair ; inferred from electronic annotation ; 6260 ; DNA replication ; traceable author statement ; 6281 ; DNA repair ; traceable author statement ; 6281 ; DNA repair ; non-traceable author statement	3684 ; damaged DNA binding ; traceable author statement ; 3690 ; double-stranded DNA binding ; traceable author statement ; 4519 ; endonuclease activity ; traceable author statement ; 4527 ; exonuclease activity ; traceable author statement ; 8309 ; double-stranded DNA specific exodeoxyribonuclease activity ; traceable author statement ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 4518 ; nuclease activity ; inferred from electronic annotation ; 4519 ; endonuclease activity ; inferred from electronic annotation
242260_at	MATR3	BG283790	2.52	4.00E-03	Matrin 3	chr5q31.2	chr5:138647261-138648184 (+)		166 ; nucleotide binding ; inferred from electronic annotation ; 3723 ; RNA binding ; inferred from electronic annotation ; 5198 ; structural molecule activity ; traceable author statement ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation
203091_at	FUBP1	NM_003902	2.52	1.90E-02	far upstream element (FUSE) binding protein 1	chr1p31.1	chr1:78186677-78217302 (-)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6366 ; transcription from RNA polymerase II promoter ; traceable author statement ; 6817 ; phosphate transport ; inferred from electronic annotation	3697 ; single-stranded DNA binding ; traceable author statement ; 3700 ; transcription factor activity ; traceable author statement ; 3676 ; nucleic acid binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation
221927_s_at		AI923458	2.49	5.45E-03	abhydrolase domain containing 11	chr7q11.23	chr7:72788362-72791052 (-)	6725 ; aromatic compound metabolism ; inferred from electronic annotation	3824 ; catalytic activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
219494_at	RAD54B	NM_012415	2.49	9.44E-03	RAD54 homolog B (S. cerevisiae)	chr8q21.3-q22	chr8:95453365-95556468 (-)	6281 ; DNA repair ; inferred from electronic annotation ; 6312 ; mitotic recombination ; traceable author statement ; 7131 ; meiotic recombination ; traceable author statement ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6974 ; response to DNA damage stimulus ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 3678 ; DNA helicase activity ; traceable author statement ; 3724 ; RNA helicase activity ; traceable author statement ; 5524 ; ATP binding ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation ; 4386 ; helicase activity ; inferred from electronic annotation
200936_at	RPL8	NM_000973	2.49	2.79E-02	ribosomal protein L8	chr8q24.3	chr8:145985957-145988332 (-)	6412 ; protein biosynthesis ; inferred from electronic annotation	3735 ; structural constituent of ribosome ; inferred from electronic annotation ; 19843 ; rRNA binding ; inferred from electronic annotation ; 3723 ; RNA binding ; inferred from electronic annotation
211989_at	SMARCE1	NM_003079	2.49	1.18E-02	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1	chr17q21.2	chr17:36037487-36057626 (-)	6337 ; nucleosome disassembly ; traceable author statement ; 6357 ; regulation of transcription from RNA polymerase II promoter ; traceable author statement ; 16568 ; chromatin modification ; inferred from electronic annotation ; 45892 ; negative regulation of transcription, DNA-dependent ; inferred from direct assay ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3677 ; DNA binding ; inferred from electronic annotation ; 3682 ; chromatin binding ; traceable author statement ; 3713 ; transcription coactivator activity ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 8080 ; N-acetyltransferase activity ; inferred from direct assay
229236_s_at	SFXN4	AI346445	2.49	7.15E-03	sideroflexin 4	chr10q26.11	chr10:120890427-120914877 (-)	6810 ; transport ; inferred from electronic annotation ; 6812 ; cation transport ; inferred from electronic annotation ; 6826 ; iron ion transport ; inferred from electronic annotation	5506 ; iron ion binding ; inferred from electronic annotation ; 8324 ; cation transporter activity ; inferred from electronic annotation
212523_s_at	KIAA0146	D63480	2.49	2.66E-02	KIAA0146 protein	chr8q11.21	chr8:48336061-48811127 (+)
217728_at	S100A6	NM_014624	2.48	4.65E-02	S100 calcium binding protein A6 (calcyclin)	chr1q21	chr1:151773699-151775127 (-)	74 ; regulation of progression through cell cycle ; inferred from electronic annotation ; 7267 ; cell-cell signaling ; not recorded ; 7409 ; axonogenesis ; non-traceable author statement ; 8283 ; cell proliferation ; inferred from electronic annotation ; 48146 ; positive regulation of fibroblast proliferation ; non-traceable author statement ; 7049 ; cell cycle ; inferred from electronic annotation ; 7049 ; cell cycle ; not recorded	5509 ; calcium ion binding ; non-traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 8083 ; growth factor activity ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 5509 ; calcium ion binding ; not recorded
204883_s_at	HUS1	AI968626	2.48	8.92E-03	HUS1 checkpoint homolog (S. pombe)	chr7p13-p12	chr7:47970306-47985775 (-)	77 ; DNA damage checkpoint ; traceable author statement ; 6281 ; DNA repair ; traceable author statement ; 6974 ; response to DNA damage stimulus ; traceable author statement
223033_s_at	SCYL1	AF297709	2.48	3.81E-02	SCY1-like 1 (S. cerevisiae)	chr11q13	chr11:65049158-65062750 (+)	6468 ; protein amino acid phosphorylation ; inferred from electronic annotation	5488 ; binding ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation
223109_at	TRUB2	BC001457	2.47	3.47E-02	TruB pseudouridine (psi) synthase homolog 2 (E. coli)	chr9q34.11	chr9:130111266-130124537 (-)	6396 ; RNA processing ; inferred from electronic annotation	4730 ; pseudouridylate synthase activity ; inferred from electronic annotation
217755_at	HN1	NM_016185	2.47	4.55E-02	hematological and neurological expressed 1	chr17q25.1	chr17:70643674-70662190 (-)
201596_x_at	KRT18	NM_000224	2.47	1.56E-02	keratin 18	chr12q13	chr12:51629177-51632961 (+)	9653 ; morphogenesis ; traceable author statement	5200 ; structural constituent of cytoskeleton ; not recorded ; 5198 ; structural molecule activity ; inferred from electronic annotation
218755_at	KIF20A	NM_005733	2.47	3.14E-03	kinesin family member 20A	chr5q31	chr5:137543246-137551259 (+)	7018 ; microtubule-based movement ; inferred from electronic annotation ; 15031 ; protein transport ; inferred from electronic annotation ; 16192 ; vesicle-mediated transport ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3777 ; microtubule motor activity ; inferred from electronic annotation ; 5215 ; transporter activity ; traceable author statement ; 5524 ; ATP binding ; inferred from electronic annotation ; 3774 ; motor activity ; inferred from electronic annotation
221879_at	CALML4	AA886335	2.46	3.51E-02	calmodulin-like 4	chr15q23	chr15:66273193-66285552 (-)		5509 ; calcium ion binding ; inferred from electronic annotation
201897_s_at	CKS1B	NM_001826	2.46	4.65E-03	CDC28 protein kinase regulatory subunit 1B	chr1q21.2	chr1:153213837-153218346 (+)	7049 ; cell cycle ; inferred from electronic annotation ; 51301 ; cell division ; inferred from electronic annotation	5515 ; protein binding ; inferred from physical interaction ; 16301 ; kinase activity ; inferred from electronic annotation ; 16538 ; cyclin-dependent protein kinase regulator activity ; inferred from electronic annotation
230875_s_at	ATP11A	AW068936	2.45	1.14E-02	ATPase, Class VI, type 11A	chr13q34	chr13:112588988-112589483 (+)	6812 ; cation transport ; inferred from electronic annotation ; 8152 ; metabolism ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 287 ; magnesium ion binding ; inferred from electronic annotation ; 4012 ; phospholipid-translocating ATPase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 15662 ; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 16887 ; ATPase activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
216532_x_at		AL138831	2.45	2.26E-03		chr6	chr6:3923294-3924332 (+)
216384_x_at	PTMA	AF257099	2.45	1.90E-02	similar to prothymosin alpha	chr12p13.2	chr12:12155363-12155693 (+)
223056_s_at	XPO5	AF298880	2.45	2.99E-03	exportin 5	chr6p21.1	chr6:43598052-43651642 (-)	6281 ; DNA repair ; inferred from electronic annotation ; 45449 ; regulation of transcription ; inferred from electronic annotation	3700 ; transcription factor activity ; inferred from electronic annotation ; 5488 ; binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction
221922_at	GPSM2	AW195581	2.44	1.41E-02	G-protein signalling modulator 2 (AGS3-like, C. elegans)	chr1p13.3	chr1:109273883-109274737 (+)	7165 ; signal transduction ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; traceable author statement	5096 ; GTPase activator activity ; inferred from electronic annotation ; 5488 ; binding ; inferred from electronic annotation ; 42802 ; protein self binding ; inferred from physical interaction ; 5515 ; protein binding ; inferred from physical interaction
235026_at	FLJ32549	AI885871	2.44	2.46E-02	hypothetical protein FLJ32549	chr12q14.2	chr12:62872687-62902322 (-)
223272_s_at	MGC13186	BC005102	2.44	3.44E-02	chromosome 1 open reading frame 57	chr1q42.2	chr1:231152992-231180842 (+)		166 ; nucleotide binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 17111 ; nucleoside-triphosphatase activity ; inferred from electronic annotation
200872_at	S100A10	NM_002966	2.44	9.69E-03	S100 calcium binding protein A10 (annexin II ligand, calpactin I, light polypeptide (p11))	chr1q21	chr1:150222017-150232920 (-)		5509 ; calcium ion binding ; inferred from electronic annotation
204531_s_at	BRCA1	NM_007295	2.44	5.55E-03	breast cancer 1, early onset	chr17q21	chr17:38449843-38530657 (-)	6357 ; regulation of transcription from RNA polymerase II promoter ; traceable author statement ; 6359 ; regulation of transcription from RNA polymerase III promoter ; traceable author statement ; 6978 ; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator ; traceable author statement ; 7049 ; cell cycle ; inferred from electronic annotation ; 16567 ; protein ubiquitination ; non-traceable author statement ; 30521 ; androgen receptor signaling pathway ; non-traceable author statement ; 42127 ; regulation of cell proliferation ; traceable author statement ; 42981 ; regulation of apoptosis ; traceable author statement ; 45739 ; positive regulation of DNA repair ; non-traceable author statement ; 45786 ; negative regulation of progression through cell cycle ; inferred from electronic annotation ; 45893 ; positive regulation of transcription, DNA-dependent ; non-traceable author statement ; 46600 ; negative regulation of centriole replication ; non-traceable author statement ; 8630 ; DNA damage response, signal transduction resulting in induction of apoptosis ; inferred from direct assay ; 6281 ; DNA repair ; inferred from electronic annotation ; 6974 ; response to DNA damage stimulus ; inferred from electronic annotation ; 16567 ; protein ubiquitination ; inferred from electronic annotation ; 6281 ; DNA repair ; traceable author statement ; 6282 ; regulation of DNA repair ; traceable author statement ; 6915 ; apoptosis ; traceable author statement ; 6974 ; response to DNA damage stimulus ; traceable author statement	3677 ; DNA binding ; traceable author statement ; 3713 ; transcription coactivator activity ; non-traceable author statement ; 4842 ; ubiquitin-protein ligase activity ; non-traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 8270 ; zinc ion binding ; traceable author statement ; 15631 ; tubulin binding ; non-traceable author statement ; 46872 ; metal ion binding ; inferred from electronic annotation ; 50681 ; androgen receptor binding ; non-traceable author statement ; 5515 ; protein binding ; inferred from direct assay ; 3677 ; DNA binding ; inferred from electronic annotation ; 4842 ; ubiquitin-protein ligase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 3713 ; transcription coactivator activity ; traceable author statement ; 16563 ; transcriptional activator activity ; traceable author statement ; 3723 ; RNA binding ; inferred from direct assay
212556_at	SCRIB	AI469403	2.43	2.83E-03	scribbled homolog (Drosophila)	chr8q24.3	chr8:144945082-144968239 (-)		5515 ; protein binding ; inferred from physical interaction ; 5515 ; protein binding ; inferred from electronic annotation
213230_at	HUMPPA	AI422335	2.43	1.09E-02	paraneoplastic antigen	chr17q25.1	chr17:70495547-70513490 (+)
209642_at	BUB1	AF043294	2.43	3.30E-03	BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast)	chr2q14	chr2:111111990-111152076 (-)	6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation ; 7094 ; mitotic spindle checkpoint ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement ; 51301 ; cell division ; inferred from electronic annotation ; 7093 ; mitotic checkpoint ; traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; traceable author statement
201853_s_at	CDC25B	NM_021873	2.42	4.14E-02	cell division cycle 25B	chr20p13	chr20:3724956-3734759 (+)	74 ; regulation of progression through cell cycle ; traceable author statement ; 6470 ; protein amino acid dephosphorylation ; inferred from electronic annotation ; 7067 ; mitosis ; traceable author statement ; 8284 ; positive regulation of cell proliferation ; traceable author statement ; 51301 ; cell division ; inferred from electronic annotation ; 87 ; M phase of mitotic cell cycle ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation ; 278 ; mitotic cell cycle ; traceable author statement	4725 ; protein tyrosine phosphatase activity ; traceable author statement ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 4721 ; phosphoprotein phosphatase activity ; inferred from electronic annotation ; 4725 ; protein tyrosine phosphatase activity ; inferred from electronic annotation
219978_s_at	NUSAP1	NM_018454	2.42	1.62E-02	nucleolar and spindle associated protein 1	chr15q15.1	chr15:39412369-39437700 (+)	70 ; mitotic sister chromatid segregation ; inferred from direct assay ; 281 ; cytokinesis after mitosis ; inferred from direct assay ; 7076 ; mitotic chromosome condensation ; inferred from direct assay ; 40001 ; establishment of mitotic spindle localization ; inferred from direct assay ; 45840 ; positive regulation of mitosis ; inferred from direct assay
243178_at	RNF149	AW969703	2.42	1.17E-02	Ring finger protein 149	chr2q11.2	chr2:101261051-101261481 (-)	6508 ; proteolysis ; inferred from electronic annotation ; 16567 ; protein ubiquitination ; inferred from electronic annotation	4842 ; ubiquitin-protein ligase activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
208795_s_at	MCM7	D55716	2.41	7.93E-03	MCM7 minichromosome maintenance deficient 7 (S. cerevisiae)	chr7q21.3-q22.1	chr7:99528339-99536969 (-)	6260 ; DNA replication ; traceable author statement ; 6270 ; DNA replication initiation ; inferred from electronic annotation ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation ; 6260 ; DNA replication ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation ; 8094 ; DNA-dependent ATPase activity ; inferred from electronic annotation ; 17111 ; nucleoside-triphosphatase activity ; inferred from electronic annotation
231784_s_at	DKFZP564O0463	AK001874	2.41	3.34E-03	WD repeats and SOF1 domain containing	chr8q22.3	chr15:49024118-49025901 (+)
227517_s_at	GAS5	AI056992	2.41	1.04E-03	RNA, U47 small nuclear	chr1q25.1	chr1:172099661-172102559 (-)
202107_s_at	MCM2	NM_004526	2.40	7.07E-03	MCM2 minichromosome maintenance deficient 2, mitotin (S. cerevisiae)	chr3q21	chr3:128800849-128823966 (+)	6260 ; DNA replication ; traceable author statement ; 6270 ; DNA replication initiation ; inferred from electronic annotation ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7049 ; cell cycle ; traceable author statement ; 6260 ; DNA replication ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3677 ; DNA binding ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation ; 8094 ; DNA-dependent ATPase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
218238_at	GTPBP4	NM_012341	2.40	1.17E-03	GTP binding protein 4	chr10p15-p14	chr10:1024396-1053629 (+)	7046 ; ribosome biogenesis ; inferred from electronic annotation ; 7264 ; small GTPase mediated signal transduction ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 5525 ; GTP binding ; inferred from electronic annotation
208757_at	TMED9	BC001123	2.40	4.13E-02	transmembrane emp24 protein transport domain containing 9	chr5q35.3	chr5:176951818-176955703 (+)	6886 ; intracellular protein transport ; inferred from electronic annotation	8320 ; protein carrier activity ; inferred from electronic annotation
235583_at	ILDR1	AI821661	2.39	2.30E-02	immunoglobulin-like domain containing receptor 1	chr3q13.33	chr3:123188859-123189708 (-)		4872 ; receptor activity ; inferred from electronic annotation
241425_at	NUPL1	AA769986	2.39	1.60E-02	Nucleoporin like 1	chr13q12.13	chr13:24774841-24775364 (+)	6810 ; transport ; inferred from electronic annotation	4867 ; serine-type endopeptidase inhibitor activity ; inferred from electronic annotation ; 15288 ; porin activity ; inferred from electronic annotation
204068_at	STK3	NM_006281	2.39	2.26E-03	serine/threonine kinase 3 (STE20 homolog, yeast)	chr8q22.2	chr8:99536042-99907085 (-)	6468 ; protein amino acid phosphorylation ; inferred from direct assay ; 6915 ; apoptosis ; inferred from electronic annotation ; 7165 ; signal transduction ; traceable author statement ; 7243 ; protein kinase cascade ; inferred from direct assay ; 43065 ; positive regulation of apoptosis ; inferred from sequence or structural similarity ; 6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 7165 ; signal transduction ; inferred from electronic annotation ; 6915 ; apoptosis ; not recorded	166 ; nucleotide binding ; inferred from electronic annotation ; 287 ; magnesium ion binding ; inferred from direct assay ; 4674 ; protein serine/threonine kinase activity ; inferred from direct assay ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from direct assay ; 16740 ; transferase activity ; inferred from electronic annotation ; 46983 ; protein dimerization activity ; inferred from sequence or structural similarity ; 287 ; magnesium ion binding ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4672 ; protein kinase activity ; traceable author statement
242881_x_at		BG285837	2.39	2.30E-02	LOC440156	chr14	chr14:18732801-18733445 (+)
222039_at	LOC146909	AA292789	2.39	1.36E-03	hypothetical protein LOC146909	chr17q21.31	chr17:40357341-40358123 (-)
232151_at		AL359055	2.38	1.25E-02	MRNA full length insert cDNA clone EUROIMAGE 2344436	chr7	chr7:20141839-20145347 (-)
228033_at	E2F7	AI341146	2.38	1.20E-02	E2F transcription factor 7	chr12q21.2	chr12:75939156-75940660 (-)
231880_at	FAM40B	AB032996	2.38	1.54E-02	family with sequence similarity 40, member B	chr7q32.1	chr7:128861522-128915473 (+)
219306_at	KNSL7	NM_020242	2.38	4.68E-03	kinesin family member 15	chr3p21.31	chr3:44778288-44869747 (+)	160 ; two-component signal transduction system (phosphorelay) ; inferred from electronic annotation ; 7018 ; microtubule-based movement ; inferred from electronic annotation ; 7067 ; mitosis ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement	155 ; two-component sensor molecule activity ; inferred from electronic annotation ; 3777 ; microtubule motor activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 3677 ; DNA binding ; traceable author statement ; 3774 ; motor activity ; traceable author statement
203968_s_at	CDC6	NM_001254	2.38	2.51E-03	CDC6 cell division cycle 6 homolog (S. cerevisiae)	chr17q21.3	chr17:35697804-35711996 (+)	76 ; DNA replication checkpoint ; traceable author statement ; 79 ; regulation of cyclin dependent protein kinase activity ; traceable author statement ; 6260 ; DNA replication ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation ; 7089 ; traversing start control point of mitotic cell cycle ; traceable author statement ; 8156 ; negative regulation of DNA replication ; traceable author statement ; 8285 ; negative regulation of cell proliferation ; traceable author statement ; 51301 ; cell division ; inferred from electronic annotation	166 ; nucleotide binding ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation ; 17111 ; nucleoside-triphosphatase activity ; inferred from electronic annotation ; 166 ; nucleotide binding ; inferred from electronic annotation
222449_at	TMEPAI	AL035541	2.38	3.79E-02	transmembrane, prostate androgen induced RNA	chr20q13.31-q13.33	chr20:55656859-55719033 (-)	30521 ; androgen receptor signaling pathway ; non-traceable author statement
228923_at	S100A6	AW166825	2.38	1.34E-02	S100 calcium binding protein A6 (calcyclin)	chr1q21	chr1:151773699-151774215 (-)	74 ; regulation of progression through cell cycle ; inferred from electronic annotation ; 7267 ; cell-cell signaling ; not recorded ; 7409 ; axonogenesis ; non-traceable author statement ; 8283 ; cell proliferation ; inferred from electronic annotation ; 48146 ; positive regulation of fibroblast proliferation ; non-traceable author statement ; 7049 ; cell cycle ; inferred from electronic annotation ; 7049 ; cell cycle ; not recorded	5509 ; calcium ion binding ; non-traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 8083 ; growth factor activity ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 5509 ; calcium ion binding ; not recorded
232174_at	EXT1	AA480392	2.38	3.35E-02	Exostoses (multiple) 1	chr8q24.11-q24.13	chr8:119166886-119169679 (-)	1501 ; skeletal development ; traceable author statement ; 6024 ; glycosaminoglycan biosynthesis ; traceable author statement ; 7049 ; cell cycle ; inferred from electronic annotation ; 7165 ; signal transduction ; traceable author statement ; 15012 ; heparan sulfate proteoglycan biosynthesis ; inferred from sequence or structural similarity ; 45786 ; negative regulation of progression through cell cycle ; inferred from electronic annotation	16757 ; transferase activity, transferring glycosyl groups ; inferred from electronic annotation ; 50508 ; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity ; inferred from sequence or structural similarity ; 50509 ; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity ; inferred from sequence or structural similarity ; 16740 ; transferase activity ; inferred from electronic annotation ; 50509 ; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity ; inferred from electronic annotation
239002_at	ASPM	AA748494	2.38	7.27E-03	asp (abnormal spindle)-like, microcephaly associated (Drosophila)	chr1q31	chr1:195379332-195382380 (-)	7049 ; cell cycle ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation ; 51301 ; cell division ; inferred from electronic annotation	5516 ; calmodulin binding ; inferred from electronic annotation
208103_s_at	ANP32E	NM_030920	2.37	1.07E-03	acidic (leucine-rich) nuclear phosphoprotein 32 family, member E ; acidic (leucine-rich) nuclear phosphoprotein 32 family, member E	chr1q21.2	chr1:148459304-148474947 (-)		19212 ; phosphatase inhibitor activity ; inferred from sequence or structural similarity
41469_at	PI3; ESI; WAP3; SKALP; WFDC14; MGC13613	L10343	2.37	2.64E-03	peptidase inhibitor 3, skin-derived (SKALP)	chr20q12-q13	chr20:43236457-43238598 (+)	7620 ; copulation ; inferred from electronic annotation	4867 ; serine-type endopeptidase inhibitor activity ; traceable author statement ; 5515 ; protein binding ; traceable author statement ; 4866 ; endopeptidase inhibitor activity ; inferred from electronic annotation ; 4867 ; serine-type endopeptidase inhibitor activity ; inferred from electronic annotation ; 4866 ; endopeptidase inhibitor activity ; traceable author statement
222077_s_at	RACGAP1	AU153848	2.37	1.64E-03	Rac GTPase activating protein 1	chr12q13.13	chr12:48669213-48669853 (-)	6118 ; electron transport ; inferred from electronic annotation ; 7242 ; intracellular signaling cascade ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation	5489 ; electron transporter activity ; inferred from electronic annotation ; 5506 ; iron ion binding ; inferred from electronic annotation
200660_at	S100A11	NM_005620	2.37	1.30E-02	S100 calcium binding protein A11 (calgizzarin)	chr1q21	chr1:150271605-150276135 (-)	8156 ; negative regulation of DNA replication ; traceable author statement ; 8285 ; negative regulation of cell proliferation ; traceable author statement	5509 ; calcium ion binding ; inferred from electronic annotation ; 5509 ; calcium ion binding ; not recorded
202954_at	UBE2C	NM_007019	2.37	2.51E-03	ubiquitin-conjugating enzyme E2C	chr20q13.12	chr20:43874709-43878997 (+)	6511 ; ubiquitin-dependent protein catabolism ; traceable author statement ; 6512 ; ubiquitin cycle ; inferred from electronic annotation ; 7049 ; cell cycle ; non-traceable author statement ; 7051 ; spindle organization and biogenesis ; non-traceable author statement ; 7067 ; mitosis ; inferred from electronic annotation ; 8054 ; cyclin catabolism ; traceable author statement ; 8284 ; positive regulation of cell proliferation ; traceable author statement ; 48015 ; phosphoinositide-mediated signaling ; non-traceable author statement ; 51301 ; cell division ; inferred from electronic annotation ; 6464 ; protein modification ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation ; 6464 ; protein modification ; traceable author statement	4842 ; ubiquitin-protein ligase activity ; traceable author statement ; 8642 ; ubiquitin-like activating enzyme activity ; inferred from electronic annotation ; 16874 ; ligase activity ; inferred from electronic annotation ; 4842 ; ubiquitin-protein ligase activity ; inferred from electronic annotation
225239_at		AI355441	2.37	1.90E-02	CDNA FLJ26120 fis, clone SYN00419	chr11	chr11:64963458-64964911 (+)
227021_at	AOF1	BE348688	2.37	1.58E-03	amine oxidase (flavin containing) domain 1	chr6p22.3	chr6:18331027-18332063 (+)	6118 ; electron transport ; inferred from electronic annotation ; 8152 ; metabolism ; inferred from electronic annotation	16491 ; oxidoreductase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
220920_at		NM_025153	2.36	1.04E-02	ATPase, Class V, type 10B	chr5q34	chr5:159992227-160044845 (-)	6812 ; cation transport ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 287 ; magnesium ion binding ; inferred from electronic annotation ; 4012 ; phospholipid-translocating ATPase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 16887 ; ATPase activity ; inferred from electronic annotation ; 15662 ; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
212021_s_at	MKI67	AU132185	2.36	3.34E-03	antigen identified by monoclonal antibody Ki-67	chr10q25-qter	chr10:129784916-129814639 (-)	74 ; regulation of progression through cell cycle ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement ; 7049 ; cell cycle ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation
220060_s_at	FLJ20641	NM_017915	2.36	1.58E-02	hypothetical protein FLJ20641	chr12q23.2	chr12:101038154-101115421 (+)
201577_at	NME1	NM_000269	2.36	1.64E-02	non-metastatic cells 1, protein (NM23A) expressed in	chr17q21.3	chr17:46585942-46594394 (+)	6183 ; GTP biosynthesis ; inferred from electronic annotation ; 6228 ; UTP biosynthesis ; inferred from electronic annotation ; 6241 ; CTP biosynthesis ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation ; 8285 ; negative regulation of cell proliferation ; traceable author statement ; 9117 ; nucleotide metabolism ; inferred from electronic annotation ; 9142 ; nucleoside triphosphate biosynthesis ; non-traceable author statement ; 45786 ; negative regulation of progression through cell cycle ; inferred from electronic annotation ; 9209 ; pyrimidine ribonucleoside triphosphate biosynthesis ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 287 ; magnesium ion binding ; inferred from direct assay ; 3677 ; DNA binding ; Unknown ; 4536 ; deoxyribonuclease activity ; inferred from direct assay ; 4550 ; nucleoside diphosphate kinase activity ; non-traceable author statement ; 5524 ; ATP binding ; non-traceable author statement ; 16301 ; kinase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 287 ; magnesium ion binding ; inferred from electronic annotation ; 4550 ; nucleoside diphosphate kinase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
201415_at	GSS	NM_000178	2.35	1.81E-02	glutathione synthetase	chr20q11.2	chr20:32979901-33007222 (-)	6520 ; amino acid metabolism ; traceable author statement ; 6750 ; glutathione biosynthesis ; inferred from electronic annotation ; 6979 ; response to oxidative stress ; traceable author statement ; 7399 ; nervous system development ; traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 4363 ; glutathione synthase activity ; traceable author statement ; 5524 ; ATP binding ; inferred from electronic annotation ; 16874 ; ligase activity ; inferred from electronic annotation ; 4363 ; glutathione synthase activity ; inferred from electronic annotation
221685_s_at	FLJ20364	AF269167	2.35	4.13E-02	hypothetical protein FLJ20364	chr5q35.1	chr5:168943324-168964354 (+)
202306_at	POLR2G	NM_002696	2.35	1.34E-02	polymerase (RNA) II (DNA directed) polypeptide G	chr11q13.1	chr11:62285590-62290757 (+)	6350 ; transcription ; inferred from electronic annotation	3723 ; RNA binding ; inferred from electronic annotation ; 3899 ; DNA-directed RNA polymerase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 16740 ; transferase activity ; inferred from electronic annotation ; 16779 ; nucleotidyltransferase activity ; inferred from electronic annotation
235408_x_at	ZNF117	AW058673	2.35	4.61E-02	Zinc finger protein 117 (HPF9)	chr7q11.2	chr7:64072260-64073157 (-)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; non-traceable author statement ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3700 ; transcription factor activity ; non-traceable author statement ; 8270 ; zinc ion binding ; non-traceable author statement ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
208744_x_at	HSPH1	BG403660	2.34	1.41E-02	heat shock 105kDa/110kDa protein 1	chr13q12.3	chr13:30608761-30634116 (-)	6457 ; protein folding ; inferred from electronic annotation ; 6986 ; response to unfolded protein ; traceable author statement ; 6986 ; response to unfolded protein ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation
206312_at	GUCY2C	NM_004963	2.34	4.13E-02	guanylate cyclase 2C (heat stable enterotoxin receptor)	chr12p12	chr12:14656842-14740696 (-)	6182 ; cGMP biosynthesis ; inferred from electronic annotation ; 6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 7168 ; receptor guanylyl cyclase signaling pathway ; traceable author statement ; 7242 ; intracellular signaling cascade ; inferred from electronic annotation ; 9190 ; cyclic nucleotide biosynthesis ; inferred from electronic annotation	4383 ; guanylate cyclase activity ; traceable author statement ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation ; 4383 ; guanylate cyclase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 16829 ; lyase activity ; inferred from electronic annotation ; 16849 ; phosphorus-oxygen lyase activity ; inferred from electronic annotation
227314_at	ITGA2	N95414	2.34	1.20E-02	Integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)	chr5	chr5:52424266-52426170 (+)	7155 ; cell adhesion ; traceable author statement ; 7160 ; cell-matrix adhesion ; traceable author statement ; 7229 ; integrin-mediated signaling pathway ; inferred from electronic annotation ; 7596 ; blood coagulation ; traceable author statement ; 9887 ; organ morphogenesis ; traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation ; 7160 ; cell-matrix adhesion ; inferred from electronic annotation	287 ; magnesium ion binding ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 5518 ; collagen binding ; traceable author statement ; 42802 ; protein self binding ; inferred from physical interaction ; 5515 ; protein binding ; inferred from electronic annotation
218049_s_at	MRPL13	NM_014078	2.34	5.58E-03	mitochondrial ribosomal protein L13	chr8q22.1-q22.3	chr8:121477267-121526557 (-)	6412 ; protein biosynthesis ; non-traceable author statement ; 6412 ; protein biosynthesis ; inferred from electronic annotation	3735 ; structural constituent of ribosome ; non-traceable author statement ; 3735 ; structural constituent of ribosome ; inferred from electronic annotation
205890_s_at	UBD	NM_006398	2.33	4.14E-02	ubiquitin D	chr6p21.31	chr6:29631374-29635475 (-)	6508 ; proteolysis ; non-traceable author statement ; 6512 ; ubiquitin cycle ; inferred from electronic annotation ; 19735 ; antimicrobial humoral response (sensu Vertebrata) ; traceable author statement ; 6464 ; protein modification ; inferred from electronic annotation ; 6464 ; protein modification ; non-traceable author statement ; 6508 ; proteolysis ; not recorded
242546_at		BE738279	2.33	2.18E-02	LOC440156	chr14q11.1	chr14:18764236-18765245 (+)
239448_at	SMAD3	AI475033	2.33	3.75E-02		chr15q22.33	chr15:65186112-65186545 (+)
226552_at	IER5L	BF110608	2.33	1.89E-02	immediate early response 5-like	chr9q34.11	chr9:130977649-130979673 (-)
218252_at	CKAP2	NM_018204	2.33	7.00E-03	cytoskeleton associated protein 2	chr13q14	chr13:51933889-51948796 (+)
223251_s_at	ANKRD10	BC001727	2.33	1.36E-03	ankyrin repeat domain 10	chr13q34	chr13:110343045-110365354 (-)
224428_s_at	CDCA7	AY029179	2.33	2.69E-02	cell division cycle associated 7 ; cell division cycle associated 7	chr2q31	chr2:173927793-173941876 (+)	51301 ; cell division ; inferred from electronic annotation ; 42127 ; regulation of cell proliferation ; inferred from direct assay
240673_at		BF115851	2.33	1.72E-02	Transcribed locus	chr4	chr4:37550183-37550653 (+)
210559_s_at	CDC2	D88357	2.32	9.85E-03	cell division cycle 2, G1 to S and G2 to M	chr10q21.1	chr10:62209903-62223768 (+)	6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation ; 7089 ; traversing start control point of mitotic cell cycle ; not recorded ; 51301 ; cell division ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation ; 74 ; regulation of progression through cell cycle ; non-traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 4693 ; cyclin-dependent protein kinase activity ; not recorded ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; non-traceable author statement
228069_at	FAM54A	AL138828	2.32	1.51E-03	family with sequence similarity 54, member A	chr6q23.3	chr6:136593860-136613078 (-)
218741_at	C22orf18	NM_024053	2.32	4.94E-02	chromosome 22 open reading frame 18	chr22q13.2	chr22:40664687-40673061 (-)
235147_at	LOC440928	R56118	2.32	2.24E-02	hypothetical gene supported by AK096649	chr2q33.1	chr2:200032479-200034387 (+)
208821_at	SNRPB	J04564	2.31	4.13E-02	small nuclear ribonucleoprotein polypeptides B and B1	chr20p13	chr20:2390297-2399465 (-)	6397 ; mRNA processing ; inferred from electronic annotation ; 8380 ; RNA splicing ; traceable author statement ; 398 ; nuclear mRNA splicing, via spliceosome ; non-traceable author statement	3723 ; RNA binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction
236244_at	HNRPU	AI458297	2.31	3.79E-02	Heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)	chr1q44	chr1:243091603-243092320 (+)	6396 ; RNA processing ; traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 3677 ; DNA binding ; traceable author statement ; 3723 ; RNA binding ; traceable author statement ; 5524 ; ATP binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 3723 ; RNA binding ; inferred from electronic annotation
211284_s_at	GRN	BC000324	2.31	3.58E-02	granulin	chr17q21.32	chr17:39778014-39785996 (+)	7165 ; signal transduction ; non-traceable author statement ; 7267 ; cell-cell signaling ; not recorded ; 8283 ; cell proliferation ; not recorded ; 8284 ; positive regulation of cell proliferation ; not recorded	5125 ; cytokine activity ; inferred from electronic annotation ; 8083 ; growth factor activity ; traceable author statement
226129_at	FLJ46072	AI949095	2.31	7.50E-03	FLJ46072 protein	chr8q24.3	chr8:144878090-144879255 (-)
226835_s_at	TALDO1 ; HSUP1	BG330520	2.31	1.46E-02	transaldolase 1 ; similar to RPE-spondin	chr11p15.5-p15.4	chr20:47328578-47339204 (+)	5975 ; carbohydrate metabolism ; traceable author statement ; 6098 ; pentose-phosphate shunt ; inferred from electronic annotation ; 5975 ; carbohydrate metabolism ; inferred from electronic annotation	4801 ; transaldolase activity ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 16740 ; transferase activity ; inferred from electronic annotation ; 4801 ; transaldolase activity ; inferred from electronic annotation
224623_at	THOC3	BE614567	2.31	2.28E-03	THO complex 3	chr5q35.2	chr5:177234867-177243873 (+)	398 ; nuclear mRNA splicing, via spliceosome ; inferred from electronic annotation ; 6406 ; mRNA export from nucleus ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation ; 6397 ; mRNA processing ; inferred from electronic annotation	3723 ; RNA binding ; inferred from electronic annotation
216194_s_at		AD001527	2.30	4.34E-02	cytoskeleton associated protein 1	chr19q13.11-q13.12	chr19:41298546-41308524 (+)	6457 ; protein folding ; inferred from electronic annotation	51082 ; unfolded protein binding ; inferred from electronic annotation
203726_s_at	LAMA3	NM_000227	2.30	1.61E-02	laminin, alpha 3	chr18q11.2	chr18:19707039-19788901 (+)	8544 ; epidermis development ; traceable author statement ; 30155 ; regulation of cell adhesion ; inferred from electronic annotation ; 30334 ; regulation of cell migration ; inferred from electronic annotation ; 45995 ; regulation of embryonic development ; inferred from electronic annotation ; 7155 ; cell adhesion ; inferred from electronic annotation ; 7155 ; cell adhesion ; inferred from sequence or structural similarity ; 7166 ; cell surface receptor linked signal transduction ; inferred from sequence or structural similarity ; 30216 ; keratinocyte differentiation ; inferred from sequence or structural similarity	5102 ; receptor binding ; inferred from electronic annotation ; 5198 ; structural molecule activity ; non-traceable author statement ; 5198 ; structural molecule activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
237104_at	CTSS	BE675415	2.30	1.32E-02	Cathepsin S	chr1q21	chr1:148987576-148988057 (-)	6508 ; proteolysis ; traceable author statement ; 6955 ; immune response ; traceable author statement ; 6508 ; proteolysis ; inferred from electronic annotation	4218 ; cathepsin S activity ; traceable author statement ; 4197 ; cysteine-type endopeptidase activity ; inferred from electronic annotation ; 4218 ; cathepsin S activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8234 ; cysteine-type peptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
204136_at	COL7A1	NM_000094	2.30	2.29E-02	collagen, type VII, alpha 1 (epidermolysis bullosa, dystrophic, dominant and recessive)	chr3p21.1	chr3:48576509-48607704 (-)	6817 ; phosphate transport ; inferred from electronic annotation ; 7155 ; cell adhesion ; inferred from electronic annotation ; 8544 ; epidermis development ; traceable author statement	4867 ; serine-type endopeptidase inhibitor activity ; inferred from electronic annotation ; 5198 ; structural molecule activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation ; 4866 ; endopeptidase inhibitor activity ; inferred from electronic annotation
222572_at	PPM2C	BG542521	2.30	2.88E-03	protein phosphatase 2C, magnesium-dependent, catalytic subunit	chr8q22.1	chr8:94998393-95007466 (+)	6470 ; protein amino acid dephosphorylation ; inferred from electronic annotation	287 ; magnesium ion binding ; inferred from electronic annotation ; 4722 ; protein serine/threonine phosphatase activity ; inferred from electronic annotation ; 4741 ; [pyruvate dehydrogenase (lipoamide)] phosphatase activity ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; inferred from electronic annotation ; 4721 ; phosphoprotein phosphatase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
229012_at	C9orf24	AW269443	2.29	3.26E-02	chromosome 9 open reading frame 24	chr9p13.3	chr9:34369016-34371598 (-)
241763_s_at	FBXO32	BF244402	2.29	1.55E-02		chr8	chr8:124608281-124608895 (-)
229666_s_at	CSTF3	AI653037	2.29	8.82E-03	cleavage stimulation factor, 3 pre-RNA, subunit 3, 77kDa	chr11p13	chr11:33119553-33139613 (-)	6378 ; mRNA polyadenylylation ; traceable author statement ; 6379 ; mRNA cleavage ; traceable author statement ; 6396 ; RNA processing ; inferred from electronic annotation ; 6397 ; mRNA processing ; inferred from electronic annotation	3723 ; RNA binding ; traceable author statement ; 5488 ; binding ; inferred from electronic annotation
204415_at	G1P3	NM_022873	2.28	3.94E-02	interferon, alpha-inducible protein (clone IFI-6-16)	chr1p35	chr1:27865167-27871295 (-)	6955 ; immune response ; traceable author statement ; 9613 ; response to pest, pathogen or parasite ; inferred from electronic annotation ; 6955 ; immune response ; inferred from electronic annotation
228674_s_at	EML4	AA524507	2.28	4.28E-02	echinoderm microtubule associated protein like 4	chr2p22-p21	chr2:42250081-42337274 (+)	7017 ; microtubule-based process ; non-traceable author statement ; 7067 ; mitosis ; non-traceable author statement
238898_at		BG028463	2.28	1.20E-02		chr6	chr6:41599610-41621892 (-)
201323_at	EBNA1BP2	NM_006824	2.28	2.28E-03	EBNA1 binding protein 2	chr1p35-p33	chr1:43402442-43410518 (-)	7046 ; ribosome biogenesis ; inferred from electronic annotation
236659_x_at	ZNF277	AI479440	2.28	1.11E-02	Zinc finger protein 277	chr7q31.1	chr7:111760014-111760443 (+)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; non-traceable author statement ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3700 ; transcription factor activity ; non-traceable author statement ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation
205361_s_at	PFDN4	AI718295	2.28	2.19E-02	prefoldin 4	chr20q13.2	chr20:52258373-52269898 (+)	6457 ; protein folding ; inferred from electronic annotation ; 7022 ; chaperonin-mediated tubulin folding ; traceable author statement	51082 ; unfolded protein binding ; inferred from electronic annotation ; 51087 ; chaperone binding ; traceable author statement
226226_at	LOC120224	AI282982	2.28	1.32E-02	transmembrane protein 45B	chr11q24.3	chr11:129227577-129234506 (+)
227928_at	PMCH	AI224977	2.28	4.13E-02	hypothetical protein FLJ20641	chr12q23.2	chr12:101114020-101115428 (+)
209589_s_at	EPHB2	AF025304	2.28	3.14E-02	EPH receptor B2	chr1p36.1-p35	chr1:22910044-23113669 (+)	6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 6468 ; protein amino acid phosphorylation ; traceable author statement ; 7169 ; transmembrane receptor protein tyrosine kinase signaling pathway ; inferred from electronic annotation ; 7399 ; nervous system development ; traceable author statement ; 16310 ; phosphorylation ; inferred from sequence or structural similarity	166 ; nucleotide binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 4713 ; protein-tyrosine kinase activity ; inferred from sequence or structural similarity ; 4872 ; receptor activity ; inferred from electronic annotation ; 5003 ; ephrin receptor activity ; inferred from electronic annotation ; 5005 ; transmembrane-ephrin receptor activity ; traceable author statement ; 5515 ; protein binding ; inferred from sequence or structural similarity ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 5003 ; ephrin receptor activity ; inferred from sequence or structural similarity ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation
225143_at	SFXN4	AW182455	2.27	2.58E-02	sideroflexin 4	chr10q26.11	chr10:120890414-120914902 (-)	6810 ; transport ; inferred from electronic annotation ; 6812 ; cation transport ; inferred from electronic annotation ; 6826 ; iron ion transport ; inferred from electronic annotation	5506 ; iron ion binding ; inferred from electronic annotation ; 8324 ; cation transporter activity ; inferred from electronic annotation
201459_at	RUVBL2	NM_006666	2.27	4.48E-02	RuvB-like 2 (E. coli)	chr19q13.3	chr19:54188967-54210994 (+)	1558 ; regulation of cell growth ; inferred from electronic annotation ; 6281 ; DNA repair ; traceable author statement ; 6310 ; DNA recombination ; traceable author statement ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6457 ; protein folding ; traceable author statement ; 16568 ; chromatin modification ; inferred from electronic annotation ; 6281 ; DNA repair ; inferred from electronic annotation ; 6310 ; DNA recombination ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3684 ; damaged DNA binding ; inferred from electronic annotation ; 4003 ; ATP-dependent DNA helicase activity ; traceable author statement ; 5524 ; ATP binding ; inferred from electronic annotation ; 8722 ; DNA helicase IV activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 16887 ; ATPase activity ; inferred from direct assay ; 42802 ; protein self binding ; inferred from direct assay ; 51082 ; unfolded protein binding ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 3678 ; DNA helicase activity ; inferred from direct assay ; 4386 ; helicase activity ; inferred from electronic annotation ; 17111 ; nucleoside-triphosphatase activity ; inferred from electronic annotation
202691_at	SNRPD1	NM_006938	2.27	3.44E-02	small nuclear ribonucleoprotein D1 polypeptide 16kDa	chr18q11.2	chr18:17446256-17464206 (+)	398 ; nuclear mRNA splicing, via spliceosome ; inferred from electronic annotation ; 6397 ; mRNA processing ; inferred from electronic annotation	5515 ; protein binding ; inferred from physical interaction
232612_s_at	APG16L	AK001690	2.27	1.98E-02	ATG16 autophagy related 16-like 1 (S. cerevisiae)	chr2q37.1	chr2:233825109-233869055 (+)	6914 ; autophagy ; inferred from electronic annotation ; 15031 ; protein transport ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation
227415_at	DGKH	BF109303	2.26	2.05E-02	hypothetical protein LOC283508	chr13q13.3	chr13:41713922-41715028 (+)
229551_x_at	ZNF367	N62196	2.26	3.62E-03	zinc finger protein 367	chr9q22|9q22.32	chr9:98188043-98188470 (-)	6357 ; regulation of transcription from RNA polymerase II promoter ; inferred from direct assay	3676 ; nucleic acid binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3700 ; transcription factor activity ; inferred from direct assay
224186_s_at	RNF123	AL136729	2.26	1.75E-02	ring finger protein 123	chr3p24.3	chr3:49725747-49733963 (+)	16567 ; protein ubiquitination ; inferred from electronic annotation	4842 ; ubiquitin-protein ligase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 16874 ; ligase activity ; inferred from electronic annotation
239841_at	C7orf24	AA137038	2.26	3.28E-03	Chromosome 7 open reading frame 24	chr7p15-p14	chr7:30509948-30510645 (-)
201231_s_at	ENO1	NM_001428	2.26	2.26E-02	enolase 1, (alpha)	chr1p36.3-p36.2	chr1:8843649-8861310 (-)	6096 ; glycolysis ; inferred from electronic annotation ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	287 ; magnesium ion binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 4634 ; phosphopyruvate hydratase activity ; traceable author statement ; 8243 ; plasminogen activator activity ; inferred from electronic annotation ; 16829 ; lyase activity ; inferred from electronic annotation ; 4634 ; phosphopyruvate hydratase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
239227_at	EXT1	AW182675	2.26	1.06E-02	Exostoses (multiple) 1	chr8q24.11-q24.13	chr8:119003405-119003864 (-)	1501 ; skeletal development ; traceable author statement ; 6024 ; glycosaminoglycan biosynthesis ; traceable author statement ; 7049 ; cell cycle ; inferred from electronic annotation ; 7165 ; signal transduction ; traceable author statement ; 15012 ; heparan sulfate proteoglycan biosynthesis ; inferred from sequence or structural similarity ; 45786 ; negative regulation of progression through cell cycle ; inferred from electronic annotation	16757 ; transferase activity, transferring glycosyl groups ; inferred from electronic annotation ; 50508 ; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity ; inferred from sequence or structural similarity ; 50509 ; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity ; inferred from sequence or structural similarity ; 16740 ; transferase activity ; inferred from electronic annotation ; 50509 ; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity ; inferred from electronic annotation
242550_at	EIF3S9	AA628539	2.26	9.44E-03	eukaryotic translation initiation factor 3, subunit 9 eta, 116kDa	chr7p22.2	chr7:2381926-2382496 (+)	6412 ; protein biosynthesis ; inferred from electronic annotation ; 6413 ; translational initiation ; inferred from electronic annotation ; 6413 ; translational initiation ; traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation ; 3723 ; RNA binding ; inferred from electronic annotation ; 3743 ; translation initiation factor activity ; inferred from electronic annotation ; 3743 ; translation initiation factor activity ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction
229376_at	PROX1	BF223556	2.26	2.68E-02	Prospero-related homeobox 1	chr1	chr1:212280060-212281005 (+)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation ; 45449 ; regulation of transcription ; inferred from electronic annotation ; 7398 ; ectoderm development ; traceable author statement ; 9887 ; organ morphogenesis ; traceable author statement	3677 ; DNA binding ; inferred from electronic annotation ; 30528 ; transcription regulator activity ; inferred from electronic annotation ; 3704 ; specific RNA polymerase II transcription factor activity ; traceable author statement
229396_at	OVOL1	AA588400	2.25	1.64E-03	ovo-like 1(Drosophila)	chr11q13	chr11:65320525-65321265 (+)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; non-traceable author statement ; 7283 ; spermatogenesis ; non-traceable author statement ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3700 ; transcription factor activity ; non-traceable author statement ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation
242626_at	LOC389432	BF696216	2.25	3.33E-02	SAM domain containing 1	chr6q24.3	chr6:147930853-147931565 (+)
227079_at	DHX8	AI632523	2.25	5.58E-03	DEAH (Asp-Glu-Ala-His) box polypeptide 8	chr17q21.31	chr17:38958232-38959684 (+)	398 ; nuclear mRNA splicing, via spliceosome ; inferred from electronic annotation ; 8380 ; RNA splicing ; traceable author statement ; 6397 ; mRNA processing ; inferred from electronic annotation ; 6396 ; RNA processing ; traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 3723 ; RNA binding ; inferred from electronic annotation ; 4004 ; ATP-dependent RNA helicase activity ; traceable author statement ; 5524 ; ATP binding ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation ; 4386 ; helicase activity ; inferred from electronic annotation ; 8026 ; ATP-dependent helicase activity ; inferred from electronic annotation
203625_x_at	SKP2	BG105365	2.25	1.49E-02	S-phase kinase-associated protein 2 (p45)	chr5p13	chr5:36187945-36219891 (+)	74 ; regulation of progression through cell cycle ; traceable author statement ; 82 ; G1/S transition of mitotic cell cycle ; traceable author statement ; 6512 ; ubiquitin cycle ; inferred from electronic annotation ; 8283 ; cell proliferation ; traceable author statement	5515 ; protein binding ; inferred from physical interaction
202483_s_at	RANBP1	NM_002882	2.25	4.86E-02	RAN binding protein 1	chr22q11.21	chr22:18485023-18494704 (+)	7165 ; signal transduction ; traceable author statement ; 46907 ; intracellular transport ; inferred from electronic annotation	5092 ; GDP-dissociation inhibitor activity ; traceable author statement ; 5096 ; GTPase activator activity ; inferred from electronic annotation ; 8536 ; Ran GTPase binding ; traceable author statement
225806_at	JUB	AI289311	2.25	1.17E-03	jub, ajuba homolog (Xenopus laevis)	chr14q11.2	chr14:22510225-22515726 (-)		8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
225520_at	MTHFD1L	AL133260	2.24	2.51E-03	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like	chr6q25.1	chr6:151228377-151464716 (+)	9396 ; folic acid and derivative biosynthesis ; inferred from electronic annotation	3824 ; catalytic activity ; inferred from electronic annotation ; 4329 ; formate-tetrahydrofolate ligase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 4488 ; methylenetetrahydrofolate dehydrogenase (NADP+) activity ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 16874 ; ligase activity ; inferred from electronic annotation
215235_at	SPTAN1	AL110273	2.24	9.47E-03	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)	chr9q33-q34	chr9:130386859-130435762 (+)	51016 ; barbed-end actin filament capping ; inferred from electronic annotation	3779 ; actin binding ; traceable author statement ; 5200 ; structural constituent of cytoskeleton ; traceable author statement ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 5516 ; calmodulin binding ; inferred from electronic annotation ; 3779 ; actin binding ; inferred from electronic annotation
214011_s_at	HSPC111	BE314601	2.24	1.04E-03	hypothetical protein HSPC111	chr5q35.2	chr5:175743554-175748196 (-)
239834_at	KCTD1	AW874669	2.24	3.90E-02	Cytokine induced apoptosis inhibitor 1	chr18q11.2	chr18:22376934-22377394 (-)	6813 ; potassium ion transport ; inferred from electronic annotation	5216 ; ion channel activity ; inferred from electronic annotation ; 5249 ; voltage-gated potassium channel activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
229548_at	UNC84B	BG231709	2.24	1.33E-02	Unc-84 homolog B (C. elegans)	chr22q13.1	chr22:37468331-37469237 (+)	7052 ; mitotic spindle organization and biogenesis ; traceable author statement ; 7097 ; nuclear migration ; traceable author statement	8017 ; microtubule binding ; traceable author statement
217977_at	SEPX1	NM_016332	2.23	2.52E-02	selenoprotein X, 1	chr16p13.3	chr16:1928245-1933247 (-)	30091 ; protein repair ; inferred from sequence or structural similarity	8270 ; zinc ion binding ; inferred from sequence or structural similarity ; 8430 ; selenium binding ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
213389_at	PNKP	BF508616	2.23	3.28E-03	Zinc finger protein 592	chr15q25.3	chr15:83146440-83147535 (+)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3677 ; DNA binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation
218039_at	NUSAP1	NM_016359	2.23	6.04E-03	nucleolar and spindle associated protein 1	chr15q15.1	chr15:39412379-39460535 (+)	70 ; mitotic sister chromatid segregation ; inferred from direct assay ; 281 ; cytokinesis after mitosis ; inferred from direct assay ; 7076 ; mitotic chromosome condensation ; inferred from direct assay ; 40001 ; establishment of mitotic spindle localization ; inferred from direct assay ; 45840 ; positive regulation of mitosis ; inferred from direct assay
215223_s_at	SOD2	W46388	2.23	3.77E-03	superoxide dismutase 2, mitochondrial	chr6q25.3	chr6:160020140-160034256 (-)	303 ; response to superoxide ; traceable author statement ; 1315 ; age-dependent response to reactive oxygen species ; inferred from mutant phenotype ; 6357 ; regulation of transcription from RNA polymerase II promoter ; inferred from mutant phenotype ; 6801 ; superoxide metabolism ; inferred from direct assay ; 6979 ; response to oxidative stress ; traceable author statement ; 16066 ; cellular defense response (sensu Vertebrata) ; inferred from mutant phenotype ; 6801 ; superoxide metabolism ; inferred from electronic annotation ; 303 ; response to superoxide ; inferred from sequence or structural similarity ; 1315 ; age-dependent response to reactive oxygen species ; inferred from sequence or structural similarity ; 6357 ; regulation of transcription from RNA polymerase II promoter ; inferred from sequence or structural similarity ; 16066 ; cellular defense response (sensu Vertebrata) ; inferred from sequence or structural similarity	8383 ; manganese superoxide dismutase activity ; inferred from direct assay ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 30145 ; manganese ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4784 ; superoxide dismutase activity ; inferred from electronic annotation
221691_x_at	NPM1	AB042278	2.23	2.51E-03	nucleophosmin (nucleolar phosphoprotein B23, numatrin) ; nucleophosmin (nucleolar phosphoprotein B23, numatrin)	chr5q35	chr1:27406007-27406761 (+)	6886 ; intracellular protein transport ; traceable author statement ; 6913 ; nucleocytoplasmic transport ; traceable author statement ; 6950 ; response to stress ; inferred from mutant phenotype ; 7098 ; centrosome cycle ; inferred from mutant phenotype ; 7569 ; cell aging ; inferred from mutant phenotype ; 8285 ; negative regulation of cell proliferation ; inferred from mutant phenotype ; 42255 ; ribosome assembly ; traceable author statement ; 51092 ; activation of NF-kappaB transcription factor ; inferred from mutant phenotype ; 6886 ; intracellular protein transport ; inferred from sequence or structural similarity ; 6913 ; nucleocytoplasmic transport ; inferred from sequence or structural similarity ; 7098 ; centrosome cycle ; inferred from sequence or structural similarity ; 7569 ; cell aging ; inferred from sequence or structural similarity ; 8285 ; negative regulation of cell proliferation ; inferred from sequence or structural similarity	3676 ; nucleic acid binding ; inferred from electronic annotation ; 3713 ; transcription coactivator activity ; inferred from direct assay ; 3723 ; RNA binding ; traceable author statement ; 30957 ; Tat protein binding ; inferred from direct assay ; 42803 ; protein homodimerization activity ; inferred from direct assay ; 46982 ; protein heterodimerization activity ; inferred from mutant phenotype ; 51059 ; NF-kappaB binding ; inferred from direct assay ; 51082 ; unfolded protein binding ; inferred from direct assay ; 5515 ; protein binding ; inferred from physical interaction ; 3723 ; RNA binding ; inferred from electronic annotation ; 3723 ; RNA binding ; inferred from sequence or structural similarity ; 5515 ; protein binding ; inferred from sequence or structural similarity ; 51059 ; NF-kappaB binding ; inferred from sequence or structural similarity ; 51082 ; unfolded protein binding ; inferred from sequence or structural similarity
218585_s_at	RAMP	NM_016448	2.23	7.35E-03	denticleless homolog (Drosophila)	chr1	chr1:210275753-210344809 (+)
202003_s_at	ACAA2	NM_006111	2.23	3.79E-02	acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase)	chr18q21.1	chr18:45563872-45593900 (-)	6629 ; lipid metabolism ; inferred from electronic annotation ; 6631 ; fatty acid metabolism ; inferred from electronic annotation	3988 ; acetyl-CoA C-acyltransferase activity ; inferred from electronic annotation ; 4316 ; 3-oxoacyl-[acyl-carrier protein] reductase activity ; not recorded ; 8415 ; acyltransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation
228014_at	C9orf115	BG030151	2.22	2.29E-03	chromosome 9 open reading frame 115	chr9q34.11	chr9:129516047-129518082 (-)	6412 ; protein biosynthesis ; inferred from electronic annotation	4045 ; aminoacyl-tRNA hydrolase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
218309_at	CaMKIINalpha	NM_018584	2.22	9.03E-03	calcium/calmodulin-dependent protein kinase II inhibitor 1	chr1p36.12	chr1:20681517-20684326 (-)		16301 ; kinase activity ; inferred from electronic annotation
200875_s_at	NOL5A	NM_006392	2.22	6.94E-03	nucleolar protein 5A (56kDa with KKE/D repeat)	chr20p13	chr20:2581486-2587039 (+)	6364 ; rRNA processing ; traceable author statement ; 7046 ; ribosome biogenesis ; inferred from electronic annotation ; 7046 ; ribosome biogenesis ; traceable author statement	3723 ; RNA binding ; traceable author statement
203418_at	CCNA2	NM_001237	2.22	8.34E-03	cyclin A2	chr4q25-q31	chr4:122958003-122964330 (-)	79 ; regulation of cyclin dependent protein kinase activity ; not recorded ; 7067 ; mitosis ; inferred from electronic annotation ; 7095 ; mitotic G2 checkpoint ; traceable author statement ; 51301 ; cell division ; inferred from electronic annotation ; 74 ; regulation of progression through cell cycle ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation
227062_at	TncRNA	AU155361	2.21	4.37E-02	trophoblast-derived noncoding RNA	chr11q13.1	chr11:64952306-64953090 (+)
204401_at	KCNN4	NM_002250	2.21	4.13E-02	potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4	chr19q13.2	chr19:48962526-48977249 (-)	6811 ; ion transport ; inferred from electronic annotation ; 6813 ; potassium ion transport ; traceable author statement ; 6952 ; defense response ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation ; 6813 ; potassium ion transport ; inferred from electronic annotation	5216 ; ion channel activity ; inferred from electronic annotation ; 5249 ; voltage-gated potassium channel activity ; inferred from electronic annotation ; 5516 ; calmodulin binding ; inferred from electronic annotation ; 15269 ; calcium-activated potassium channel activity ; traceable author statement ; 5267 ; potassium channel activity ; inferred from electronic annotation ; 15269 ; calcium-activated potassium channel activity ; inferred from electronic annotation
228654_at	LOC139886	AU145277	2.21	5.16E-03	hypothetical protein LOC139886	chrXq11.1	chrX:62483831-62486023 (-)	7276 ; gametogenesis ; inferred from electronic annotation
222036_s_at		AI859865	2.21	1.17E-03	MCM4 minichromosome maintenance deficient 4 (S. cerevisiae)	chr8q11.2	chr8:49052283-49053270 (+)	6260 ; DNA replication ; non-traceable author statement ; 6270 ; DNA replication initiation ; inferred from electronic annotation ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6260 ; DNA replication ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; non-traceable author statement ; 8094 ; DNA-dependent ATPase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation
235952_at		AA521504	2.21	2.47E-02	Transcribed locus	chr13q14.11	chr13:41707095-41707674 (+)
225295_at	SLC39A10	AB033091	2.20	3.53E-02	solute carrier family 39 (zinc transporter), member 10	chr2q32.3	chr2:196230183-196310666 (+)	30001 ; metal ion transport ; inferred from electronic annotation	3676 ; nucleic acid binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46873 ; metal ion transporter activity ; inferred from electronic annotation
222874_s_at	CLN8	AF123757	2.20	1.65E-02	ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)	chr8p23	chr8:1699347-1716340 (+)	7399 ; nervous system development ; traceable author statement
225868_at	TRIM47	AW249467	2.20	2.28E-02	tripartite motif-containing 47	chr17	chr17:71381839-71385868 (-)	16567 ; protein ubiquitination ; inferred from electronic annotation	4842 ; ubiquitin-protein ligase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
238273_at	SLC13A4	AW007221	2.20	1.78E-02	solute carrier family 13 (sodium/sulfate symporters), member 4	chr7q33	chr7:134997865-134998208 (+)	6811 ; ion transport ; inferred from electronic annotation ; 6814 ; sodium ion transport ; inferred from electronic annotation ; 8272 ; sulfate transport ; traceable author statement ; 9613 ; response to pest, pathogen or parasite ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation	5215 ; transporter activity ; inferred from electronic annotation ; 15293 ; symporter activity ; inferred from electronic annotation ; 15382 ; sodium:sulfate symporter activity ; traceable author statement ; 31402 ; sodium ion binding ; inferred from electronic annotation
225439_at	CML66	AI802955	2.20	1.36E-03	NudC domain containing 1	chr8q23	chr8:110322324-110415494 (-)
201005_at	CD9	NM_001769	2.20	1.06E-02	CD9 antigen (p24)	chr12p13.3	chr12:6179875-6217686 (+)	6928 ; cell motility ; inferred from direct assay ; 7155 ; cell adhesion ; inferred from direct assay ; 7342 ; fusion of sperm to egg plasma membrane ; inferred from direct assay ; 30168 ; platelet activation ; non-traceable author statement ; 30913 ; paranodal junction formation ; inferred from sequence or structural similarity ; 7155 ; cell adhesion ; inferred from electronic annotation ; 7338 ; fertilization (sensu Metazoa) ; inferred from electronic annotation	5515 ; protein binding ; inferred from physical interaction ; 5515 ; protein binding ; inferred from electronic annotation
230656_s_at	CIRH1A	AL578336	2.20	2.13E-02	cirrhosis, autosomal recessive 1A (cirhin)	chr16q22.1	chr16:67748537-67760425 (+)
204733_at	KLK6	NM_002774	2.20	2.73E-02	kallikrein 6 (neurosin, zyme)	chr19q13.3	chr19:56153705-56164741 (-)	6508 ; proteolysis ; inferred from electronic annotation ; 7417 ; central nervous system development ; non-traceable author statement ; 9611 ; response to wounding ; non-traceable author statement ; 16540 ; protein autoprocessing ; non-traceable author statement ; 30574 ; collagen catabolism ; non-traceable author statement ; 42246 ; tissue regeneration ; non-traceable author statement ; 42445 ; hormone metabolism ; non-traceable author statement ; 42552 ; myelination ; non-traceable author statement ; 42982 ; amyloid precursor protein metabolism ; non-traceable author statement ; 45595 ; regulation of cell differentiation ; non-traceable author statement	4293 ; tissue kallikrein activity ; non-traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 8233 ; peptidase activity ; inferred from electronic annotation ; 4252 ; serine-type endopeptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
200839_s_at	CTSB	NM_001908	2.20	1.65E-02	cathepsin B	chr8p22	chr8:11739236-11762982 (-)	6508 ; proteolysis ; traceable author statement ; 6508 ; proteolysis ; inferred from electronic annotation	4213 ; cathepsin B activity ; traceable author statement ; 4197 ; cysteine-type endopeptidase activity ; inferred from electronic annotation ; 4213 ; cathepsin B activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8234 ; cysteine-type peptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
210319_x_at	MSX2	D89377	2.20	3.94E-02	msh homeo box homolog 2 (Drosophila)	chr5q34-q35	chr5:174084207-174090507 (+)	1501 ; skeletal development ; traceable author statement ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation ; 45449 ; regulation of transcription ; inferred from electronic annotation	3700 ; transcription factor activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 3677 ; DNA binding ; inferred from electronic annotation ; 3677 ; DNA binding ; traceable author statement
222958_s_at	DEPDC1	AK000490	2.19	5.84E-03	DEP domain containing 1	chr1p31.2	chr9:107560182-107564216 (+)	7242 ; intracellular signaling cascade ; inferred from electronic annotation
203068_at	KLHL21	NM_014851	2.19	1.66E-02	kelch-like 21 (Drosophila)	chr1p36.31	chr1:6573365-6585648 (-)		5515 ; protein binding ; inferred from electronic annotation
205740_s_at	MGC10433	NM_024321	2.19	2.85E-02	hypothetical protein MGC10433	chr19q13.12	chr19:40811818-40820426 (+)		166 ; nucleotide binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation ; 3723 ; RNA binding ; inferred from electronic annotation
213338_at	RIS1	BF062629	2.19	1.65E-02	Ras-induced senescence 1	chr3p21.3	chr3:45240959-45242766 (-)
39966_at	CSPG5	AF059274	2.18	4.05E-03	chondroitin sulfate proteoglycan 5 (neuroglycan C)	chr3p21.3	chr3:47578732-47595280 (-)	1558 ; regulation of cell growth ; inferred from electronic annotation ; 7399 ; nervous system development ; traceable author statement ; 30154 ; cell differentiation ; inferred from electronic annotation ; 46907 ; intracellular transport ; traceable author statement ; 7275 ; development ; inferred from electronic annotation ; 7399 ; nervous system development ; inferred from electronic annotation	5515 ; protein binding ; inferred from physical interaction ; 5515 ; protein binding ; traceable author statement ; 8083 ; growth factor activity ; traceable author statement
219990_at	FLJ23311	NM_024680	2.18	1.50E-02	E2F transcription factor 8	chr11p15.1	chr11:19202189-19210494 (-)	74 ; regulation of progression through cell cycle ; inferred from electronic annotation ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3677 ; DNA binding ; inferred from electronic annotation ; 3700 ; transcription factor activity ; inferred from electronic annotation
202705_at	CCNB2	NM_004701	2.18	4.11E-03	cyclin B2	chr15q22.2	chr15:57184611-57204535 (+)	74 ; regulation of progression through cell cycle ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation ; 51301 ; cell division ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation	5515 ; protein binding ; inferred from physical interaction
200772_x_at		BF686442	2.18	2.29E-02	prothymosin, alpha (gene sequence 28)	chr2q35-q36	chr2:232281479-232286495 (+)	74 ; regulation of progression through cell cycle ; not recorded ; 6350 ; transcription ; traceable author statement ; 7275 ; development ; not recorded
213226_at	EXOSC9	AI346350	2.18	7.46E-03	Cyclin A2	chr4q25-q31	chr4:122956953-122958076 (-)	79 ; regulation of cyclin dependent protein kinase activity ; not recorded ; 7067 ; mitosis ; inferred from electronic annotation ; 7095 ; mitotic G2 checkpoint ; traceable author statement ; 51301 ; cell division ; inferred from electronic annotation ; 74 ; regulation of progression through cell cycle ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation
203358_s_at	EZH2	NM_004456	2.18	1.65E-02	enhancer of zeste homolog 2 (Drosophila)	chr7q35-q36	chr7:148135409-148212231 (-)	6325 ; establishment and/or maintenance of chromatin architecture ; traceable author statement ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; traceable author statement ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3677 ; DNA binding ; traceable author statement ; 3677 ; DNA binding ; inferred from electronic annotation
235387_at	FLJ13273	AA740875	2.17	6.99E-03	hypothetical protein FLJ13273	chr4q24	chr4:106987291-106988330 (+)		8168 ; methyltransferase activity ; inferred from electronic annotation ; 8757 ; S-adenosylmethionine-dependent methyltransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation
204822_at	TTK	NM_003318	2.17	8.34E-03	TTK protein kinase	chr6q13-q21	chr6:80771104-80808952 (+)	74 ; regulation of progression through cell cycle ; traceable author statement ; 6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 7052 ; mitotic spindle organization and biogenesis ; traceable author statement ; 7094 ; mitotic spindle checkpoint ; traceable author statement ; 8284 ; positive regulation of cell proliferation ; traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; traceable author statement ; 4713 ; protein-tyrosine kinase activity ; traceable author statement ; 5488 ; binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation
201890_at	RRM2	BE966236	2.17	4.46E-02	ribonucleotide reductase M2 polypeptide	chr2p25-p24	chr2:10179961-10188991 (+)	6260 ; DNA replication ; non-traceable author statement ; 9186 ; deoxyribonucleoside diphosphate metabolism ; inferred from electronic annotation ; 6260 ; DNA replication ; inferred from electronic annotation	4748 ; ribonucleoside-diphosphate reductase activity ; non-traceable author statement ; 5506 ; iron ion binding ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4748 ; ribonucleoside-diphosphate reductase activity ; inferred from electronic annotation
213523_at	CCNE1	AI671049	2.17	4.74E-03	cyclin E1	chr19q12	chr19:34994770-35007059 (+)	74 ; regulation of progression through cell cycle ; inferred from electronic annotation ; 82 ; G1/S transition of mitotic cell cycle ; non-traceable author statement ; 30521 ; androgen receptor signaling pathway ; non-traceable author statement ; 45893 ; positive regulation of transcription, DNA-dependent ; non-traceable author statement ; 51301 ; cell division ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation	3713 ; transcription coactivator activity ; non-traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 50681 ; androgen receptor binding ; non-traceable author statement
225655_at	UHRF1	AK025578	2.17	8.90E-03	ubiquitin-like, containing PHD and RING finger domains, 1	chr19p13.3	chr12:20595770-20598590 (+)	6281 ; DNA repair ; inferred from electronic annotation ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation ; 16567 ; protein ubiquitination ; inferred from electronic annotation ; 6464 ; protein modification ; inferred from electronic annotation ; 6512 ; ubiquitin cycle ; inferred from electronic annotation ; 6974 ; response to DNA damage stimulus ; inferred from electronic annotation	3677 ; DNA binding ; inferred from electronic annotation ; 4842 ; ubiquitin-protein ligase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 16874 ; ligase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
227607_at	AMSH-LP	AI638611	2.17	2.26E-03	associated molecule with the SH3 domain of STAM (AMSH) like protein	chr10q23.31	chr10:90662837-90673224 (+)	6512 ; ubiquitin cycle ; inferred from electronic annotation	4221 ; ubiquitin thiolesterase activity ; inferred from electronic annotation ; 8237 ; metallopeptidase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
203262_s_at	FAM50A	NM_004699	2.16	4.13E-02	family with sequence similarity 50, member A	chrXq28	chrX:153325701-153332190 (+)
224387_at	COMMD5; HCARG; HT002	AF290195	2.16	3.75E-02	COMM domain containing 5 ; COMM domain containing 5	chr8q24-qter	chr8:146046479-146049696 (-)
227936_at	FLJ32370	AI671172	2.16	1.01E-02	transmembrane protein 68	chr8q12.1	chr8:56837313-56848491 (-)	8152 ; metabolism ; inferred from electronic annotation	8415 ; acyltransferase activity ; inferred from electronic annotation
204026_s_at	ZWINT	NM_007057	2.16	2.68E-03	ZW10 interactor	chr10q21-q22	chr10:57787212-57791019 (-)	7049 ; cell cycle ; non-traceable author statement ; 7051 ; spindle organization and biogenesis ; non-traceable author statement ; 48015 ; phosphoinositide-mediated signaling ; non-traceable author statement
239331_at		AW954199	2.16	4.45E-02	Transcribed locus	chr7q32.3	chr7:130240074-130240634 (-)
209161_at	PRPF4	AI184802	2.16	1.49E-02	PRP4 pre-mRNA processing factor 4 homolog (yeast)	chr9q31-q33	chr9:115077764-115095205 (+)	398 ; nuclear mRNA splicing, via spliceosome ; inferred from electronic annotation ; 8380 ; RNA splicing ; non-traceable author statement ; 6397 ; mRNA processing ; inferred from electronic annotation ; 8380 ; RNA splicing ; inferred from electronic annotation ; 6396 ; RNA processing ; traceable author statement ; 8380 ; RNA splicing ; traceable author statement	31202 ; RNA splicing factor activity, transesterification mechanism ; non-traceable author statement
219255_x_at	IL17RB	NM_018725	2.16	9.85E-03	interleukin 17 receptor B	chr3p21.1	chr3:53855652-53874659 (+)	1558 ; regulation of cell growth ; non-traceable author statement ; 6952 ; defense response ; traceable author statement	4872 ; receptor activity ; inferred from electronic annotation ; 4907 ; interleukin receptor activity ; non-traceable author statement
238342_at	KIAA0220	BF677084	2.16	4.25E-02	PI-3-kinase-related kinase SMG-1-like	chr16	chr16:21786404-21786991 (+)
218883_s_at	MLF1IP	NM_024629	2.16	7.07E-03	MLF1 interacting protein	chr4q35.1	chr4:185853151-185887158 (-)
212023_s_at	MKI67	AU147044	2.16	5.30E-03	antigen identified by monoclonal antibody Ki-67	chr10q25-qter	chr10:129784916-129814639 (-)	74 ; regulation of progression through cell cycle ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement ; 7049 ; cell cycle ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation
208549_x_at		NM_016171	2.16	9.89E-03	prothymosin, alpha (gene sequence 28) ; similar to prothymosin alpha ; hypothetical gene supported by BC013859 ; hypothetical gene supported by BC013859; BC070480	chr2q35-q36	chr12:12155363-12155693 (+)	74 ; regulation of progression through cell cycle ; not recorded ; 6350 ; transcription ; traceable author statement ; 7275 ; development ; not recorded
202503_s_at	KIAA0101	NM_014736	2.15	1.13E-02	KIAA0101	chr15q22.31	chr15:62444842-62460684 (-)
204962_s_at	CENPA	NM_001809	2.15	8.34E-03	centromere protein A, 17kDa	chr2p24-p21	chr2:26862424-26870958 (+)	6334 ; nucleosome assembly ; inferred from electronic annotation ; 7001 ; chromosome organization and biogenesis (sensu Eukaryota) ; traceable author statement ; 7001 ; chromosome organization and biogenesis (sensu Eukaryota) ; inferred from electronic annotation	3677 ; DNA binding ; inferred from electronic annotation ; 3682 ; chromatin binding ; traceable author statement
212540_at	CDC34	BG476661	2.15	2.52E-02	cell division cycle 34	chr19p13.3	chr19:482708-493087 (+)	82 ; G1/S transition of mitotic cell cycle ; non-traceable author statement ; 6270 ; DNA replication initiation ; non-traceable author statement ; 6512 ; ubiquitin cycle ; non-traceable author statement ; 6464 ; protein modification ; inferred from electronic annotation ; 6512 ; ubiquitin cycle ; inferred from electronic annotation ; 6464 ; protein modification ; non-traceable author statement	4840 ; ubiquitin conjugating enzyme activity ; non-traceable author statement ; 4842 ; ubiquitin-protein ligase activity ; non-traceable author statement ; 8642 ; ubiquitin-like activating enzyme activity ; inferred from electronic annotation ; 16874 ; ligase activity ; inferred from electronic annotation ; 4842 ; ubiquitin-protein ligase activity ; inferred from electronic annotation
226473_at	MGC10561	BE514414	2.15	6.14E-03	chromobox homolog 2 (Pc class homolog, Drosophila)	chr17q25.3	chr17:75373579-75376375 (+)	6333 ; chromatin assembly or disassembly ; inferred from electronic annotation ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 16481 ; negative regulation of transcription ; non-traceable author statement ; 16568 ; chromatin modification ; non-traceable author statement ; 16568 ; chromatin modification ; inferred from electronic annotation	3677 ; DNA binding ; inferred from electronic annotation ; 3682 ; chromatin binding ; inferred from electronic annotation ; 16564 ; transcriptional repressor activity ; non-traceable author statement
222398_s_at	U5-116KD	BC002360	2.15	4.44E-02	elongation factor Tu GTP binding domain containing 2	chr17q21.31	chr17:40283804-40327421 (-)	398 ; nuclear mRNA splicing, via spliceosome ; inferred from electronic annotation ; 6412 ; protein biosynthesis ; inferred from electronic annotation ; 8380 ; RNA splicing ; traceable author statement ; 6397 ; mRNA processing ; inferred from electronic annotation ; 6397 ; mRNA processing ; traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 3924 ; GTPase activity ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 5525 ; GTP binding ; inferred from electronic annotation
202267_at	LAMC2	NM_005562	2.15	5.73E-03	laminin, gamma 2	chr1q25-q31	chr1:181422021-181480662 (+)	7155 ; cell adhesion ; inferred from electronic annotation ; 8544 ; epidermis development ; traceable author statement	5198 ; structural molecule activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation ; 8201 ; heparin binding ; inferred from electronic annotation
205133_s_at	HSPE1	NM_002157	2.15	3.72E-03	heat shock 10kDa protein 1 (chaperonin 10)	chr2q33.1	chr15:88978920-88979453 (+)	6457 ; protein folding ; inferred from electronic annotation ; 6986 ; response to unfolded protein ; inferred from electronic annotation	5524 ; ATP binding ; inferred from electronic annotation ; 51082 ; unfolded protein binding ; inferred from electronic annotation
241464_s_at		AI973033	2.15	1.00E-02	Transcribed locus, weakly similar to NP_997360.1 FLJ27365 protein [Homo sapiens]	chr22q13.31	chr22:44854894-44855452 (+)
219819_s_at	MRPS28	NM_014018	2.14	3.32E-03	mitochondrial ribosomal protein S28	chr8q21.1-q21.2	chr8:80993647-81105044 (-)		3723 ; RNA binding ; inferred from electronic annotation ; 3735 ; structural constituent of ribosome ; inferred from electronic annotation
227165_at	C13orf3	AI829603	2.14	4.30E-03	chromosome 13 open reading frame 3	chr13q12.11	chr13:20625734-20648824 (-)
209773_s_at	RRM2	BC001886	2.13	1.81E-02	ribonucleotide reductase M2 polypeptide	chr2p25-p24	chr2:10180332-10187376 (+)	6260 ; DNA replication ; non-traceable author statement ; 9186 ; deoxyribonucleoside diphosphate metabolism ; inferred from electronic annotation ; 6260 ; DNA replication ; inferred from electronic annotation	4748 ; ribonucleoside-diphosphate reductase activity ; non-traceable author statement ; 5506 ; iron ion binding ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4748 ; ribonucleoside-diphosphate reductase activity ; inferred from electronic annotation
231319_x_at	KIF9	AI657069	2.13	2.34E-02	kinesin family member 9	chr3p21.31	chr3:47291722-47293869 (-)	7018 ; microtubule-based movement ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3777 ; microtubule motor activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 3774 ; motor activity ; inferred from electronic annotation
213842_x_at	WBSCR20C	AK021688	2.13	4.43E-02	Williams Beuren syndrome chromosome region 20C	chr7q11.23	chr7:74877583-74884079 (+)
209212_s_at	KLF5	AB030824	2.13	3.44E-02	Kruppel-like factor 5 (intestinal)	chr13q22.1	chr13:72531264-72548071 (+)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6366 ; transcription from RNA polymerase II promoter ; traceable author statement	3677 ; DNA binding ; inferred from electronic annotation ; 3702 ; RNA polymerase II transcription factor activity ; traceable author statement ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation
227647_at	KCNE3	AI692703	2.13	2.07E-02	potassium voltage-gated channel, Isk-related family, member 3	chr11q13-q14	chr11:73843533-73845519 (-)	6811 ; ion transport ; inferred from electronic annotation ; 6813 ; potassium ion transport ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation	5249 ; voltage-gated potassium channel activity ; inferred from electronic annotation ; 30955 ; potassium ion binding ; inferred from electronic annotation ; 5216 ; ion channel activity ; inferred from electronic annotation ; 5244 ; voltage-gated ion channel activity ; inferred from electronic annotation
228879_at		BG502554	2.13	1.61E-02		chr17	chr17:59577083-59577566 (+)
224200_s_at	RAD18	AB035274	2.13	2.08E-02	RAD18 homolog (S. cerevisiae)	chr3p25-p24	chr3:8896949-8980144 (-)	6281 ; DNA repair ; non-traceable author statement ; 16567 ; protein ubiquitination ; inferred from electronic annotation ; 6281 ; DNA repair ; inferred from electronic annotation ; 6974 ; response to DNA damage stimulus ; inferred from electronic annotation	3684 ; damaged DNA binding ; non-traceable author statement ; 4842 ; ubiquitin-protein ligase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation
201120_s_at	PGRMC1	AL547946	2.13	1.81E-02	progesterone receptor membrane component 1	chrXq22-q24	chrX:118254278-118262457 (+)		4872 ; receptor activity ; inferred from electronic annotation ; 5496 ; steroid binding ; traceable author statement ; 5496 ; steroid binding ; inferred from electronic annotation
226332_at	MGC40405 ; LOC401015	AI569932	2.13	5.34E-03	hypothetical protein MGC40405 ; similar to RIKEN cDNA 5830415L20	chr7q21.2	chr10:60145989-60147298 (+)		8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
209387_s_at	TM4SF1; L6; H-L6; M3S1; TAAL6	M90657	2.12	2.58E-02	transmembrane 4 L six family member 1	chr3q21-q25	chr3:150570019-150578086 (-)
232150_at	C20orf18	AA134418	2.12	2.05E-02	Chromosome 20 open reading frame 18	chr20p13	chr20:341666-342998 (+)	16567 ; protein ubiquitination ; inferred from electronic annotation ; 6464 ; protein modification ; inferred from electronic annotation ; 6512 ; ubiquitin cycle ; inferred from electronic annotation	4842 ; ubiquitin-protein ligase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 16874 ; ligase activity ; inferred from electronic annotation
209360_s_at	RUNX1	D43968	2.12	1.01E-02	runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene)	chr21q22.3	chr21:35081974-35182857 (-)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; non-traceable author statement ; 7275 ; development ; traceable author statement ; 45944 ; positive regulation of transcription from RNA polymerase II promoter ; inferred from direct assay ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3700 ; transcription factor activity ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; non-traceable author statement ; 16563 ; transcriptional activator activity ; inferred from direct assay ; 3677 ; DNA binding ; inferred from electronic annotation ; 3700 ; transcription factor activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 3677 ; DNA binding ; non-traceable author statement
216212_s_at	DKC1; NAP57; NOLA4; XAP101; dyskerin	AJ010395	2.12	2.58E-02	dyskeratosis congenita 1, dyskerin	chrXq28	chrX:153644332-153658336 (+)	74 ; regulation of progression through cell cycle ; traceable author statement ; 6364 ; rRNA processing ; traceable author statement ; 7004 ; telomerase-dependent telomere maintenance ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement ; 6364 ; rRNA processing ; inferred from electronic annotation ; 6396 ; RNA processing ; inferred from electronic annotation ; 7046 ; ribosome biogenesis ; inferred from electronic annotation ; 6396 ; RNA processing ; traceable author statement	3720 ; telomerase activity ; inferred from direct assay ; 3723 ; RNA binding ; traceable author statement ; 4730 ; pseudouridylate synthase activity ; inferred from electronic annotation ; 16853 ; isomerase activity ; inferred from electronic annotation ; 3723 ; RNA binding ; inferred from electronic annotation
239381_at	KLK7	AU155415	2.12	4.13E-02	kallikrein 7 (chymotryptic, stratum corneum)	chr19q13.33	chr19:56171546-56171972 (-)	6508 ; proteolysis ; inferred from electronic annotation ; 8544 ; epidermis development ; traceable author statement	4252 ; serine-type endopeptidase activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 8236 ; serine-type peptidase activity ; traceable author statement
235052_at	FLJ38451	AV758821	2.12	2.12E-02	FLJ38451 protein	chr19q13.11	chr19:40139097-40141193 (-)		3676 ; nucleic acid binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
236312_at		AA938184	2.12	3.28E-02	Transcribed locus, weakly similar to NP_060312.1 hypothetical protein FLJ20489 [Homo sapiens]	chr4	chr4:121196213-121196807 (-)
207828_s_at	CENPF	NM_005196	2.12	5.45E-04	centromere protein F, 350/400ka (mitosin)	chr1q32-q41	chr1:212843160-212904053 (+)	67 ; DNA replication and chromosome cycle ; traceable author statement ; 7088 ; regulation of mitosis ; traceable author statement ; 51301 ; cell division ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation ; 7067 ; mitosis ; traceable author statement
201037_at	PFKP	NM_002627	2.12	1.51E-03	phosphofructokinase, platelet	chr10p15.3-p15.2	chr10:3099754-3168974 (+)	6096 ; glycolysis ; inferred from electronic annotation ; 6096 ; glycolysis ; non-traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 287 ; magnesium ion binding ; inferred from electronic annotation ; 3872 ; 6-phosphofructokinase activity ; inferred from electronic annotation ; 3872 ; 6-phosphofructokinase activity ; traceable author statement ; 5524 ; ATP binding ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
242558_at	CTNNB1	AW362945	2.11	3.26E-02	Catenin (cadherin-associated protein), beta 1, 88kDa	chr3p21	chr3:41230052-41230902 (+)	6350 ; transcription ; inferred from electronic annotation ; 6357 ; regulation of transcription from RNA polymerase II promoter ; not recorded ; 7155 ; cell adhesion ; inferred from electronic annotation ; 16055 ; Wnt receptor signaling pathway ; inferred from electronic annotation ; 30521 ; androgen receptor signaling pathway ; non-traceable author statement ; 45893 ; positive regulation of transcription, DNA-dependent ; non-traceable author statement ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3713 ; transcription coactivator activity ; non-traceable author statement ; 4871 ; signal transducer activity ; non-traceable author statement ; 5198 ; structural molecule activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 50681 ; androgen receptor binding ; non-traceable author statement ; 5488 ; binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
209507_at	RPA3	BC005264	2.11	1.56E-02	replication protein A3, 14kDa	chr7p22	chr7:7643081-7646619 (-)	6260 ; DNA replication ; traceable author statement ; 6281 ; DNA repair ; not recorded ; 6260 ; DNA replication ; inferred from electronic annotation	3676 ; nucleic acid binding ; inferred from electronic annotation ; 3697 ; single-stranded DNA binding ; traceable author statement
201601_x_at	IFITM1	NM_003641	2.11	3.56E-02	interferon induced transmembrane protein 1 (9-27)	chr11p15.5	chr11:304061-305272 (+)	74 ; regulation of progression through cell cycle ; traceable author statement ; 6955 ; immune response ; inferred from electronic annotation ; 7166 ; cell surface receptor linked signal transduction ; traceable author statement ; 8285 ; negative regulation of cell proliferation ; traceable author statement ; 9607 ; response to biotic stimulus ; inferred from electronic annotation	5057 ; receptor signaling protein activity ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction
201111_at	CSE1L	AF053641	2.11	9.89E-03	CSE1 chromosome segregation 1-like (yeast)	chr20q13	chr20:47096255-47146891 (+)	59 ; protein import into nucleus, docking ; inferred from electronic annotation ; 6915 ; apoptosis ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement ; 15031 ; protein transport ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation ; 6915 ; apoptosis ; inferred from electronic annotation ; 8283 ; cell proliferation ; inferred from electronic annotation	5488 ; binding ; inferred from electronic annotation ; 8262 ; importin-alpha export receptor activity ; traceable author statement ; 8565 ; protein transporter activity ; inferred from electronic annotation ; 8262 ; importin-alpha export receptor activity ; inferred from electronic annotation
235705_at	TRIO	BF676361	2.11	2.95E-02		chr5p15.1-p14	chr5:14482752-14483332 (+)
230862_at		BF448693	2.11	1.50E-02	Transcribed locus	chr3q21.3	chr3:129882644-129883154 (-)
204616_at	UCHL3	NM_006002	2.10	8.56E-03	ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase)	chr13q22.2	chr13:75021936-75078036 (+)	6511 ; ubiquitin-dependent protein catabolism ; non-traceable author statement ; 6512 ; ubiquitin cycle ; inferred from electronic annotation ; 6511 ; ubiquitin-dependent protein catabolism ; inferred from electronic annotation	4221 ; ubiquitin thiolesterase activity ; traceable author statement ; 8234 ; cysteine-type peptidase activity ; inferred from electronic annotation ; 4221 ; ubiquitin thiolesterase activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
36830_at	MIPEP	U80034	2.10	1.57E-02	mitochondrial intermediate peptidase	chr13q12	chr13:23202330-23361533 (-)	6508 ; proteolysis ; inferred from electronic annotation ; 6627 ; mitochondrial protein processing ; traceable author statement	287 ; magnesium ion binding ; inferred from electronic annotation ; 4243 ; mitochondrial intermediate peptidase activity ; inferred from electronic annotation ; 5506 ; iron ion binding ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 30145 ; manganese ion binding ; inferred from electronic annotation ; 50897 ; cobalt ion binding ; inferred from electronic annotation ; 4222 ; metalloendopeptidase activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8237 ; metallopeptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4222 ; metalloendopeptidase activity ; traceable author statement
201066_at	CYC1	NM_001916	2.10	3.15E-02	cytochrome c-1	chr8q24.3	chr8:145221982-145224415 (+)	6118 ; electron transport ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation	5506 ; iron ion binding ; inferred from electronic annotation ; 20037 ; heme binding ; inferred from electronic annotation ; 45155 ; electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity ; traceable author statement ; 46872 ; metal ion binding ; inferred from electronic annotation ; 5489 ; electron transporter activity ; inferred from electronic annotation
201420_s_at	MEP50	BF975273	2.10	3.57E-03	WD repeat domain 77	chr1p13.2	chr1:111784127-111793590 (-)		4872 ; receptor activity ; inferred from electronic annotation
205483_s_at	G1P2	NM_005101	2.10	3.05E-02	interferon, alpha-inducible protein (clone IFI-15K)	chr1p36.33	chr1:938741-939782 (+)	6464 ; protein modification ; inferred from electronic annotation ; 6955 ; immune response ; inferred from electronic annotation ; 7267 ; cell-cell signaling ; non-traceable author statement	5515 ; protein binding ; non-traceable author statement
242538_at	TFDP1	AW007021	2.09	1.61E-02	Transcription factor Dp-1	chr13q34	chr13:113340527-113341194 (+)	74 ; regulation of progression through cell cycle ; inferred from electronic annotation ; 74 ; regulation of progression through cell cycle ; traceable author statement ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6357 ; regulation of transcription from RNA polymerase II promoter ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement ; 7049 ; cell cycle ; inferred from electronic annotation	3700 ; transcription factor activity ; inferred from electronic annotation ; 3700 ; transcription factor activity ; traceable author statement ; 3713 ; transcription coactivator activity ; traceable author statement ; 3677 ; DNA binding ; inferred from electronic annotation
240243_at	FGF2	AW592991	2.09	1.27E-02	Fibroblast growth factor 2 (basic)	chr4q26-q27	chr4:124028137-124028654 (-)	74 ; regulation of progression through cell cycle ; inferred from electronic annotation ; 187 ; activation of MAPK activity ; traceable author statement ; 1525 ; angiogenesis ; inferred from electronic annotation ; 6935 ; chemotaxis ; traceable author statement ; 7165 ; signal transduction ; non-traceable author statement ; 7265 ; Ras protein signal transduction ; traceable author statement ; 7267 ; cell-cell signaling ; not recorded ; 7399 ; nervous system development ; traceable author statement ; 7517 ; muscle development ; not recorded ; 8283 ; cell proliferation ; inferred from electronic annotation ; 8284 ; positive regulation of cell proliferation ; traceable author statement ; 9887 ; organ morphogenesis ; traceable author statement ; 30154 ; cell differentiation ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation	5515 ; protein binding ; inferred from physical interaction ; 8083 ; growth factor activity ; inferred from electronic annotation ; 8201 ; heparin binding ; inferred from electronic annotation
204162_at	KNTC2	NM_006101	2.09	1.99E-02	kinetochore associated 2	chr18p11.32	chr18:2561604-2606626 (+)	70 ; mitotic sister chromatid segregation ; traceable author statement ; 7067 ; mitosis ; traceable author statement ; 7049 ; cell cycle ; non-traceable author statement ; 7051 ; spindle organization and biogenesis ; non-traceable author statement ; 48015 ; phosphoinositide-mediated signaling ; non-traceable author statement
226031_at	FLJ20097	AA523733	2.09	3.50E-02	hypothetical protein FLJ20097	chr7q21.3	chr7:92761791-92826548 (+)	160 ; two-component signal transduction system (phosphorelay) ; inferred from electronic annotation	155 ; two-component sensor molecule activity ; inferred from electronic annotation
218984_at	FLJ20485	NM_019042	2.09	1.85E-03	hypothetical protein FLJ20485	chr7q22.2	chr7:104884197-104898511 (-)	8033 ; tRNA processing ; inferred from electronic annotation	4730 ; pseudouridylate synthase activity ; inferred from electronic annotation ; 16853 ; isomerase activity ; inferred from electronic annotation
233964_at	FLJ14753	AL110135	2.09	4.28E-02	Hippocampus abundant transcript-like 1	chr9	chr9:96249745-96253669 (-)	15904 ; tetracycline transport ; inferred from electronic annotation	15520 ; tetracycline:hydrogen antiporter activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction
208687_x_at	HSPA8	AF352832	2.09	3.42E-03	heat shock 70kDa protein 8	chr11q24.1	chr12:4076841-4079030 (+)	6457 ; protein folding ; inferred from electronic annotation ; 6457 ; protein folding ; non-traceable author statement ; 6986 ; response to unfolded protein ; inferred from electronic annotation ; 6986 ; response to unfolded protein ; non-traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 42623 ; ATPase activity, coupled ; non-traceable author statement ; 51082 ; unfolded protein binding ; inferred from electronic annotation
225307_at	ZNF511	AL583632	2.09	2.06E-02	zinc finger protein 511	chr10q26.3	chr10:134972410-134976655 (+)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3676 ; nucleic acid binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
240247_at		AI653240	2.08	1.41E-02	Transcribed locus	chr15q13.2	---
202219_at	SLC6A8	NM_005629	2.08	4.13E-02	solute carrier family 6 (neurotransmitter transporter, creatine), member 8	chrXq28	chr16:33685402-33694027 (+)	1504 ; neurotransmitter uptake ; not recorded ; 6811 ; ion transport ; inferred from electronic annotation ; 6814 ; sodium ion transport ; inferred from electronic annotation ; 6936 ; muscle contraction ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation ; 6836 ; neurotransmitter transport ; inferred from electronic annotation ; 6810 ; transport ; traceable author statement	5309 ; creatine:sodium symporter activity ; traceable author statement ; 15293 ; symporter activity ; inferred from electronic annotation ; 31402 ; sodium ion binding ; inferred from electronic annotation ; 5309 ; creatine:sodium symporter activity ; inferred from electronic annotation ; 5328 ; neurotransmitter:sodium symporter activity ; inferred from electronic annotation
235425_at	SGOL2	AW965339	2.08	1.67E-03	shugoshin-like 2 (S. pombe)	chr2q33.1	chr2:201144030-201144783 (+)
63009_at	FLJ10539	AI188402	2.08	2.27E-02	SHQ1 homolog (S. cerevisiae)	chr3p13	chr3:72881411-72881958 (-)
210766_s_at	CSE1L	AF053640	2.08	1.21E-03	CSE1 chromosome segregation 1-like (yeast)	chr20q13	chr20:47096282-47146490 (+)	59 ; protein import into nucleus, docking ; inferred from electronic annotation ; 6915 ; apoptosis ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement ; 15031 ; protein transport ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation ; 6915 ; apoptosis ; inferred from electronic annotation ; 8283 ; cell proliferation ; inferred from electronic annotation	5488 ; binding ; inferred from electronic annotation ; 8262 ; importin-alpha export receptor activity ; traceable author statement ; 8565 ; protein transporter activity ; inferred from electronic annotation ; 8262 ; importin-alpha export receptor activity ; inferred from electronic annotation
203744_at	HMGB3; HMG4; HMG2A	NM_005342	2.08	1.34E-02	high-mobility group box 3	chrXq28	chr1:162592540-162594081 (+)	6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7275 ; development ; traceable author statement	8301 ; DNA bending activity ; traceable author statement ; 3677 ; DNA binding ; inferred from electronic annotation
203234_at	UPP1	NM_003364	2.08	1.50E-02	uridine phosphorylase 1	chr7p12.3	chr7:48095386-48114540 (+)	9116 ; nucleoside metabolism ; inferred from electronic annotation ; 9166 ; nucleotide catabolism ; inferred from electronic annotation ; 6139 ; nucleobase, nucleoside, nucleotide and nucleic acid metabolism ; traceable author statement	4850 ; uridine phosphorylase activity ; traceable author statement ; 16757 ; transferase activity, transferring glycosyl groups ; inferred from electronic annotation ; 3824 ; catalytic activity ; inferred from electronic annotation ; 4850 ; uridine phosphorylase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation
203214_x_at	CDC2	NM_001786	2.07	1.04E-03	cell division cycle 2, G1 to S and G2 to M	chr10q21.1	chr10:62208241-62223768 (+)	6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation ; 7089 ; traversing start control point of mitotic cell cycle ; not recorded ; 51301 ; cell division ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation ; 74 ; regulation of progression through cell cycle ; non-traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 4693 ; cyclin-dependent protein kinase activity ; not recorded ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; non-traceable author statement
235609_at	BRIP1	BF056791	2.07	9.47E-03	BRCA1 interacting protein C-terminal helicase 1	chr17	chr17:57113411-57113988 (-)	77 ; DNA damage checkpoint ; non-traceable author statement ; 6139 ; nucleobase, nucleoside, nucleotide and nucleic acid metabolism ; inferred from electronic annotation ; 6302 ; double-strand break repair ; non-traceable author statement ; 6357 ; regulation of transcription from RNA polymerase II promoter ; inferred from direct assay ; 6281 ; DNA repair ; inferred from electronic annotation ; 6974 ; response to DNA damage stimulus ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3677 ; DNA binding ; non-traceable author statement ; 4003 ; ATP-dependent DNA helicase activity ; non-traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 16818 ; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 4003 ; ATP-dependent DNA helicase activity ; inferred from electronic annotation ; 4386 ; helicase activity ; inferred from electronic annotation ; 8026 ; ATP-dependent helicase activity ; inferred from electronic annotation
222697_s_at	FLJ11342	AI521709	2.07	2.05E-02	abhydrolase domain containing 10	chr3q13.2	chr3:113180533-113194741 (+)	6725 ; aromatic compound metabolism ; inferred from electronic annotation	3824 ; catalytic activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
203415_at	PDCD6	NM_013232	2.07	3.42E-02	programmed cell death 6	chr5pter-p15.2	chr5:324804-367916 (+)	6915 ; apoptosis ; inferred from electronic annotation ; 8624 ; induction of apoptosis by extracellular signals ; traceable author statement ; 7165 ; signal transduction ; inferred from electronic annotation ; 45449 ; regulation of transcription ; inferred from electronic annotation	5509 ; calcium ion binding ; inferred from electronic annotation ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 30528 ; transcription regulator activity ; inferred from electronic annotation
208433_s_at	LRP8	NM_017522	2.07	6.12E-03	low density lipoprotein receptor-related protein 8, apolipoprotein e receptor	chr1p34	chr1:53484827-53566172 (-)	6508 ; proteolysis ; non-traceable author statement ; 6629 ; lipid metabolism ; non-traceable author statement ; 6897 ; endocytosis ; inferred from direct assay ; 7165 ; signal transduction ; traceable author statement ; 19221 ; cytokine and chemokine mediated signaling pathway ; non-traceable author statement ; 6897 ; endocytosis ; inferred from electronic annotation ; 6629 ; lipid metabolism ; traceable author statement	4888 ; transmembrane receptor activity ; traceable author statement ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 8034 ; lipoprotein binding ; Unknown ; 30227 ; apolipoprotein E receptor activity ; inferred from direct assay ; 30227 ; apolipoprotein E receptor activity ; traceable author statement ; 4872 ; receptor activity ; inferred from electronic annotation
222450_at	TMEPAI	AL035541	2.07	2.14E-02	transmembrane, prostate androgen induced RNA	chr20q13.31-q13.33	chr20:55656859-55719033 (-)	30521 ; androgen receptor signaling pathway ; non-traceable author statement
48808_at		AI144299	2.07	2.12E-02	dihydrofolate reductase	chr5q11.2-q13.2	chr18:22001825-22002953 (-)	6545 ; glycine biosynthesis ; non-traceable author statement ; 6730 ; one-carbon compound metabolism ; inferred from electronic annotation ; 9165 ; nucleotide biosynthesis ; non-traceable author statement ; 6545 ; glycine biosynthesis ; inferred from electronic annotation ; 9165 ; nucleotide biosynthesis ; inferred from electronic annotation	4146 ; dihydrofolate reductase activity ; non-traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 50661 ; NADP binding ; inferred from electronic annotation ; 4146 ; dihydrofolate reductase activity ; inferred from electronic annotation
218220_at	C12orf10	NM_021640	2.07	4.36E-02	chromosome 12 open reading frame 10	chr12q13	chr12:51979768-51987221 (+)
230060_at	CDCA7	AI277642	2.07	1.55E-02	cell division cycle associated 7	chr2q31	chr2:173936312-173937904 (+)	51301 ; cell division ; inferred from electronic annotation ; 42127 ; regulation of cell proliferation ; inferred from direct assay
228124_at	C20orf22	AW303865	2.07	3.11E-02	chromosome 20 open reading frame 22	chr20p11.21	chr20:25223379-25318725 (-)		3824 ; catalytic activity ; inferred from electronic annotation
240800_x_at	RSAFD1	AW502656	2.07	4.91E-03	Radical S-adenosyl methionine and flavodoxin domains 1	chr7q11.21-q11.22	chr7:66129531-66129934 (+)	6118 ; electron transport ; inferred from electronic annotation	3824 ; catalytic activity ; inferred from electronic annotation ; 5489 ; electron transporter activity ; inferred from electronic annotation ; 5506 ; iron ion binding ; inferred from electronic annotation ; 10181 ; FMN binding ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation
218187_s_at	FLJ20989	NM_023080	2.07	7.27E-03	chromosome 8 open reading frame 33	chr8q24.3	chr8:146248629-146251814 (+)
212242_at	TUBA1	AL565074	2.06	3.56E-02	tubulin, alpha 1 (testis specific)	chr2q35	chr2:219823249-219825197 (-)	7018 ; microtubule-based movement ; inferred from electronic annotation ; 51258 ; protein polymerization ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3924 ; GTPase activity ; inferred from electronic annotation ; 5198 ; structural molecule activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5525 ; GTP binding ; inferred from electronic annotation
212836_at	POLD3	D26018	2.06	1.20E-02	polymerase (DNA-directed), delta 3, accessory subunit	chr11q14	chr11:73981276-74031419 (+)	731 ; DNA synthesis during DNA repair ; non-traceable author statement ; 6298 ; mismatch repair ; non-traceable author statement ; 6260 ; DNA replication ; inferred from electronic annotation	3677 ; DNA binding ; Unknown ; 3891 ; delta DNA polymerase activity ; non-traceable author statement ; 16740 ; transferase activity ; inferred from electronic annotation ; 3887 ; DNA-directed DNA polymerase activity ; inferred from electronic annotation ; 16779 ; nucleotidyltransferase activity ; inferred from electronic annotation
229981_at	SNX5	AA131508	2.06	1.49E-02	sorting nexin 5	chr20p11	chr20:17870804-17872626 (-)	7242 ; intracellular signaling cascade ; inferred from electronic annotation ; 15031 ; protein transport ; inferred from electronic annotation
228623_at		AI224133	2.06	4.14E-02	Transcribed locus, weakly similar to XP_517454.1 PREDICTED: similar to hypothetical protein MGC45438 [Pan troglodytes]	chrX	chrX:73386952-73387596 (-)
210418_s_at		AF023265	2.06	3.51E-02	isocitrate dehydrogenase 3 (NAD+) beta	chr20p13	chr20:2587042-2592835 (-)	5975 ; carbohydrate metabolism ; traceable author statement ; 6099 ; tricarboxylic acid cycle ; inferred from electronic annotation ; 6102 ; isocitrate metabolism ; traceable author statement ; 8152 ; metabolism ; inferred from electronic annotation	4449 ; isocitrate dehydrogenase (NAD+) activity ; traceable author statement ; 5489 ; electron transporter activity ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 4449 ; isocitrate dehydrogenase (NAD+) activity ; inferred from electronic annotation
201315_x_at	IFITM2	NM_006435	2.06	2.30E-02	interferon induced transmembrane protein 2 (1-8D)	chr11p15.5	chr11:297914-299392 (+)	6955 ; immune response ; traceable author statement ; 9607 ; response to biotic stimulus ; inferred from electronic annotation ; 6955 ; immune response ; inferred from electronic annotation	5515 ; protein binding ; inferred from physical interaction
212115_at	C16orf34	AK023154	2.06	7.27E-03	chromosome 16 open reading frame 34	chr16p13.3	chr16:1668298-1692081 (+)
205394_at	CHEK1	NM_001274	2.06	1.85E-03	CHK1 checkpoint homolog (S. pombe)	chr11q24-q24	chr11:125001852-125030781 (+)	77 ; DNA damage checkpoint ; traceable author statement ; 79 ; regulation of cyclin dependent protein kinase activity ; traceable author statement ; 6281 ; DNA repair ; inferred from electronic annotation ; 6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation ; 7131 ; meiotic recombination ; traceable author statement ; 7276 ; gametogenesis ; traceable author statement ; 8285 ; negative regulation of cell proliferation ; traceable author statement ; 6974 ; response to DNA damage stimulus ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; traceable author statement
208029_s_at	LAPTM4B	NM_018407	2.06	3.75E-02	lysosomal associated protein transmembrane 4 beta ; lysosomal associated protein transmembrane 4 beta	chr8q22.1	chr8:98857341-98933998 (+)
204127_at	RFC3	BC000149	2.06	2.60E-03	replication factor C (activator 1) 3, 38kDa	chr13q12.3-q13	chr13:33290274-33309632 (+)	6260 ; DNA replication ; inferred from electronic annotation ; 6271 ; DNA strand elongation ; traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 3887 ; DNA-directed DNA polymerase activity ; not recorded ; 8047 ; enzyme activator activity ; not recorded ; 17111 ; nucleoside-triphosphatase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation
214728_x_at	SMARCA4	AK026573	2.06	2.51E-02	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4	chr19p13.2	chr19:10993460-11033733 (+)	6350 ; transcription ; inferred from electronic annotation ; 6357 ; regulation of transcription from RNA polymerase II promoter ; traceable author statement ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3700 ; transcription factor activity ; traceable author statement ; 3713 ; transcription coactivator activity ; traceable author statement ; 4386 ; helicase activity ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 4386 ; helicase activity ; inferred from electronic annotation
224247_s_at	MRPS10; MRP-S10; FLJ10567; PNAS-122	AF277180	2.06	3.08E-02	mitochondrial ribosomal protein S10	chr6p21.1-p12.1	chr6:42283763-42293572 (-)	6412 ; protein biosynthesis ; inferred from electronic annotation	3735 ; structural constituent of ribosome ; inferred from electronic annotation
216870_x_at	DLEU2	AF264787	2.06	3.32E-02	deleted in lymphocytic leukemia, 2 ; BCMS upstream neighbor-like	chr13q14.3	chr13:49515572-49554115 (-)	7049 ; cell cycle ; inferred from electronic annotation ; 45786 ; negative regulation of progression through cell cycle ; inferred from electronic annotation
219226_at	CRK7	NM_016507	2.06	1.27E-02	CDC2-related protein kinase 7	chr17q12	chr17:34871817-34942044 (+)	46777 ; protein amino acid autophosphorylation ; inferred from direct assay ; 6468 ; protein amino acid phosphorylation ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3702 ; RNA polymerase II transcription factor activity ; non-traceable author statement ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from direct assay ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation
231772_x_at	CENPH	AL572471	2.06	1.84E-02	centromere protein H	chr5p15.2	chr5:68521130-68541904 (+)	69 ; centromere and kinetochore complex maturation ; non-traceable author statement	5515 ; protein binding ; inferred from direct assay
216088_s_at		AL078633	2.06	2.06E-02	proteasome (prosome, macropain) subunit, alpha type, 7	chr20q13.33	chr20:60145307-60151047 (-)	6511 ; ubiquitin-dependent protein catabolism ; inferred from electronic annotation	4298 ; threonine endopeptidase activity ; inferred from electronic annotation ; 4175 ; endopeptidase activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
227898_s_at	FLJ38705	AW576245	2.05	9.02E-03	zinc finger protein 41 homolog (mouse)	chr8q24.3	chr8:144412998-144418801 (+)		3676 ; nucleic acid binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
222352_at	FBXO31	BE465371	2.05	2.95E-02	F-box protein 31	chr16q24.2	chr16:85918093-85919238 (-)	6512 ; ubiquitin cycle ; inferred from electronic annotation
222904_s_at	TMC5	AW469181	2.05	1.69E-02	transmembrane channel-like 5	chr16p12.3	chr16:19392998-19417579 (+)
203554_x_at	PTTG1	NM_004219	2.05	2.57E-03	pituitary tumor-transforming 1	chr5q35.1	chr5:159781442-159788323 (+)	67 ; DNA replication and chromosome cycle ; inferred from electronic annotation ; 6281 ; DNA repair ; inferred from electronic annotation ; 6366 ; transcription from RNA polymerase II promoter ; traceable author statement ; 7059 ; chromosome segregation ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation ; 7283 ; spermatogenesis ; traceable author statement ; 51301 ; cell division ; inferred from electronic annotation ; 6259 ; DNA metabolism ; inferred from electronic annotation ; 6974 ; response to DNA damage stimulus ; inferred from electronic annotation ; 7049 ; cell cycle ; inferred from electronic annotation	3700 ; transcription factor activity ; traceable author statement ; 4869 ; cysteine protease inhibitor activity ; non-traceable author statement ; 5515 ; protein binding ; inferred from physical interaction
218046_s_at	MRPS16	NM_016065	2.05	1.67E-02	mitochondrial ribosomal protein S16	chr10q22.1	chr10:74680505-74682415 (-)	6412 ; protein biosynthesis ; non-traceable author statement ; 6412 ; protein biosynthesis ; inferred from electronic annotation	3735 ; structural constituent of ribosome ; non-traceable author statement ; 3735 ; structural constituent of ribosome ; inferred from electronic annotation
236817_at		AI336346	2.05	9.69E-03	Transcribed locus	chr6	chr6:143785645-143786100 (-)
201457_x_at	BUB3	AF081496	2.05	2.06E-03	BUB3 budding uninhibited by benzimidazoles 3 homolog (yeast)	chr10q26	chr10:124903919-124913522 (+)	7067 ; mitosis ; traceable author statement ; 7094 ; mitotic spindle checkpoint ; not recorded ; 8283 ; cell proliferation ; traceable author statement ; 7093 ; mitotic checkpoint ; traceable author statement
235389_at	PHF20	BG168139	2.04	4.53E-02	PHD finger protein 20	chr20	chr20:33823359-33826389 (+)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3676 ; nucleic acid binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
204408_at	APEX2	NM_014481	2.04	1.53E-02	APEX nuclease (apurinic/apyrimidinic endonuclease) 2	chrXp11.21	chrX:55043514-55050926 (+)	6281 ; DNA repair ; inferred from electronic annotation ; 6974 ; response to DNA damage stimulus ; inferred from electronic annotation	3906 ; DNA-(apurinic or apyrimidinic site) lyase activity ; inferred from electronic annotation ; 4519 ; endonuclease activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 16829 ; lyase activity ; inferred from electronic annotation ; 4518 ; nuclease activity ; inferred from electronic annotation
207850_at	CXCL3	NM_002090	2.04	3.60E-02	chemokine (C-X-C motif) ligand 3	chr4q21	chr4:75121177-75123269 (-)	6935 ; chemotaxis ; inferred from electronic annotation ; 6954 ; inflammatory response ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; not recorded ; 7600 ; sensory perception ; inferred from electronic annotation ; 6955 ; immune response ; inferred from electronic annotation	8009 ; chemokine activity ; traceable author statement ; 5125 ; cytokine activity ; inferred from electronic annotation ; 8009 ; chemokine activity ; inferred from electronic annotation
206550_s_at	NUP155	NM_004298	2.04	4.19E-02	nucleoporin 155kDa	chr5p13.1	chr5:37327697-37406644 (-)	6810 ; transport ; inferred from electronic annotation ; 6913 ; nucleocytoplasmic transport ; inferred from electronic annotation	5215 ; transporter activity ; traceable author statement ; 5487 ; nucleocytoplasmic transporter activity ; inferred from electronic annotation ; 17056 ; structural constituent of nuclear pore ; inferred from electronic annotation
201821_s_at	TIMM17A	BC004439	2.04	1.49E-02	translocase of inner mitochondrial membrane 17 homolog A (yeast)	chr1q32.1	chr1:200191271-200205698 (+)	6626 ; protein targeting to mitochondrion ; traceable author statement ; 6605 ; protein targeting ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation ; 6886 ; intracellular protein transport ; inferred from electronic annotation ; 15031 ; protein transport ; inferred from electronic annotation	15450 ; protein translocase activity ; inferred from electronic annotation ; 8565 ; protein transporter activity ; inferred from electronic annotation
218567_x_at	DPP3	NM_005700	2.04	1.55E-02	dipeptidylpeptidase 3	chr11q12-q13.1	chr11:66006236-66033703 (+)	6508 ; proteolysis ; traceable author statement ; 6508 ; proteolysis ; inferred from electronic annotation	4177 ; aminopeptidase activity ; inferred from electronic annotation ; 8237 ; metallopeptidase activity ; inferred from electronic annotation ; 17039 ; dipeptidyl-peptidase III activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 8239 ; dipeptidyl-peptidase activity ; traceable author statement
242727_at	ARL8	BG032269	2.03	3.94E-02	ADP-ribosylation factor-like 8	chr10p12.33	chr10:19006432-19006949 (+)	6886 ; intracellular protein transport ; inferred from electronic annotation ; 7264 ; small GTPase mediated signal transduction ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 5525 ; GTP binding ; inferred from electronic annotation
201521_s_at	NCBP2	NM_007362	2.03	3.83E-03	nuclear cap binding protein subunit 2, 20kDa	chr3q29	chr3:198148126-198153795 (-)	6397 ; mRNA processing ; inferred from electronic annotation ; 6406 ; mRNA export from nucleus ; inferred from electronic annotation ; 6408 ; snRNA export from nucleus ; non-traceable author statement ; 6810 ; transport ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 339 ; RNA cap binding ; non-traceable author statement ; 3676 ; nucleic acid binding ; inferred from electronic annotation ; 3723 ; RNA binding ; inferred from electronic annotation
227245_at	FLJ13089	AW511198	2.03	4.86E-03	hypothetical protein FLJ13089	chr12q24.13	chr12:110951554-111030983 (-)		5488 ; binding ; inferred from electronic annotation
234725_s_at	SEMA4B	AK026133	2.03	4.18E-02	sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B	chr15q25	chr15:88567792-88573894 (+)	7399 ; nervous system development ; inferred from electronic annotation ; 30154 ; cell differentiation ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation	4872 ; receptor activity ; inferred from electronic annotation
239545_at	CAS1	AI335004	2.03	2.80E-02	O-acetyltransferase	chr7q21.3	chr7:94003953-94004397 (+)		16740 ; transferase activity ; inferred from electronic annotation
201664_at	SMC4L1	AL136877	2.03	3.28E-03	SMC4 structural maintenance of chromosomes 4-like 1 (yeast)	chr3q26.1	chr3:161601076-161635433 (+)	7001 ; chromosome organization and biogenesis (sensu Eukaryota) ; traceable author statement ; 7049 ; cell cycle ; inferred from electronic annotation ; 7076 ; mitotic chromosome condensation ; inferred from direct assay ; 51301 ; cell division ; inferred from electronic annotation ; 7067 ; mitosis ; inferred from electronic annotation ; 7076 ; mitotic chromosome condensation ; inferred from electronic annotation ; 51276 ; chromosome organization and biogenesis ; inferred from electronic annotation ; 70 ; mitotic sister chromatid segregation ; traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation ; 5524 ; ATP binding ; traceable author statement ; 16887 ; ATPase activity ; inferred from electronic annotation ; 46982 ; protein heterodimerization activity ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation
201710_at	MYBL2	NM_002466	2.03	4.38E-02	v-myb myeloblastosis viral oncogene homolog (avian)-like 2	chr20q13.1	chr20:41735858-41778538 (+)	74 ; regulation of progression through cell cycle ; non-traceable author statement ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6366 ; transcription from RNA polymerase II promoter ; not recorded ; 6916 ; anti-apoptosis ; not recorded ; 7275 ; development ; not recorded ; 6350 ; transcription ; inferred from electronic annotation ; 45449 ; regulation of transcription ; inferred from electronic annotation	3700 ; transcription factor activity ; traceable author statement ; 3677 ; DNA binding ; inferred from electronic annotation
233599_at	C9orf3	AK025151	2.03	2.68E-02	Chromosome 9 open reading frame 3	chr9q22.32	chr9:96863819-96866020 (+)	6508 ; proteolysis ; inferred from direct assay ; 6508 ; proteolysis ; inferred from electronic annotation	4177 ; aminopeptidase activity ; inferred from direct assay ; 4179 ; membrane alanyl aminopeptidase activity ; inferred from electronic annotation ; 8237 ; metallopeptidase activity ; inferred from direct assay ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4177 ; aminopeptidase activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8237 ; metallopeptidase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
224361_s_at	IL17RB	AF250309	2.03	1.99E-02	interleukin 17 receptor B ; interleukin 17 receptor B	chr3p21.1	chr3:53855655-53874448 (+)	1558 ; regulation of cell growth ; non-traceable author statement ; 6952 ; defense response ; traceable author statement	4872 ; receptor activity ; inferred from electronic annotation ; 4907 ; interleukin receptor activity ; non-traceable author statement
224308_s_at	KIAA1287	AL136800	2.03	3.62E-03	KIAA1287	chr17q23.2	chr17:57297512-57360159 (-)
204493_at	BID	NM_001196	2.03	2.40E-02	BH3 interacting domain death agonist	chr22q11.1	chr22:16597977-16637226 (-)	8625 ; induction of apoptosis via death domain receptors ; traceable author statement ; 8637 ; apoptotic mitochondrial changes ; traceable author statement ; 43065 ; positive regulation of apoptosis ; inferred from electronic annotation ; 6915 ; apoptosis ; inferred from electronic annotation ; 42981 ; regulation of apoptosis ; inferred from electronic annotation	5123 ; death receptor binding ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction
200679_x_at	HMGB1	BE311760	2.03	3.46E-02	high-mobility group box 1	chr13q12	chr13:29932583-29938069 (-)	6268 ; DNA unwinding during replication ; non-traceable author statement ; 6281 ; DNA repair ; traceable author statement ; 6288 ; base-excision repair, DNA ligation ; inferred from direct assay ; 6310 ; DNA recombination ; traceable author statement ; 6325 ; establishment and/or maintenance of chromatin architecture ; traceable author statement ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6357 ; regulation of transcription from RNA polymerase II promoter ; inferred from direct assay ; 17055 ; negative regulation of transcriptional preinitiation complex formation ; inferred from direct assay	3677 ; DNA binding ; inferred from electronic annotation ; 8134 ; transcription factor binding ; traceable author statement ; 8301 ; DNA bending activity ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 3677 ; DNA binding ; traceable author statement
226316_at	C13orf10	BF592957	2.03	4.41E-02	CDNA FLJ14866 fis, clone PLACE1002066	chr13	chr13:78783963-78785810 (-)
217772_s_at	MTCH2	NM_014342	2.03	7.46E-03	mitochondrial carrier homolog 2 (C. elegans)	chr11p11.2	chr11:47596839-47620642 (-)	6810 ; transport ; inferred from electronic annotation	5488 ; binding ; inferred from electronic annotation
222768_s_at	CGI-09	BE897074	2.02	4.48E-02	CGI-09 protein	chr20p12.3	chr20:5866485-5879173 (-)	6446 ; regulation of translational initiation ; inferred from electronic annotation	3743 ; translation initiation factor activity ; inferred from electronic annotation
201112_s_at	CSE1L	NM_001316	2.02	8.44E-03	CSE1 chromosome segregation 1-like (yeast)	chr20q13	chr20:47096255-47146490 (+)	59 ; protein import into nucleus, docking ; inferred from electronic annotation ; 6915 ; apoptosis ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement ; 15031 ; protein transport ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation ; 6915 ; apoptosis ; inferred from electronic annotation ; 8283 ; cell proliferation ; inferred from electronic annotation	5488 ; binding ; inferred from electronic annotation ; 8262 ; importin-alpha export receptor activity ; traceable author statement ; 8565 ; protein transporter activity ; inferred from electronic annotation ; 8262 ; importin-alpha export receptor activity ; inferred from electronic annotation
210707_x_at	PMS2L11; PMSR6	U38980	2.02	1.42E-02	postmeiotic segregation increased 2-like 11	chr7q11.23	chr7:76448201-76483108 (+)
230323_s_at	LOC120224	AW242836	2.02	2.11E-02	transmembrane protein 45B	chr11q24.3	chr11:129234154-129234614 (+)
209165_at	AATF	AF083208	2.02	1.81E-02	apoptosis antagonizing transcription factor	chr17q11.2-q12	chr17:32380370-32488249 (+)		5515 ; protein binding ; inferred from physical interaction
228323_at	AF15Q14	BF248364	2.02	1.77E-02	cancer susceptibility candidate 5	chr15q14	chr15:38702621-38743829 (+)	1675 ; acrosome formation ; non-traceable author statement
224846_at	SHKBP1	AI348000	2.02	4.72E-02	SH3KBP1 binding protein 1	chr19q13.2	chr19:45774621-45789143 (+)	6813 ; potassium ion transport ; inferred from electronic annotation	5216 ; ion channel activity ; inferred from electronic annotation ; 5249 ; voltage-gated potassium channel activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
216841_s_at	SOD2	X15132	2.02	1.09E-02	superoxide dismutase 2, mitochondrial	chr6q25.3	chr6:160023301-160034249 (-)	303 ; response to superoxide ; traceable author statement ; 1315 ; age-dependent response to reactive oxygen species ; inferred from mutant phenotype ; 6357 ; regulation of transcription from RNA polymerase II promoter ; inferred from mutant phenotype ; 6801 ; superoxide metabolism ; inferred from direct assay ; 6979 ; response to oxidative stress ; traceable author statement ; 16066 ; cellular defense response (sensu Vertebrata) ; inferred from mutant phenotype ; 6801 ; superoxide metabolism ; inferred from electronic annotation ; 303 ; response to superoxide ; inferred from sequence or structural similarity ; 1315 ; age-dependent response to reactive oxygen species ; inferred from sequence or structural similarity ; 6357 ; regulation of transcription from RNA polymerase II promoter ; inferred from sequence or structural similarity ; 16066 ; cellular defense response (sensu Vertebrata) ; inferred from sequence or structural similarity	8383 ; manganese superoxide dismutase activity ; inferred from direct assay ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 30145 ; manganese ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4784 ; superoxide dismutase activity ; inferred from electronic annotation
37117_at		Z83838	2.02	3.99E-03	Rho GTPase activating protein 8 ; PRR5-ARHGAP8 fusion	chr22q13.31	chr22:43589215-43637331 (+)
209482_at	POP7	BC001430	2.02	1.25E-02	processing of precursor 7, ribonuclease P subunit (S. cerevisiae)	chr7q22	chr7:100141701-100143045 (+)	8033 ; tRNA processing ; inferred from electronic annotation	3676 ; nucleic acid binding ; inferred from electronic annotation ; 4526 ; ribonuclease P activity ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 4526 ; ribonuclease P activity ; inferred from electronic annotation
213310_at	EIF2C2	AI613483	2.01	3.30E-03	Eukaryotic translation initiation factor 2C, 2	chr8q24	chr8:141601643-141605441 (-)	6412 ; protein biosynthesis ; non-traceable author statement ; 6412 ; protein biosynthesis ; inferred from electronic annotation	3743 ; translation initiation factor activity ; non-traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 3743 ; translation initiation factor activity ; inferred from electronic annotation
218188_s_at	TIMM13	NM_012458	2.01	2.52E-02	translocase of inner mitochondrial membrane 13 homolog (yeast)	chr19p13.3	chr19:2377563-2378562 (-)	7605 ; sensory perception of sound ; traceable author statement ; 15031 ; protein transport ; inferred from electronic annotation ; 45039 ; protein import into mitochondrial inner membrane ; inferred from electronic annotation ; 6605 ; protein targeting ; inferred from electronic annotation ; 6626 ; protein targeting to mitochondrion ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation ; 6626 ; protein targeting to mitochondrion ; traceable author statement	8270 ; zinc ion binding ; traceable author statement
213449_at	POP1	D31765	2.01	2.64E-03	processing of precursor 1, ribonuclease P/MRP subunit (S. cerevisiae)	chr8q22.1	chr8:99198718-99241239 (+)	1682 ; tRNA 5-leader removal ; inferred from electronic annotation ; 16078 ; tRNA catabolism ; inferred from direct assay ; 8033 ; tRNA processing ; inferred from electronic annotation	171 ; ribonuclease MRP activity ; inferred from direct assay ; 4526 ; ribonuclease P activity ; inferred from direct assay ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 42802 ; protein self binding ; inferred from physical interaction ; 5515 ; protein binding ; inferred from physical interaction ; 4526 ; ribonuclease P activity ; inferred from electronic annotation
218336_at	PFDN2	NM_012394	2.01	2.55E-02	prefoldin 2	chr1q23.3	chr1:159336970-159354459 (-)	6457 ; protein folding ; non-traceable author statement ; 6457 ; protein folding ; inferred from electronic annotation	51082 ; unfolded protein binding ; non-traceable author statement ; 51082 ; unfolded protein binding ; inferred from electronic annotation
220865_s_at	TPRT	NM_014317	2.01	2.47E-02	trans-prenyltransferase	chr10p12.1	chr10:27026593-27075730 (+)	8299 ; isoprenoid biosynthesis ; inferred from electronic annotation	16740 ; transferase activity ; inferred from electronic annotation
226691_at	KIAA1856	AI936523	2.01	3.10E-02	KIAA1856 protein	chr7p22.1	chr7:57067601-57082151 (+)
216387_x_at		AL353580	2.01	1.41E-02	similar to nucleophosmin 1; nucleolar phosphoprotein B23; numatrin; nucleophosmin/nucleoplasmin family, member 1	chr13	chr13:67304008-67304960 (-)
238688_at	TPM1	AI521618	2.01	1.50E-02	Tropomyosin 1 (alpha)	chr15q22.1	chr15:61146813-61148236 (+)	6937 ; regulation of muscle contraction ; traceable author statement ; 7517 ; muscle development ; inferred from electronic annotation ; 8016 ; regulation of heart contraction rate ; traceable author statement ; 46580 ; negative regulation of Ras protein signal transduction ; inferred from electronic annotation	3779 ; actin binding ; inferred from electronic annotation ; 8307 ; structural constituent of muscle ; traceable author statement ; 5200 ; structural constituent of cytoskeleton ; inferred from electronic annotation ; 5099 ; Ras GTPase activator activity ; inferred from electronic annotation ; 3743 ; translation initiation factor activity ; inferred from electronic annotation
234989_at	TncRNA	AV699657	2.01	1.51E-02	trophoblast-derived noncoding RNA	chr11q13.1	chr11:64955726-64956977 (+)
238172_at	NDUFA10	AA192765	2.01	2.26E-02	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa	chr2q37.3	chr2:240554961-240555426 (-)	6091 ; generation of precursor metabolites and energy ; not recorded ; 6139 ; nucleobase, nucleoside, nucleotide and nucleic acid metabolism ; inferred from electronic annotation	3954 ; NADH dehydrogenase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 8137 ; NADH dehydrogenase (ubiquinone) activity ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 16773 ; phosphotransferase activity, alcohol group as acceptor ; inferred from electronic annotation
218982_s_at	MRPS17	NM_015969	2.01	3.31E-03	mitochondrial ribosomal protein S17	chr7p11	chr7:55988363-55990525 (+)	6412 ; protein biosynthesis ; non-traceable author statement ; 6810 ; transport ; inferred from electronic annotation ; 6412 ; protein biosynthesis ; inferred from electronic annotation	3676 ; nucleic acid binding ; inferred from electronic annotation ; 3735 ; structural constituent of ribosome ; non-traceable author statement ; 3735 ; structural constituent of ribosome ; inferred from electronic annotation ; 5488 ; binding ; inferred from electronic annotation
219630_at	MAP17	NM_005764	2.01	3.73E-02	PDZK1 interacting protein 1	chr1p33	chr1:47421852-47428314 (-)
224232_s_at	PX19	AF112203	2.01	4.55E-02	px19-like protein	chr5q35.3	chr1:209447041-209448241 (+)	6955 ; immune response ; traceable author statement ; 7275 ; development ; traceable author statement ; 45449 ; regulation of transcription ; inferred from electronic annotation	30528 ; transcription regulator activity ; inferred from electronic annotation
211921_x_at	PTMA	AF348514	2.00	1.07E-02	prothymosin, alpha (gene sequence 28) ; prothymosin, alpha (gene sequence 28)	chr2q35-q36	chr12:12155363-12155693 (+)	74 ; regulation of progression through cell cycle ; not recorded ; 6350 ; transcription ; traceable author statement ; 7275 ; development ; not recorded
209875_s_at	SPP1	M83248	2.00	4.19E-02	secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1)	chr4q21-q25	chr4:89115893-89123308 (+)	1503 ; ossification ; traceable author statement ; 6916 ; anti-apoptosis ; inferred from sequence or structural similarity ; 7155 ; cell adhesion ; inferred from electronic annotation ; 7160 ; cell-matrix adhesion ; non-traceable author statement ; 7267 ; cell-cell signaling ; traceable author statement ; 30502 ; negative regulation of bone mineralization ; non-traceable author statement ; 30595 ; immune cell chemotaxis ; traceable author statement ; 42088 ; T-helper 1 type immune response ; traceable author statement ; 42102 ; positive regulation of T cell proliferation ; traceable author statement ; 45637 ; regulation of myeloid cell differentiation ; traceable author statement ; 50930 ; induction of positive chemotaxis ; traceable author statement ; 1503 ; ossification ; inferred from electronic annotation ; 6954 ; inflammatory response ; traceable author statement	5125 ; cytokine activity ; inferred from sequence or structural similarity ; 5178 ; integrin binding ; non-traceable author statement ; 5515 ; protein binding ; inferred from electronic annotation ; 8083 ; growth factor activity ; traceable author statement ; 5125 ; cytokine activity ; inferred from electronic annotation
223413_s_at	LYAR	AW958593	2.00	1.67E-02	hypothetical protein FLJ20425	chr4p16.2	chr4:4320336-4342797 (-)		46872 ; metal ion binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
218355_at	KIF4A	NM_012310	2.00	2.54E-03	kinesin family member 4A	chrXq13.1	chr5:154373566-154377875 (+)	6996 ; organelle organization and biogenesis ; traceable author statement ; 7018 ; microtubule-based movement ; inferred from electronic annotation ; 8089 ; anterograde axon cargo transport ; traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 3777 ; microtubule motor activity ; traceable author statement ; 5524 ; ATP binding ; inferred from electronic annotation ; 3774 ; motor activity ; inferred from electronic annotation ; 3777 ; microtubule motor activity ; inferred from electronic annotation
224903_at	CIRH1A	AL519818	2.00	7.07E-03	cirrhosis, autosomal recessive 1A (cirhin)	chr16q22.1	chr16:67723918-67760428 (+)
227340_s_at	RGMB	AL117590	0.50	4.25E-02	RGM domain family, member B	chr5q21.1	chr5:98156464-98159517 (+)
228346_at		H47630	0.50	4.70E-02	Transcribed locus, moderately similar to XP_498452.1 PREDICTED: hypothetical protein XP_498452 [Homo sapiens]	chr19p13.2	chr19:12052185-12053375 (+)
201535_at	UBL3	NM_007106	0.50	6.98E-03	ubiquitin-like 3	chr13q12-q13	chr13:29236545-29321783 (-)	6464 ; protein modification ; inferred from electronic annotation
209459_s_at	ABAT	AF237813	0.50	1.61E-02	4-aminobutyrate aminotransferase	chr16p13.2	chr16:8783434-8784660 (+)	7268 ; synaptic transmission ; non-traceable author statement ; 9448 ; gamma-aminobutyric acid metabolism ; inferred from electronic annotation ; 42135 ; neurotransmitter catabolism ; inferred from electronic annotation	3867 ; 4-aminobutyrate transaminase activity ; non-traceable author statement ; 16740 ; transferase activity ; inferred from electronic annotation ; 30170 ; pyridoxal phosphate binding ; inferred from electronic annotation ; 47298 ; (S)-3-amino-2-methylpropionate transaminase activity ; inferred from electronic annotation ; 3867 ; 4-aminobutyrate transaminase activity ; inferred from electronic annotation ; 8483 ; transaminase activity ; inferred from electronic annotation
219882_at	FLJ23033	NM_024686	0.50	1.77E-02	tubulin tyrosine ligase-like family, member 7	chr1p31.1	chr1:84107973-84176172 (-)	6464 ; protein modification ; inferred from electronic annotation	4835 ; tubulin-tyrosine ligase activity ; inferred from electronic annotation
204519_s_at	TM4SF11	NM_015993	0.50	3.56E-02	plasma membrane proteolipid (plasmolipin)	chr16q13	chr16:55847509-55876072 (-)	6811 ; ion transport ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation	5216 ; ion channel activity ; inferred from electronic annotation
205059_s_at	IDUA	NM_000203	0.50	2.23E-02	iduronidase, alpha-L-	chr4p16.3	chr4:970784-988286 (+)	5975 ; carbohydrate metabolism ; inferred from electronic annotation ; 5984 ; disaccharide metabolism ; traceable author statement ; 30203 ; glycosaminoglycan metabolism ; inferred from electronic annotation	3940 ; L-iduronidase activity ; traceable author statement ; 3940 ; L-iduronidase activity ; inferred from electronic annotation ; 4553 ; hydrolase activity, hydrolyzing O-glycosyl compounds ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 16798 ; hydrolase activity, acting on glycosyl bonds ; inferred from electronic annotation
228831_s_at	GNG7	AL039870	0.50	1.34E-02	guanine nucleotide binding protein (G protein), gamma 7	chr19p13.3	chr19:2462217-2462894 (-)	7165 ; signal transduction ; inferred from electronic annotation ; 8277 ; regulation of G-protein coupled receptor protein signaling pathway ; traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation	4871 ; signal transducer activity ; inferred from electronic annotation
206978_at	CCR2	NM_000647	0.50	1.11E-02	chemokine (C-C motif) receptor 2 ; chemokine (C-C motif) receptor 2	chr3p21	chr3:46373983-46377423 (+)	6935 ; chemotaxis ; traceable author statement ; 6954 ; inflammatory response ; traceable author statement ; 6968 ; cellular defense response ; traceable author statement ; 7165 ; signal transduction ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation ; 7194 ; negative regulation of adenylate cyclase activity ; traceable author statement ; 7204 ; elevation of cytosolic calcium ion concentration ; traceable author statement ; 7259 ; JAK-STAT cascade ; traceable author statement ; 19735 ; antimicrobial humoral response (sensu Vertebrata) ; traceable author statement ; 6955 ; immune response ; traceable author statement ; 9611 ; response to wounding ; traceable author statement	1584 ; rhodopsin-like receptor activity ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 16493 ; C-C chemokine receptor activity ; inferred from electronic annotation ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; inferred from electronic annotation ; 4950 ; chemokine receptor activity ; traceable author statement
206042_x_at	SNRPN	NM_022804	0.50	1.46E-02	small nuclear ribonucleoprotein polypeptide N ; SNRPN upstream reading frame	chr15q11.2	chr15:22751227-22764322 (+)	6397 ; mRNA processing ; inferred from electronic annotation	3723 ; RNA binding ; inferred from electronic annotation
227769_at	EIF4E3	AI703476	0.49	1.43E-02	G protein-coupled receptor 27	chr3	chr3:71887025-71888333 (+)	7165 ; signal transduction ; traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation ; 7165 ; signal transduction ; inferred from electronic annotation	1584 ; rhodopsin-like receptor activity ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; traceable author statement
225728_at	ARGBP2	AI659533	0.49	8.37E-03	Importin 9	chr4q35.1	chr4:186743591-186745178 (-)	59 ; protein import into nucleus, docking ; inferred from electronic annotation ; 15031 ; protein transport ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation ; 6606 ; protein import into nucleus ; non-traceable author statement	8536 ; Ran GTPase binding ; inferred from sequence or structural similarity ; 8565 ; protein transporter activity ; inferred from direct assay ; 42393 ; histone binding ; inferred from sequence or structural similarity ; 5515 ; protein binding ; inferred from physical interaction ; 8565 ; protein transporter activity ; inferred from electronic annotation
227498_at		AI480314	0.49	4.45E-02	CDNA FLJ11723 fis, clone HEMBA1005314	chr11	chr11:15944571-15946635 (-)
212414_s_at	12:00 AM	D50918	0.49	2.24E-02	septin 6 ; cytokine-like nuclear factor n-pac	chrXq24	chrX:118634938-118711351 (-)	910 ; cytokinesis ; traceable author statement ; 7049 ; cell cycle ; inferred from electronic annotation ; 6098 ; pentose-phosphate shunt ; inferred from electronic annotation ; 51301 ; cell division ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 5515 ; protein binding ; traceable author statement ; 5525 ; GTP binding ; inferred from electronic annotation ; 5525 ; GTP binding ; traceable author statement ; 4616 ; phosphogluconate dehydrogenase (decarboxylating) activity ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation
220017_x_at	CYP2C9	NM_000771	0.49	4.26E-02	cytochrome P450, family 2, subfamily C, polypeptide 9	chr10q24	chr10:96688429-96739137 (+)	6118 ; electron transport ; non-traceable author statement ; 6118 ; electron transport ; inferred from electronic annotation	5506 ; iron ion binding ; inferred from electronic annotation ; 16712 ; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen ; inferred from electronic annotation ; 18676 ; (S)-limonene 7-monooxygenase activity ; inferred from electronic annotation ; 20037 ; heme binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4497 ; monooxygenase activity ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 4497 ; monooxygenase activity ; non-traceable author statement
219680_at	NOD9	NM_024618	0.49	2.47E-02	NOD9 protein	chr11q23.3	chr11:118550638-118559933 (+)		166 ; nucleotide binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation
236586_at		R37396	0.49	3.90E-02	Transcribed locus, moderately similar to XP_209041.2 PREDICTED: similar to KIAA1503 protein [Homo sapiens]	chr11q13.5-q14	chr11:77003848-77004777 (+)
210479_s_at	RORA	L14611	0.49	9.68E-03	RAR-related orphan receptor A	chr15q21-q22	chr15:58576900-58671930 (-)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7165 ; signal transduction ; non-traceable author statement	3700 ; transcription factor activity ; inferred from electronic annotation ; 3707 ; steroid hormone receptor activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 4879 ; ligand-dependent nuclear receptor activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 4879 ; ligand-dependent nuclear receptor activity ; traceable author statement
204465_s_at	INA	NM_004692	0.49	1.55E-02	internexin neuronal intermediate filament protein, alpha	chr10q24.33	chr10:105026913-105040089 (+)	7399 ; nervous system development ; inferred from electronic annotation ; 30154 ; cell differentiation ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation	5200 ; structural constituent of cytoskeleton ; traceable author statement ; 5198 ; structural molecule activity ; inferred from electronic annotation
1405_i_at	CCL5	M21121	0.49	3.00E-02	chemokine (C-C motif) ligand 5	chr17q11.2-q12	chr17:31222639-31231443 (-)	6874 ; calcium ion homeostasis ; traceable author statement ; 6887 ; exocytosis ; traceable author statement ; 6928 ; cell motility ; traceable author statement ; 6935 ; chemotaxis ; traceable author statement ; 6954 ; inflammatory response ; traceable author statement ; 6968 ; cellular defense response ; traceable author statement ; 6979 ; response to oxidative stress ; traceable author statement ; 7155 ; cell adhesion ; traceable author statement ; 7165 ; signal transduction ; traceable author statement ; 7267 ; cell-cell signaling ; traceable author statement ; 7600 ; sensory perception ; inferred from electronic annotation ; 9615 ; response to virus ; traceable author statement ; 6935 ; chemotaxis ; inferred from electronic annotation ; 6954 ; inflammatory response ; inferred from electronic annotation ; 6955 ; immune response ; inferred from electronic annotation ; 6955 ; immune response ; traceable author statement	8009 ; chemokine activity ; traceable author statement ; 5125 ; cytokine activity ; inferred from electronic annotation ; 8009 ; chemokine activity ; inferred from electronic annotation ; 4871 ; signal transducer activity ; traceable author statement ; 5102 ; receptor binding ; traceable author statement
221588_x_at	ALDH6A1	AI640855	0.49	1.04E-03	aldehyde dehydrogenase 6 family, member A1	chr14q24.3	chr14:73594122-73597130 (-)	6220 ; pyrimidine nucleotide metabolism ; non-traceable author statement ; 6573 ; valine metabolism ; non-traceable author statement ; 8152 ; metabolism ; inferred from electronic annotation ; 6573 ; valine metabolism ; inferred from electronic annotation	4491 ; methylmalonate-semialdehyde dehydrogenase (acylating) activity ; non-traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 18478 ; malonate-semialdehyde dehydrogenase (acetylating) activity ; inferred from electronic annotation ; 4491 ; methylmalonate-semialdehyde dehydrogenase (acylating) activity ; inferred from electronic annotation
235766_x_at	RAB27A	AA743462	0.49	1.65E-02	Eukaryotic translation initiation factor 2C, 2	chr15	chr15:53282458-53282905 (-)	6412 ; protein biosynthesis ; non-traceable author statement ; 6412 ; protein biosynthesis ; inferred from electronic annotation	3743 ; translation initiation factor activity ; non-traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 3743 ; translation initiation factor activity ; inferred from electronic annotation
243221_at	FAM20A	AA579773	0.49	1.14E-02	Family with sequence similarity 20, member A	chr17q24.2	chr17:64097457-64097902 (-)
239294_at		AA810265	0.49	1.61E-02	Transcribed locus	chr7	chr7:106335859-106336651 (+)
218718_at	PDGFC	NM_016205	0.49	4.11E-02	platelet derived growth factor C	chr4q32	chr4:157902213-158111996 (-)	7417 ; central nervous system development ; traceable author statement	8083 ; growth factor activity ; inferred from electronic annotation ; 8083 ; growth factor activity ; traceable author statement
211671_s_at		U01351	0.48	1.46E-02	nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) ; nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)	chr5q31.3	chr5:142640919-142763447 (-)	6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6366 ; transcription from RNA polymerase II promoter ; traceable author statement ; 6954 ; inflammatory response ; not recorded ; 7165 ; signal transduction ; traceable author statement ; 6350 ; transcription ; inferred from electronic annotation ; 6351 ; transcription, DNA-dependent ; traceable author statement	3700 ; transcription factor activity ; traceable author statement ; 4883 ; glucocorticoid receptor activity ; traceable author statement ; 5496 ; steroid binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 3700 ; transcription factor activity ; inferred from electronic annotation ; 3707 ; steroid hormone receptor activity ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 4879 ; ligand-dependent nuclear receptor activity ; inferred from electronic annotation ; 4883 ; glucocorticoid receptor activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
231791_at	ASAH2	AL047141	0.48	1.53E-02	N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2	chr10q11.23	chr10:52172677-52184988 (+)	6672 ; ceramide metabolism ; traceable author statement ; 7165 ; signal transduction ; traceable author statement	16787 ; hydrolase activity ; inferred from electronic annotation
235193_at	FLJ10980	BG036618	0.48	2.27E-02	Hypothetical protein FLJ10980	chr15q21.2	chr15:50735541-50736504 (-)
237140_x_at		BE671397	0.48	4.13E-02	Transcribed locus	chr14	chr14:37123168-37123568 (-)
220122_at	MCTP1	NM_024717	0.48	3.74E-02	multiple C2-domains with two transmembrane regions 1	chr5q15	chr5:94068049-94234703 (-)
225207_at	PDK4	AV707102	0.48	1.11E-02	pyruvate dehydrogenase kinase, isoenzyme 4	chr7q21.3	chr7:95050744-95052702 (-)	6006 ; glucose metabolism ; traceable author statement ; 6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 16310 ; phosphorylation ; inferred from electronic annotation	4740 ; [pyruvate dehydrogenase (lipoamide)] kinase activity ; traceable author statement ; 5524 ; ATP binding ; inferred from electronic annotation ; 4740 ; [pyruvate dehydrogenase (lipoamide)] kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; traceable author statement ; 16740 ; transferase activity ; inferred from electronic annotation ; 16772 ; transferase activity, transferring phosphorus-containing groups ; inferred from electronic annotation
234317_s_at	DKFZp762K222	AL390216	0.48	3.35E-02	storkhead box 2	chr4q35.1	chr4:185168919-185175575 (+)
212224_at	ALDH1A1	NM_000689	0.48	2.21E-02	aldehyde dehydrogenase 1 family, member A1	chr9q21.13	chr9:74705406-74757791 (-)	6081 ; aldehyde metabolism ; traceable author statement ; 8152 ; metabolism ; inferred from electronic annotation	1758 ; retinal dehydrogenase activity ; inferred from electronic annotation ; 4029 ; aldehyde dehydrogenase (NAD) activity ; traceable author statement ; 5489 ; electron transporter activity ; traceable author statement ; 5497 ; androgen binding ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation
222918_at	RAB9B	AL139228	0.48	4.30E-02	RAB9B, member RAS oncogene family	chrXq22.1-q22.3	chrX:102963910-102973815 (-)	6886 ; intracellular protein transport ; inferred from electronic annotation ; 6895 ; Golgi to endosome transport ; non-traceable author statement ; 7264 ; small GTPase mediated signal transduction ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation ; 15031 ; protein transport ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 5525 ; GTP binding ; non-traceable author statement ; 5525 ; GTP binding ; inferred from electronic annotation
202037_s_at	SFRP1	NM_003012	0.48	7.07E-03	secreted frizzled-related protein 1	chr8p12-p11.1	chr8:41238635-41286137 (-)	16055 ; Wnt receptor signaling pathway ; inferred from electronic annotation ; 30154 ; cell differentiation ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation
203498_at	DSCR1L1	NM_005822	0.48	9.44E-03	Down syndrome critical region gene 1-like 1	chr6p12.3	chr6:46296433-46401364 (-)	7417 ; central nervous system development ; non-traceable author statement ; 19722 ; calcium-mediated signaling ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 30346 ; protein phosphatase 2B binding ; non-traceable author statement
239146_at	OR5K1	AI634844	0.48	1.78E-02	chromosome 3 open reading frame 4	chr3q12.1	chr3:99702319-99718638 (-)
205328_at	CLDN10	NM_006984	0.48	1.25E-02	claudin 10	chr13q31-q34	chr13:95002982-95028492 (+)	7155 ; cell adhesion ; traceable author statement ; 16338 ; calcium-independent cell-cell adhesion ; inferred from sequence or structural similarity	5198 ; structural molecule activity ; inferred from electronic annotation ; 42802 ; protein self binding ; inferred from sequence or structural similarity ; 5515 ; protein binding ; inferred from sequence or structural similarity
232204_at	EBF	AF208502	0.48	4.36E-02	early B-cell factor	chr5q34	chr5:158058140-158459121 (-)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation	3677 ; DNA binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from direct assay ; 8270 ; zinc ion binding ; inferred from electronic annotation
211456_x_at		AF333388	0.48	4.02E-02	Similar to 60S ribosomal protein L35	chr16	chr16:55261251-55262487 (+)	6412 ; protein biosynthesis ; traceable author statement ; 6412 ; protein biosynthesis ; inferred from electronic annotation	3729 ; mRNA binding ; traceable author statement ; 3735 ; structural constituent of ribosome ; traceable author statement ; 3735 ; structural constituent of ribosome ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
212843_at	NCAM1	AA126505	0.48	1.14E-02	neural cell adhesion molecule 1	chr11q23.1	chr11:112608724-112653830 (+)	7155 ; cell adhesion ; non-traceable author statement ; 7267 ; cell-cell signaling ; not recorded ; 7268 ; synaptic transmission ; not recorded ; 7155 ; cell adhesion ; inferred from electronic annotation	5515 ; protein binding ; inferred from electronic annotation
203130_s_at		NM_004522	0.48	6.71E-03	kinesin family member 5C	chr2q23.1	chr2:149349288-149591519 (+)	6996 ; organelle organization and biogenesis ; traceable author statement ; 7018 ; microtubule-based movement ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3777 ; microtubule motor activity ; traceable author statement ; 5524 ; ATP binding ; inferred from electronic annotation ; 3774 ; motor activity ; inferred from electronic annotation ; 3777 ; microtubule motor activity ; inferred from electronic annotation
219213_at	JAM2	NM_021219	0.48	2.29E-02	junctional adhesion molecule 2	chr21q21.2	chr21:25933802-26008963 (+)	16337 ; cell-cell adhesion ; non-traceable author statement
205671_s_at	HLA-DOB	NM_002120	0.48	4.43E-02	major histocompatibility complex, class II, DO beta	chr6p21.3	chr6:32888526-32892762 (-)	6955 ; immune response ; inferred from electronic annotation ; 19884 ; antigen presentation, exogenous antigen ; inferred from electronic annotation ; 19886 ; antigen processing, exogenous antigen via MHC class II ; inferred from electronic annotation	45012 ; MHC class II receptor activity ; traceable author statement ; 45012 ; MHC class II receptor activity ; inferred from electronic annotation
219003_s_at	MANEA	NM_024641	0.48	1.13E-02	mannosidase, endo-alpha	chr6q16.1	chr6:96141350-96162315 (+)	5975 ; carbohydrate metabolism ; inferred from electronic annotation	4569 ; glycoprotein endo-alpha-1,2-mannosidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 16798 ; hydrolase activity, acting on glycosyl bonds ; inferred from electronic annotation
205907_s_at	OMD	AI765819	0.48	1.87E-02	osteomodulin	chr9q22.31	chr9:94216233-94226523 (-)	7155 ; cell adhesion ; inferred from electronic annotation	5515 ; protein binding ; inferred from electronic annotation
220351_at	CCRL1	NM_016557	0.48	1.65E-02	chemokine (C-C motif) receptor-like 1	chr3q22	chr3:133798826-133803744 (+)	6935 ; chemotaxis ; traceable author statement ; 6955 ; immune response ; traceable author statement ; 7165 ; signal transduction ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation	1584 ; rhodopsin-like receptor activity ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 16493 ; C-C chemokine receptor activity ; inferred from electronic annotation ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; inferred from electronic annotation ; 4950 ; chemokine receptor activity ; traceable author statement
228007_at		AL133101	0.48	1.54E-02	CDNA clone IMAGE:5270591	chr6q22	chr6:118888627-118891327 (-)
240422_at	FMO5	AI935710	0.47	2.83E-03	Chaperonin containing TCP1, subunit 8 (theta)	chr1q21.1	chr1:145123589-145124166 (-)	6118 ; electron transport ; inferred from electronic annotation ; 6457 ; protein folding ; inferred from electronic annotation ; 44267 ; cellular protein metabolism ; inferred from electronic annotation	4497 ; monooxygenase activity ; inferred from electronic annotation ; 4499 ; dimethylaniline monooxygenase (N-oxide-forming) activity ; inferred from electronic annotation ; 4499 ; dimethylaniline monooxygenase (N-oxide-forming) activity ; non-traceable author statement ; 50660 ; FAD binding ; inferred from electronic annotation ; 50661 ; NADP binding ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 166 ; nucleotide binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 51082 ; unfolded protein binding ; inferred from electronic annotation
205259_at	NR3C2	NM_000901	0.47	8.34E-03	nuclear receptor subfamily 3, group C, member 2	chr4q31.1	chr4:149219369-149582973 (-)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6883 ; sodium ion homeostasis ; not recorded ; 7165 ; signal transduction ; traceable author statement ; 7588 ; excretion ; not recorded	3700 ; transcription factor activity ; traceable author statement ; 3707 ; steroid hormone receptor activity ; traceable author statement ; 5496 ; steroid binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 3700 ; transcription factor activity ; inferred from electronic annotation ; 3707 ; steroid hormone receptor activity ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 4879 ; ligand-dependent nuclear receptor activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
238755_at		AA876179	0.47	3.43E-02	Transcribed locus	chr11p15.2	chr11:12989284-12990338 (+)
227762_at		AW244016	0.47	5.58E-03	Transcribed locus	chr11	chr11:113629859-113630327 (+)
223422_s_at	ARHGAP24	AI743534	0.47	3.65E-02	Rho GTPase activating protein 24	chr4q21.23-q21.3	chr4:87070430-87142845 (+)		5096 ; GTPase activator activity ; inferred from electronic annotation
205049_s_at	CD79A	NM_001783	0.47	1.39E-02	CD79A antigen (immunoglobulin-associated alpha) ; CD79A antigen (immunoglobulin-associated alpha)	chr19q13.2	chr19:47073178-47077278 (+)	6952 ; defense response ; traceable author statement ; 7166 ; cell surface receptor linked signal transduction ; traceable author statement ; 7166 ; cell surface receptor linked signal transduction ; inferred from electronic annotation	4888 ; transmembrane receptor activity ; inferred from electronic annotation
216058_s_at	CYP2C19	X65962	0.47	7.07E-03	cytochrome P450, family 2, subfamily C, polypeptide 19	chr10q24.1-q24.3	chr10:96525207-96602928 (+)	6118 ; electron transport ; inferred from electronic annotation	5506 ; iron ion binding ; inferred from electronic annotation ; 16712 ; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen ; inferred from electronic annotation ; 18676 ; (S)-limonene 7-monooxygenase activity ; inferred from electronic annotation ; 19825 ; oxygen binding ; traceable author statement ; 20037 ; heme binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4497 ; monooxygenase activity ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 4497 ; monooxygenase activity ; traceable author statement
222716_s_at	SNX24	AU144093	0.47	4.78E-02	sorting nexing 24	chr5q23.2	chr5:122209086-122372799 (+)	7242 ; intracellular signaling cascade ; inferred from electronic annotation ; 15031 ; protein transport ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation
202741_at	PRKACB	AA130247	0.47	2.05E-02	protein kinase, cAMP-dependent, catalytic, beta	chr1p36.1	chr1:84316435-84476769 (+)	6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 7165 ; signal transduction ; traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 4691 ; cAMP-dependent protein kinase activity ; traceable author statement ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation
212741_at	MAOA	AA923354	0.47	1.60E-02	monoamine oxidase A	chrXp11.3	chrX:43488632-43491008 (+)	6118 ; electron transport ; inferred from electronic annotation ; 6584 ; catecholamine metabolism ; inferred from electronic annotation ; 7610 ; behavior ; traceable author statement ; 42135 ; neurotransmitter catabolism ; inferred from electronic annotation ; 6576 ; biogenic amine metabolism ; traceable author statement	8131 ; amine oxidase activity ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 8131 ; amine oxidase activity ; not recorded
201348_at	GPX3	NM_002084	0.47	3.65E-02	glutathione peroxidase 3 (plasma)	chr5q23	chr5:150380111-150388741 (+)	6982 ; response to lipid hydroperoxide ; not recorded ; 6979 ; response to oxidative stress ; inferred from electronic annotation	4602 ; glutathione peroxidase activity ; traceable author statement ; 5489 ; electron transporter activity ; traceable author statement ; 8430 ; selenium binding ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 4601 ; peroxidase activity ; inferred from electronic annotation ; 4602 ; glutathione peroxidase activity ; inferred from electronic annotation
219064_at	ITIH5	NM_030569	0.47	3.79E-02	inter-alpha (globulin) inhibitor H5	chr10p14	chr10:7644394-7699251 (-)	30212 ; hyaluronan metabolism ; inferred from electronic annotation	4867 ; serine-type endopeptidase inhibitor activity ; inferred from electronic annotation
235591_at	SSTR1	R62424	0.47	3.74E-02	somatostatin receptor 1	chr14q13	chr14:37751136-37752021 (+)	7187 ; G-protein signaling, coupled to cyclic nucleotide second messenger ; traceable author statement ; 7267 ; cell-cell signaling ; traceable author statement ; 7584 ; response to nutrient ; traceable author statement ; 7586 ; digestion ; traceable author statement ; 8285 ; negative regulation of cell proliferation ; traceable author statement ; 7165 ; signal transduction ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation ; 7166 ; cell surface receptor linked signal transduction ; traceable author statement	1584 ; rhodopsin-like receptor activity ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 4994 ; somatostatin receptor activity ; traceable author statement ; 4994 ; somatostatin receptor activity ; inferred from direct assay ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; inferred from electronic annotation ; 4994 ; somatostatin receptor activity ; inferred from electronic annotation
210298_x_at	FHL1	AF098518	0.47	4.43E-02	four and a half LIM domains 1	chrXq26	chrX:135079778-135119850 (+)	7517 ; muscle development ; non-traceable author statement ; 9887 ; organ morphogenesis ; non-traceable author statement ; 16049 ; cell growth ; non-traceable author statement ; 30154 ; cell differentiation ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation	8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
203799_at	DCL-1	NM_014880	0.47	1.36E-02	CD302 antigen	chr2q24.2	chr2:160333609-160348227 (-)		5529 ; sugar binding ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation
232424_at	PRDM16	AI623202	0.47	7.09E-03	PR domain containing 16	chr1p36.23-p33	chr1:3318123-3345043 (+)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; Unknown ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3676 ; nucleic acid binding ; inferred from electronic annotation ; 3700 ; transcription factor activity ; non-traceable author statement ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation
219670_at	FLJ11588	NM_024603	0.47	1.04E-03	chromosome 1 open reading frame 165	chr1p33	chr1:48966128-49015090 (-)
217941_s_at	ERBB2IP	NM_018695	0.47	1.14E-02	erbb2 interacting protein	chr5q12.3	chr5:65258139-65412098 (+)	7049 ; cell cycle ; inferred from sequence or structural similarity ; 7049 ; cell cycle ; non-traceable author statement ; 7155 ; cell adhesion ; inferred from sequence or structural similarity ; 7155 ; cell adhesion ; non-traceable author statement ; 7173 ; epidermal growth factor receptor signaling pathway ; inferred from sequence or structural similarity ; 7173 ; epidermal growth factor receptor signaling pathway ; traceable author statement ; 7229 ; integrin-mediated signaling pathway ; inferred from sequence or structural similarity ; 7229 ; integrin-mediated signaling pathway ; non-traceable author statement ; 16049 ; cell growth ; inferred from sequence or structural similarity ; 16049 ; cell growth ; non-traceable author statement ; 45104 ; intermediate filament cytoskeleton organization and biogenesis ; inferred from sequence or structural similarity ; 45104 ; intermediate filament cytoskeleton organization and biogenesis ; non-traceable author statement ; 45175 ; basal protein localization ; inferred from sequence or structural similarity ; 45175 ; basal protein localization ; non-traceable author statement ; 45197 ; establishment and/or maintenance of epithelial cell polarity ; inferred from sequence or structural similarity ; 45197 ; establishment and/or maintenance of epithelial cell polarity ; non-traceable author statement	5176 ; ErbB-2 class receptor binding ; inferred from sequence or structural similarity ; 5176 ; ErbB-2 class receptor binding ; traceable author statement ; 5178 ; integrin binding ; inferred from physical interaction ; 5178 ; integrin binding ; inferred from sequence or structural similarity ; 5200 ; structural constituent of cytoskeleton ; inferred from sequence or structural similarity ; 5200 ; structural constituent of cytoskeleton ; non-traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 5515 ; protein binding ; inferred from sequence or structural similarity ; 5515 ; protein binding ; inferred from electronic annotation
209737_at	AIP1	AB014605	0.47	2.51E-03	membrane associated guanylate kinase, WW and PDZ domain containing 2	chr7q21	chr7:77484333-78238339 (-)		5515 ; protein binding ; inferred from physical interaction ; 5515 ; protein binding ; inferred from electronic annotation
209460_at	ABAT	AF237813	0.47	1.23E-02	4-aminobutyrate aminotransferase	chr16p13.2	chr16:8783434-8784660 (+)	7268 ; synaptic transmission ; non-traceable author statement ; 9448 ; gamma-aminobutyric acid metabolism ; inferred from electronic annotation ; 42135 ; neurotransmitter catabolism ; inferred from electronic annotation	3867 ; 4-aminobutyrate transaminase activity ; non-traceable author statement ; 16740 ; transferase activity ; inferred from electronic annotation ; 30170 ; pyridoxal phosphate binding ; inferred from electronic annotation ; 47298 ; (S)-3-amino-2-methylpropionate transaminase activity ; inferred from electronic annotation ; 3867 ; 4-aminobutyrate transaminase activity ; inferred from electronic annotation ; 8483 ; transaminase activity ; inferred from electronic annotation
212230_at	PPAP2B	AV725664	0.47	2.30E-02	phosphatidic acid phosphatase type 2B	chr1pter-p22.1	chr1:56733020-56755266 (-)	6629 ; lipid metabolism ; non-traceable author statement ; 8354 ; germ cell migration ; traceable author statement	4721 ; phosphoprotein phosphatase activity ; traceable author statement ; 8195 ; phosphatidate phosphatase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
221511_x_at	CCPG1	AB033080	0.47	3.02E-03	cell cycle progression 1	chr15q21.1	chr15:53434336-53487534 (-)
220542_s_at	PLUNC	NM_016583	0.47	4.10E-02	palate, lung and nasal epithelium carcinoma associated	chr20q11.2	chr20:31287478-31294771 (+)	9618 ; response to pathogenic bacteria ; non-traceable author statement ; 45087 ; innate immune response ; non-traceable author statement	8289 ; lipid binding ; inferred from electronic annotation
230130_at	SLIT2	AI692523	0.47	2.12E-02	Transcribed locus	chr4p15.2	chr4:20230647-20231281 (-)
228423_at	FLJ21159	AI887898	0.47	3.96E-02	ASAP	chr4q32.1	chr4:156483259-156483922 (-)
213371_at	LDB3	AI803302	0.47	4.23E-02	LIM domain binding 3	chr10q22.3-q23.2	chr10:88418407-88485141 (+)		5515 ; protein binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
242828_at	FIGN	BG109695	0.47	4.44E-02	Fidgetin	chr2q24.3	chr2:164170631-164171446 (-)		166 ; nucleotide binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 17111 ; nucleoside-triphosphatase activity ; inferred from electronic annotation
209606_at	PSCDBP	L06633	0.47	3.81E-02	pleckstrin homology, Sec7 and coiled-coil domains, binding protein ; pleckstrin homology, Sec7 and coiled-coil domains, binding protein	chr2q11.2	chr2:157979776-158008764 (-)	30155 ; regulation of cell adhesion ; inferred from direct assay	5515 ; protein binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from direct assay
217824_at	UBE2J1	AW500009	0.46	1.19E-02	ubiquitin-conjugating enzyme E2, J1 (UBC6 homolog, yeast)	chr6q15	chr6:90093062-90119315 (-)	6512 ; ubiquitin cycle ; inferred from electronic annotation ; 6464 ; protein modification ; inferred from electronic annotation	4842 ; ubiquitin-protein ligase activity ; inferred from electronic annotation ; 8642 ; ubiquitin-like activating enzyme activity ; inferred from electronic annotation ; 16874 ; ligase activity ; inferred from electronic annotation
218332_at	BEX1	NM_018476	0.46	4.72E-02	brain expressed, X-linked 1	chrXq21-q23	chrX:102204236-102205737 (-)
228239_at	C21orf51	AA148789	0.46	9.89E-03	chromosome 21 open reading frame 51	chr21q22.12	chr21:34673596-34696938 (+)
204187_at	GMPR	NM_006877	0.46	4.76E-02	guanosine monophosphate reductase ; guanosine monophosphate reductase	chr6p23	chr6:16346832-16403750 (+)	9117 ; nucleotide metabolism ; inferred from electronic annotation ; 9409 ; response to cold ; traceable author statement ; 6139 ; nucleobase, nucleoside, nucleotide and nucleic acid metabolism ; not recorded	3920 ; GMP reductase activity ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 30955 ; potassium ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3824 ; catalytic activity ; inferred from electronic annotation ; 3920 ; GMP reductase activity ; inferred from electronic annotation
235658_at		AW058580	0.46	2.18E-02	Transcribed locus	chr11	chr11:122339191-122339780 (+)
209655_s_at	TM4SF10	AI803181	0.46	2.95E-02	transmembrane protein 47	chrXp11.4	chrX:34555113-34585322 (-)
205352_at	SERPINI1	NM_005025	0.46	1.34E-02	serpin peptidase inhibitor, clade I (neuroserpin), member 1	chr3q26.1	chr3:168936242-169026050 (+)	7417 ; central nervous system development ; traceable author statement ; 7422 ; peripheral nervous system development ; traceable author statement	4867 ; serine-type endopeptidase inhibitor activity ; traceable author statement ; 4866 ; endopeptidase inhibitor activity ; inferred from electronic annotation ; 4867 ; serine-type endopeptidase inhibitor activity ; inferred from electronic annotation
203404_at	ARMCX2	NM_014782	0.46	1.64E-02	armadillo repeat containing, X-linked 2	chrXq21.33-q22.2	chrX:100797108-100801478 (-)		5488 ; binding ; inferred from electronic annotation
228160_at	LOC400642	AI433706	0.46	7.35E-03	hypothetical gene supported by BC041875; BX648984	chr18p11.31	chr18:5235990-5236503 (+)
242993_at	PCK2	AI215629	0.46	2.18E-02	Phosphoenolpyruvate carboxykinase 2 (mitochondrial)	chr14q11.1-q11.2	chr14:23640940-23641700 (+)	6094 ; gluconeogenesis ; inferred from electronic annotation ; 6006 ; glucose metabolism ; not recorded	166 ; nucleotide binding ; inferred from electronic annotation ; 4613 ; phosphoenolpyruvate carboxykinase (GTP) activity ; inferred from electronic annotation ; 5525 ; GTP binding ; inferred from electronic annotation ; 16829 ; lyase activity ; inferred from electronic annotation ; 30145 ; manganese ion binding ; inferred from electronic annotation ; 4611 ; phosphoenolpyruvate carboxykinase activity ; inferred from electronic annotation ; 16831 ; carboxy-lyase activity ; inferred from electronic annotation ; 4611 ; phosphoenolpyruvate carboxykinase activity ; traceable author statement
216842_x_at	RBM	U38460	0.46	8.70E-03	RNA binding motif protein, Y-linked, family 1, member A1 ; RNA binding motif protein, Y-linked, family 2, member F pseudogene ; RNA binding motif protein, Y-linked, family 1, member F ; RNA binding motif protein, Y-linked, family 1, member B ; RNA binding motif protein, Y-linked, family 1, member D ; RNA binding motif protein, Y-linked, family 1, member E ; RNA binding motif protein, Y-linked, family 1, member J	chrYq11.223	chrY:8840020-8840154 (+)	6396 ; RNA processing ; traceable author statement ; 7283 ; spermatogenesis ; traceable author statement ; 7283 ; spermatogenesis ; non-traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 3723 ; RNA binding ; traceable author statement ; 3676 ; nucleic acid binding ; inferred from electronic annotation ; 3723 ; RNA binding ; inferred from electronic annotation ; 3723 ; RNA binding ; non-traceable author statement
230661_at	RPESP	AW451999	0.46	4.81E-02	Hypothetical protein LOC286191	chr8q13.3	---
205757_at	ENTPD5	NM_001249	0.46	1.46E-02	ectonucleoside triphosphate diphosphohydrolase 5	chr14q24	chr14:73502935-73552387 (-)		287 ; magnesium ion binding ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 17110 ; nucleoside-diphosphatase activity ; inferred from electronic annotation
211144_x_at	CD3G	M30894	0.46	3.28E-02	T cell receptor gamma constant 2	chr7p15	chr7:38245720-38337083 (-)
238780_s_at	KCNJ5	AA506997	0.46	1.49E-02	MRNA; cDNA DKFZp779F2345 (from clone DKFZp779F2345)	chr11	chr11:128295829-128296267 (+)
209752_at	REG1A	AF172331	0.46	3.71E-02	regenerating islet-derived 1 alpha (pancreatic stone protein, pancreatic thread protein)	chr2p12	chr2:79201445-79203896 (+)	8284 ; positive regulation of cell proliferation ; traceable author statement	5529 ; sugar binding ; inferred from electronic annotation
205999_x_at	CYP3A4	AF182273	0.46	3.54E-02	cytochrome P450, family 3, subfamily A, polypeptide 4	chr7q21.1	chr7:99193508-99219649 (-)	6118 ; electron transport ; inferred from electronic annotation ; 6629 ; lipid metabolism ; traceable author statement ; 6805 ; xenobiotic metabolism ; inferred from sequence or structural similarity ; 6805 ; xenobiotic metabolism ; traceable author statement	5506 ; iron ion binding ; inferred from electronic annotation ; 16712 ; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen ; inferred from electronic annotation ; 19825 ; oxygen binding ; traceable author statement ; 20037 ; heme binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 50381 ; unspecific monooxygenase activity ; inferred from electronic annotation ; 50591 ; quinine 3-monooxygenase activity ; inferred from electronic annotation ; 4497 ; monooxygenase activity ; inferred from sequence or structural similarity ; 4497 ; monooxygenase activity ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 4497 ; monooxygenase activity ; traceable author statement ; 50649 ; testosterone 6-beta-hydroxylase activity ; inferred from direct assay ; 4497 ; monooxygenase activity ; inferred from direct assay
209524_at	HDGFRP3	AK001280	0.46	2.61E-02	hepatoma-derived growth factor, related protein 3	chr15q11.2	chr15:81596577-81667325 (-)	8283 ; cell proliferation ; non-traceable author statement	3682 ; chromatin binding ; inferred from sequence or structural similarity ; 8083 ; growth factor activity ; inferred from electronic annotation
237461_at	NALP7	AA565499	0.46	4.28E-02	NACHT, leucine rich repeat and PYD containing 7	chr19q13.42	chr19:60126689-60130881 (-)		166 ; nucleotide binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation
224840_at	FKBP5	AI753747	0.46	1.75E-02	FK506 binding protein 5	chr6p21.3-21.2	chr6:35649344-35651470 (-)	6457 ; protein folding ; traceable author statement ; 6457 ; protein folding ; inferred from electronic annotation	3755 ; peptidyl-prolyl cis-trans isomerase activity ; inferred from electronic annotation ; 5528 ; FK506 binding ; traceable author statement ; 16853 ; isomerase activity ; inferred from electronic annotation ; 51082 ; unfolded protein binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5488 ; binding ; inferred from electronic annotation
208581_x_at	MT1X	NM_005952	0.46	3.53E-02	metallothionein 1X	chr16q13	chr16:55273882-55275462 (+)	10038 ; response to metal ion ; traceable author statement ; 6118 ; electron transport ; inferred from electronic annotation	5507 ; copper ion binding ; inferred from electronic annotation ; 46870 ; cadmium ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; traceable author statement ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 5489 ; electron transporter activity ; inferred from electronic annotation ; 5506 ; iron ion binding ; inferred from electronic annotation
204720_s_at	DNAJC6	AV729634	0.46	4.55E-02	DnaJ (Hsp40) homolog, subfamily C, member 6	chr1pter-q31.3	chr1:65503024-65654140 (+)	6457 ; protein folding ; inferred from electronic annotation ; 6470 ; protein amino acid dephosphorylation ; inferred from electronic annotation	4721 ; phosphoprotein phosphatase activity ; inferred from electronic annotation ; 31072 ; heat shock protein binding ; inferred from electronic annotation ; 51082 ; unfolded protein binding ; inferred from electronic annotation
222717_at	SDPR	BF982174	0.46	4.41E-02	serum deprivation response (phosphatidylserine binding protein)	chr2q32-q33	chr2:192407275-192420070 (-)		5543 ; phospholipid binding ; traceable author statement
229127_at	ATP5J	BF195118	0.46	8.37E-03	Junctional adhesion molecule 2	chr21q21.1	chr21:26010315-26011862 (+)	16337 ; cell-cell adhesion ; non-traceable author statement
232122_s_at	FLJ12604	AK022666	0.46	2.52E-02	ventricular zone expressed PH domain homolog 1 (zebrafish)	chr3q24-q25	chr3:158460276-158564246 (-)
219747_at	FLJ23191	NM_024574	0.46	1.27E-02	hypothetical protein FLJ23191	chr4q27	chr4:122176233-122178186 (-)
218820_at	C14orf132	NM_020215	0.46	3.56E-02	chromosome 14 open reading frame 132	chr14q32.2	chr14:95626518-95629977 (+)
206191_at	ENTPD3	NM_001248	0.45	4.75E-02	ectonucleoside triphosphate diphosphohydrolase 3	chr3p21.3	chr3:40403696-40445113 (+)		287 ; magnesium ion binding ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
238751_at	ARGBP2	AI343000	0.45	1.16E-02	Sorbin and SH3 domain containing 2	chr4q35.1	chr4:186800509-186801264 (-)	6810 ; transport ; inferred from electronic annotation	5515 ; protein binding ; non-traceable author statement ; 5200 ; structural constituent of cytoskeleton ; traceable author statement ; 8093 ; cytoskeletal adaptor activity ; traceable author statement ; 8307 ; structural constituent of muscle ; traceable author statement
212526_at	SPG20	AK002207	0.45	2.87E-02	spastic paraplegia 20, spartin (Troyer syndrome)	chr13q13.3	chr13:35775001-35818420 (-)
204388_s_at	MAOA	NM_000240	0.45	1.46E-02	monoamine oxidase A	chrXp11.3	chrX:43400525-43489001 (+)	6118 ; electron transport ; inferred from electronic annotation ; 6584 ; catecholamine metabolism ; inferred from electronic annotation ; 7610 ; behavior ; traceable author statement ; 42135 ; neurotransmitter catabolism ; inferred from electronic annotation ; 6576 ; biogenic amine metabolism ; traceable author statement	8131 ; amine oxidase activity ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 8131 ; amine oxidase activity ; not recorded
211355_x_at	LEPR	U52914	0.45	4.70E-02	leptin receptor	chr1p31	chr1:65764012-65871530 (+)	6112 ; energy reserve metabolism ; traceable author statement ; 7166 ; cell surface receptor linked signal transduction ; traceable author statement ; 7275 ; development ; traceable author statement	4896 ; hematopoietin/interferon-class (D200-domain) cytokine receptor activity ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 4888 ; transmembrane receptor activity ; traceable author statement
236360_at	FLJ42875	BE551964	0.45	2.45E-02	FLJ42875 protein	chr1p36.32	chr1:2966042-2966517 (-)
226248_s_at	KIAA1324	AI565067	0.45	2.72E-02	KIAA1324	chr1p13.3	chr1:109533262-109550924 (+)
205364_at	ACOX2	NM_003500	0.45	1.49E-02	acyl-Coenzyme A oxidase 2, branched chain	chr3p14.3	chr3:58465903-58495965 (-)	6118 ; electron transport ; inferred from electronic annotation ; 6629 ; lipid metabolism ; inferred from electronic annotation ; 6631 ; fatty acid metabolism ; inferred from electronic annotation ; 6635 ; fatty acid beta-oxidation ; inferred from electronic annotation ; 8206 ; bile acid metabolism ; traceable author statement	3995 ; acyl-CoA dehydrogenase activity ; inferred from electronic annotation ; 3997 ; acyl-CoA oxidase activity ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 50660 ; FAD binding ; inferred from electronic annotation ; 3997 ; acyl-CoA oxidase activity ; inferred from electronic annotation
205295_at	CKMT2	NM_001825	0.45	4.05E-03	creatine kinase, mitochondrial 2 (sarcomeric)	chr5q13.3	chr5:80575614-80597972 (+)	6091 ; generation of precursor metabolites and energy ; not recorded ; 6936 ; muscle contraction ; traceable author statement	4111 ; creatine kinase activity ; traceable author statement ; 4111 ; creatine kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 16772 ; transferase activity, transferring phosphorus-containing groups ; inferred from electronic annotation
209633_at	PPP2R3A	AL389975	0.45	7.07E-03	protein phosphatase 2 (formerly 2A), regulatory subunit B, alpha	chr3q22.1	chr3:137167256-137349426 (+)	6470 ; protein amino acid dephosphorylation ; inferred from sequence or structural similarity	4721 ; phosphoprotein phosphatase activity ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5515 ; protein binding ; inferred from sequence or structural similarity ; 8601 ; protein phosphatase type 2A regulator activity ; traceable author statement ; 16787 ; hydrolase activity ; inferred from electronic annotation
241446_at	ADAM28	AA479832	0.45	3.90E-02	ADAM metallopeptidase domain 28	chr8p21.2	chr8:24252669-24253601 (+)	6508 ; proteolysis ; inferred from electronic annotation ; 7283 ; spermatogenesis ; traceable author statement	4222 ; metalloendopeptidase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8237 ; metallopeptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 8237 ; metallopeptidase activity ; traceable author statement
228038_at	SOX2	AI669815	0.45	4.23E-02	SRY (sex determining region Y)-box 2	chr3q26.3-q27	chr3:182914305-182914915 (+)	6325 ; establishment and/or maintenance of chromatin architecture ; non-traceable author statement ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; non-traceable author statement ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3700 ; transcription factor activity ; non-traceable author statement ; 3677 ; DNA binding ; inferred from electronic annotation ; 3677 ; DNA binding ; non-traceable author statement
222294_s_at	RAB27A	AW971415	0.45	1.06E-02	Eukaryotic translation initiation factor 2C, 2	chr15	chr15:53282455-53282714 (-)	6412 ; protein biosynthesis ; non-traceable author statement ; 6412 ; protein biosynthesis ; inferred from electronic annotation	3743 ; translation initiation factor activity ; non-traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 3743 ; translation initiation factor activity ; inferred from electronic annotation
210258_at	RGS13	AF030107	0.45	2.12E-02	regulator of G-protein signalling 13	chr1q31.2	chr1:190871904-190896010 (+)	9968 ; negative regulation of signal transduction ; inferred from electronic annotation	4871 ; signal transducer activity ; inferred from electronic annotation
204639_at	ADA	NM_000022	0.45	2.91E-02	adenosine deaminase	chr20q12-q13.11	chr20:42681577-42713757 (-)	9117 ; nucleotide metabolism ; inferred from electronic annotation ; 9168 ; purine ribonucleoside monophosphate biosynthesis ; inferred from electronic annotation ; 19735 ; antimicrobial humoral response (sensu Vertebrata) ; traceable author statement	4000 ; adenosine deaminase activity ; inferred from electronic annotation ; 4000 ; adenosine deaminase activity ; traceable author statement ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 19239 ; deaminase activity ; inferred from electronic annotation
244101_at		AI522053	0.45	3.00E-02		chr1q21.2	chr3:27654820-27655271 (+)
224405_at	IRTA2	AF343663	0.45	2.46E-02	Fc receptor-like 5 ; Fc receptor-like 5	chr1q21	chr1:155768377-155788869 (-)		4872 ; receptor activity ; inferred from electronic annotation
225721_at	SYNPO2	AI658662	0.45	1.50E-02	Synaptopodin 2	chr4q26	chr4:120176334-120179122 (+)		3779 ; actin binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
221667_s_at	HSPB8	AF133207	0.45	4.42E-02	heat shock 22kDa protein 8	chr12q24.23	chr12:118101144-118116888 (+)	6457 ; protein folding ; inferred from electronic annotation ; 6986 ; response to unfolded protein ; inferred from electronic annotation	4674 ; protein serine/threonine kinase activity ; non-traceable author statement ; 16301 ; kinase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 51082 ; unfolded protein binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation
213765_at	MFAP5	AW665892	0.45	8.16E-03	microfibrillar associated protein 5	chr12p13.1-p12.3	chr12:8689805-8690789 (-)		5201 ; extracellular matrix structural constituent ; traceable author statement
222940_at	SULT1E1	U55764	0.45	3.00E-02	sulfotransferase family 1E, estrogen-preferring, member 1	chr4q13.1	chr4:70741519-70760452 (-)	8202 ; steroid metabolism ; traceable author statement	4304 ; estrone sulfotransferase activity ; traceable author statement ; 5496 ; steroid binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4304 ; estrone sulfotransferase activity ; inferred from electronic annotation ; 8146 ; sulfotransferase activity ; inferred from electronic annotation
231015_at	KLF15	AW014734	0.44	1.63E-03	Kruppel-like factor 15	chr3q13-q21	chr3:127544167-127544670 (-)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3677 ; DNA binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation
226333_at	IL6R	AV700030	0.44	4.14E-02	interleukin 6 receptor	chr1	chr1:152705894-152708549 (+)	6955 ; immune response ; traceable author statement ; 7166 ; cell surface receptor linked signal transduction ; traceable author statement ; 7275 ; development ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement	4872 ; receptor activity ; inferred from electronic annotation ; 4896 ; hematopoietin/interferon-class (D200-domain) cytokine receptor activity ; inferred from electronic annotation ; 4915 ; interleukin-6 receptor activity ; traceable author statement ; 19899 ; enzyme binding ; inferred from physical interaction ; 5515 ; protein binding ; inferred from physical interaction
202436_s_at	CYP1B1	AU144855	0.44	4.10E-02	cytochrome P450, family 1, subfamily B, polypeptide 1	chr2p21	chr2:38148155-38157214 (-)	1747 ; eye development (sensu Mammalia) ; traceable author statement ; 6118 ; electron transport ; inferred from electronic annotation ; 7601 ; visual perception ; traceable author statement	4497 ; monooxygenase activity ; inferred from electronic annotation ; 5489 ; electron transporter activity ; traceable author statement ; 5506 ; iron ion binding ; inferred from electronic annotation ; 19825 ; oxygen binding ; traceable author statement ; 20037 ; heme binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 50381 ; unspecific monooxygenase activity ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation
227084_at	DTNA	AW339310	0.44	2.23E-02	dystrobrevin, alpha	chr18q12	chr18:30716117-30725363 (+)	6941 ; striated muscle contraction ; traceable author statement ; 7165 ; signal transduction ; traceable author statement ; 7274 ; neuromuscular synaptic transmission ; traceable author statement ; 7268 ; synaptic transmission ; traceable author statement	5509 ; calcium ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; traceable author statement
201540_at	FHL1	NM_001449	0.44	3.56E-02	four and a half LIM domains 1	chrXq26	chrX:135079750-135121177 (+)	7517 ; muscle development ; non-traceable author statement ; 9887 ; organ morphogenesis ; non-traceable author statement ; 16049 ; cell growth ; non-traceable author statement ; 30154 ; cell differentiation ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation	8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
242985_x_at	LOC285671	H05502	0.44	4.26E-02	ring finger protein 180	chr5q12.2	chr5:63661879-63701464 (+)	16567 ; protein ubiquitination ; inferred from electronic annotation	4842 ; ubiquitin-protein ligase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
204730_at	RIMS3	NM_014747	0.44	3.53E-02	regulating synaptic membrane exocytosis 3	chr1pter-p22.2	chr1:40858938-40903911 (-)	6836 ; neurotransmitter transport ; inferred from electronic annotation ; 6887 ; exocytosis ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation
241329_s_at		AI820912	0.44	3.56E-02		chr17	chr17:34335274-34335679 (-)
206197_at	NME5	NM_003551	0.44	3.00E-02	non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase)	chr5q31	chr5:137479150-137502796 (-)	302 ; response to reactive oxygen species ; inferred from sequence or structural similarity ; 6183 ; GTP biosynthesis ; inferred from electronic annotation ; 6228 ; UTP biosynthesis ; inferred from electronic annotation ; 6241 ; CTP biosynthesis ; inferred from electronic annotation ; 6916 ; anti-apoptosis ; inferred from sequence or structural similarity ; 7283 ; spermatogenesis ; traceable author statement ; 7286 ; spermatid development ; inferred from sequence or structural similarity ; 9116 ; nucleoside metabolism ; traceable author statement ; 30154 ; cell differentiation ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation ; 7283 ; spermatogenesis ; inferred from electronic annotation	4550 ; nucleoside diphosphate kinase activity ; traceable author statement ; 5524 ; ATP binding ; inferred from electronic annotation ; 4550 ; nucleoside diphosphate kinase activity ; inferred from electronic annotation
216336_x_at		AL031602	0.44	1.93E-02	Metallothionein 1M	chr16q13	chr1:33189329-33189739 (-)		5507 ; copper ion binding ; inferred from electronic annotation ; 46870 ; cadmium ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
218974_at	FLJ10159	NM_018013	0.44	3.65E-02	hypothetical protein FLJ10159	chr6q21	chr6:108061950-108087364 (+)
217826_s_at	UBE2J1	NM_016021	0.44	4.69E-03	ubiquitin-conjugating enzyme E2, J1 (UBC6 homolog, yeast)	chr6q15	chr6:90095425-90119151 (-)	6512 ; ubiquitin cycle ; inferred from electronic annotation ; 6464 ; protein modification ; inferred from electronic annotation	4842 ; ubiquitin-protein ligase activity ; inferred from electronic annotation ; 8642 ; ubiquitin-like activating enzyme activity ; inferred from electronic annotation ; 16874 ; ligase activity ; inferred from electronic annotation
203542_s_at	KLF9	AI690205	0.44	1.22E-03	Kruppel-like factor 9	chr9q13	chr9:72189332-72219360 (-)	6350 ; transcription ; inferred from electronic annotation ; 6357 ; regulation of transcription from RNA polymerase II promoter ; traceable author statement ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3700 ; transcription factor activity ; traceable author statement ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation
240138_at		BF433815	0.44	3.53E-02	Transcribed locus	chr11	chr11:41157327-41157678 (-)
204965_at	GC	NM_000583	0.44	7.07E-03	group-specific component (vitamin D binding protein)	chr4q12-q13	chr4:72826276-72868626 (-)	51180 ; vitamin transport ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation	3779 ; actin binding ; inferred from physical interaction ; 5386 ; carrier activity ; traceable author statement ; 5499 ; vitamin D binding ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 3779 ; actin binding ; inferred from electronic annotation ; 5386 ; carrier activity ; inferred from electronic annotation ; 5499 ; vitamin D binding ; inferred from electronic annotation
222838_at	SLAMF7	AL121985	0.44	2.32E-02	SLAM family member 7	chr1q23.1-q24.1	chr1:158975699-158991229 (+)	7155 ; cell adhesion ; non-traceable author statement ; 30101 ; natural killer cell activation ; non-traceable author statement ; 42267 ; natural killer cell mediated cytotoxicity ; non-traceable author statement	4872 ; receptor activity ; inferred from electronic annotation
217179_x_at		X79782	0.44	4.19E-02	(clone 9F2L) Ig rearranged L-chain mRNA V-region, 5 end	chr22q11.22	chr22:21007041-21007326 (+)	6955 ; immune response ; non-traceable author statement	3823 ; antigen binding ; inferred from electronic annotation ; 3823 ; antigen binding ; non-traceable author statement
242488_at		R55784	0.44	2.97E-02	CDNA FLJ38396 fis, clone FEBRA2007957	chr1	chr1:238144948-238145373 (+)
238117_at	PPOX	AW615133	0.43	1.12E-02	protoporphyrinogen oxidase	chr1q22	chr1:159413847-159414427 (+)	6118 ; electron transport ; inferred from electronic annotation ; 6783 ; heme biosynthesis ; traceable author statement ; 6779 ; porphyrin biosynthesis ; inferred from electronic annotation ; 6783 ; heme biosynthesis ; inferred from electronic annotation	4729 ; protoporphyrinogen oxidase activity ; traceable author statement ; 5489 ; electron transporter activity ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 4729 ; protoporphyrinogen oxidase activity ; inferred from electronic annotation
203875_at	SMARCA1	NM_003069	0.43	2.95E-02	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1	chrXq25	chrX:128408414-128480107 (-)	6338 ; chromatin remodeling ; traceable author statement ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 4386 ; helicase activity ; inferred from electronic annotation ; 4386 ; helicase activity ; traceable author statement ; 5524 ; ATP binding ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation
231211_s_at	LOC541469	AI254026	0.43	3.44E-02	hypothetical LOC541469 protein	chr19q13.2	chr19:43487397-43487483 (-)
223970_at	RETNLB	AF323084	0.43	4.18E-02	resistin like beta	chr3q13.1	chr3:109957175-109958820 (-)	8283 ; cell proliferation ; non-traceable author statement	5179 ; hormone activity ; inferred from electronic annotation
239262_at		AI498395	0.43	3.90E-02	CDNA FLJ26242 fis, clone DMC00770	chr11q14.1	chr11:86298591-86299061 (-)
211675_s_at		AF054589	0.43	4.57E-02	MyoD family inhibitor domain containing ; MyoD family inhibitor domain containing	chr7q31.1-q31.2	chr7:114349444-114446031 (+)	9615 ; response to virus ; non-traceable author statement
209515_s_at	RAB27A	U38654	0.43	2.07E-02	RAB27A, member RAS oncogene family	chr15q15-q21.1	chr15:53283429-53349877 (-)	6886 ; intracellular protein transport ; inferred from electronic annotation ; 7264 ; small GTPase mediated signal transduction ; inferred from electronic annotation ; 15031 ; protein transport ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3924 ; GTPase activity ; traceable author statement ; 5525 ; GTP binding ; inferred from electronic annotation
212730_at	DMN	AK026420	0.43	4.56E-02	desmuslin	chr15q26.3	chr15:97463500-97493321 (+)		5515 ; protein binding ; inferred from physical interaction ; 8307 ; structural constituent of muscle ; non-traceable author statement ; 5198 ; structural molecule activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from sequence or structural similarity ; 8307 ; structural constituent of muscle ; inferred from sequence or structural similarity
218651_s_at	FLJ11196	NM_018357	0.43	1.54E-02	La ribonucleoprotein domain family, member 6	chr15q23	chr15:68910930-68933552 (-)	6396 ; RNA processing ; inferred from electronic annotation ; 6405 ; RNA export from nucleus ; inferred from electronic annotation	3723 ; RNA binding ; inferred from electronic annotation ; 166 ; nucleotide binding ; inferred from electronic annotation
226694_at	PALM2-AKAP2	BG540494	0.43	4.01E-02	PALM2-AKAP2 protein	chr9q31-q33	chr9:111973906-111974613 (+)	8360 ; regulation of cell shape ; inferred from electronic annotation	19899 ; enzyme binding ; non-traceable author statement ; 16301 ; kinase activity ; inferred from electronic annotation
213992_at	COL4A6	AI889941	0.43	3.05E-02	collagen, type IV, alpha 6	chrXq22	chrX:107285493-107568316 (-)	6817 ; phosphate transport ; inferred from electronic annotation ; 7155 ; cell adhesion ; inferred from electronic annotation ; 30198 ; extracellular matrix organization and biogenesis ; non-traceable author statement	5201 ; extracellular matrix structural constituent ; non-traceable author statement ; 5515 ; protein binding ; inferred from electronic annotation ; 5198 ; structural molecule activity ; inferred from electronic annotation ; 5201 ; extracellular matrix structural constituent ; inferred from electronic annotation
220306_at	FAM46C	NM_017709	0.43	1.46E-02	family with sequence similarity 46, member C	chr1p12	chr1:117950194-117968929 (+)
227209_at	CNTN1	AI091445	0.43	3.27E-02	Contactin 1	chr12q11-q12	chr12:39750841-39752481 (+)	7155 ; cell adhesion ; non-traceable author statement ; 7219 ; Notch signaling pathway ; inferred from electronic annotation ; 7155 ; cell adhesion ; inferred from electronic annotation	5515 ; protein binding ; inferred from electronic annotation
228640_at	PCDH7	BE644809	0.43	4.48E-02	BH-protocadherin (brain-heart)	chr4	chr4:30757072-30757519 (+)	7155 ; cell adhesion ; inferred from electronic annotation ; 7156 ; homophilic cell adhesion ; inferred from electronic annotation	5509 ; calcium ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
219368_at	NAP1L2	NM_021963	0.43	4.03E-02	nucleosome assembly protein 1-like 2	chrXq13	chrX:72348894-72351409 (-)	6334 ; nucleosome assembly ; traceable author statement ; 6334 ; nucleosome assembly ; inferred from electronic annotation
202760_s_at	PALM2-AKAP2	NM_007203	0.43	2.76E-02	A kinase (PRKA) anchor protein 2 ; PALM2-AKAP2 protein	chr9q31-q33	chr9:111582397-111972303 (+)	8360 ; regulation of cell shape ; inferred from electronic annotation	16301 ; kinase activity ; inferred from electronic annotation ; 19899 ; enzyme binding ; non-traceable author statement
56256_at	SIDT2	AA150165	0.43	3.77E-03	SID1 transmembrane family, member 2	chr11q23.3	chr11:116572516-116573368 (+)
205901_at	PNOC	NM_006228	0.42	1.14E-02	prepronociceptin	chr8p21	chr8:28230567-28256786 (+)	7165 ; signal transduction ; traceable author statement ; 7218 ; neuropeptide signaling pathway ; inferred from electronic annotation ; 7268 ; synaptic transmission ; inferred from electronic annotation ; 7600 ; sensory perception ; traceable author statement	1515 ; opioid peptide activity ; inferred from electronic annotation ; 5184 ; neuropeptide hormone activity ; traceable author statement
229485_x_at	LOC152573	AI735586	0.42	2.80E-02	hypothetical protein BC012029	chr4p13	chr4:42097790-42099261 (+)
205433_at	BCHE	NM_000055	0.42	3.28E-03	butyrylcholinesterase	chr3q26.1-q26.2	chr3:166973386-167037944 (-)	50783 ; cocaine metabolism ; traceable author statement	1540 ; beta-amyloid binding ; non-traceable author statement ; 4104 ; cholinesterase activity ; non-traceable author statement ; 4759 ; serine esterase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 19899 ; enzyme binding ; non-traceable author statement ; 3824 ; catalytic activity ; inferred from electronic annotation ; 4104 ; cholinesterase activity ; inferred from electronic annotation ; 4104 ; cholinesterase activity ; traceable author statement ; 3824 ; catalytic activity ; non-traceable author statement
225283_at	ARRDC4	AV701177	0.42	2.07E-03	arrestin domain containing 4	chr15q26.3	chr15:96313540-96318067 (+)
205609_at	ANGPT1	NM_001146	0.42	2.29E-02	angiopoietin 1	chr8q22.3-q23	chr8:108330898-108384756 (-)	1525 ; angiogenesis ; inferred from electronic annotation ; 7165 ; signal transduction ; traceable author statement ; 30154 ; cell differentiation ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation	5102 ; receptor binding ; traceable author statement
225817_at	CGNL1	AB051536	0.42	1.30E-03	cingulin-like 1	chr15q21.3	chr15:55531628-55630207 (+)		3774 ; motor activity ; inferred from electronic annotation
235892_at		AI620881	0.42	3.56E-02	Transcribed locus, moderately similar to XP_510261.1 PREDICTED: similar to Gamma-tubulin complex component 5 (GCP-5) [Pan troglodytes]	chr11	chr11:110666722-110667196 (-)
226594_at	COQ6	AA528157	0.42	2.43E-02	Coenzyme Q6 homolog (yeast)	chr14q24	chr14:73499688-73501511 (-)	6118 ; electron transport ; inferred from electronic annotation ; 6725 ; aromatic compound metabolism ; inferred from electronic annotation ; 6744 ; ubiquinone biosynthesis ; inferred from electronic annotation ; 8152 ; metabolism ; inferred from electronic annotation	4497 ; monooxygenase activity ; inferred from electronic annotation ; 15997 ; ubiquinone biosynthesis monooxygenase activity ; inferred from electronic annotation ; 50660 ; FAD binding ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation
206361_at	GPR44	NM_004778	0.42	1.82E-02	G protein-coupled receptor 44	chr11q12-q13.3	chr11:60374982-60380020 (-)	6955 ; immune response ; traceable author statement ; 7165 ; signal transduction ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation	1584 ; rhodopsin-like receptor activity ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 4982 ; N-formyl peptide receptor activity ; inferred from electronic annotation ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; traceable author statement
214669_x_at		BG485135	0.42	4.01E-02	Immunoglobulin kappa variable 1-5	chr2p12	chr2:88938041-89223725 (-)	6955 ; immune response ; non-traceable author statement	3823 ; antigen binding ; non-traceable author statement
209293_x_at	ID4	U16153	0.42	2.64E-03	inhibitor of DNA binding 4, dominant negative helix-loop-helix protein	chr6p22-p21	chr6:19945650-19947640 (+)	6357 ; regulation of transcription from RNA polymerase II promoter ; traceable author statement ; 45449 ; regulation of transcription ; inferred from electronic annotation	3714 ; transcription corepressor activity ; traceable author statement ; 30528 ; transcription regulator activity ; inferred from electronic annotation
205357_s_at	AGTR1	NM_000685	0.42	8.79E-03	angiotensin II receptor, type 1	chr3q21-q25	chr3:149898323-149943478 (+)	7165 ; signal transduction ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; non-traceable author statement ; 7200 ; G-protein signaling, coupled to IP3 second messenger (phospholipase C activating) ; traceable author statement ; 7204 ; elevation of cytosolic calcium ion concentration ; traceable author statement ; 7589 ; fluid secretion ; not recorded ; 8015 ; circulation ; non-traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; traceable author statement	1584 ; rhodopsin-like receptor activity ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 4945 ; angiotensin type II receptor activity ; non-traceable author statement ; 4945 ; angiotensin type II receptor activity ; traceable author statement ; 4947 ; bradykinin receptor activity ; inferred from electronic annotation ; 16494 ; C-X-C chemokine receptor activity ; inferred from electronic annotation ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; inferred from electronic annotation ; 4945 ; angiotensin type II receptor activity ; inferred from electronic annotation
233496_s_at	CFL2	AV726166	0.42	4.45E-02	cofilin 2 (muscle)	chr14q12	chr14:34251446-34252709 (-)		3779 ; actin binding ; inferred from electronic annotation
242269_at	FLJ42875	AW771314	0.42	2.68E-02	FLJ42875 protein	chr1p36.32	chr1:2966040-2968079 (-)
201427_s_at	SEPP1	NM_005410	0.42	2.57E-02	selenoprotein P, plasma, 1	chr5q31	chr5:42835746-42847717 (-)	6979 ; response to oxidative stress ; traceable author statement	8430 ; selenium binding ; traceable author statement ; 8430 ; selenium binding ; inferred from electronic annotation
219259_at	SEMA4A	NM_022367	0.42	9.01E-03	sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A	chr1q22	chr1:154409300-154414158 (+)	6259 ; DNA metabolism ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation ; 7399 ; nervous system development ; inferred from electronic annotation ; 30154 ; cell differentiation ; inferred from electronic annotation	3677 ; DNA binding ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 8094 ; DNA-dependent ATPase activity ; inferred from electronic annotation
217480_x_at	IGKV1OR15-118; IGKVP2; IGKV1OR118	M20812	0.42	1.65E-02	similar to Ig kappa chain	chr2p11.1	chr10:42000775-42001243 (+)
206461_x_at	MT1H	NM_005951	0.42	4.89E-02	metallothionein 1H	chr16q13	chr16:55261274-55262541 (+)		5507 ; copper ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 46870 ; cadmium ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; not recorded
226099_at	ELL2	AI924426	0.42	1.99E-02	elongation factor, RNA polymerase II, 2	chr5q15	chr1:156410782-156412153 (-)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6368 ; RNA elongation from RNA polymerase II promoter ; traceable author statement	3702 ; RNA polymerase II transcription factor activity ; traceable author statement
217269_s_at		AP_001672	0.42	1.67E-02	protease, serine, 7 (enterokinase)	chr21q21|21q21.1	chr21:18564156-18677966 (-)	6508 ; proteolysis ; inferred from electronic annotation	4275 ; enteropeptidase activity ; inferred from electronic annotation ; 5044 ; scavenger receptor activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 4252 ; serine-type endopeptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
209305_s_at	GADD45B	AF078077	0.42	9.89E-03	growth arrest and DNA-damage-inducible, beta	chr19p13.3	chr19:2427256-2428664 (+)	185 ; activation of MAPKKK activity ; traceable author statement ; 6915 ; apoptosis ; traceable author statement ; 6950 ; response to stress ; traceable author statement ; 30154 ; cell differentiation ; inferred from electronic annotation ; 6915 ; apoptosis ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation
206170_at	ADRB2	NM_000024	0.42	8.84E-03	adrenergic, beta-2-, receptor, surface	chr5q31-q32	chr5:148185000-148188447 (+)	187 ; activation of MAPK activity ; traceable author statement ; 6898 ; receptor mediated endocytosis ; traceable author statement ; 7171 ; transmembrane receptor protein tyrosine kinase activation (dimerization) ; traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; traceable author statement ; 7188 ; G-protein signaling, coupled to cAMP nucleotide second messenger ; traceable author statement ; 7190 ; adenylate cyclase activation ; traceable author statement ; 7243 ; protein kinase cascade ; traceable author statement ; 8333 ; endosome to lysosome transport ; traceable author statement ; 7165 ; signal transduction ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation ; 7166 ; cell surface receptor linked signal transduction ; traceable author statement ; 7165 ; signal transduction ; non-traceable author statement	1584 ; rhodopsin-like receptor activity ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 4941 ; beta2-adrenergic receptor activity ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; inferred from electronic annotation ; 4941 ; beta2-adrenergic receptor activity ; inferred from electronic annotation ; 4939 ; beta-adrenergic receptor activity ; traceable author statement
229849_at		AI807950	0.42	4.77E-02	Transcribed locus, weakly similar to XP_517655.1 PREDICTED: similar to KIAA0825 protein [Pan troglodytes]	chr7	chr7:29922768-29923315 (+)
222565_s_at	PRKD3	BF978541	0.42	3.62E-02	protein kinase D3	chr2p21	chr2:37331148-37397726 (-)	6468 ; protein amino acid phosphorylation ; traceable author statement ; 7205 ; protein kinase C activation ; traceable author statement ; 7242 ; intracellular signaling cascade ; inferred from electronic annotation ; 6468 ; protein amino acid phosphorylation ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4697 ; protein kinase C activity ; traceable author statement ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 19992 ; diacylglycerol binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation
216321_s_at	NR3C1	X03348	0.42	4.13E-02	nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)	chr5q31.3	chr5:142637693-142763087 (-)	6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6366 ; transcription from RNA polymerase II promoter ; traceable author statement ; 6954 ; inflammatory response ; not recorded ; 7165 ; signal transduction ; traceable author statement ; 6350 ; transcription ; inferred from electronic annotation ; 6351 ; transcription, DNA-dependent ; traceable author statement	3700 ; transcription factor activity ; traceable author statement ; 4883 ; glucocorticoid receptor activity ; traceable author statement ; 5496 ; steroid binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 3700 ; transcription factor activity ; inferred from electronic annotation ; 3707 ; steroid hormone receptor activity ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 4879 ; ligand-dependent nuclear receptor activity ; inferred from electronic annotation ; 4883 ; glucocorticoid receptor activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
241866_at	SLC16A7	AW975728	0.42	4.19E-03	solute carrier family 16 (monocarboxylic acid transporters), member 7	chr12q13	chr12:58461385-58462005 (+)	6810 ; transport ; inferred from electronic annotation ; 6848 ; pyruvate transport ; traceable author statement ; 15711 ; organic anion transport ; inferred from electronic annotation	5215 ; transporter activity ; inferred from electronic annotation ; 5477 ; pyruvate carrier activity ; traceable author statement ; 15293 ; symporter activity ; inferred from electronic annotation ; 15355 ; monocarboxylate porter activity ; inferred from electronic annotation
225895_at	SYNPO2	AI634580	0.42	2.05E-02	synaptopodin 2	chr4q26	chr4:120173502-120176422 (+)		3779 ; actin binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
203881_s_at	DMD	NM_004010	0.42	2.06E-02	dystrophin (muscular dystrophy, Duchenne and Becker types)	chrXp21.2	chrX:31047265-33056466 (-)	6936 ; muscle contraction ; not recorded ; 7016 ; cytoskeletal anchoring ; inferred from sequence or structural similarity ; 7517 ; muscle development ; non-traceable author statement ; 7016 ; cytoskeletal anchoring ; non-traceable author statement ; 7022 ; chaperonin-mediated tubulin folding ; inferred from electronic annotation	3779 ; actin binding ; inferred from electronic annotation ; 3779 ; actin binding ; inferred from sequence or structural similarity ; 3779 ; actin binding ; traceable author statement ; 5200 ; structural constituent of cytoskeleton ; traceable author statement ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 8307 ; structural constituent of muscle ; traceable author statement ; 5198 ; structural molecule activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 51082 ; unfolded protein binding ; inferred from electronic annotation
236996_at		AA724992	0.42	4.11E-02	Transcribed locus	chr1	chr1:219068640-219069126 (-)
215115_x_at	NTRK3	AI613045	0.42	2.89E-03	neurotrophic tyrosine kinase, receptor, type 3	chr15q25	chr15:86220951-86284991 (-)	6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 7169 ; transmembrane receptor protein tyrosine kinase signaling pathway ; traceable author statement ; 7399 ; nervous system development ; inferred from electronic annotation ; 30154 ; cell differentiation ; inferred from electronic annotation ; 7169 ; transmembrane receptor protein tyrosine kinase signaling pathway ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 4714 ; transmembrane receptor protein tyrosine kinase activity ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 43121 ; neurotrophin binding ; traceable author statement ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation
234978_at	SLC36A4	AL542358	0.41	3.75E-02	solute carrier family 36 (proton/amino acid symporter), member 4	chr11q21	chr11:92520497-92570704 (-)	6865 ; amino acid transport ; inferred from electronic annotation	5279 ; amino acid-polyamine transporter activity ; inferred from electronic annotation
204940_at	PLN	NM_002667	0.41	2.29E-02	phospholamban	chr6q22.1	chr6:118976164-118988231 (+)	6816 ; calcium ion transport ; inferred from electronic annotation ; 6936 ; muscle contraction ; not recorded ; 8015 ; circulation ; non-traceable author statement ; 6816 ; calcium ion transport ; not recorded	5246 ; calcium channel regulator activity ; inferred from electronic annotation ; 42030 ; ATPase inhibitor activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5246 ; calcium channel regulator activity ; not recorded
223315_at	NTN4	AF278532	0.41	1.90E-02	netrin 4	chr12q22-q23	chr12:94575713-94708667 (-)		5198 ; structural molecule activity ; inferred from electronic annotation
201030_x_at	LDHB	NM_002300	0.41	4.55E-02	lactate dehydrogenase B	chr12p12.2-p12.1	chr12:21679542-21702029 (-)	6100 ; tricarboxylic acid cycle intermediate metabolism ; inferred from electronic annotation ; 19642 ; anaerobic glycolysis ; inferred from electronic annotation ; 6096 ; glycolysis ; inferred from electronic annotation	4459 ; L-lactate dehydrogenase activity ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 4459 ; L-lactate dehydrogenase activity ; inferred from electronic annotation
230081_at	PLCXD3	AI694325	0.41	3.40E-03	phosphatidylinositol-specific phospholipase C, X domain containing 3	chr5p13.1	chr5:41342802-41343675 (-)	7165 ; signal transduction ; inferred from electronic annotation ; 7242 ; intracellular signaling cascade ; inferred from electronic annotation	4629 ; phospholipase C activity ; inferred from electronic annotation
238197_at	GATA5	N72525	0.41	4.13E-02	GATA binding protein 5	chr20q13.33	chr20:60472545-60473016 (-)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 45941 ; positive regulation of transcription ; inferred from electronic annotation	3700 ; transcription factor activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 16563 ; transcriptional activator activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation
213564_x_at		BE042354	0.41	3.35E-02	lactate dehydrogenase B	chr12p12.2-p12.1	chr12:21679542-21698879 (-)	6100 ; tricarboxylic acid cycle intermediate metabolism ; inferred from electronic annotation ; 19642 ; anaerobic glycolysis ; inferred from electronic annotation ; 6096 ; glycolysis ; inferred from electronic annotation	4459 ; L-lactate dehydrogenase activity ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 4459 ; L-lactate dehydrogenase activity ; inferred from electronic annotation
224367_at	BEX2	AF251053	0.41	3.11E-02	brain expressed X-linked 2 ; brain expressed X-linked 2	chrXq22	chrX:102450930-102452462 (-)
202746_at		AL021786	0.41	6.14E-03	integral membrane protein 2A	chrXq13.3-Xq21.2	chrX:78502536-78509703 (-)
214916_x_at		BG340548	0.41	2.82E-02	immunoglobulin heavy locus ; immunoglobulin heavy constant alpha 1 ; immunoglobulin heavy constant alpha 2 (A2m marker) ; immunoglobulin heavy constant delta ; immunoglobulin heavy constant gamma 1 (G1m marker) ; immunoglobulin heavy constant gamma 2 (G2m marker) ; immunoglobulin heavy constant gamma 3 (G3m marker) ; immunoglobulin heavy constant mu ; hypothetical protein MGC27165 ; similar to Ig heavy chain V-III region VH26 precursor	chr14q32.33	chr14:105393215-105796763 (-)	6955 ; immune response ; non-traceable author statement ; 18298 ; protein-chromophore linkage ; inferred from electronic annotation ; 6955 ; immune response ; inferred from electronic annotation	3823 ; antigen binding ; non-traceable author statement ; 3823 ; antigen binding ; traceable author statement ; 4872 ; receptor activity ; inferred from electronic annotation ; 3823 ; antigen binding ; inferred from electronic annotation
207016_s_at	ALDH1A2	AB015228	0.41	1.61E-02	aldehyde dehydrogenase 1 family, member A2	chr15q22.1	chr15:56032920-56093478 (-)	6776 ; vitamin A metabolism ; traceable author statement ; 8152 ; metabolism ; inferred from electronic annotation	1758 ; retinal dehydrogenase activity ; inferred from electronic annotation ; 4028 ; aldehyde dehydrogenase activity ; traceable author statement ; 5489 ; electron transporter activity ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; traceable author statement
206478_at	KIAA0125	NM_014792	0.41	2.13E-02	KIAA0125	chr14q32.33	chr14:105461656-105469545 (+)
203543_s_at	KLF9	NM_001206	0.40	1.72E-02	Kruppel-like factor 9	chr9q13	chr9:72189644-72219360 (-)	6350 ; transcription ; inferred from electronic annotation ; 6357 ; regulation of transcription from RNA polymerase II promoter ; traceable author statement ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3700 ; transcription factor activity ; traceable author statement ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation
205051_s_at	KIT	NM_000222	0.40	4.81E-02	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog	chr4q11-q12	chr4:55218917-55301612 (+)	6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 6470 ; protein amino acid dephosphorylation ; not recorded ; 7165 ; signal transduction ; traceable author statement ; 7169 ; transmembrane receptor protein tyrosine kinase signaling pathway ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 4716 ; receptor signaling protein tyrosine kinase activity ; traceable author statement ; 4872 ; receptor activity ; inferred from electronic annotation ; 5021 ; vascular endothelial growth factor receptor activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 4714 ; transmembrane receptor protein tyrosine kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 4713 ; protein-tyrosine kinase activity ; traceable author statement ; 4714 ; transmembrane receptor protein tyrosine kinase activity ; not recorded
223824_at	C10orf59	BC005364	0.40	5.34E-03	chromosome 10 open reading frame 59	chr10q23.31	chr10:90034695-90332950 (-)	6118 ; electron transport ; inferred from electronic annotation ; 6725 ; aromatic compound metabolism ; inferred from electronic annotation ; 8152 ; metabolism ; inferred from electronic annotation	4497 ; monooxygenase activity ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation
209457_at	DUSP5	U16996	0.40	5.58E-03	dual specificity phosphatase 5	chr10q25	chr10:112247824-112261111 (+)	6470 ; protein amino acid dephosphorylation ; traceable author statement ; 6470 ; protein amino acid dephosphorylation ; inferred from electronic annotation	4725 ; protein tyrosine phosphatase activity ; traceable author statement ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 17017 ; MAP kinase phosphatase activity ; inferred from electronic annotation ; 4721 ; phosphoprotein phosphatase activity ; inferred from electronic annotation ; 8138 ; protein tyrosine/serine/threonine phosphatase activity ; inferred from electronic annotation
216481_at	GRIP2	AF052177	0.40	1.51E-03	glutamate receptor interacting protein 2	chr3p24-p23	chr3:14507681-14529370 (-)		5515 ; protein binding ; inferred from electronic annotation
204326_x_at		NM_002450	0.40	1.99E-02	metallothionein 1X	chr16q13	chr16:55273901-55275608 (+)	10038 ; response to metal ion ; traceable author statement ; 6118 ; electron transport ; inferred from electronic annotation	5507 ; copper ion binding ; inferred from electronic annotation ; 46870 ; cadmium ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; traceable author statement ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 5489 ; electron transporter activity ; inferred from electronic annotation ; 5506 ; iron ion binding ; inferred from electronic annotation
204337_at		AL514445	0.40	4.25E-02	regulator of G-protein signalling 4	chr1q23.3	chr1:161305773-161313216 (+)	188 ; inactivation of MAPK activity ; traceable author statement ; 8277 ; regulation of G-protein coupled receptor protein signaling pathway ; traceable author statement ; 9968 ; negative regulation of signal transduction ; inferred from electronic annotation	4871 ; signal transducer activity ; inferred from electronic annotation ; 5096 ; GTPase activator activity ; traceable author statement ; 5516 ; calmodulin binding ; traceable author statement
235830_at		AI797043	0.40	3.19E-02	Transcribed locus	chr6q22.1	chr6:116675040-116675813 (+)
221974_at		AW770748	0.40	1.96E-02	Small nuclear ribonucleoprotein polypeptide N	chr15q11.2	chr15:22916151-22916666 (+)	6397 ; mRNA processing ; inferred from electronic annotation	3723 ; RNA binding ; inferred from electronic annotation
218573_at	MAGEH1	NM_014061	0.40	1.13E-02	melanoma antigen family H, 1	chrXp11.21	chrX:55495262-55496686 (+)	6915 ; apoptosis ; traceable author statement
207317_s_at	CASQ2	NM_001232	0.40	2.25E-02	calsequestrin 2 (cardiac muscle)	chr1p13.3-p11	chr1:116044165-116112793 (-)	6941 ; striated muscle contraction ; traceable author statement ; 7507 ; heart development ; traceable author statement ; 7517 ; muscle development ; inferred from electronic annotation	5509 ; calcium ion binding ; inferred from electronic annotation ; 5509 ; calcium ion binding ; not recorded
226982_at	ELL2	AI745624	0.40	1.66E-02	elongation factor, RNA polymerase II, 2	chr5q15	chr5:95246559-95247998 (-)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6368 ; RNA elongation from RNA polymerase II promoter ; traceable author statement	3702 ; RNA polymerase II transcription factor activity ; traceable author statement
219298_at	ECHDC3	NM_024693	0.40	4.77E-02	enoyl Coenzyme A hydratase domain containing 3	chr10p14	chr10:11824448-11846070 (+)	8152 ; metabolism ; inferred from electronic annotation	3824 ; catalytic activity ; inferred from electronic annotation
222102_at	GSTA3	NM_000847	0.40	1.14E-02	glutathione S-transferase A3	chr6p12.1	chr6:52869402-52878612 (-)	6950 ; response to stress ; not recorded ; 8152 ; metabolism ; inferred from electronic annotation	4364 ; glutathione transferase activity ; traceable author statement ; 16740 ; transferase activity ; inferred from electronic annotation ; 4364 ; glutathione transferase activity ; inferred from electronic annotation
226933_s_at	ID4	AV646610	0.40	1.17E-02	Inhibitor of DNA binding 4, dominant negative helix-loop-helix protein	chr6p22-p21	chr6:19947422-19948036 (-)	6357 ; regulation of transcription from RNA polymerase II promoter ; traceable author statement ; 45449 ; regulation of transcription ; inferred from electronic annotation	3714 ; transcription corepressor activity ; traceable author statement ; 30528 ; transcription regulator activity ; inferred from electronic annotation
205913_at	PLIN	NM_002666	0.40	1.91E-02	perilipin	chr15q26	chr15:88008606-88023588 (-)	6629 ; lipid metabolism ; non-traceable author statement ; 6629 ; lipid metabolism ; inferred from electronic annotation	8289 ; lipid binding ; non-traceable author statement
229019_at	ZNF533	AI694320	0.40	4.58E-02	zinc finger protein 533	chr2q31.2-q31.3	chr2:180014957-180015415 (-)		3676 ; nucleic acid binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
209699_x_at	AKR1C2	U05598	0.40	1.88E-02	aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III)	chr10p15-p14	chr10:4995619-5010158 (+)	6629 ; lipid metabolism ; traceable author statement ; 6810 ; transport ; traceable author statement ; 7586 ; digestion ; traceable author statement ; 8202 ; steroid metabolism ; inferred from electronic annotation ; 15722 ; canalicular bile acid transport ; traceable author statement	5488 ; binding ; traceable author statement ; 5489 ; electron transporter activity ; traceable author statement ; 15125 ; bile acid transporter activity ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 47026 ; 3-alpha-hydroxysteroid dehydrogenase (A-specific) activity ; inferred from electronic annotation ; 47115 ; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity ; inferred from electronic annotation
216708_x_at	IGLC2	D84143	0.40	4.91E-03	Immunoglobulin lambda joining 3	chr22q11.1-q11.2	chr22:21431403-21577205 (-)	6955 ; immune response ; non-traceable author statement ; 6955 ; immune response ; inferred from electronic annotation	3823 ; antigen binding ; non-traceable author statement
242281_at	GLUL	AW665656	0.40	3.02E-03	Transcribed locus	chr1	chr1:180617462-180618018 (-)
229177_at	MGC45438	AI823572	0.40	3.08E-02	hypothetical protein MGC45438	chr16p13.3	chr16:5034123-5055889 (-)
209392_at	ENPP2	L35594	0.40	1.74E-02	ectonucleotide pyrophosphatase/phosphodiesterase 2 (autotaxin)	chr8q24.1	chr8:120638506-120720251 (-)	6796 ; phosphate metabolism ; traceable author statement ; 6928 ; cell motility ; traceable author statement ; 6935 ; chemotaxis ; non-traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; traceable author statement ; 9117 ; nucleotide metabolism ; inferred from electronic annotation	3676 ; nucleic acid binding ; inferred from electronic annotation ; 4519 ; endonuclease activity ; inferred from electronic annotation ; 4528 ; phosphodiesterase I activity ; traceable author statement ; 4551 ; nucleotide diphosphatase activity ; traceable author statement ; 8134 ; transcription factor binding ; traceable author statement ; 16787 ; hydrolase activity ; traceable author statement ; 3824 ; catalytic activity ; inferred from electronic annotation ; 4551 ; nucleotide diphosphatase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
218694_at	ARMCX1	NM_016608	0.40	5.44E-03	armadillo repeat containing, X-linked 1	chrXq21.33-q22.2	chrX:100692169-100696329 (+)		5488 ; binding ; inferred from electronic annotation
208126_s_at	CYP2C18	NM_000772	0.40	2.38E-02	cytochrome P450, family 2, subfamily C, polypeptide 18 ; cytochrome P450, family 2, subfamily C, polypeptide 18	chr10q24	chr10:96433367-96485514 (+)	6118 ; electron transport ; inferred from electronic annotation	4497 ; monooxygenase activity ; traceable author statement ; 5506 ; iron ion binding ; inferred from electronic annotation ; 19825 ; oxygen binding ; traceable author statement ; 20037 ; heme binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 50381 ; unspecific monooxygenase activity ; inferred from electronic annotation ; 4497 ; monooxygenase activity ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation
209632_at	PPP2R3A	AI760130	0.40	8.34E-03	protein phosphatase 2 (formerly 2A), regulatory subunit B, alpha	chr3q22.1	chr3:137167256-137349426 (+)	6470 ; protein amino acid dephosphorylation ; inferred from sequence or structural similarity	4721 ; phosphoprotein phosphatase activity ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5515 ; protein binding ; inferred from sequence or structural similarity ; 8601 ; protein phosphatase type 2A regulator activity ; traceable author statement ; 16787 ; hydrolase activity ; inferred from electronic annotation
229070_at	C6orf105	AA470369	0.39	3.51E-02	chromosome 6 open reading frame 105	chr6p24.1	chr6:11821875-11822365 (-)
223822_at	FLJ10052	BC004888	0.39	4.68E-03	sushi domain containing 4	chr1q41	chr1:221474874-221603428 (-)
204763_s_at	GNAO1	NM_020988	0.39	1.86E-02	guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O	chr16q13	chr16:54783648-54948651 (+)	6936 ; muscle contraction ; traceable author statement ; 7165 ; signal transduction ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation ; 7399 ; nervous system development ; not recorded ; 7411 ; axon guidance ; not recorded	166 ; nucleotide binding ; inferred from electronic annotation ; 3924 ; GTPase activity ; traceable author statement ; 5057 ; receptor signaling protein activity ; not recorded ; 5525 ; GTP binding ; inferred from electronic annotation ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 19001 ; guanyl nucleotide binding ; inferred from electronic annotation
226587_at	SNRPN	BE783065	0.39	2.55E-02	Small nuclear ribonucleoprotein polypeptide N	chr15	chr15:22829740-22832730 (+)	6397 ; mRNA processing ; inferred from electronic annotation	3723 ; RNA binding ; inferred from electronic annotation
209822_s_at	VLDLR	L22431	0.39	1.85E-03	very low density lipoprotein receptor	chr9p24	chr9:2612079-2644463 (+)	6629 ; lipid metabolism ; inferred from electronic annotation ; 6869 ; lipid transport ; inferred from electronic annotation ; 6897 ; endocytosis ; inferred from electronic annotation ; 7165 ; signal transduction ; traceable author statement ; 7399 ; nervous system development ; traceable author statement ; 7613 ; memory ; traceable author statement ; 8202 ; steroid metabolism ; inferred from electronic annotation ; 8203 ; cholesterol metabolism ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation	4872 ; receptor activity ; inferred from electronic annotation ; 5041 ; low-density lipoprotein receptor activity ; traceable author statement ; 5319 ; lipid transporter activity ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation
229278_at		AW474916	0.39	1.27E-02	Transcribed locus	chrX	chrX:55527775-55528264 (-)
211742_s_at	EVI2B	BC005926	0.39	4.13E-02	ecotropic viral integration site 2B ; ecotropic viral integration site 2B	chr17q11.2	chr17:26654918-26665217 (-)
203296_s_at	ATP1A2	NM_000702	0.39	1.91E-02	ATPase, Na+/K+ transporting, alpha 2 (+) polypeptide	chr1q21-q23	chr1:158352171-158380077 (+)	6813 ; potassium ion transport ; inferred from sequence or structural similarity ; 6814 ; sodium ion transport ; inferred from sequence or structural similarity ; 8152 ; metabolism ; inferred from electronic annotation ; 15672 ; monovalent inorganic cation transport ; inferred from electronic annotation ; 15991 ; ATP hydrolysis coupled proton transport ; inferred from sequence or structural similarity ; 30317 ; sperm motility ; inferred from sequence or structural similarity ; 30641 ; hydrogen ion homeostasis ; inferred from sequence or structural similarity ; 6812 ; cation transport ; inferred from electronic annotation ; 6813 ; potassium ion transport ; inferred from electronic annotation ; 6814 ; sodium ion transport ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 287 ; magnesium ion binding ; inferred from electronic annotation ; 5391 ; sodium:potassium-exchanging ATPase activity ; inferred from sequence or structural similarity ; 5524 ; ATP binding ; inferred from electronic annotation ; 15077 ; monovalent inorganic cation transporter activity ; inferred from electronic annotation ; 15662 ; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 16820 ; hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances ; inferred from electronic annotation ; 30955 ; potassium ion binding ; inferred from electronic annotation ; 31402 ; sodium ion binding ; inferred from electronic annotation ; 3824 ; catalytic activity ; inferred from electronic annotation ; 5391 ; sodium:potassium-exchanging ATPase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 5391 ; sodium:potassium-exchanging ATPase activity ; not recorded
227194_at	FAM3B	BF106962	0.39	4.13E-02	family with sequence similarity 3, member B	chr21q22.3	chr21:41610632-41651579 (+)	30073 ; insulin secretion ; inferred from direct assay	5125 ; cytokine activity ; non-traceable author statement ; 5125 ; cytokine activity ; inferred from electronic annotation
221606_s_at	NSBP1	BC005342	0.39	2.30E-02	nucleosomal binding protein 1	chrXq13.3	chrX:80256225-80263793 (-)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; non-traceable author statement ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3677 ; DNA binding ; inferred from electronic annotation ; 3682 ; chromatin binding ; non-traceable author statement ; 16563 ; transcriptional activator activity ; non-traceable author statement
213519_s_at	LAMA2	AI078169	0.39	3.81E-02	laminin, alpha 2 (merosin, congenital muscular dystrophy)	chr6q22-q23	chr6:129870399-129879401 (+)	7517 ; muscle development ; traceable author statement ; 30155 ; regulation of cell adhesion ; inferred from electronic annotation ; 30334 ; regulation of cell migration ; inferred from electronic annotation ; 45995 ; regulation of embryonic development ; inferred from electronic annotation ; 7155 ; cell adhesion ; inferred from electronic annotation	5102 ; receptor binding ; inferred from electronic annotation ; 5198 ; structural molecule activity ; traceable author statement ; 5198 ; structural molecule activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
212859_x_at	MT1E	BF217861	0.39	4.38E-02	metallothionein 1E (functional)	chr16q13	chr16:55216896-55218525 (+)		5507 ; copper ion binding ; non-traceable author statement ; 8270 ; zinc ion binding ; non-traceable author statement ; 46870 ; cadmium ion binding ; non-traceable author statement ; 46872 ; metal ion binding ; inferred from electronic annotation ; 5507 ; copper ion binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46870 ; cadmium ion binding ; inferred from electronic annotation
205541_s_at	GSPT2	NM_018094	0.39	2.13E-02	G1 to S phase transition 2 ; G1 to S phase transition 2	chrXp11.23-p11.21	chrX:51503283-51505763 (+)	82 ; G1/S transition of mitotic cell cycle ; inferred from sequence or structural similarity ; 184 ; mRNA catabolism, nonsense-mediated decay ; inferred from sequence or structural similarity ; 6412 ; protein biosynthesis ; inferred from electronic annotation	5515 ; protein binding ; inferred from physical interaction ; 3747 ; translation release factor activity ; inferred from sequence or structural similarity ; 3924 ; GTPase activity ; inferred from sequence or structural similarity ; 5515 ; protein binding ; inferred from sequence or structural similarity ; 166 ; nucleotide binding ; inferred from electronic annotation ; 5525 ; GTP binding ; inferred from electronic annotation
229327_s_at	MAF	BE674528	0.39	3.65E-02	V-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian)	chr16	chr16:78188721-78189853 (+)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6366 ; transcription from RNA polymerase II promoter ; traceable author statement	3677 ; DNA binding ; inferred from electronic annotation ; 3702 ; RNA polymerase II transcription factor activity ; traceable author statement
228850_s_at	SLIT2	AI963304	0.38	3.54E-02		chr4	chr4:20230638-20231282 (+)
213629_x_at	MT1F	BF246115	0.38	2.24E-02	metallothionein 1F (functional)	chr16q13	chr16:55249335-55250716 (+)		5507 ; copper ion binding ; non-traceable author statement ; 8270 ; zinc ion binding ; non-traceable author statement ; 46870 ; cadmium ion binding ; non-traceable author statement ; 46872 ; metal ion binding ; inferred from electronic annotation ; 5507 ; copper ion binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46870 ; cadmium ion binding ; inferred from electronic annotation
218236_s_at	PRKD3	NM_005813	0.38	8.92E-03	protein kinase D3	chr2p21	chr2:37331272-37397726 (-)	6468 ; protein amino acid phosphorylation ; traceable author statement ; 7205 ; protein kinase C activation ; traceable author statement ; 7242 ; intracellular signaling cascade ; inferred from electronic annotation ; 6468 ; protein amino acid phosphorylation ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4697 ; protein kinase C activity ; traceable author statement ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 19992 ; diacylglycerol binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation
228370_at	SNRPN	BF114870	0.38	2.17E-02	Small nuclear ribonucleoprotein polypeptide N	chr15q11.2	chr15:22797597-22798644 (+)	6397 ; mRNA processing ; inferred from electronic annotation	3723 ; RNA binding ; inferred from electronic annotation
201842_s_at	EFEMP1	AI826799	0.38	2.29E-02	EGF-containing fibulin-like extracellular matrix protein 1	chr2p16	chr2:55946605-56004421 (-)	7601 ; visual perception ; traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation	5509 ; calcium ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5198 ; structural molecule activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
205969_at	AADAC	NM_001086	0.38	2.13E-02	arylacetamide deacetylase (esterase)	chr3q21.3-q25.2	chr3:153014555-153028964 (+)	8152 ; metabolism ; inferred from electronic annotation	19213 ; deacetylase activity ; inferred from direct assay ; 3824 ; catalytic activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; traceable author statement
227690_at	GABRB3	BE502537	0.38	4.22E-02	Gamma-aminobutyric acid (GABA) A receptor, beta 3	chr15q11.2-q12	chr15:24339791-24342328 (-)	6811 ; ion transport ; inferred from electronic annotation ; 7165 ; signal transduction ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation ; 6810 ; transport ; traceable author statement	4890 ; GABA-A receptor activity ; traceable author statement ; 5216 ; ion channel activity ; inferred from electronic annotation ; 5230 ; extracellular ligand-gated ion channel activity ; inferred from electronic annotation ; 30594 ; neurotransmitter receptor activity ; inferred from electronic annotation ; 4890 ; GABA-A receptor activity ; inferred from electronic annotation
222156_x_at	CCPG1	AK022459	0.38	1.09E-03	cell cycle progression 1	chr15q21.1	chr15:53435134-53487806 (-)
206121_at	AMPD1	NM_000036	0.38	1.67E-03	adenosine monophosphate deaminase 1 (isoform M)	chr1p13	chr1:115017244-115039699 (-)	9117 ; nucleotide metabolism ; inferred from electronic annotation ; 9168 ; purine ribonucleoside monophosphate biosynthesis ; inferred from electronic annotation	3876 ; AMP deaminase activity ; traceable author statement ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 3876 ; AMP deaminase activity ; inferred from electronic annotation ; 19239 ; deaminase activity ; inferred from electronic annotation
214152_at	PIGB	AU144243	0.38	1.04E-03	cell cycle progression 1	chr15q21.1	chr15:53434331-53435477 (-)
205381_at	LRRC17	NM_005824	0.37	4.00E-03	leucine rich repeat containing 17	chr7q22.1	chr7:102340687-102372632 (+)
208763_s_at	DSIPI	AL110191	0.37	5.58E-03	TSC22 domain family, member 3	chrXq22.3	chrX:106843109-106846947 (-)	6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; traceable author statement	3700 ; transcription factor activity ; inferred from electronic annotation ; 3700 ; transcription factor activity ; traceable author statement
207175_at	ACDC	NM_004797	0.37	1.37E-02	adiponectin, C1Q and collagen domain containing	chr3q27	chr3:188053525-188313327 (+)	6091 ; generation of precursor metabolites and energy ; traceable author statement ; 6817 ; phosphate transport ; inferred from electronic annotation	5179 ; hormone activity ; inferred from electronic annotation
228214_at	SOX6	AW242286	0.37	4.70E-02	SRY (sex determining region Y)-box 6	chr11	chr11:15947199-15947653 (-)	6325 ; establishment and/or maintenance of chromatin architecture ; non-traceable author statement ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; non-traceable author statement ; 7517 ; muscle development ; non-traceable author statement ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3700 ; transcription factor activity ; non-traceable author statement ; 3677 ; DNA binding ; inferred from electronic annotation ; 3677 ; DNA binding ; non-traceable author statement
207547_s_at	TU3A	NM_007177	0.37	1.20E-02	TU3A protein	chr3p21.1	chr3:58524886-58538531 (-)	1558 ; regulation of cell growth ; inferred from direct assay ; 1558 ; regulation of cell growth ; inferred from electronic annotation
222835_at	FLJ13710	BG163478	0.37	4.05E-03	hypothetical protein FLJ13710	chr15q23	chr15:69739922-69860040 (+)		4222 ; metalloendopeptidase activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation
204469_at	PTPRZ1	NM_002851	0.37	3.14E-03	protein tyrosine phosphatase, receptor-type, Z polypeptide 1	chr7q31.3	chr7:121300642-121489324 (+)	6470 ; protein amino acid dephosphorylation ; traceable author statement ; 6730 ; one-carbon compound metabolism ; inferred from electronic annotation ; 7417 ; central nervous system development ; traceable author statement ; 6470 ; protein amino acid dephosphorylation ; inferred from electronic annotation	4089 ; carbonate dehydratase activity ; inferred from electronic annotation ; 5001 ; transmembrane receptor protein tyrosine phosphatase activity ; traceable author statement ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 4721 ; phosphoprotein phosphatase activity ; inferred from electronic annotation ; 4725 ; protein tyrosine phosphatase activity ; inferred from electronic annotation ; 8330 ; protein tyrosine/threonine phosphatase activity ; non-traceable author statement
238018_at	LOC285016	BF449053	0.37	2.27E-02	hypothetical protein LOC285016	chr2p25.3	chr2:269557-277299 (-)
210524_x_at		AF078844	0.37	1.65E-02		chr17	chr17:59248850-59249403 (-)
219132_at	PELI2	NM_021255	0.37	2.11E-02	pellino homolog 2 (Drosophila)	chr14q21	chr14:55654955-55837773 (+)		5515 ; protein binding ; inferred from physical interaction
228503_at		AW025023	0.37	6.12E-03	CDNA: FLJ22648 fis, clone HSI07329	chrX	chrX:83201768-83205300 (-)
223551_at	PKIB	AF225513	0.37	1.36E-02	protein kinase (cAMP-dependent, catalytic) inhibitor beta	chr6q22.31	chr6:123080403-123088734 (+)	6469 ; negative regulation of protein kinase activity ; inferred from electronic annotation	4862 ; cAMP-dependent protein kinase inhibitor activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 4860 ; protein kinase inhibitor activity ; inferred from electronic annotation
238862_at	DKFZp761N1114	AW818475	0.36	2.42E-02	hypothetical protein DKFZp761N1114	chr1q32.1	chr1:203836412-203837109 (+)
230788_at	GCNT2	BF059748	0.36	1.78E-02	glucosaminyl (N-acetyl) transferase 2, I-branching enzyme	chr6p24	chr6:10737214-10737586 (+)	6024 ; glycosaminoglycan biosynthesis ; traceable author statement ; 6493 ; protein amino acid O-linked glycosylation ; not recorded ; 7275 ; development ; traceable author statement	8109 ; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity ; traceable author statement ; 8375 ; acetylglucosaminyltransferase activity ; inferred from electronic annotation ; 16757 ; transferase activity, transferring glycosyl groups ; inferred from electronic annotation ; 8109 ; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation
226281_at	DNER	BF059512	0.36	1.61E-02	delta-notch-like EGF repeat-containing transmembrane	chr2q36.3	chr2:229930591-230161414 (-)	7417 ; central nervous system development ; inferred from expression pattern ; 1764 ; neuron migration ; non-traceable author statement ; 6897 ; endocytosis ; non-traceable author statement ; 7416 ; synaptogenesis ; non-traceable author statement	5198 ; structural molecule activity ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 4888 ; transmembrane receptor activity ; traceable author statement ; 30276 ; clathrin binding ; traceable author statement ; 5509 ; calcium ion binding ; non-traceable author statement
213800_at	CFH	X04697	0.36	1.49E-02	complement factor H	chr1q32	chr1:194887784-194925993 (+)	6955 ; immune response ; inferred from electronic annotation ; 6957 ; complement activation, alternative pathway ; inferred from electronic annotation ; 45087 ; innate immune response ; inferred from electronic annotation ; 6956 ; complement activation ; traceable author statement
219543_at	MAWBP	NM_022129	0.36	1.13E-03	MAWD binding protein	chr10pter-q25.3	chr10:69712422-69726897 (-)	9058 ; biosynthesis ; inferred from electronic annotation	16491 ; oxidoreductase activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; inferred from electronic annotation
235915_at		R88990	0.36	2.01E-02		chr4	chr4:187448032-187448859 (+)
204754_at	HLF	W60800	0.36	2.52E-02	Hepatic leukemia factor	chr17q22	chr17:50697398-50757424 (+)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6366 ; transcription from RNA polymerase II promoter ; traceable author statement ; 7275 ; development ; traceable author statement ; 48511 ; rhythmic process ; inferred from electronic annotation	3690 ; double-stranded DNA binding ; traceable author statement ; 3677 ; DNA binding ; inferred from electronic annotation ; 3677 ; DNA binding ; traceable author statement
209894_at	LEPR	U50748	0.36	1.25E-02	leptin receptor	chr1p31	chr1:65803836-65873698 (+)	6112 ; energy reserve metabolism ; traceable author statement ; 7166 ; cell surface receptor linked signal transduction ; traceable author statement ; 7275 ; development ; traceable author statement	4896 ; hematopoietin/interferon-class (D200-domain) cytokine receptor activity ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 4888 ; transmembrane receptor activity ; traceable author statement
236308_at	MGC33530	D60436	0.36	1.65E-02	hypothetical protein LOC285878	chr7p11.2	chr7:54605049-54605318 (+)
206212_at	CPA2	NM_001869	0.36	1.65E-02	carboxypeptidase A2 (pancreatic)	chr7q32	chr7:129693959-129716871 (+)	6508 ; proteolysis ; inferred from electronic annotation ; 7039 ; vacuolar protein catabolism ; traceable author statement ; 6508 ; proteolysis ; not recorded	4180 ; carboxypeptidase activity ; inferred from electronic annotation ; 4182 ; carboxypeptidase A activity ; traceable author statement ; 8237 ; metallopeptidase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4182 ; carboxypeptidase A activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
241789_at	RBMS3	AW338699	0.36	2.85E-02	RNA binding motif, single stranded interacting protein	chr3	chr3:30023088-30023531 (+)		166 ; nucleotide binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation ; 3723 ; RNA binding ; inferred from electronic annotation
228481_at	POSTN	BG541187	0.36	4.22E-02	Periostin, osteoblast specific factor	chr13q13.3	chr13:37046713-37049722 (-)	1501 ; skeletal development ; traceable author statement ; 7155 ; cell adhesion ; inferred from direct assay ; 7155 ; cell adhesion ; inferred from electronic annotation	5515 ; protein binding ; inferred from electronic annotation ; 8201 ; heparin binding ; inferred from sequence or structural similarity ; 8201 ; heparin binding ; inferred from electronic annotation
220059_at	BRDG1	NM_012108	0.36	2.40E-02	BCR downstream signaling 1	chr4q13.2	chr4:68107040-68155206 (+)	6886 ; intracellular protein transport ; traceable author statement ; 6944 ; membrane fusion ; traceable author statement ; 6959 ; humoral immune response ; not recorded ; 7242 ; intracellular signaling cascade ; inferred from electronic annotation ; 7165 ; signal transduction ; traceable author statement
221589_s_at	ALDH6A1	AW612403	0.36	4.44E-03	Aldehyde dehydrogenase 6 family, member A1	chr14q24.3	chr14:73594122-73597130 (-)	6220 ; pyrimidine nucleotide metabolism ; non-traceable author statement ; 6573 ; valine metabolism ; non-traceable author statement ; 8152 ; metabolism ; inferred from electronic annotation ; 6573 ; valine metabolism ; inferred from electronic annotation	4491 ; methylmalonate-semialdehyde dehydrogenase (acylating) activity ; non-traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 18478 ; malonate-semialdehyde dehydrogenase (acetylating) activity ; inferred from electronic annotation ; 4491 ; methylmalonate-semialdehyde dehydrogenase (acylating) activity ; inferred from electronic annotation
235965_at	DKFZP434B0335	BF513674	0.36	5.34E-03	DKFZP434B0335 protein	chr7q21.3	chr7:97682188-97682690 (+)
213502_x_at	LOC91316	AA398569	0.36	4.87E-02	similar to bK246H3.1 (immunoglobulin lambda-like polypeptide 1, pre-B-cell specific)	chr22q11.23	chr22:22310673-22362549 (-)	7242 ; intracellular signaling cascade ; inferred from electronic annotation	5085 ; guanyl-nucleotide exchange factor activity ; inferred from electronic annotation
209813_x_at	TRGV9	M16768	0.35	3.86E-02	T cell receptor gamma constant 2 ; T cell receptor gamma constant 2 ; T cell receptor gamma variable 9 ; T cell receptor gamma variable 9 ; similar to T-cell receptor gamma chain C region PT-gamma-1/2 ; similar to T-cell receptor gamma chain C region PT-gamma-1/2 ; similar to T-cell receptor gamma chain V region PT-gamma-1/2 precursor ; similar to T-cell receptor gamma chain V region PT-gamma-1/2 precursor ; TCR gamma alternate reading frame protein ; TCR gamma alternate reading frame protein	chr7p15	chr7:38265768-38323770 (-)	6955 ; immune response ; non-traceable author statement	4872 ; receptor activity ; inferred from electronic annotation ; 42287 ; MHC protein binding ; non-traceable author statement ; 42605 ; peptide antigen binding ; non-traceable author statement
215118_s_at	MGC27165	AW519168	0.35	1.49E-02	Translocation associated fusion protein IRTA1/IGA1 (IRTA1/IGHA1)	chr14q32.33	chr14:105241338-105244707 (-)
228974_at	MGC48625	AI816281	0.35	5.54E-03	Zinc finger protein 677	chr19q13.41	chr19:58433661-58435532 (-)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3676 ; nucleic acid binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
239183_at	ANGPTL1	W67461	0.35	3.97E-02	angiopoietin-like 1	chr1q25.2	chr1:177085296-177085945 (-)		5102 ; receptor binding ; traceable author statement
210119_at	KCNJ15	U73191	0.35	3.26E-02	potassium inwardly-rectifying channel, subfamily J, member 15	chr21q22.2	chr21:38590766-38594596 (+)	6811 ; ion transport ; inferred from electronic annotation ; 6813 ; potassium ion transport ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation ; 6813 ; potassium ion transport ; inferred from electronic annotation	5242 ; inward rectifier potassium channel activity ; traceable author statement ; 5244 ; voltage-gated ion channel activity ; inferred from electronic annotation ; 5267 ; potassium channel activity ; inferred from electronic annotation ; 30955 ; potassium ion binding ; inferred from electronic annotation ; 5216 ; ion channel activity ; inferred from electronic annotation ; 5242 ; inward rectifier potassium channel activity ; inferred from electronic annotation
228740_at		BF059276	0.35	8.00E-03	CDNA clone IMAGE:5276765	chr14	chr14:57529987-57531004 (-)
220012_at	ERO1LB	NM_019891	0.35	6.29E-03	ERO1-like beta (S. cerevisiae)	chr1q42.2-q43	chr1:234448232-234511871 (-)	6118 ; electron transport ; inferred from electronic annotation ; 6457 ; protein folding ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation	16491 ; oxidoreductase activity ; non-traceable author statement ; 51082 ; unfolded protein binding ; non-traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation
201117_s_at	CPE	NM_001873	0.35	1.06E-02	carboxypeptidase E	chr4q32.3	chr4:166519543-166638926 (+)	6464 ; protein modification ; non-traceable author statement ; 6508 ; proteolysis ; inferred from electronic annotation ; 7218 ; neuropeptide signaling pathway ; non-traceable author statement ; 8152 ; metabolism ; traceable author statement	4180 ; carboxypeptidase activity ; traceable author statement ; 4182 ; carboxypeptidase A activity ; inferred from electronic annotation ; 4183 ; carboxypeptidase E activity ; inferred from electronic annotation ; 8237 ; metallopeptidase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4180 ; carboxypeptidase activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
225720_at	SYNPO2	AW009747	0.35	2.13E-02	Synaptopodin 2	chr4q26	chr4:120176334-120179122 (+)		3779 ; actin binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
242943_at	SIAT8D	AA352113	0.35	3.56E-02	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4	chr5q21	chr5:100174073-100174769 (-)	6486 ; protein amino acid glycosylation ; inferred from electronic annotation ; 6491 ; N-glycan processing ; traceable author statement ; 7399 ; nervous system development ; traceable author statement ; 9311 ; oligosaccharide metabolism ; traceable author statement ; 6464 ; protein modification ; traceable author statement	8373 ; sialyltransferase activity ; traceable author statement ; 8373 ; sialyltransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 16757 ; transferase activity, transferring glycosyl groups ; inferred from electronic annotation
240242_at		BE222843	0.35	4.01E-02	Transcribed locus	chr3	chr3:194599452-194599886 (-)
205498_at	GHR	NM_000163	0.35	1.40E-03	growth hormone receptor	chr5p13-p12	chr5:42459782-42757736 (+)	1501 ; skeletal development ; traceable author statement ; 6897 ; endocytosis ; inferred from electronic annotation ; 40007 ; growth ; traceable author statement	4872 ; receptor activity ; inferred from electronic annotation ; 4903 ; growth hormone receptor activity ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 4896 ; hematopoietin/interferon-class (D200-domain) cytokine receptor activity ; inferred from electronic annotation
210299_s_at	FHL1	AF063002	0.35	2.14E-02	four and a half LIM domains 1	chrXq26	chrX:135079750-135120769 (+)	7517 ; muscle development ; non-traceable author statement ; 9887 ; organ morphogenesis ; non-traceable author statement ; 16049 ; cell growth ; non-traceable author statement ; 30154 ; cell differentiation ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation	8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
229125_at	LOC163782	AA456955	0.35	3.17E-02	ankyrin repeat domain 38	chr1p31.3	chr1:62475408-62476339 (-)
232054_at	PCDH20	AA040057	0.35	3.79E-02	protocadherin 20	chr13q21	chr13:60881821-60887282 (-)	7155 ; cell adhesion ; inferred from electronic annotation ; 7156 ; homophilic cell adhesion ; inferred from electronic annotation	5509 ; calcium ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
222043_at	CLU	AI982754	0.35	2.11E-02	clusterin (complement lysis inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone-repressed prostate message 2, apolipoprotein J)	chr8p21-p12	chr8:27511160-27513313 (-)	6629 ; lipid metabolism ; non-traceable author statement ; 6915 ; apoptosis ; inferred from electronic annotation ; 6955 ; immune response ; inferred from electronic annotation ; 6958 ; complement activation, classical pathway ; inferred from electronic annotation ; 7338 ; fertilization (sensu Metazoa) ; not recorded ; 8219 ; cell death ; inferred from electronic annotation ; 45087 ; innate immune response ; inferred from electronic annotation ; 6956 ; complement activation ; traceable author statement
214151_s_at	PIGB	AU144243	0.34	2.78E-02	cell cycle progression 1	chr15q21.1	chr15:53434331-53435477 (-)
207601_at	SULT1B1	NM_014465	0.34	2.08E-02	sulfotransferase family, cytosolic, 1B, member 1	chr4q13.3	chr4:70627276-70655548 (-)	6629 ; lipid metabolism ; inferred from electronic annotation ; 8202 ; steroid metabolism ; inferred from electronic annotation ; 18958 ; phenol metabolism ; inferred from direct assay ; 42403 ; thyroid hormone metabolism ; inferred from direct assay ; 6576 ; biogenic amine metabolism ; traceable author statement	8146 ; sulfotransferase activity ; inferred from direct assay ; 16740 ; transferase activity ; inferred from electronic annotation ; 8146 ; sulfotransferase activity ; inferred from electronic annotation ; 8146 ; sulfotransferase activity ; traceable author statement
215103_at	CYP2C18	AW192911	0.34	4.02E-02	cytochrome P450, family 2, subfamily C, polypeptide 18	chr10q24	chr10:96433367-96485935 (+)	6118 ; electron transport ; inferred from electronic annotation	4497 ; monooxygenase activity ; traceable author statement ; 5506 ; iron ion binding ; inferred from electronic annotation ; 19825 ; oxygen binding ; traceable author statement ; 20037 ; heme binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 50381 ; unspecific monooxygenase activity ; inferred from electronic annotation ; 4497 ; monooxygenase activity ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation
203914_x_at	HPGD	NM_000860	0.34	4.75E-02	hydroxyprostaglandin dehydrogenase 15-(NAD)	chr4q34-q35	chr4:175647981-175680194 (-)	6629 ; lipid metabolism ; inferred from electronic annotation ; 6631 ; fatty acid metabolism ; inferred from electronic annotation ; 6693 ; prostaglandin metabolism ; inferred from electronic annotation ; 8152 ; metabolism ; inferred from electronic annotation	4667 ; prostaglandin-D synthase activity ; not recorded ; 5489 ; electron transporter activity ; not recorded ; 16404 ; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; traceable author statement ; 16404 ; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity ; non-traceable author statement
211458_s_at	GABARAPL3	AF180519	0.34	2.38E-02	GABA(A) receptor-associated protein like 1 ; GABA(A) receptors associated protein like 3	chr12p13.2	chr12:10256765-10266966 (+)	6605 ; protein targeting ; inferred from sequence or structural similarity ; 7268 ; synaptic transmission ; inferred from sequence or structural similarity	5515 ; protein binding ; inferred from physical interaction ; 5515 ; protein binding ; inferred from sequence or structural similarity ; 48487 ; beta-tubulin binding ; inferred from sequence or structural similarity ; 50811 ; GABA receptor binding ; inferred from sequence or structural similarity
219440_at	RAI2	NM_021785	0.34	2.86E-02	retinoic acid induced 2	chrXp22	chrX:17728091-17730428 (-)	9790 ; embryonic development ; non-traceable author statement
231325_at	UNC5D	AI802048	0.34	3.94E-02	Unc-5 homolog D (C. elegans)	chr8p12	chr8:35773007-35773609 (+)	6915 ; apoptosis ; inferred from electronic annotation ; 7165 ; signal transduction ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation	4872 ; receptor activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
206637_at	P2RY14	NM_014879	0.34	2.30E-02	purinergic receptor P2Y, G-protein coupled, 14	chr3q21-q25	chr3:152412594-152478847 (-)	7165 ; signal transduction ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; non-traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation	1584 ; rhodopsin-like receptor activity ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 45028 ; purinergic nucleotide receptor activity, G-protein coupled ; inferred from electronic annotation ; 45029 ; UDP-activated nucleotide receptor activity ; non-traceable author statement ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; inferred from electronic annotation
226811_at	FAM46C	AL046017	0.34	2.18E-02	family with sequence similarity 46, member C	chr1p12	chr1:117970179-117972517 (+)
213933_at	PTGER3	AW242315	0.34	2.05E-02	Prostaglandin E receptor 3 (subtype EP3)	chr1p31.2	chr1:71244813-71246562 (-)	6351 ; transcription, DNA-dependent ; traceable author statement ; 7165 ; signal transduction ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; traceable author statement ; 8219 ; cell death ; traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation	1584 ; rhodopsin-like receptor activity ; inferred from electronic annotation ; 4879 ; ligand-dependent nuclear receptor activity ; traceable author statement ; 4957 ; prostaglandin E receptor activity ; traceable author statement ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; inferred from electronic annotation ; 4955 ; prostaglandin receptor activity ; inferred from electronic annotation ; 4957 ; prostaglandin E receptor activity ; inferred from electronic annotation ; 4957 ; prostaglandin E receptor activity ; non-traceable author statement
228329_at	DAB1	AA700440	0.34	1.85E-03	Disabled homolog 1 (Drosophila)	chr1	chr1:57233040-57234517 (-)	7399 ; nervous system development ; inferred from electronic annotation ; 30154 ; cell differentiation ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation
239237_at	AMPH	AI798822	0.34	7.07E-03	Amphiphysin (Stiff-Man syndrome with breast cancer 128kDa autoantigen)	chr7	chr7:38382113-38382582 (+)	6897 ; endocytosis ; traceable author statement ; 7268 ; synaptic transmission ; traceable author statement	5515 ; protein binding ; inferred from electronic annotation
210375_at	PTGER3	X83858	0.33	1.81E-02	prostaglandin E receptor 3 (subtype EP3)	chr1p31.2	chr1:71209051-71286079 (-)	6351 ; transcription, DNA-dependent ; traceable author statement ; 7165 ; signal transduction ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; traceable author statement ; 8219 ; cell death ; traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation	1584 ; rhodopsin-like receptor activity ; inferred from electronic annotation ; 4879 ; ligand-dependent nuclear receptor activity ; traceable author statement ; 4957 ; prostaglandin E receptor activity ; traceable author statement ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; inferred from electronic annotation ; 4955 ; prostaglandin receptor activity ; inferred from electronic annotation ; 4957 ; prostaglandin E receptor activity ; inferred from electronic annotation ; 4957 ; prostaglandin E receptor activity ; non-traceable author statement
204260_at	CHGB	NM_001819	0.33	3.14E-03	chromogranin B (secretogranin 1)	chr20pter-p12	chr20:5840167-5854003 (+)		5179 ; hormone activity ; traceable author statement
204955_at	SRPX	NM_006307	0.33	4.68E-03	sushi-repeat-containing protein, X-linked	chrXp21.1	chrX:37893553-37965029 (-)	7155 ; cell adhesion ; inferred from electronic annotation	5515 ; protein binding ; inferred from electronic annotation
217506_at		H49382	0.33	4.70E-02	Hypothetical gene supported by BC041875; BX648984	chr18p11.31	chr18:5232791-5233300 (+)
230716_at	LOC285733	AI935557	0.33	2.16E-02	hypothetical protein LOC285733	chr6q23.1	chr6:131190258-131198122 (+)
235849_at	MGC45780	BE787752	0.33	2.26E-02	scavenger receptor class A, member 5 (putative)	chr8p21.1	chr8:27783559-27784198 (-)	6817 ; phosphate transport ; inferred from electronic annotation	4872 ; receptor activity ; inferred from electronic annotation ; 5044 ; scavenger receptor activity ; inferred from electronic annotation
231202_at	ALDH1L2	AI654224	0.33	1.65E-02	aldehyde dehydrogenase 1 family, member L2	chr12q23.3	chr12:103937697-103938442 (-)	8152 ; metabolism ; inferred from electronic annotation ; 9058 ; biosynthesis ; inferred from electronic annotation ; 6730 ; one-carbon compound metabolism ; inferred from electronic annotation ; 9258 ; 10-formyltetrahydrofolate catabolism ; inferred from electronic annotation	16491 ; oxidoreductase activity ; inferred from electronic annotation ; 16742 ; hydroxymethyl-, formyl- and related transferase activity ; inferred from electronic annotation ; 48037 ; cofactor binding ; inferred from electronic annotation ; 16155 ; formyltetrahydrofolate dehydrogenase activity ; inferred from electronic annotation
206488_s_at	CD36	NM_000072	0.33	7.07E-03	CD36 antigen (collagen type I receptor, thrombospondin receptor)	chr7q11.2	chr7:80113568-80141668 (+)	6629 ; lipid metabolism ; non-traceable author statement ; 6631 ; fatty acid metabolism ; not recorded ; 6810 ; transport ; inferred from electronic annotation ; 7155 ; cell adhesion ; traceable author statement ; 7596 ; blood coagulation ; traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation	4872 ; receptor activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
211682_x_at	UGT2B28	AF177272	0.33	2.88E-02	UDP glucuronosyltransferase 2 family, polypeptide B28 ; UDP glucuronosyltransferase 2 family, polypeptide B28	chr4q13.2	chr4:70180805-70195356 (+)	6805 ; xenobiotic metabolism ; inferred from direct assay ; 8152 ; metabolism ; inferred from direct assay ; 8152 ; metabolism ; inferred from electronic annotation ; 6805 ; xenobiotic metabolism ; traceable author statement ; 8210 ; estrogen metabolism ; traceable author statement	15020 ; glucuronosyltransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 16757 ; transferase activity, transferring glycosyl groups ; inferred from electronic annotation ; 16758 ; transferase activity, transferring hexosyl groups ; inferred from electronic annotation
222257_s_at	ACE2	AK026461	0.33	2.18E-02	angiotensin I converting enzyme (peptidyl-dipeptidase A) 2	chrXp22	chrX:15489080-15494331 (-)	6508 ; proteolysis ; inferred from electronic annotation ; 46718 ; viral entry into host cell ; traceable author statement	1618 ; viral receptor activity ; non-traceable author statement ; 4180 ; carboxypeptidase activity ; inferred from direct assay ; 4246 ; peptidyl-dipeptidase A activity ; inferred from electronic annotation ; 5515 ; protein binding ; non-traceable author statement ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4180 ; carboxypeptidase activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8237 ; metallopeptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
207761_s_at	DKFZP586A0522	NM_014033	0.33	9.89E-03	DKFZP586A0522 protein	chr12q13.13	chr12:49605068-49612555 (+)		8168 ; methyltransferase activity ; inferred from electronic annotation ; 8757 ; S-adenosylmethionine-dependent methyltransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation
216705_s_at	ADA	X02189	0.33	2.44E-02	adenosine deaminase	chr20q12-q13.11	chr20:42681888-42713757 (-)	9117 ; nucleotide metabolism ; inferred from electronic annotation ; 9168 ; purine ribonucleoside monophosphate biosynthesis ; inferred from electronic annotation ; 19735 ; antimicrobial humoral response (sensu Vertebrata) ; traceable author statement	4000 ; adenosine deaminase activity ; inferred from electronic annotation ; 4000 ; adenosine deaminase activity ; traceable author statement ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 19239 ; deaminase activity ; inferred from electronic annotation
217165_x_at	MT1F; MGC32732	M10943	0.33	2.73E-02	metallothionein 1F (functional)	chr16q13	chr16:55230151-55250577 (+)		5507 ; copper ion binding ; non-traceable author statement ; 8270 ; zinc ion binding ; non-traceable author statement ; 46870 ; cadmium ion binding ; non-traceable author statement ; 46872 ; metal ion binding ; inferred from electronic annotation ; 5507 ; copper ion binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46870 ; cadmium ion binding ; inferred from electronic annotation
230595_at	LOC572558	BF677651	0.33	1.09E-02	hypothetical locus LOC572558	chr9q13	chr9:68436757-68439445 (+)
222453_at	CYBRD1	AL136693	0.33	1.56E-02	cytochrome b reductase 1	chr2q31.1	chr2:172087232-172122883 (+)	6118 ; electron transport ; inferred from electronic annotation
229638_at	IRX3	AI681917	0.33	2.64E-03	iroquois homeobox protein 3	chr16q12.2	chr16:52874718-52877268 (-)	6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 45449 ; regulation of transcription ; inferred from electronic annotation	3700 ; transcription factor activity ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation
221286_s_at	PACAP	NM_016459	0.32	4.45E-02	proapoptotic caspase adaptor protein	chr5q23-5q31	chr5:138751093-138751637 (-)
203951_at	CNN1	NM_001299	0.32	2.05E-02	calponin 1, basic, smooth muscle	chr19p13.2-p13.1	chr19:11510664-11522247 (+)	6940 ; regulation of smooth muscle contraction ; traceable author statement ; 31032 ; actomyosin structure organization and biogenesis ; inferred from electronic annotation	3779 ; actin binding ; inferred from electronic annotation ; 5516 ; calmodulin binding ; inferred from electronic annotation
219737_s_at	PCDH9	AI524125	0.32	2.02E-02	protocadherin 9	chr13q14.3-q21.1	chr13:65774971-66700691 (-)	7155 ; cell adhesion ; inferred from electronic annotation ; 7156 ; homophilic cell adhesion ; inferred from electronic annotation	5509 ; calcium ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
223557_s_at	TMEFF2	AB017269	0.32	2.68E-02	transmembrane protein with EGF-like and two follistatin-like domains 2	chr2q32.3	chr2:192523052-192767863 (-)
230578_at	ZNF471	AL042523	0.32	1.98E-02	Zinc finger protein 471	chr19	chr19:61732764-61733397 (+)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3677 ; DNA binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation
213247_at	C9orf13	AA716107	0.32	5.27E-03	sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1	chr9q32	chr9:112168276-112209168 (-)		5509 ; calcium ion binding ; inferred from electronic annotation
229963_at	LOC340542	AV726956	0.32	3.65E-02	NGFRAP1-like 1	chrXq22.1	chrX:101295339-101295876 (-)
209867_s_at	LEC3	AF307080	0.32	4.11E-02	latrophilin 3	chr4q13.1	chr4:61749969-62620762 (+)	7165 ; signal transduction ; inferred from electronic annotation ; 7218 ; neuropeptide signaling pathway ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; non-traceable author statement	4872 ; receptor activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; non-traceable author statement ; 5529 ; sugar binding ; inferred from electronic annotation ; 16524 ; latrotoxin receptor activity ; inferred from electronic annotation ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; traceable author statement
228504_at	SCN7A	AI828648	0.32	1.30E-02	Sodium channel, voltage-gated, type VII, alpha	chr2	chr2:166968224-166969164 (-)	6812 ; cation transport ; inferred from electronic annotation ; 6814 ; sodium ion transport ; traceable author statement ; 6936 ; muscle contraction ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation ; 6811 ; ion transport ; inferred from electronic annotation ; 6814 ; sodium ion transport ; inferred from electronic annotation	5248 ; voltage-gated sodium channel activity ; traceable author statement ; 5261 ; cation channel activity ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 31402 ; sodium ion binding ; inferred from electronic annotation ; 5216 ; ion channel activity ; inferred from electronic annotation ; 5244 ; voltage-gated ion channel activity ; inferred from electronic annotation ; 5248 ; voltage-gated sodium channel activity ; inferred from electronic annotation
235977_at		BF433341	0.31	2.52E-02	MRNA; cDNA DKFZp686N1345 (from clone DKFZp686N1345)	chr2q11.2	chr2:100264791-100265292 (-)
204755_x_at	HLF	M95585	0.31	1.98E-02	hepatic leukemia factor	chr17q22	chr17:50697525-50755887 (+)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6366 ; transcription from RNA polymerase II promoter ; traceable author statement ; 7275 ; development ; traceable author statement ; 48511 ; rhythmic process ; inferred from electronic annotation	3690 ; double-stranded DNA binding ; traceable author statement ; 3677 ; DNA binding ; inferred from electronic annotation ; 3677 ; DNA binding ; traceable author statement
230087_at	PRIMA1	AI823645	0.31	5.58E-03	Proline rich membrane anchor 1	chr14q32.13	chr14:93254396-93254925 (-)	42135 ; neurotransmitter catabolism ; inferred from electronic annotation
234346_x_at		AK021431	0.31	2.52E-02		chr20q11.2	chr20:33253512-33254567 (+)
209167_at	GPM6B	AI419030	0.31	4.46E-02	glycoprotein M6B	chrXp22.2	chrX:13698962-13745099 (-)	7399 ; nervous system development ; non-traceable author statement ; 30154 ; cell differentiation ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation ; 7399 ; nervous system development ; inferred from electronic annotation
229230_at	OSTalpha	AA702685	0.31	3.88E-02	organic solute transporter alpha	chr3q29	chr3:197438313-197444923 (+)
215565_at	DTNB	AK022277	0.31	7.46E-03	dystrobrevin, beta	chr2p24	chr2:25459709-25504389 (+)		5509 ; calcium ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; traceable author statement ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
240509_s_at	GREM2	BF064262	0.31	4.47E-02	gremlin 2, cysteine knot superfamily, homolog (Xenopus laevis)	chr1q43	chr1:238719501-238719994 (-)		5125 ; cytokine activity ; inferred from electronic annotation
216207_x_at	IGKV1D-13	AW408194	0.31	2.24E-02	immunoglobulin kappa variable 1D-13	chr2p12	chr2:89830252-89830731 (+)
228854_at		AI492388	0.31	3.72E-03	Transcribed locus	chr11	chr11:113630901-113631908 (+)
223784_at	TMEM27	AF229179	0.31	5.58E-03	transmembrane protein 27	chrXp22	chrX:15555361-15592842 (-)
225491_at	SLC1A2	AL157452	0.30	6.18E-03	solute carrier family 1 (glial high affinity glutamate transporter), member 2	chr11p13-p12	chr11:35229327-35232251 (-)	6810 ; transport ; inferred from electronic annotation ; 6835 ; dicarboxylic acid transport ; inferred from electronic annotation ; 7268 ; synaptic transmission ; traceable author statement ; 15813 ; L-glutamate transport ; traceable author statement	5313 ; L-glutamate transporter activity ; traceable author statement ; 15293 ; symporter activity ; inferred from electronic annotation ; 17153 ; sodium:dicarboxylate symporter activity ; inferred from electronic annotation
215379_x_at	IGLC2	AV698647	0.30	4.30E-02	immunoglobulin lambda locus ; immunoglobulin lambda constant 1 (Mcg marker) ; immunoglobulin lambda constant 2 (Kern-Oz- marker) ; immunoglobulin lambda variable 3-25 ; immunoglobulin lambda variable 2-14 ; immunoglobulin lambda joining 3	chr22q11.1-q11.2	chr22:21431202-21573495 (+)	6955 ; immune response ; non-traceable author statement ; 6955 ; immune response ; inferred from electronic annotation	3823 ; antigen binding ; non-traceable author statement ; 3823 ; antigen binding ; inferred from electronic annotation
244740_at	MGC9913	BE855713	0.30	1.65E-02	hypothetical protein MGC9913	chr19q13.43	chr19:61681330-61697525 (+)
219093_at	FLJ20701	NM_017933	0.30	6.10E-03	hypothetical protein FLJ20701 ; hypothetical protein FLJ20701	chr2q36.3	chr2:229596954-229728926 (-)
207254_at	SLC15A1	NM_005073	0.30	1.46E-02	solute carrier family 15 (oligopeptide transporter), member 1	chr13q33-q34	chr13:98134056-98202909 (-)	6857 ; oligopeptide transport ; inferred from electronic annotation ; 7586 ; digestion ; traceable author statement ; 15031 ; protein transport ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation ; 6810 ; transport ; traceable author statement ; 15833 ; peptide transport ; non-traceable author statement	5215 ; transporter activity ; inferred from electronic annotation ; 15198 ; oligopeptide transporter activity ; inferred from electronic annotation ; 15293 ; symporter activity ; inferred from electronic annotation ; 15333 ; peptide:hydrogen symporter activity ; traceable author statement
213921_at	SST	NM_001048	0.30	4.14E-02	somatostatin	chr3q28	chr3:188869393-188870896 (-)		5179 ; hormone activity ; inferred from electronic annotation
206030_at	ASPA	NM_000049	0.30	2.56E-02	aspartoacylase (Canavan disease)	chr17pter-p13	chr17:3326045-3349449 (+)	6533 ; aspartate catabolism ; traceable author statement ; 8152 ; metabolism ; inferred from electronic annotation	4046 ; aminoacylase activity ; traceable author statement ; 16788 ; hydrolase activity, acting on ester bonds ; inferred from electronic annotation ; 19807 ; aspartoacylase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
223529_at	SYT4	AB037763	0.30	1.50E-02	synaptotagmin IV	chr18q12.3	chr18:39101854-39111430 (-)	6810 ; transport ; inferred from electronic annotation ; 17158 ; regulation of calcium ion-dependent exocytosis ; inferred from sequence or structural similarity ; 48489 ; synaptic vesicle transport ; inferred from sequence or structural similarity	5215 ; transporter activity ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
227827_at	ARGBP2	AW138143	0.30	9.14E-03	Sorbin and SH3 domain containing 2	chr4q35.1	chr4:186798113-186799907 (-)	6810 ; transport ; inferred from electronic annotation	5515 ; protein binding ; non-traceable author statement ; 5200 ; structural constituent of cytoskeleton ; traceable author statement ; 8093 ; cytoskeletal adaptor activity ; traceable author statement ; 8307 ; structural constituent of muscle ; traceable author statement
229975_at	BMPR1B	AI826437	0.30	4.68E-02	Bone morphogenetic protein receptor, type IB	chr4	chr4:96297531-96298615 (+)	1501 ; skeletal development ; inferred from mutant phenotype ; 1502 ; cartilage condensation ; non-traceable author statement ; 1550 ; ovarian cumulus expansion ; inferred from sequence or structural similarity ; 1654 ; eye development ; inferred from sequence or structural similarity ; 6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 6703 ; estrogen biosynthesis ; inferred from sequence or structural similarity ; 30509 ; BMP signaling pathway ; non-traceable author statement ; 35108 ; limb morphogenesis ; inferred from mutant phenotype ; 42698 ; menstrual cycle ; inferred from sequence or structural similarity ; 45597 ; positive regulation of cell differentiation ; inferred from mutant phenotype ; 7178 ; transmembrane receptor protein serine/threonine kinase signaling pathway ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 287 ; magnesium ion binding ; inferred from electronic annotation ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 5024 ; transforming growth factor beta receptor activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 30145 ; manganese ion binding ; inferred from electronic annotation ; 4675 ; transmembrane receptor protein serine/threonine kinase activity ; inferred from mutant phenotype ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 4675 ; transmembrane receptor protein serine/threonine kinase activity ; inferred from electronic annotation ; 4702 ; receptor signaling protein serine/threonine kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4675 ; transmembrane receptor protein serine/threonine kinase activity ; non-traceable author statement
231124_x_at	LY9	AI524095	0.29	2.23E-02	lymphocyte antigen 9	chr1q21.3-q22	chr1:159038694-159039153 (+)	7155 ; cell adhesion ; inferred from electronic annotation ; 16064 ; humoral defense mechanism (sensu Vertebrata) ; non-traceable author statement	5515 ; protein binding ; inferred from electronic annotation
219197_s_at	SCUBE2	AI424243	0.29	1.66E-02	signal peptide, CUB domain, EGF-like 2	chr11p15.3	chr11:8998510-9069731 (-)		5509 ; calcium ion binding ; inferred from electronic annotation
204939_s_at	PLN	NM_002667	0.29	4.24E-02	phospholamban	chr6q22.1	chr6:118976164-118988231 (+)	6816 ; calcium ion transport ; inferred from electronic annotation ; 6936 ; muscle contraction ; not recorded ; 8015 ; circulation ; non-traceable author statement ; 6816 ; calcium ion transport ; not recorded	5246 ; calcium channel regulator activity ; inferred from electronic annotation ; 42030 ; ATPase inhibitor activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5246 ; calcium channel regulator activity ; not recorded
229160_at	MUM1L1	AI967987	0.29	3.35E-02	melanoma associated antigen (mutated) 1-like 1	chrXq22.3	chrX:105338505-105339603 (+)
210155_at	MYOC	D88214	0.29	9.03E-03	myocilin, trabecular meshwork inducible glucocorticoid response	chr1q23-q24	chr1:169871336-169888417 (-)	7601 ; visual perception ; not recorded ; 9653 ; morphogenesis ; traceable author statement	5198 ; structural molecule activity ; traceable author statement ; 16524 ; latrotoxin receptor activity ; inferred from electronic annotation
213355_at	SIAT10	AI989567	0.29	2.11E-02	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	chr3q12.1	chr3:99933849-99997379 (+)	6040 ; amino sugar metabolism ; traceable author statement ; 6486 ; protein amino acid glycosylation ; inferred from electronic annotation ; 6664 ; glycolipid metabolism ; traceable author statement ; 9249 ; protein-lipoylation ; traceable author statement	8373 ; sialyltransferase activity ; traceable author statement ; 8373 ; sialyltransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 16757 ; transferase activity, transferring glycosyl groups ; inferred from electronic annotation
234535_at		AL137501	0.29	1.23E-02	MRNA; cDNA DKFZp761G241 (from clone DKFZp761G241)	chr5q31	---
209357_at	CITED2	AF109161	0.29	2.28E-03	Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2	chr6q23.3	chr6:139735087-139737450 (-)	6357 ; regulation of transcription from RNA polymerase II promoter ; traceable author statement ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 45449 ; regulation of transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; non-traceable author statement	3700 ; transcription factor activity ; traceable author statement ; 5515 ; protein binding ; non-traceable author statement ; 30528 ; transcription regulator activity ; inferred from electronic annotation
204457_s_at	GAS1	NM_002048	0.29	3.90E-02	growth arrest-specific 1	chr9q21.3-q22	chr9:88749097-88751924 (-)	7049 ; cell cycle ; inferred from electronic annotation ; 7050 ; cell cycle arrest ; traceable author statement ; 8285 ; negative regulation of cell proliferation ; traceable author statement ; 45749 ; negative regulation of S phase of mitotic cell cycle ; non-traceable author statement ; 7050 ; cell cycle arrest ; inferred from electronic annotation
210640_s_at	GPR30	U63917	0.29	2.05E-02	G protein-coupled receptor 30	chr7p22.3	chr7:1094301-1099971 (+)	7165 ; signal transduction ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation	1584 ; rhodopsin-like receptor activity ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 45028 ; purinergic nucleotide receptor activity, G-protein coupled ; inferred from electronic annotation ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; traceable author statement
209292_at		AL022726	0.29	4.00E-03	Inhibitor of DNA binding 4, dominant negative helix-loop-helix protein	chr6p22-p21	chr6:19945596-19950407 (+)	6357 ; regulation of transcription from RNA polymerase II promoter ; traceable author statement ; 45449 ; regulation of transcription ; inferred from electronic annotation	3714 ; transcription corepressor activity ; traceable author statement ; 30528 ; transcription regulator activity ; inferred from electronic annotation
221008_s_at	AGXT2L1	NM_031279	0.29	2.05E-02	alanine-glyoxylate aminotransferase 2-like 1 ; alanine-glyoxylate aminotransferase 2-like 1	chr4q25	chr4:109882652-109903613 (-)	6520 ; amino acid metabolism ; non-traceable author statement	8483 ; transaminase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 30170 ; pyridoxal phosphate binding ; inferred from electronic annotation ; 8453 ; alanine-glyoxylate transaminase activity ; non-traceable author statement
237466_s_at	HHIP	AW444502	0.29	1.78E-02	hedgehog interacting protein	chr4q28-q32	chr4:145878359-145879486 (+)
210168_at	C6	J05064	0.29	4.91E-03	complement component 6	chr5p13	chr5:41178340-41249369 (-)	6955 ; immune response ; inferred from electronic annotation ; 6958 ; complement activation, classical pathway ; inferred from electronic annotation ; 9618 ; response to pathogenic bacteria ; traceable author statement ; 19835 ; cytolysis ; inferred from electronic annotation ; 45087 ; innate immune response ; inferred from electronic annotation ; 6956 ; complement activation ; traceable author statement
225996_at		AV709727	0.29	3.27E-02	MRNA; cDNA DKFZp686N1345 (from clone DKFZp686N1345)	chr2q11.2	chr2:100256184-100258325 (-)
228885_at	MAMDC2	AI862120	0.29	7.87E-03	MAM domain containing 2	chr9q21.11	chr9:72030482-72031708 (+)	6412 ; protein biosynthesis ; inferred from electronic annotation	5515 ; protein binding ; inferred from physical interaction ; 3735 ; structural constituent of ribosome ; inferred from electronic annotation
206293_at	SULT2A1	U08024	0.28	3.30E-02	sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1	chr19q13.3	chr19:53065681-53081346 (-)	6629 ; lipid metabolism ; inferred from electronic annotation ; 7586 ; digestion ; non-traceable author statement ; 8202 ; steroid metabolism ; traceable author statement ; 30573 ; bile acid catabolism ; inferred from electronic annotation ; 8202 ; steroid metabolism ; inferred from electronic annotation	4027 ; alcohol sulfotransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 8146 ; sulfotransferase activity ; inferred from electronic annotation ; 8146 ; sulfotransferase activity ; traceable author statement
211548_s_at	HPGD	J05594	0.28	4.64E-02	hydroxyprostaglandin dehydrogenase 15-(NAD)	chr4q34-q35	chr4:175648186-175680194 (-)	6629 ; lipid metabolism ; inferred from electronic annotation ; 6631 ; fatty acid metabolism ; inferred from electronic annotation ; 6693 ; prostaglandin metabolism ; inferred from electronic annotation ; 8152 ; metabolism ; inferred from electronic annotation	4667 ; prostaglandin-D synthase activity ; not recorded ; 5489 ; electron transporter activity ; not recorded ; 16404 ; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; traceable author statement ; 16404 ; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity ; non-traceable author statement
205857_at	SLC18A2	AI269290	0.28	4.53E-02	solute carrier family 18 (vesicular monoamine), member 2	chr10	chr10:118990623-119029233 (+)	15844 ; monoamine transport ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation ; 6836 ; neurotransmitter transport ; inferred from electronic annotation	5215 ; transporter activity ; inferred from electronic annotation ; 8504 ; monoamine transporter activity ; traceable author statement
207249_s_at	SLC28A2	NM_004212	0.28	4.43E-02	solute carrier family 28 (sodium-coupled nucleoside transporter), member 2	chr15q15	chr15:43331725-43355425 (+)	6139 ; nucleobase, nucleoside, nucleotide and nucleic acid metabolism ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation ; 15860 ; purine nucleoside transport ; traceable author statement	1882 ; nucleoside binding ; inferred from electronic annotation ; 5415 ; nucleoside:sodium symporter activity ; inferred from electronic annotation ; 15211 ; purine nucleoside transporter activity ; traceable author statement
225571_at	LIFR	AA701657	0.28	1.68E-03	leukemia inhibitory factor receptor	chr5p13-p12	chr5:38510821-38512867 (-)	7166 ; cell surface receptor linked signal transduction ; traceable author statement	4872 ; receptor activity ; inferred from electronic annotation ; 4923 ; leukemia inhibitory factor receptor activity ; traceable author statement ; 4896 ; hematopoietin/interferon-class (D200-domain) cytokine receptor activity ; inferred from electronic annotation
223823_at	KCNMB2	AF209747	0.28	2.28E-03	potassium large conductance calcium-activated channel, subfamily M, beta member 2	chr3q26.2-q27.1	chr3:179759181-180044910 (+)	1508 ; regulation of action potential ; inferred from direct assay ; 5513 ; detection of calcium ion ; inferred from direct assay ; 6811 ; ion transport ; inferred from electronic annotation ; 6813 ; potassium ion transport ; inferred from direct assay ; 6939 ; smooth muscle contraction ; not recorded ; 19228 ; generation of action potential ; inferred from direct assay ; 19229 ; regulation of vasoconstriction ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation ; 6813 ; potassium ion transport ; inferred from electronic annotation	5216 ; ion channel activity ; inferred from electronic annotation ; 8200 ; ion channel inhibitor activity ; traceable author statement ; 15269 ; calcium-activated potassium channel activity ; inferred from direct assay ; 15459 ; potassium channel regulator activity ; traceable author statement ; 15269 ; calcium-activated potassium channel activity ; inferred from electronic annotation
228766_at	CD36	AW299226	0.28	2.95E-03	CD36 antigen (collagen type I receptor, thrombospondin receptor)	chr7	chr7:80145923-80146525 (+)	6629 ; lipid metabolism ; non-traceable author statement ; 6631 ; fatty acid metabolism ; not recorded ; 6810 ; transport ; inferred from electronic annotation ; 7155 ; cell adhesion ; traceable author statement ; 7596 ; blood coagulation ; traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation	4872 ; receptor activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
209074_s_at	TU3A	AL050264	0.28	1.61E-02	TU3A protein	chr3p21.1	chr3:58526227-58538144 (-)	1558 ; regulation of cell growth ; inferred from direct assay ; 1558 ; regulation of cell growth ; inferred from electronic annotation
230117_at	MGC33530	AI420977	0.28	9.03E-03	hypothetical protein LOC285878	chr7p11.2	chr7:54605703-54606267 (+)
229352_at	NOX5	AA885360	0.28	2.84E-02	sperm equatorial segment protein 1	chr15q23	chr15:67009917-67026203 (+)
242733_at	HPGD	AI457588	0.28	3.56E-02	Hydroxyprostaglandin dehydrogenase 15-(NAD)	chr4q34-q35	chr4:175656458-175656915 (-)	6629 ; lipid metabolism ; inferred from electronic annotation ; 6631 ; fatty acid metabolism ; inferred from electronic annotation ; 6693 ; prostaglandin metabolism ; inferred from electronic annotation ; 8152 ; metabolism ; inferred from electronic annotation	4667 ; prostaglandin-D synthase activity ; not recorded ; 5489 ; electron transporter activity ; not recorded ; 16404 ; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; traceable author statement ; 16404 ; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity ; non-traceable author statement
217073_x_at	APOA1	X02162	0.27	1.96E-02	apolipoprotein A-I ; similar to Apolipoprotein A-I precursor (Apo-AI)	chr11q23-q24	chr22_random:13497-15369 (+)	6629 ; lipid metabolism ; inferred from electronic annotation ; 6869 ; lipid transport ; inferred from electronic annotation ; 8015 ; circulation ; traceable author statement ; 8202 ; steroid metabolism ; inferred from electronic annotation ; 8203 ; cholesterol metabolism ; traceable author statement ; 42157 ; lipoprotein metabolism ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation ; 8203 ; cholesterol metabolism ; inferred from electronic annotation ; 30301 ; cholesterol transport ; traceable author statement	5319 ; lipid transporter activity ; inferred from electronic annotation ; 8035 ; high-density lipoprotein binding ; traceable author statement ; 8289 ; lipid binding ; inferred from electronic annotation ; 8289 ; lipid binding ; traceable author statement ; 5319 ; lipid transporter activity ; not recorded
237108_x_at	FLJ42875	AW611845	0.27	1.27E-02	FLJ42875 protein	chr1p36.32	chr1:2966038-2967649 (-)
212592_at	IGJ	AV733266	0.27	3.94E-02	Immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides	chr4q21	chr4:71740122-71751208 (-)	6955 ; immune response ; non-traceable author statement	3823 ; antigen binding ; non-traceable author statement
201116_s_at	CPE	AI922855	0.27	8.90E-03	carboxypeptidase E	chr4q32.3	chr4:166519543-166639147 (+)	6464 ; protein modification ; non-traceable author statement ; 6508 ; proteolysis ; inferred from electronic annotation ; 7218 ; neuropeptide signaling pathway ; non-traceable author statement ; 8152 ; metabolism ; traceable author statement	4180 ; carboxypeptidase activity ; traceable author statement ; 4182 ; carboxypeptidase A activity ; inferred from electronic annotation ; 4183 ; carboxypeptidase E activity ; inferred from electronic annotation ; 8237 ; metallopeptidase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4180 ; carboxypeptidase activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
206310_at	SPINK2	NM_021114	0.27	3.28E-03	serine peptidase inhibitor, Kazal type 2 (acrosin-trypsin inhibitor)	chr4q12	chr4:57370790-57382650 (-)		4867 ; serine-type endopeptidase inhibitor activity ; inferred from electronic annotation ; 4866 ; endopeptidase inhibitor activity ; inferred from electronic annotation ; 4866 ; endopeptidase inhibitor activity ; traceable author statement
224339_s_at	ANGPTL1	AB056476	0.27	2.18E-02	angiopoietin-like 1 ; angiopoietin-like 1	chr1q25.2	chr1:177086729-177106795 (-)		5102 ; receptor binding ; traceable author statement
213764_s_at	MFAP5	AW665892	0.27	3.28E-02	microfibrillar associated protein 5	chr12p13.1-p12.3	chr12:8689805-8690789 (-)		5201 ; extracellular matrix structural constituent ; traceable author statement
209763_at		AL049176	0.27	6.23E-03	chordin-like 1	chrXq22.3	chrX:109803739-109925649 (-)	7275 ; development ; inferred from electronic annotation
228802_at	RBPMS2	BE348466	0.27	2.58E-02	RNA binding protein with multiple splicing 2	chr15q22.31	chr15:62819143-62820087 (-)		166 ; nucleotide binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation ; 3723 ; RNA binding ; inferred from electronic annotation
206363_at	MAF	NM_005360	0.27	2.05E-02	v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian)	chr16q22-q23	chr16:78185735-78192112 (-)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6366 ; transcription from RNA polymerase II promoter ; traceable author statement	3677 ; DNA binding ; inferred from electronic annotation ; 3702 ; RNA polymerase II transcription factor activity ; traceable author statement
203305_at	F13A1	NM_000129	0.27	1.56E-04	coagulation factor XIII, A1 polypeptide	chr6p25.3-p24.3	chr6:6089316-6265901 (-)	7596 ; blood coagulation ; traceable author statement ; 18149 ; peptide cross-linking ; inferred from electronic annotation ; 7596 ; blood coagulation ; inferred from electronic annotation	3810 ; protein-glutamine gamma-glutamyltransferase activity ; traceable author statement ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 8415 ; acyltransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 3810 ; protein-glutamine gamma-glutamyltransferase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
210198_s_at	PLP1	BC002665	0.26	1.61E-02	proteolipid protein 1 (Pelizaeus-Merzbacher disease, spastic paraplegia 2, uncomplicated)	chrXq22	chrX:102918433-102933704 (+)		5198 ; structural molecule activity ; inferred from electronic annotation
227826_s_at	ARGBP2	AW138143	0.26	2.43E-02	Sorbin and SH3 domain containing 2	chr4q35.1	chr4:186798113-186799907 (-)	6810 ; transport ; inferred from electronic annotation	5515 ; protein binding ; non-traceable author statement ; 5200 ; structural constituent of cytoskeleton ; traceable author statement ; 8093 ; cytoskeletal adaptor activity ; traceable author statement ; 8307 ; structural constituent of muscle ; traceable author statement
227478_at	SETBP1	BF739885	0.26	2.89E-02	hypothetical protein LOC284262	chr18q21.1	chr18:40900649-40902473 (+)
235050_at	SLC2A12	AI742872	0.26	9.02E-03	solute carrier family 2 (facilitated glucose transporter), member 12	chr6q23.2	chr6:134352809-134354022 (-)	6810 ; transport ; inferred from electronic annotation ; 8643 ; carbohydrate transport ; inferred from electronic annotation	5215 ; transporter activity ; inferred from electronic annotation ; 5351 ; sugar porter activity ; inferred from electronic annotation
224404_s_at	IRTA2	AF343662	0.26	8.47E-03	Fc receptor-like 5 ; Fc receptor-like 5	chr1q21	chr1:155760228-155788869 (-)		4872 ; receptor activity ; inferred from electronic annotation
219304_s_at	PDGFD	NM_025208	0.26	4.64E-03	platelet derived growth factor D	chr11q22.3	chr11:103283130-103539971 (-)	6464 ; protein modification ; inferred from electronic annotation ; 6508 ; proteolysis ; inferred from electronic annotation	4190 ; aspartic-type endopeptidase activity ; inferred from electronic annotation ; 8083 ; growth factor activity ; inferred from electronic annotation
230135_at		AI822137	0.26	2.95E-02	CDNA FLJ42405 fis, clone ASTRO3000474	chr4	chr4:145884553-145885872 (+)
228462_at	IRX2	AI928035	0.25	4.82E-02	iroquois homeobox protein 2	chr5p15.33	chr5:2799675-2801586 (-)	6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 45449 ; regulation of transcription ; inferred from electronic annotation	3700 ; transcription factor activity ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation
211276_at		AF063606	0.25	2.29E-02	transcription elongation factor A (SII)-like 2	chrXq22.1-q22.3	chrX:101267365-101269339 (+)		3746 ; translation elongation factor activity ; inferred from electronic annotation
217546_at	MT1K	R06655	0.25	3.53E-02	metallothionein 1M	chr16q13	chr16:55223645-55225394 (+)		5507 ; copper ion binding ; inferred from electronic annotation ; 46870 ; cadmium ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
209374_s_at	IGHM	BC001872	0.25	3.32E-02	immunoglobulin heavy constant mu	chr14q32.33	chr14:105391366-105901096 (-)	6955 ; immune response ; non-traceable author statement ; 6955 ; immune response ; inferred from electronic annotation	3823 ; antigen binding ; non-traceable author statement ; 3823 ; antigen binding ; traceable author statement ; 4872 ; receptor activity ; inferred from electronic annotation ; 3823 ; antigen binding ; inferred from electronic annotation
205751_at	SH3GL2	NM_003026	0.25	1.98E-02	SH3-domain GRB2-like 2	chr9p22	chr9:17568770-17787120 (+)	7165 ; signal transduction ; traceable author statement ; 7417 ; central nervous system development ; traceable author statement	5515 ; protein binding ; inferred from physical interaction ; 8289 ; lipid binding ; inferred from electronic annotation ; 8415 ; acyltransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 42802 ; protein self binding ; inferred from physical interaction ; 5515 ; protein binding ; inferred from electronic annotation
213071_at	DPT	AL049798	0.25	4.68E-03	dermatopontin	chr1q12-q23	chr1:166931329-166965045 (-)	7155 ; cell adhesion ; inferred from electronic annotation	5515 ; protein binding ; traceable author statement ; 5515 ; protein binding ; inferred from electronic annotation
231734_at	RBP2	NM_004164	0.25	3.41E-02	retinol binding protein 2, cellular	chr3q23	chr3:140654415-140682279 (-)	6776 ; vitamin A metabolism ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation ; 8544 ; epidermis development ; traceable author statement	8289 ; lipid binding ; inferred from electronic annotation ; 16918 ; retinal binding ; inferred from electronic annotation ; 19841 ; retinol binding ; inferred from electronic annotation ; 5488 ; binding ; inferred from electronic annotation ; 5501 ; retinoid binding ; traceable author statement
209687_at	CXCL12	U19495	0.25	7.50E-03	chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1)	chr10q11.1	chr10:44192586-44200563 (-)	6874 ; calcium ion homeostasis ; traceable author statement ; 6935 ; chemotaxis ; traceable author statement ; 6954 ; inflammatory response ; not recorded ; 7155 ; cell adhesion ; traceable author statement ; 7165 ; signal transduction ; traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; traceable author statement ; 7267 ; cell-cell signaling ; not recorded ; 7600 ; sensory perception ; inferred from electronic annotation ; 8015 ; circulation ; traceable author statement ; 8064 ; regulation of actin polymerization and/or depolymerization ; traceable author statement ; 9615 ; response to virus ; traceable author statement ; 6935 ; chemotaxis ; inferred from electronic annotation ; 6955 ; immune response ; inferred from electronic annotation ; 6955 ; immune response ; traceable author statement	8009 ; chemokine activity ; traceable author statement ; 8083 ; growth factor activity ; inferred from electronic annotation ; 5125 ; cytokine activity ; inferred from electronic annotation ; 8009 ; chemokine activity ; inferred from electronic annotation ; 4871 ; signal transducer activity ; traceable author statement ; 5102 ; receptor binding ; traceable author statement
204450_x_at	APOA1	NM_000039	0.25	7.27E-03	apolipoprotein A-I ; similar to Apolipoprotein A-I precursor (Apo-AI)	chr11q23-q24	chr22_random:13497-15367 (+)	6629 ; lipid metabolism ; inferred from electronic annotation ; 6869 ; lipid transport ; inferred from electronic annotation ; 8015 ; circulation ; traceable author statement ; 8202 ; steroid metabolism ; inferred from electronic annotation ; 8203 ; cholesterol metabolism ; traceable author statement ; 42157 ; lipoprotein metabolism ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation ; 8203 ; cholesterol metabolism ; inferred from electronic annotation ; 30301 ; cholesterol transport ; traceable author statement	5319 ; lipid transporter activity ; inferred from electronic annotation ; 8035 ; high-density lipoprotein binding ; traceable author statement ; 8289 ; lipid binding ; inferred from electronic annotation ; 8289 ; lipid binding ; traceable author statement ; 5319 ; lipid transporter activity ; not recorded
231978_at	TPCN2	AL137479	0.25	7.07E-03	two pore segment channel 2	chr11q13.2	chr11:68596956-68686301 (+)	6810 ; transport ; inferred from electronic annotation ; 6811 ; ion transport ; inferred from electronic annotation ; 6812 ; cation transport ; inferred from electronic annotation	5216 ; ion channel activity ; inferred from electronic annotation ; 5261 ; cation channel activity ; inferred from electronic annotation
219059_s_at	XLKD1	AL574194	0.25	3.02E-03	extracellular link domain containing 1	chr11p15	chr11:10535927-10546740 (-)	7155 ; cell adhesion ; inferred from electronic annotation ; 6928 ; cell motility ; traceable author statement ; 7160 ; cell-matrix adhesion ; traceable author statement ; 9611 ; response to wounding ; traceable author statement ; 9653 ; morphogenesis ; traceable author statement	5540 ; hyaluronic acid binding ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 4872 ; receptor activity ; traceable author statement
231166_at	GPR155	AI733474	0.25	2.45E-03	G protein-coupled receptor 155	chr2q31.1	chr2:175005213-175005781 (-)	7242 ; intracellular signaling cascade ; inferred from electronic annotation
207251_at	MEP1B	NM_005925	0.24	2.20E-02	meprin A, beta	chr18q12.2-q12.3	chr18:28023985-28054362 (+)	6508 ; proteolysis ; inferred from electronic annotation ; 7586 ; digestion ; traceable author statement	4238 ; meprin A activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; traceable author statement ; 8533 ; astacin activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8237 ; metallopeptidase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 4222 ; metalloendopeptidase activity ; not recorded
214156_at	MYRIP	AL050090	0.24	1.81E-02	myosin VIIA and Rab interacting protein	chr3p22.1	chr3:40260940-40276813 (+)	6886 ; intracellular protein transport ; inferred from electronic annotation	3779 ; actin binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation ; 17137 ; Rab GTPase binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
228004_at		AL121722	0.24	1.65E-02		chr20	chr20:22489193-22496526 (-)
205933_at	SETBP1	NM_015559	0.24	1.50E-02	SET binding protein 1	chr18q21.1	chr18:40535466-40898771 (+)		3677 ; DNA binding ; inferred from electronic annotation
217889_s_at	CYBRD1	NM_024843	0.24	4.20E-02	cytochrome b reductase 1	chr2q31.1	chr2:172087269-172119794 (+)	6118 ; electron transport ; inferred from electronic annotation
244509_at	GPR155	AW449728	0.24	3.14E-03	G protein-coupled receptor 155	chr2q31.1	chr2:175008849-175009368 (-)	7242 ; intracellular signaling cascade ; inferred from electronic annotation
207899_at	GIP	NM_004123	0.24	3.27E-02	gastric inhibitory polypeptide	chr17q21.3-q22	chr17:44390916-44400954 (-)	7165 ; signal transduction ; traceable author statement	5179 ; hormone activity ; traceable author statement ; 5179 ; hormone activity ; inferred from electronic annotation
244370_at	KIAA2022	AI743137	0.23	2.27E-02	KIAA2022 protein	chrXq13.3	chrX:73870130-73870474 (-)
230003_at		AW779917	0.23	2.28E-03	Transcribed locus	chr12	chr12:58469147-58469902 (+)
223623_at	ECRG4	AF325503	0.23	7.45E-03	esophageal cancer related gene 4 protein	chr2q12.2	chr2:106048544-106061040 (+)
214836_x_at		BG536224	0.23	2.00E-02	Immunoglobulin kappa light chain VJ region (ID POM010) ; Immunoglobulin kappa light chain VJ region (ID POM022) ; (clone TR1.6VL) anti-thyroid peroxidase monoclonal autoantibody IgK chain, V region	chr2p12	chr2:89302288-89303060 (-)
206898_at	CDH19	NM_021153	0.23	4.11E-02	cadherin 19, type 2	chr18q22-q23	chr18:62322529-62422196 (-)	7156 ; homophilic cell adhesion ; inferred from electronic annotation ; 7156 ; homophilic cell adhesion ; non-traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation ; 16337 ; cell-cell adhesion ; non-traceable author statement	5509 ; calcium ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
203980_at	FABP4	NM_001442	0.23	4.13E-03	fatty acid binding protein 4, adipocyte	chr8q21	chr8:82553480-82558004 (-)	6810 ; transport ; inferred from electronic annotation	5504 ; fatty acid binding ; traceable author statement ; 5488 ; binding ; inferred from electronic annotation ; 8289 ; lipid binding ; inferred from electronic annotation
205675_at	MTP	AI623321	0.23	4.85E-02	microsomal triglyceride transfer protein (large polypeptide, 88kDa)	chr4	chr4:100715003-100764176 (+)	6629 ; lipid metabolism ; traceable author statement ; 6869 ; lipid transport ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation	5319 ; lipid transporter activity ; inferred from electronic annotation ; 8289 ; lipid binding ; inferred from electronic annotation ; 5488 ; binding ; traceable author statement
231944_at	ERO1LB	AL045717	0.23	3.14E-03	ERO1-like beta (S. cerevisiae)	chr1q42.2-q43	chr1:234445479-234448433 (-)	6118 ; electron transport ; inferred from electronic annotation ; 6457 ; protein folding ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation	16491 ; oxidoreductase activity ; non-traceable author statement ; 51082 ; unfolded protein binding ; non-traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation
219159_s_at	SLAMF7	NM_021181	0.23	5.84E-03	SLAM family member 7	chr1q23.1-q24.1	chr1:158975704-158989654 (+)	7155 ; cell adhesion ; non-traceable author statement ; 30101 ; natural killer cell activation ; non-traceable author statement ; 42267 ; natural killer cell mediated cytotoxicity ; non-traceable author statement	4872 ; receptor activity ; inferred from electronic annotation
241925_x_at		BF207870	0.23	1.32E-02	Transcribed locus	chr12	chr12:58467237-58469392 (+)
216576_x_at		AF103529	0.22	3.94E-02	IG light chain V-region, VK gene	chr2	chr2:89590121-89590379 (+)
225575_at	LIFR	AI680541	0.22	2.64E-03	leukemia inhibitory factor receptor	chr5p13-p12	chr5:38510821-38512867 (-)	7166 ; cell surface receptor linked signal transduction ; traceable author statement	4872 ; receptor activity ; inferred from electronic annotation ; 4923 ; leukemia inhibitory factor receptor activity ; traceable author statement ; 4896 ; hematopoietin/interferon-class (D200-domain) cytokine receptor activity ; inferred from electronic annotation
234367_x_at	TMPRSS6	AL022314	0.22	3.05E-03	transmembrane protease, serine 6	chr22q12.3	chr22:35800591-35800694 (-)	1525 ; angiogenesis ; non-traceable author statement ; 6508 ; proteolysis ; inferred from direct assay ; 7242 ; intracellular signaling cascade ; non-traceable author statement ; 30198 ; extracellular matrix organization and biogenesis ; non-traceable author statement ; 42730 ; fibrinolysis ; inferred from direct assay ; 6508 ; proteolysis ; inferred from electronic annotation	4252 ; serine-type endopeptidase activity ; inferred from direct assay ; 8233 ; peptidase activity ; inferred from electronic annotation ; 4252 ; serine-type endopeptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
202747_s_at	ITM2A	NM_004867	0.22	6.77E-03	integral membrane protein 2A	chrXq13.3-Xq21.2	chrX:78503122-78509506 (-)
216401_x_at	IGKV	AJ408433	0.22	1.98E-02	Immunoglobulin kappa variable 1-5	chr2	chr2:88942161-89378418 (-)	6955 ; immune response ; non-traceable author statement	3823 ; antigen binding ; non-traceable author statement
214677_x_at	IGLC2	X57812	0.22	4.45E-02	immunoglobulin lambda locus ; immunoglobulin lambda constant 1 (Mcg marker) ; immunoglobulin lambda constant 2 (Kern-Oz- marker) ; immunoglobulin lambda variable 3-25 ; immunoglobulin lambda variable 2-14 ; immunoglobulin lambda joining 3	chr22q11.1-q11.2	chr22:21573159-21573568 (+)	6955 ; immune response ; non-traceable author statement ; 6955 ; immune response ; inferred from electronic annotation	3823 ; antigen binding ; non-traceable author statement ; 3823 ; antigen binding ; inferred from electronic annotation
219230_at	FLJ10970	NM_018286	0.22	1.04E-02	hypothetical protein FLJ10970	chr17q22	chr17:51151988-51155141 (-)
215176_x_at		AW404894	0.21	1.97E-02	Immunoglobulin kappa light chain variable region (IGKV gene), clone 25	chr2	chr2:88938269-89400942 (-)
209170_s_at	m6b1	AF016004	0.21	2.27E-02	glycoprotein M6B	chrXp22.2	chrX:13702019-13745074 (-)	7399 ; nervous system development ; non-traceable author statement ; 30154 ; cell differentiation ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation ; 7399 ; nervous system development ; inferred from electronic annotation
205820_s_at	APOC3	NM_000040	0.21	1.55E-02	apolipoprotein C-III ; similar to Apolipoprotein C-III precursor (Apo-CIII)	chr11q23.1-q23.2	chr11:116205833-116208997 (+)	6869 ; lipid transport ; inferred from electronic annotation ; 16042 ; lipid catabolism ; inferred from electronic annotation ; 42157 ; lipoprotein metabolism ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation ; 6629 ; lipid metabolism ; traceable author statement	5319 ; lipid transporter activity ; inferred from electronic annotation ; 8289 ; lipid binding ; inferred from electronic annotation ; 5319 ; lipid transporter activity ; not recorded
227198_at	LAF4	AW085505	0.21	1.42E-02	AF4/FMR2 family, member 3	chr2q11.2-q12	chr2:99530149-99531503 (-)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7275 ; development ; traceable author statement	3677 ; DNA binding ; inferred from electronic annotation
226228_at	AQP4	T15657	0.21	1.92E-02	aquaporin 4	chr18q11.2-q12.1	chr18:22686007-22688594 (-)	6810 ; transport ; traceable author statement ; 7399 ; nervous system development ; traceable author statement ; 7588 ; excretion ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation	15250 ; water channel activity ; not recorded ; 5215 ; transporter activity ; inferred from electronic annotation ; 5372 ; water transporter activity ; traceable author statement ; 15288 ; porin activity ; inferred from electronic annotation
207057_at	SLC16A7	NM_004731	0.21	1.67E-03	solute carrier family 16 (monocarboxylic acid transporters), member 7	chr12q13	chr12:58369421-58460250 (+)	6810 ; transport ; inferred from electronic annotation ; 6848 ; pyruvate transport ; traceable author statement ; 15711 ; organic anion transport ; inferred from electronic annotation	5215 ; transporter activity ; inferred from electronic annotation ; 5477 ; pyruvate carrier activity ; traceable author statement ; 15293 ; symporter activity ; inferred from electronic annotation ; 15355 ; monocarboxylate porter activity ; inferred from electronic annotation
239533_at	GPR155	AI970061	0.20	8.44E-03	G protein-coupled receptor 155	chr2q31.1	chr2:175007296-175007722 (-)	7242 ; intracellular signaling cascade ; inferred from electronic annotation
209138_x_at		M87790	0.20	4.43E-02	Immunoglobulin lambda joining 3	chr22q11.1-q11.2	chr22:21370404-21573613 (+)	6955 ; immune response ; non-traceable author statement ; 6955 ; immune response ; inferred from electronic annotation	3823 ; antigen binding ; non-traceable author statement
202992_at	C7	NM_000587	0.20	7.07E-03	complement component 7	chr5p13	chr5:40964436-41018794 (+)	6955 ; immune response ; inferred from electronic annotation ; 6957 ; complement activation, alternative pathway ; inferred from electronic annotation ; 6958 ; complement activation, classical pathway ; inferred from electronic annotation ; 9618 ; response to pathogenic bacteria ; traceable author statement ; 19835 ; cytolysis ; inferred from electronic annotation ; 45087 ; innate immune response ; inferred from electronic annotation ; 6956 ; complement activation ; traceable author statement
228262_at	FLJ14503	AW237462	0.20	3.02E-02	hypothetical protein FLJ14503	chrXp22.12	chrX:19934905-19936189 (-)
226582_at	LOC400043	AL520272	0.20	1.54E-02	hypothetical gene supported by BC009385	chr12q13.13	chr12:52806112-52812891 (+)
206002_at	GPR64	NM_005756	0.20	1.70E-02	G protein-coupled receptor 64	chrXp22.13	chrX:18917352-19010788 (-)	7165 ; signal transduction ; inferred from electronic annotation ; 7218 ; neuropeptide signaling pathway ; inferred from electronic annotation ; 7283 ; spermatogenesis ; traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; traceable author statement	4872 ; receptor activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; traceable author statement ; 4871 ; signal transducer activity ; inferred from electronic annotation
217022_s_at	MGC27165	S55735	0.20	4.26E-02	immunoglobulin heavy constant alpha 1 ; immunoglobulin heavy constant alpha 2 (A2m marker) ; hypothetical protein MGC27165	chr14q32.33	chr14:105244519-105762834 (-)	6955 ; immune response ; non-traceable author statement ; 18298 ; protein-chromophore linkage ; inferred from electronic annotation ; 6955 ; immune response ; inferred from electronic annotation	3823 ; antigen binding ; non-traceable author statement ; 3823 ; antigen binding ; traceable author statement
219728_at	TTID	NM_006790	0.20	1.37E-02	myotilin	chr5q31	chr5:137231472-137251440 (+)	6936 ; muscle contraction ; traceable author statement ; 7517 ; muscle development ; inferred from electronic annotation	3779 ; actin binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 8307 ; structural constituent of muscle ; traceable author statement ; 5198 ; structural molecule activity ; inferred from electronic annotation
238222_at	GDDR	AI821357	0.20	4.91E-02	down-regulated in gastric cancer GDDR	chr2p14	chr2:69025869-69033605 (-)
204777_s_at	MAL	NM_002371	0.19	3.28E-03	mal, T-cell differentiation protein	chr2cen-q13	chr2:95055205-95083462 (+)	1766 ; lipid raft polarization ; traceable author statement ; 6917 ; induction of apoptosis ; non-traceable author statement ; 7165 ; signal transduction ; traceable author statement ; 7417 ; central nervous system development ; traceable author statement ; 7516 ; hemocyte development ; traceable author statement ; 30154 ; cell differentiation ; traceable author statement ; 42552 ; myelination ; non-traceable author statement ; 42552 ; myelination ; traceable author statement ; 45176 ; apical protein localization ; traceable author statement ; 6118 ; electron transport ; inferred from electronic annotation	8289 ; lipid binding ; traceable author statement ; 15267 ; channel or pore class transporter activity ; traceable author statement ; 16505 ; apoptotic protease activator activity ; non-traceable author statement ; 19911 ; structural constituent of myelin sheath ; inferred from direct assay ; 5489 ; electron transporter activity ; inferred from electronic annotation
229839_at	MGC45780	AI799784	0.19	4.13E-02	Scavenger receptor class A, member 5 (putative)	chr8p21.1	chr8:27783317-27783703 (-)	6817 ; phosphate transport ; inferred from electronic annotation	4872 ; receptor activity ; inferred from electronic annotation ; 5044 ; scavenger receptor activity ; inferred from electronic annotation
204712_at	WIF1	NM_007191	0.19	8.90E-03	WNT inhibitory factor 1	chr12q14.3	chr12:63730675-63801350 (-)	7165 ; signal transduction ; non-traceable author statement ; 7267 ; cell-cell signaling ; not recorded ; 7275 ; development ; inferred from electronic annotation ; 16055 ; Wnt receptor signaling pathway ; inferred from electronic annotation	4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation
204697_s_at	CHGA	NM_001275	0.18	1.61E-02	chromogranin A (parathyroid secretory protein 1)	chr14q32	chr14:92459244-92471389 (+)	8217 ; regulation of blood pressure ; traceable author statement	5509 ; calcium ion binding ; inferred from electronic annotation
209612_s_at	ADH1B	M24317	0.18	5.58E-03	alcohol dehydrogenase IB (class I), beta polypeptide	chr4q21-q23	chr4:100447559-100461541 (-)	6069 ; ethanol oxidation ; traceable author statement	4024 ; alcohol dehydrogenase activity, zinc-dependent ; traceable author statement ; 5489 ; electron transporter activity ; traceable author statement ; 8270 ; zinc ion binding ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4022 ; alcohol dehydrogenase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 4022 ; alcohol dehydrogenase activity ; traceable author statement
220794_at	GREM2	NM_022469	0.18	2.28E-02	gremlin 2, cysteine knot superfamily, homolog (Xenopus laevis)	chr1q43	chr1:238721656-238842072 (-)		5125 ; cytokine activity ; inferred from electronic annotation
201849_at	BNIP3	NM_004052	0.18	7.03E-03	BCL2/adenovirus E1B 19kDa interacting protein 3	chr10q26.3	chr14:27803385-27804917 (+)	6915 ; apoptosis ; inferred from electronic annotation ; 6916 ; anti-apoptosis ; traceable author statement ; 43065 ; positive regulation of apoptosis ; inferred from electronic annotation	5515 ; protein binding ; non-traceable author statement
231120_x_at	PKIB	AL569326	0.18	3.53E-02	protein kinase (cAMP-dependent, catalytic) inhibitor beta	chr6q22.31	chr6:123088761-123089216 (+)	6469 ; negative regulation of protein kinase activity ; inferred from electronic annotation	4862 ; cAMP-dependent protein kinase inhibitor activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 4860 ; protein kinase inhibitor activity ; inferred from electronic annotation
209291_at	ID4	AW157094	0.18	3.72E-03	inhibitor of DNA binding 4, dominant negative helix-loop-helix protein	chr6p22-p21	chr6:19945596-19950407 (+)	6357 ; regulation of transcription from RNA polymerase II promoter ; traceable author statement ; 45449 ; regulation of transcription ; inferred from electronic annotation	3714 ; transcription corepressor activity ; traceable author statement ; 30528 ; transcription regulator activity ; inferred from electronic annotation
205267_at	POU2AF1	NM_006235	0.18	2.12E-02	POU domain, class 2, associating factor 1	chr11q23.1	chr11:110728192-110755627 (-)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6366 ; transcription from RNA polymerase II promoter ; traceable author statement ; 6959 ; humoral immune response ; traceable author statement	3713 ; transcription coactivator activity ; traceable author statement ; 3712 ; transcription cofactor activity ; traceable author statement
220723_s_at	FLJ21511	NM_025087	0.17	7.15E-03	hypothetical protein FLJ21511	chr4p12-p11	chr4:48683021-48758850 (+)
217138_x_at	IGLC2	AJ249377	0.17	2.38E-02	Immunoglobulin lambda joining 3	chr22q11.1-q11.2	chr22:21431403-21431698 (-)	6955 ; immune response ; non-traceable author statement ; 6955 ; immune response ; inferred from electronic annotation	3823 ; antigen binding ; non-traceable author statement
214046_at		AA017721	0.17	4.67E-03	CDNA FLJ37727 fis, clone BRHIP2019972	chr6	chr6:96768402-96770209 (+)
203924_at	GSTA2	NM_000846	0.17	6.71E-03	glutathione S-transferase A1	chr6p12.1	chr6:52764539-52776577 (-)	8152 ; metabolism ; Unknown ; 6749 ; glutathione metabolism ; inferred from direct assay	4364 ; glutathione transferase activity ; non-traceable author statement ; 16740 ; transferase activity ; inferred from electronic annotation ; 4364 ; glutathione transferase activity ; inferred from direct assay ; 4364 ; glutathione transferase activity ; inferred from electronic annotation
226612_at	FLJ25076	H17038	0.16	2.06E-03	similar to CG4502-PA	chr5p15.31	chr5:6501955-6545705 (+)
237625_s_at	IGKC	BG548679	0.16	4.94E-02	Immunoglobulin kappa variable 1-5	chr2	chr2:88940993-88941534 (-)	6955 ; immune response ; non-traceable author statement	3823 ; antigen binding ; non-traceable author statement
216687_x_at	UGT2B15	U06641	0.16	5.58E-03	UDP glucuronosyltransferase 2 family, polypeptide B15	chr4q13	chr4:69194910-69570920 (-)	6805 ; xenobiotic metabolism ; traceable author statement ; 8152 ; metabolism ; inferred from electronic annotation ; 8202 ; steroid metabolism ; traceable author statement	15020 ; glucuronosyltransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 16757 ; transferase activity, transferring glycosyl groups ; inferred from electronic annotation ; 16758 ; transferase activity, transferring hexosyl groups ; inferred from electronic annotation
215214_at	IGLC2	H53689	0.15	7.03E-03	immunoglobulin lambda variable 3-25	chr22q11.1-q11.2	chr22:21359226-21567699 (+)
209613_s_at	ADH1B	M21692	0.14	1.02E-02	alcohol dehydrogenase IB (class I), beta polypeptide	chr4q21-q23	chr4:100446763-100461543 (-)	6069 ; ethanol oxidation ; traceable author statement	4024 ; alcohol dehydrogenase activity, zinc-dependent ; traceable author statement ; 5489 ; electron transporter activity ; traceable author statement ; 8270 ; zinc ion binding ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4022 ; alcohol dehydrogenase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 4022 ; alcohol dehydrogenase activity ; traceable author statement
209555_s_at	CD36	M98399	0.14	1.61E-02	CD36 antigen (collagen type I receptor, thrombospondin receptor)	chr7q11.2	chr7:80105927-80144259 (+)	6629 ; lipid metabolism ; non-traceable author statement ; 6631 ; fatty acid metabolism ; not recorded ; 6810 ; transport ; inferred from electronic annotation ; 7155 ; cell adhesion ; traceable author statement ; 7596 ; blood coagulation ; traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation	4872 ; receptor activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
242372_s_at	DKFZp761N1114	AL542291	0.14	1.30E-02	hypothetical protein DKFZp761N1114	chr1q32.1	chr1:203833528-203836723 (+)
220191_at	GKN1	NM_019617	0.14	4.83E-02	gastrokine 1	chr2p14	chr2:69055208-69061610 (+)	74 ; regulation of progression through cell cycle ; inferred from electronic annotation ; 7586 ; digestion ; non-traceable author statement ; 8283 ; cell proliferation ; inferred from electronic annotation	8083 ; growth factor activity ; inferred from electronic annotation
239006_at	SLC26A7	AI758950	0.14	1.49E-02	solute carrier family 26, member 7	chr8q23	chr8:92479114-92479554 (+)	6810 ; transport ; inferred from electronic annotation	5215 ; transporter activity ; inferred from electronic annotation
204719_at	ABCA8	NM_007168	0.14	1.27E-02	ATP-binding cassette, sub-family A (ABC1), member 8	chr17q24	chr17:64375027-64463087 (-)	6810 ; transport ; inferred from direct assay	42626 ; ATPase activity, coupled to transmembrane movement of substances ; inferred from direct assay ; 166 ; nucleotide binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16887 ; ATPase activity ; inferred from electronic annotation ; 17111 ; nucleoside-triphosphatase activity ; inferred from electronic annotation
236430_at	TMED6	AA708152	0.14	2.52E-02	transmembrane emp24 protein transport domain containing 6	chr16q22.1	chr16:67934649-67943173 (-)	6886 ; intracellular protein transport ; inferred from electronic annotation	8320 ; protein carrier activity ; inferred from electronic annotation
205261_at	PGC	NM_002630	0.13	3.95E-02	progastricsin (pepsinogen C)	chr6p21.3-p21.1	chr6:41812429-41823099 (-)	6508 ; proteolysis ; traceable author statement ; 7586 ; digestion ; traceable author statement ; 6508 ; proteolysis ; inferred from electronic annotation ; 7586 ; digestion ; inferred from electronic annotation	4194 ; pepsin A activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 4190 ; aspartic-type endopeptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 4190 ; aspartic-type endopeptidase activity ; traceable author statement
231773_at	ANGPTL1	BF002046	0.13	1.49E-02	angiopoietin-like 1	chr1q25.2	chr1:177086260-177101534 (-)		5102 ; receptor binding ; traceable author statement
229254_at	DKFZp761N1114	BE550027	0.13	1.43E-03	hypothetical protein DKFZp761N1114	chr1q32.1	chr1:203837448-203838669 (+)
207139_at	ATP4A	NM_000704	0.13	5.34E-03	ATPase, H+/K+ exchanging, alpha polypeptide	chr19q13.1	chr19:40732938-40746401 (-)	6813 ; potassium ion transport ; inferred from electronic annotation ; 8152 ; metabolism ; inferred from electronic annotation ; 15992 ; proton transport ; inferred from electronic annotation ; 6812 ; cation transport ; inferred from electronic annotation ; 15672 ; monovalent inorganic cation transport ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 287 ; magnesium ion binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 8900 ; hydrogen:potassium-exchanging ATPase activity ; traceable author statement ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 16820 ; hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances ; inferred from electronic annotation ; 30955 ; potassium ion binding ; inferred from electronic annotation ; 3824 ; catalytic activity ; inferred from electronic annotation ; 15077 ; monovalent inorganic cation transporter activity ; inferred from electronic annotation ; 15662 ; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism ; inferred from electronic annotation
213068_at	DPT	AI146848	0.13	9.16E-03	dermatopontin	chr1q12-q23	chr1:166931329-166965045 (-)	7155 ; cell adhesion ; inferred from electronic annotation	5515 ; protein binding ; traceable author statement ; 5515 ; protein binding ; inferred from electronic annotation
207245_at	UGT2B17	NM_001077	0.13	1.69E-02	UDP glucuronosyltransferase 2 family, polypeptide B17	chr4q13	chr4:69085499-69116840 (-)	8152 ; metabolism ; inferred from electronic annotation ; 8202 ; steroid metabolism ; traceable author statement	15020 ; glucuronosyltransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 16757 ; transferase activity, transferring glycosyl groups ; inferred from electronic annotation ; 16758 ; transferase activity, transferring hexosyl groups ; inferred from electronic annotation ; 15020 ; glucuronosyltransferase activity ; traceable author statement
219564_at	KCNJ16	NM_018658	0.12	1.63E-03	potassium inwardly-rectifying channel, subfamily J, member 16	chr17q23.1-q24.2	chr17:65583020-65643339 (+)	6811 ; ion transport ; inferred from electronic annotation ; 6813 ; potassium ion transport ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation	5242 ; inward rectifier potassium channel activity ; inferred from electronic annotation ; 5244 ; voltage-gated ion channel activity ; inferred from electronic annotation ; 5267 ; potassium channel activity ; inferred from electronic annotation ; 30955 ; potassium ion binding ; inferred from electronic annotation ; 5216 ; ion channel activity ; inferred from electronic annotation
205979_at	SCGB2A1	NM_002407	0.12	1.62E-02	secretoglobin, family 2A, member 1	chr11q13	chr11:61732715-61737984 (+)		5497 ; androgen binding ; non-traceable author statement ; 5496 ; steroid binding ; inferred from electronic annotation
206535_at	SLC2A2	NM_000340	0.12	5.58E-03	solute carrier family 2 (facilitated glucose transporter), member 2	chr3q26.1-q26.2	chr3:172196830-172227462 (-)	5975 ; carbohydrate metabolism ; traceable author statement ; 8643 ; carbohydrate transport ; inferred from electronic annotation ; 15758 ; glucose transport ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation	5215 ; transporter activity ; inferred from electronic annotation ; 5351 ; sugar porter activity ; inferred from electronic annotation ; 5355 ; glucose transporter activity ; traceable author statement ; 5355 ; glucose transporter activity ; inferred from electronic annotation
209966_x_at	ESRRG	AF094518	0.12	1.13E-03	estrogen-related receptor gamma	chr1q41	chr1:214745452-214963364 (-)	6350 ; transcription ; inferred from electronic annotation ; 7275 ; development ; inferred from sequence or structural similarity ; 45893 ; positive regulation of transcription, DNA-dependent ; inferred from sequence or structural similarity ; 6355 ; regulation of transcription, DNA-dependent ; inferred from sequence or structural similarity ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3700 ; transcription factor activity ; inferred from electronic annotation ; 3707 ; steroid hormone receptor activity ; inferred from electronic annotation ; 5496 ; steroid binding ; inferred from electronic annotation ; 5516 ; calmodulin binding ; inferred from sequence or structural similarity ; 16563 ; transcriptional activator activity ; inferred from sequence or structural similarity ; 46872 ; metal ion binding ; inferred from electronic annotation ; 50682 ; AF-2 domain binding ; inferred from sequence or structural similarity ; 3677 ; DNA binding ; inferred from sequence or structural similarity ; 4879 ; ligand-dependent nuclear receptor activity ; inferred from sequence or structural similarity ; 3677 ; DNA binding ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 4879 ; ligand-dependent nuclear receptor activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
213456_at	SOSTDC1	AI927000	0.11	4.69E-03	sclerostin domain containing 1	chr7p21.1	chr7:16467693-16471999 (-)	16055 ; Wnt receptor signaling pathway ; inferred from electronic annotation
206641_at	TNFRSF17	NM_001192	0.10	7.31E-03	tumor necrosis factor receptor superfamily, member 17	chr16p13.1	chr16:11966464-11969426 (+)	6955 ; immune response ; inferred from electronic annotation ; 7165 ; signal transduction ; traceable author statement ; 7275 ; development ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement ; 19735 ; antimicrobial humoral response (sensu Vertebrata) ; not recorded	4872 ; receptor activity ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 4872 ; receptor activity ; inferred from electronic annotation
206334_at	LIPF	NM_004190	0.10	1.49E-02	lipase, gastric	chr10q23.31	chr10:90414195-90428542 (+)	6629 ; lipid metabolism ; inferred from electronic annotation ; 6641 ; triacylglycerol metabolism ; non-traceable author statement ; 16042 ; lipid catabolism ; inferred from electronic annotation	4806 ; triacylglycerol lipase activity ; traceable author statement ; 8289 ; lipid binding ; non-traceable author statement ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 16789 ; carboxylic ester hydrolase activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; inferred from electronic annotation ; 4806 ; triacylglycerol lipase activity ; inferred from electronic annotation
213265_at	PGA5	AI570199	0.09	2.34E-02	pepsinogen 5, group I (pepsinogen A)	chr11q13	chr11:60746415-60755742 (+)	6508 ; proteolysis ; inferred from electronic annotation ; 7586 ; digestion ; inferred from electronic annotation ; 6508 ; proteolysis ; non-traceable author statement ; 7586 ; digestion ; non-traceable author statement	4190 ; aspartic-type endopeptidase activity ; inferred from electronic annotation ; 4194 ; pepsin A activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 4194 ; pepsin A activity ; traceable author statement
207546_at	ATP4B	NM_000705	0.08	4.68E-03	ATPase, H+/K+ exchanging, beta polypeptide	chr13q34	chr13:113351184-113360514 (-)	6811 ; ion transport ; inferred from electronic annotation ; 6813 ; potassium ion transport ; inferred from electronic annotation ; 6814 ; sodium ion transport ; inferred from electronic annotation ; 15992 ; proton transport ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation	5391 ; sodium:potassium-exchanging ATPase activity ; inferred from electronic annotation ; 8900 ; hydrogen:potassium-exchanging ATPase activity ; traceable author statement ; 30955 ; potassium ion binding ; inferred from electronic annotation ; 15078 ; hydrogen ion transporter activity ; inferred from electronic annotation
207392_x_at	UGT2B15	NM_001076	0.08	3.30E-03	UDP glucuronosyltransferase 2 family, polypeptide B15	chr4q13	chr4:69546973-69570951 (-)	6805 ; xenobiotic metabolism ; traceable author statement ; 8152 ; metabolism ; inferred from electronic annotation ; 8202 ; steroid metabolism ; traceable author statement	15020 ; glucuronosyltransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 16757 ; transferase activity, transferring glycosyl groups ; inferred from electronic annotation ; 16758 ; transferase activity, transferring hexosyl groups ; inferred from electronic annotation
207981_s_at	ESRRG	NM_001438	0.07	1.18E-03	estrogen-related receptor gamma	chr1q41	chr1:214743216-215329570 (-)	6350 ; transcription ; inferred from electronic annotation ; 7275 ; development ; inferred from sequence or structural similarity ; 45893 ; positive regulation of transcription, DNA-dependent ; inferred from sequence or structural similarity ; 6355 ; regulation of transcription, DNA-dependent ; inferred from sequence or structural similarity ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3700 ; transcription factor activity ; inferred from electronic annotation ; 3707 ; steroid hormone receptor activity ; inferred from electronic annotation ; 5496 ; steroid binding ; inferred from electronic annotation ; 5516 ; calmodulin binding ; inferred from sequence or structural similarity ; 16563 ; transcriptional activator activity ; inferred from sequence or structural similarity ; 46872 ; metal ion binding ; inferred from electronic annotation ; 50682 ; AF-2 domain binding ; inferred from sequence or structural similarity ; 3677 ; DNA binding ; inferred from sequence or structural similarity ; 4879 ; ligand-dependent nuclear receptor activity ; inferred from sequence or structural similarity ; 3677 ; DNA binding ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 4879 ; ligand-dependent nuclear receptor activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
221095_s_at		NM_005136	0.07	4.67E-03	potassium voltage-gated channel, Isk-related family, member 2	chr21q22.12	chr21:34664574-34665306 (+)	6811 ; ion transport ; inferred from electronic annotation ; 6813 ; potassium ion transport ; traceable author statement ; 6936 ; muscle contraction ; traceable author statement ; 8016 ; regulation of heart contraction rate ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation ; 6813 ; potassium ion transport ; inferred from electronic annotation ; 8015 ; circulation ; non-traceable author statement	5249 ; voltage-gated potassium channel activity ; traceable author statement ; 30955 ; potassium ion binding ; inferred from electronic annotation ; 5216 ; ion channel activity ; inferred from electronic annotation ; 5244 ; voltage-gated ion channel activity ; inferred from electronic annotation ; 5249 ; voltage-gated potassium channel activity ; inferred from electronic annotation
207033_at	GIF	NM_005142	0.05	8.90E-03	gastric intrinsic factor (vitamin B synthesis)	chr11q13	chr11:59353323-59369534 (-)	6811 ; ion transport ; inferred from electronic annotation ; 6824 ; cobalt ion transport ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation	5488 ; binding ; inferred from electronic annotation ; 15087 ; cobalt ion transporter activity ; inferred from electronic annotation ; 50897 ; cobalt ion binding ; inferred from electronic annotation ; 5488 ; binding ; not recorded
